Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AC135068.1		ENSG00000278263	"Novel protein, identical to IGHV4-4"		15	21742364-21742799	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 52.2;lymphoid tissue: 57.9;urinary bladder: 97.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	30	"memory B-cell: 24.0;naive B-cell: 7.7"	"Lineage enriched"	"Detected in single"	45	"B-cells: 24.0"	"Not detected"	"Not detected"																	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"						"unprognostic (1.48e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.93e-1)"			"prognostic favorable (2.52e-4)"		"unprognostic (1.05e-1)"		"unprognostic (9.75e-3)"	"unprognostic (1.80e-2)"		"unprognostic (5.51e-6)"	"unprognostic (5.57e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.22e-1)"	1.0	0.0	0.2	27.3	0.1	4.2	5.4	0.0	0.0	3.7	0.0	52.2	22.6	0.2	0.0	3.7	0.5	0.5	2.1	0.1	0.0	0.2	1.0	5.5	5.5	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.4	22.1	0.0	30.1	2.1	0.0	1.1	6.0	0.0	0.0	9.4	22.3	0.1	0.0	7.8	0.7	0.0	57.9	97.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.2	0.0	0.0	7.7	0.3	0.0	0.0	0.0	0.0	0.0	0.5	1.9	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC136616.2		ENSG00000277761			Unmapped	1167457-1257196	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 79.1;lymphoid tissue: 57.0;salivary gland: 52.2;stomach 1: 71.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	99	"memory B-cell: 21.7;naive B-cell: 6.8"	"Lineage enriched"	"Detected in single"	150	"B-cells: 21.7"	"Not detected"	"Not detected"																	NA	NA			"Cluster 19: B-cells - Humoral immune response"																								0.4	43.0	0.2	31.0	0.2	8.5	25.5	0.0	0.9	1.7	0.3	79.1	36.1	0.5	8.8	1.7	1.9	7.1	0.6	0.0	0.1	0.4	2.3	11.7	6.1	0.4	0.2	22.9	2.7	0.1		0.0	0.3	0.7	34.9	0.1	52.2	0.6	0.6	0.5	40.5	1.0	0.0	25.0	71.5	4.9	0.1	26.3	0.6	0.0	57.0	26.8		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	6.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.2	0.2	0.0	0.9	0.0	0.1	0.4	0.2	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACADM	"ACAD1, MCAD, MCADH"	ENSG00000117054	"Acyl-CoA dehydrogenase medium chain"	P11310	1	75724431-75787575	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 367.3;skeletal muscle: 380.0;tongue: 475.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 373.1;Distal tubular cells: 344.4;Hepatocytes: 261.2;Proximal tubular cells: 564.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 289.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006198, HPA026542"	Enhanced		Enhanced	Mitochondria		NA	NA		930000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA006198: AB_1078087, HPA026542: AB_1844469"	"unprognostic (9.04e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.09e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.68e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.35e-1)"	"prognostic favorable (3.83e-8)"	"unprognostic (1.27e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.24e-1)"	81.9	82.2	25.2	24.3	25.0	17.3	69.9	26.6	42.2	29.3	30.4	46.8	103.9	20.0	25.3	51.3	30.6	27.8	217.8	24.3	25.9	295.9	367.3	22.6	42.6	26.9	26.8	35.7	35.9	66.3	19.2	16.9	25.8	26.8	49.5	21.2	31.4	26.2	380.0	14.4	75.6	25.5	26.2	27.4	52.8	35.7	25.8	29.7	38.4	475.9	44.3	32.7	21.3	25.2	25.8	20.5	61.0	26.8	53.1	42.1	17.5	48.1	40.4	46.1	38.5	38.3	39.5	289.1	40.7	34.4	39.0	22.8	54.9	41.8	57.8	113.0	25.5	94.4	58.5	58.3	36.4	80.0	23.9	50.7	23.5	39.8	22.8	35.0	36.2	56.6	102.3	60.4	50.5	9.6	96.3	40.6	50.2	80.4	49.5	118.8	83.8	30.6	77.9	70.7	33.8	43.0	38.0	111.6	102.0	43.1	32.7	107.6	20.2	29.9	29.6	26.6	78.1	38.6	62.0	128.1	25.8	67.0	35.3	15.3	14.2	19.3	17.1	20.9	27.3	40.7	17.8	21.5	21.4	24.6	20.3	23.6	0.5	25.0	20.4	23.2	19.5	19.5	25.2	25.0	26.6	42.2	24.3	25.9	26.9	26.8	25.8	26.2	25.8	25.2	42.9	57.7	58.3	29.7	56.5	27.3	41.8	69.0	44.3	39.0	49.0	40.9	373.1	52.9	63.0	58.8	25.0	35.8	39.4	42.6	344.4	37.9	55.4	27.1	32.2	36.2	40.7	67.6	51.6	26.5	19.5	47.6	26.0	25.4	44.9	61.5	43.9	261.2	75.7	30.3	46.7	38.7	63.1	45.6	22.2	24.4	46.9	38.2	51.6	19.7	32.8	53.7	29.9	36.2	36.0	21.2	49.7	45.5	74.9	24.2	88.0	564.8	106.7	30.0	0.0	38.6	43.7	76.3	86.1	46.6	27.0	15.3	39.4	72.5	46.7	35.9
ACP5	"HPAP, TRAP"	ENSG00000102575	"Acid phosphatase 5, tartrate resistant"	P13686	19	11574660-11579008	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 174.1"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 426.9;Hofbauer cells: 426.7;Macrophages: 298.2;Proximal tubular cells: 145.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 200.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 41.1;K-562: 30.4;RPMI-8226: 41.4;SK-MEL-30: 127.6;U-138 MG: 102.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB002584, HPA057655, HPA059463"	Enhanced		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		4000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB002584: AB_564039, HPA057655: AB_2683490, HPA059463: AB_2684028"	"unprognostic (4.27e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.93e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.13e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.66e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	9.4	6.0	2.2	42.4	3.9	9.4	25.6	2.5	21.4	34.7	3.0	46.4	31.9	19.2	7.8	23.4	8.6	26.7	5.1	1.9	3.9	74.0	32.5	174.1	87.1	4.1	3.1	20.3	11.9	2.4	1.3	13.3	6.0	19.6	36.4	20.1	14.3	7.0	1.4	24.9	30.2	13.3	4.1	43.5	38.7	4.0	15.7	25.4	3.0	5.0	43.6	33.1	11.3	5.7	10.2	1.1	0.0	0.2	0.5	0.0	41.1	1.1	25.8	0.0	0.1	0.4	0.3	1.4	1.8	9.0	5.9	0.3	0.0	4.5	0.1	12.1	0.8	0.3	0.0	5.0	1.4	0.1	0.6	0.0	4.1	0.4	0.0	0.0	0.0	0.0	30.4	0.2	0.0	2.3	0.9	1.4	0.8	0.3	0.7	0.4	1.8	41.4	0.0	0.4	0.7	1.0	0.0	0.0	127.6	1.1	0.2	0.4	0.9	102.9	1.2	1.8	0.3	0.7	5.7	0.6	23.7	0.1	4.0	0.4	35.3	76.6	15.8	36.1	8.8	200.1	26.0	19.6	7.3	110.9	35.3	20.2	10.4	13.3	36.3	62.5	67.8	36.4	2.2	3.9	2.5	21.4	1.9	3.9	4.1	3.1	6.0	4.1	15.7	5.7	2.2	9.6	7.8	0.0	75.7	10.3	11.0	21.8	25.0	18.3	14.6	18.4	1.4	15.7	5.7	7.3	18.8	33.4	21.2	7.0	9.8	1.8	0.2	0.7	9.1	30.9	3.0	24.5	0.0	11.3	32.7	19.8	10.7	0.9	63.7	0.8	426.9	8.4	426.7	1.7	0.0	4.7	10.2	106.0	68.6	0.7	1.8	298.2	14.2	1.0	79.8	48.5	8.2	0.0	0.1	4.4	20.4	12.0	33.4	14.5	12.7	145.8	2.5	41.4	0.0	0.4	2.8	0.1	0.2	14.6	11.1	26.1	29.5	0.1	6.7	6.1
ADD1		ENSG00000087274	"Adducin 1"	P35611	4	2843857-2930076	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 402.4;Rod photoreceptor cells: 624.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009794, HPA035873, HPA035874"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA		360000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	Nucleoplasm	"CAB009794: AB_633663, HPA035873: AB_2674836, HPA035874: AB_2674837"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (3.94e-4)"	"unprognostic (5.22e-2)"	"prognostic favorable (1.29e-7)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-3)"	104.4	70.0	96.4	60.7	119.7	65.9	89.1	86.7	117.7	96.5	46.4	127.9	65.5	121.4	57.9	71.9	96.3	69.0	111.2	99.2	90.9	74.1	53.7	93.5	65.3	91.5	100.4	129.5	56.4	67.5	70.1	66.0	92.3	86.1	62.7	269.1	61.9	107.3	166.3	69.4	92.3	110.2	76.0	88.9	84.3	53.2	113.2	76.0	71.7	115.0	62.1	115.3	82.9	116.2	74.7	61.2	142.0	73.8	205.8	152.6	53.2	123.2	146.9	125.6	105.3	90.5	91.8	38.7	63.0	212.3	146.6	46.6	107.5	103.4	104.3	49.9	49.4	109.5	50.4	87.9	100.4	65.8	74.7	151.6	95.2	110.4	44.0	130.1	158.5	71.9	116.0	90.8	145.1	43.7	203.7	91.6	80.0	67.9	85.7	89.1	78.6	45.7	91.2	162.2	84.8	110.0	88.9	35.8	76.9	107.0	84.2	61.7	193.4	102.1	52.4	84.7	103.0	72.5	63.3	48.9	98.2	80.4	100.9	20.1	7.6	35.5	19.1	7.3	17.6	23.8	10.6	16.3	12.0	31.2	9.8	11.8	10.5	27.2	11.4	25.4	14.8	16.0	96.4	119.7	86.7	117.7	99.2	90.9	91.5	100.4	92.3	76.0	113.2	116.2	89.3	70.5	45.4	141.3	66.5	26.9	29.8	33.0	27.9	99.5	41.2	41.5	78.0	40.0	46.3	60.7	402.4	35.5	84.0	51.3	15.6	37.3	48.5	43.9	61.2	89.4	57.7	57.9	85.7	45.8	32.5	72.9	39.8	58.1	37.3	53.0	84.3	41.8	41.8	111.0	83.2	39.3	28.5	51.6	42.2	35.9	77.6	47.4	35.6	72.1	58.3	233.8	120.5	68.9	178.6	53.2	39.4	121.9	49.7	35.8	48.6	44.6	40.4	624.3	98.6	58.4	73.1	45.3	33.2	30.5	36.7	36.5	55.6	80.7	45.1	33.0
AICDA	"AID, ARP2, CDA2, HIGM2"	ENSG00000111732	"Activation induced cytidine deaminase"	Q9GZX7	12	8602170-8612867	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 15.4"	"Cell type enhanced"	"Detected in single"		"Proximal enterocytes: 2.6"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"memory B-cell: 1.9;naive B-cell: 3.8"	"Lineage enriched"	"Detected in single"	6	"B-cells: 3.8"	"Group enriched"	"Detected in some"	7	"Daudi: 142.5;U-698: 118.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (2.71e-2)"	"unprognostic (1.39e-2)"		"unprognostic (7.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.73e-3)"		"unprognostic (1.11e-1)"	"unprognostic (4.05e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.96e-2)"		"unprognostic (4.04e-6)"	"unprognostic (8.82e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.65e-1)"	0.2	0.1	0.4	3.7	0.3	0.6	0.0	1.2	0.6	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.5	0.3	0.3	0.1	0.0	0.1	0.2	15.4	0.2	0.3	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.1	0.2	0.3	0.0	1.4	0.3	0.8	0.0	0.0	0.7	0.2	0.2	0.3	0.4	0.2	0.0	12.0	0.1	0.1	0.6	0.1	0.0	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	142.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	5.3	0.2	0.1	0.0	2.0	19.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.5	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.1	1.3	0.1	0.1	0.6	0.1	0.4	0.5	0.1	0.0	0.1	118.4	0.0	0.3	0.1	0.5	0.2	0.1	0.1	0.1	0.0	1.9	0.1	0.0	0.1	3.8	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.2	0.4	0.3	1.2	0.6	0.3	0.1	0.2	0.3	0.3	0.0	0.3	0.6	0.2	0.0	0.6	0.0	0.9	0.3	0.6	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.6	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.6	0.2	0.0	0.7	0.0	0.8	0.1	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.1	0.3
AIM2	PYHIN4	ENSG00000163568	"Absent in melanoma 2"	O14862	1	159062484-159147096	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"	DNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.5;lymphoid tissue: 50.3"	"Group enriched"	"Detected in some"	4	"B-cells: 64.2;Early spermatids: 24.0;Late spermatids: 33.3;Plasma cells: 40.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 15.1"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"memory B-cell: 143.8;naive B-cell: 63.7"	"Lineage enriched"	"Detected in many"	7	"B-cells: 143.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 94.6;HDLM-2: 132.5;Karpas-707: 50.4;U-266/70: 41.7;U-266/84: 34.2;U-87 MG: 38.6"	"Low region specificity"	"Detected in many"							"HPA031365, HPA040309"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 57: B-cells - Immune response"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA031365: AB_10601332, HPA040309: AB_2676925"	"unprognostic (6.05e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.08e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.10e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.23e-12)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-3)"	1.2	0.6	0.9	21.6	0.6	1.2	0.9	0.9	0.9	0.6	8.1	2.4	1.8	0.4	0.3	1.6	0.4	2.3	0.3	0.8	0.6	0.5	1.7	1.7	50.3	1.3	0.9	0.2	0.4	0.0	9.8	0.9	1.1	0.9	2.2	0.4	1.3	0.1	0.3	0.6	15.5	0.8	0.8	24.9	3.2	2.5	0.8	4.1	0.7	1.0	49.4	14.0	0.5	0.7	15.8	0.0	0.9	0.0	0.0	12.5	0.0	0.0	1.6	1.1	1.0	0.0	0.0	94.6	0.1	0.0	0.1	0.1	0.0	0.0	1.0	132.5	0.0	3.3	0.1	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	50.4	0.0	0.0	0.0	0.3	0.9	0.0	0.4	0.0	0.0	8.9	0.0	8.3	8.6	0.0	0.2	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.1	17.9	0.3	41.7	34.2	0.8	38.6	3.4	6.7	20.7	8.2	0.0	2.0	7.0	5.4	143.8	5.3	3.5	4.2	63.7	0.5	1.3	16.3	0.0	8.2	0.0	11.9	5.0	0.9	0.6	0.9	0.9	0.8	0.6	1.3	0.9	1.1	0.8	0.8	0.7	0.4	0.0	0.0	0.0	64.2	0.0	0.1	0.2	0.0	0.7	0.1	0.3	0.3	0.0	0.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	24.0	0.0	0.0	0.9	0.0	0.4	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.4	0.0	0.0	3.2	1.9	33.3	0.3	3.2	3.6	0.0	4.0	0.3	0.0	0.5	0.0	0.1	0.1	0.7	40.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	1.7	0.4	1.4	0.0	0.0	10.0	0.0	0.0	0.4
AK8	"C9orf98, FLJ32704"	ENSG00000165695	"Adenylate kinase 8"	Q96MA6	9	132725578-132878777	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 19.3;fallopian tube: 25.8;testis: 15.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 102.3;Endometrial ciliated cells: 26.1;Late spermatids: 134.1;monocytes: 49.2;Respiratory ciliated cells: 36.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	30	"memory B-cell: 6.2;naive B-cell: 4.9;NK-cell: 3.1"	"Group enriched"	"Detected in many"	30	"B-cells: 6.2;NK-cells: 3.1"	"Cell line enhanced"	"Detected in some"		"MCF7: 3.1;RPTEC TERT1: 3.6;T-47d: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021443, HPA023894"	Enhanced					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 3: Monocytes - Immune response regulation"			"HPA021443: AB_1845852, HPA023894: AB_1845854"	"unprognostic (4.14e-2)"	"unprognostic (1.20e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (9.89e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.43e-1)"	0.7	1.2	2.2	0.5	2.5	0.1	1.0	1.7	2.3	2.5	5.6	0.5	0.0	1.3	19.3	0.9	25.8	1.3	0.2	2.5	3.1	2.3	0.1	2.1	0.6	4.2	6.8	1.6	0.7	3.1	1.8	0.4	4.5	0.9	0.3	2.7	1.7	2.7	0.0	1.6	0.1	0.7	3.7	0.1	0.8	15.9	3.3	1.5	4.7	0.2	4.3	0.5	0.5	2.5	1.1	0.7	0.3	1.6	0.2	0.4	0.3	0.1	0.1	0.1	0.0	0.3	1.2	0.0	0.3	0.2	0.3	0.2	0.3	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.7	0.0	0.0	1.0	0.5	0.3	0.4	0.4	0.0	0.8	0.0	0.0	0.3	3.1	0.7	0.3	0.1	0.4	0.5	0.0	0.0	0.0	3.6	0.0	0.6	0.6	1.5	0.0	0.2	0.3	2.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	4.9	0.1	0.0	0.0	3.1	0.0	0.0	0.0	0.1	2.2	2.5	1.7	2.3	2.5	3.1	4.2	6.8	4.5	3.7	3.3	2.5	0.2	3.2	1.7	9.4	1.5	0.5	0.5	3.9	0.6	0.3	0.8	0.5	1.2	0.0	3.4	3.7	0.0	0.4	0.1	0.3	0.0	2.8	102.3	26.1	1.1	1.1	0.0	0.4	4.9	0.5	0.3	0.8	0.0	1.3	0.0	0.4	0.7	0.0	1.7	0.0	5.1	0.9	2.0	0.3	0.3	134.1	6.2	1.8	1.8	0.0	49.2	0.8	0.0	4.5	5.0	1.2	0.3	4.1	0.0	0.6	0.0	6.0	36.7	1.8	0.0	0.8	2.7	24.3	5.6	0.4	1.6	0.4	0.2	1.0	0.5	0.7
ANKAR	FLJ25415	ENSG00000151687	"Ankyrin and armadillo repeat containing"	Q7Z5J8	2	189674290-189761193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 5.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 82.9;Early spermatids: 88.8;Inhibitory neurons: 60.6;Oligodendrocyte precursor cells: 87.0;Oligodendrocytes: 80.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036168	Uncertain		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Centriolar satellite"	Nucleoplasm	"HPA036168: AB_10673345"	"unprognostic (2.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.34e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-2)"	0.2	0.4	0.2	0.2	0.3	0.2	0.4	1.0	0.3	0.2	1.4	0.2	0.2	0.4	0.6	0.2	0.3	0.3	0.1	0.2	0.3	0.2	0.4	0.3	0.5	0.3	0.3	0.3	0.5	0.6	0.1	0.3	0.3	0.5	0.4	0.6	0.5	0.2	0.1	0.3	0.3	0.2	0.2	0.4	0.5	5.8	0.3	0.1	0.5	0.0	0.3	0.2	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.4	0.6	0.1	0.2	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.0	0.3	0.2	0.3	0.3	0.3	0.3	0.2	0.3	0.6	10.5	3.2	8.2	82.9	13.4	1.3	7.2	2.5	5.2	12.6	4.1	3.8	4.7	4.3	2.8	11.0	14.6	1.2	8.1	3.3	1.9	3.3	88.8	2.8	8.4	8.9	0.0	10.1	46.0	4.3	1.1	9.7	13.3	2.8	0.0	8.4	7.1	2.4	2.4	3.3	60.6	5.7	2.0	1.9	4.9	46.1	21.8	5.6	7.2	47.8	3.4	6.1	13.4	87.0	80.5	4.5	5.6	13.9	5.1	4.1	4.8	2.7	1.5	46.2	6.6	15.8	8.4	20.3	11.1	5.2	1.3	0.1	9.6	4.8	4.2	4.1
ANKRD37	Lrp2bp	ENSG00000186352	"Ankyrin repeat domain 37"	Q7Z713	4	185396021-185400628	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 93.7"	"Cell type enhanced"	"Detected in all"		"Club cells: 257.6;Endometrial ciliated cells: 271.9;Respiratory ciliated cells: 263.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036626, HPA058127"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	Mitochondria	"HPA036626: AB_10671963, HPA058127: AB_2683614"	"unprognostic (9.08e-2)"	"unprognostic (2.85e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.36e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.08e-1)"	16.9	10.3	30.7	4.3	31.7	3.3	13.4	32.2	58.7	36.6	45.2	11.2	7.8	6.1	3.7	69.5	11.7	6.7	27.4	31.5	31.9	14.3	26.2	9.9	4.1	33.7	32.9	29.1	17.5	1.4	21.8	15.1	32.1	35.2	9.5	93.7	31.2	5.7	30.2	14.9	6.4	4.4	33.9	7.1	9.0	11.2	34.7	5.1	23.9	13.3	7.5	10.8	29.6	32.4	12.6	1.6	1.1	5.4	7.4	4.5	4.9	4.8	3.7	3.7	6.8	2.9	3.4	4.3	2.4	8.4	6.4	4.3	6.5	6.2	4.2	12.4	0.7	2.8	5.8	8.3	3.3	2.4	7.6	1.2	6.4	3.0	3.6	23.8	3.9	2.9	5.0	8.2	9.4	2.6	2.6	12.1	1.7	1.1	8.3	0.5	1.5	13.4	4.5	1.1	7.2	12.9	3.7	4.1	14.4	4.6	4.1	2.3	5.1	6.6	5.0	4.2	5.1	13.3	5.2	2.2	20.9	2.8	6.9	0.5	3.3	8.3	4.1	3.2	3.9	6.8	3.6	6.7	2.0	6.9	2.4	3.4	1.2	3.9	3.3	3.4	4.5	2.5	30.7	31.7	32.2	58.7	31.5	31.9	33.7	32.9	32.1	33.9	34.7	32.4	39.3	22.4	28.7	9.1	104.2	59.4	41.8	197.9	42.7	29.9	66.9	92.3	1.8	11.5	257.6	9.2	29.2	25.0	69.8	93.8	25.4	25.2	6.2	271.9	18.9	44.7	119.9	8.4	8.0	23.3	43.0	28.6	142.2	96.5	61.7	7.7	12.1	25.8	15.4	10.1	7.9	186.6	89.5	8.1	170.2	3.2	9.3	53.3	142.3	12.2	17.7	99.8	1.0	4.0	4.6	32.3	53.3	11.7	223.5	38.5	60.9	31.5	263.3	115.2	6.6	27.3	38.7	32.1	28.4	54.0	48.2	84.4	65.8	7.4	50.8	20.2
APOBEC3B	"FLJ21201, PHRBNL"	ENSG00000179750	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3B"	Q9UH17	22	38982347-38992804	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.4;intestine: 12.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 11.8;Ductal cells: 14.7;Erythroid cells: 14.1;Plasma cells: 26.2;Urothelial cells: 11.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 7.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 256.0;Karpas-707: 283.6"									"HPA056980, HPA066719"			Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA056980: AB_2683298, HPA066719: AB_2685711"	"unprognostic (2.92e-2)"	"prognostic favorable (2.58e-5)"	"unprognostic (4.29e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.36e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (8.47e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.04e-1)"	0.9	1.2	0.1	5.7	0.1	28.4	2.0	0.1	0.2	1.2	0.1	12.1	7.3	1.0	0.4	3.0	0.7	1.1	0.8	0.1	0.1	2.7	1.1	1.9	5.9	0.1	0.1	0.7	3.3	1.2	0.2	1.6	0.1	0.4	12.0	0.3	2.8	0.2	0.4	2.1	4.3	1.4	0.1	6.4	4.1	0.3	0.2	2.5	1.3	0.2	8.6	7.6	1.5	0.2	256.0	28.0	10.5	68.1	1.5	6.0	18.6	23.0	19.7	43.0	56.5	54.7	46.6	3.0	20.4	22.9	63.0	108.2	1.3	4.5	43.1	92.1	2.5	72.5	5.6	14.0	0.7	61.7	43.0	2.3	0.5	45.1	2.2	8.9	17.0	0.0	41.6	283.6	68.1	6.9	0.2	35.3	0.3	24.6	25.2	1.8	105.0	95.6	9.1	42.2	1.8	0.0	0.0	0.3	16.0	1.8	33.0	18.1	10.2	48.0	81.9	7.5	0.7	62.8	18.0	0.3	34.4	68.2	100.7	0.4	1.0	0.0	0.2	4.9	0.0	7.2	0.5	0.3	0.6	3.1	0.0	0.3	1.4	1.7	1.7	0.0	2.8	3.5	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.0	1.7	0.0	2.2	5.4	3.2	11.8	0.6	0.0	1.5	0.5	0.3	0.0	8.1	0.0	0.0	1.0	0.4	4.6	0.0	14.7	0.0	5.9	0.6	0.2	0.0	14.1	0.0	1.8	1.8	0.8	3.1	5.3	0.0	0.8	0.4	0.0	2.1	0.0	0.0	0.4	10.2	1.2	6.3	0.0	0.0	2.3	7.2	0.0	1.4	0.0	0.0	0.0	0.0	6.0	9.9	0.0	26.2	1.4	0.4	0.3	9.3	0.0	0.0	0.0	0.9	0.0	0.0	4.2	3.3	0.8	0.5	0.1	1.6	11.4
ARL4D	ARF4L	ENSG00000175906	"ADP ribosylation factor like GTPase 4D"	P49703	17	43398993-43401137	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 224.3;Early spermatids: 220.8;Rod photoreceptor cells: 259.6;Squamous epithelial cells: 223.4;Suprabasal keratinocytes: 254.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 32.3;naive B-cell: 36.1"	"Lineage enriched"	"Detected in all"	4	"B-cells: 36.1"	"Cell line enhanced"	"Detected in many"		"HHSteC: 57.1;hTCEpi: 76.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 8.7;cerebral cortex: 8.8;hippocampal formation: 5.7;olfactory bulb: 4.2;spinal cord: 5.4"	HPA060379	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Vesicles	"Golgi apparatus"	"HPA060379: AB_2684269"	"unprognostic (9.53e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.34e-2)"	"prognostic favorable (1.16e-5)"	"unprognostic (7.71e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (2.47e-1)"	"unprognostic (4.59e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.49e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (9.25e-4)"	21.0	4.3	7.9	2.2	8.7	0.9	7.2	9.1	11.6	29.3	12.6	27.9	2.0	20.2	4.7	82.2	22.1	7.3	12.7	8.1	7.1	30.5	56.4	16.2	1.6	5.6	5.7	9.7	2.2	8.1	21.6	7.7	5.7	11.0	3.5	85.1	16.9	15.2	1.9	44.9	6.0	14.8	5.4	16.7	7.6	32.1	5.7	1.6	38.3	3.4	3.0	28.5	39.5	9.3	8.7	10.9	6.7	5.2	12.5	17.2	3.1	21.0	21.5	14.6	18.8	9.7	37.7	0.1	10.3	22.6	10.0	23.4	4.5	32.0	10.0	1.9	7.5	0.7	8.7	22.5	57.1	2.4	2.1	19.2	76.1	21.3	45.8	13.2	6.3	2.3	1.4	0.4	14.3	0.5	5.4	5.0	7.1	0.8	10.1	9.1	1.5	1.0	24.9	18.8	7.9	5.6	16.5	0.4	15.8	14.4	30.6	8.5	1.3	21.0	6.7	27.2	6.4	2.1	1.1	0.0	25.8	1.9	7.1	0.1	2.8	2.1	5.1	4.3	3.2	32.3	4.2	4.7	8.4	36.1	4.6	5.2	0.0	2.1	1.4	2.5	1.0	4.6	7.9	8.7	9.1	11.6	8.1	7.1	5.6	5.7	5.7	5.4	5.7	9.3	28.8	0.0	1.7	0.7	37.9	224.3	41.4	142.2	132.1	155.5	35.3	60.6	12.7	5.7	49.5	132.4	116.7	39.9	37.4	1.5	76.3	2.3	220.8	55.5	33.3	32.2	11.9	4.0	9.1	1.8	24.1	52.3	5.6	69.6	0.0	20.7	22.9	29.7	8.1	16.8	9.3	5.4	26.4	4.1	77.9	55.3	15.8	16.6	26.6	1.0	1.4	70.1	2.1	2.5	1.3	3.7	0.9	22.6	1.4	9.5	0.3	17.6	7.6	259.6	13.1	11.1	45.1	25.0	9.2	223.4	254.6	105.5	31.7	19.3	4.6	78.1
BAG2		ENSG00000112208	"BAG cochaperone 2"	O95816	6	57172326-57189833	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 73.3;Early spermatids: 152.3;Spermatocytes: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018862, HPA019918"	Enhanced		Supported	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol	"Intermediate filaments"	"HPA018862: AB_2669957, HPA019918: AB_2670317"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.32e-3)"	"prognostic unfavorable (6.72e-6)"	"unprognostic (1.10e-1)"	"unprognostic (7.79e-5)"	"unprognostic (6.20e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.56e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.97e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (6.24e-3)"	3.7	4.4	2.5	6.6	2.7	1.5	1.7	2.8	4.0	11.4	3.0	32.6	2.1	25.1	3.9	7.2	9.1	7.3	9.1	2.5	2.7	2.8	4.1	5.0	2.7	2.3	2.7	8.5	1.6	0.4	2.0	7.6	2.4	11.2	4.5	4.9	1.0	15.9	9.2	1.3	6.5	29.0	2.3	1.1	7.8	6.4	2.6	1.3	4.6	6.5	2.1	22.5	5.9	3.0	17.2	9.3	3.9	13.8	9.4	26.9	10.9	27.2	25.8	19.2	18.2	12.1	8.6	5.7	25.3	43.2	15.7	3.1	22.5	2.4	18.3	18.3	16.4	16.7	13.3	27.5	14.5	14.8	3.7	13.1	1.2	15.8	14.6	11.4	15.2	13.0	34.1	7.9	19.1	1.3	10.5	12.4	14.8	0.3	9.6	9.5	10.9	11.4	23.2	2.8	4.9	4.4	12.2	0.9	10.1	17.8	2.1	12.7	20.8	10.9	17.9	23.2	27.4	5.3	5.5	12.5	9.7	5.8	1.0	0.1	0.2	0.5	1.9	0.2	2.2	3.5	1.7	1.9	0.9	3.0	3.4	2.9	0.1	2.1	0.0	0.3	2.0	1.1	2.5	2.7	2.8	4.0	2.5	2.7	2.3	2.7	2.4	2.3	2.6	3.0	2.4	3.2	3.7	4.6	16.7	2.4	4.6	5.0	1.8	6.9	4.1	2.7	40.0	0.0	3.8	3.7	12.5	73.3	8.0	0.6	1.9	11.6	152.3	11.0	35.5	3.1	1.8	12.2	8.1	3.7	18.2	46.2	3.1	4.2	4.5	25.6	2.2	15.8	15.8	10.1	10.0	0.3	14.2	2.6	6.6	35.9	31.1	5.1	7.2	5.6	9.1	8.2	3.1	10.6	10.6	5.4	1.3	38.7	13.0	6.2	0.4	33.9	9.1	16.9	6.6	32.1	31.0	93.5	9.8	1.3	3.8	18.9	12.2	30.6	1.3	2.1
BANK1	"BANK, FLJ20706"	ENSG00000153064	"B cell scaffold protein with ankyrin repeats 1"	Q8NDB2	4	101411286-102074812	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"B-cell activation"		"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 24.2;lymphoid tissue: 96.4"	"Cell type enriched"	"Detected in many"	10	"B-cells: 455.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	14	"memory B-cell: 310.4;naive B-cell: 253.0"	"Lineage enriched"	"Detected in many"	16	"B-cells: 310.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 13.6;HEL: 10.6;HL-60: 9.6;U-266/70: 31.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA037002	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		19000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA037002: AB_10672383"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.75e-1)"	8.5	3.6	0.6	35.1	0.6	6.2	2.2	1.5	0.9	2.3	0.2	2.8	2.4	0.8	3.2	0.8	2.3	3.0	0.7	0.5	0.7	3.2	0.3	8.1	82.2	0.8	0.8	0.1	0.5	0.4	1.5	0.8	0.9	5.8	3.3	0.2	2.4	4.7	0.1	0.7	24.2	1.0	0.9	56.1	7.4	3.0	1.0	9.7	12.9	0.2	96.4	7.6	0.7	0.6	0.0	3.0	0.0	0.0	3.4	1.4	0.1	0.1	0.1	0.4	0.6	0.1	4.6	13.6	1.2	0.0	0.0	0.2	0.1	1.5	0.4	0.0	0.0	10.6	2.6	0.0	0.1	9.6	0.0	0.6	0.4	0.0	0.0	1.2	0.1	0.0	0.1	4.0	0.6	0.5	0.0	0.6	0.0	0.4	5.7	0.2	0.6	0.0	0.4	6.1	2.6	0.0	0.3	0.2	0.0	0.1	0.5	2.5	1.3	0.0	0.6	0.0	0.0	31.0	0.0	2.2	0.1	5.3	0.0	10.8	1.7	19.7	0.4	0.5	0.1	310.4	0.1	0.2	10.5	253.0	0.1	0.1	0.9	1.5	0.2	5.2	0.2	11.3	0.6	0.6	1.5	0.9	0.5	0.7	0.8	0.8	0.9	0.9	1.0	0.6	3.5	44.8	27.1	6.8	455.9	0.1	2.2	0.5	0.0	0.2	1.7	0.4	0.5	0.0	10.0	3.7	0.0	2.1	5.8	0.0	0.0	0.2	2.8	13.1	1.0	1.3	0.0	6.1	7.3	0.2	0.6	1.4	6.1	15.2	1.3	0.1	0.0	0.1	1.5	0.0	1.6	0.4	2.0	2.9	25.1	2.0	0.0	13.0	5.4	4.7	2.8	1.8	1.0	1.0	1.3	4.1	1.3	0.4	13.7	4.4	0.2	4.2	2.2	0.1	0.0	0.1	0.8	1.9	5.6	0.8	1.1	0.3	12.9	2.1	1.1	4.3
BCAR3	"AND-34, NSP2, SH2D3B"	ENSG00000137936	"BCAR3 adaptor protein, NSP family member"	O75815	1	93561741-93847150	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 72.5;Basal prostatic cells: 149.0;Extravillous trophoblasts: 75.0;Urothelial cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.0;memory B-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 159.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014858	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"	Centrosome	"HPA014858: AB_1845302"	"unprognostic (9.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.60e-3)"	"prognostic unfavorable (8.41e-4)"	"prognostic unfavorable (5.42e-4)"	"prognostic unfavorable (8.92e-7)"	"unprognostic (2.44e-1)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.51e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (2.13e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.87e-1)"	31.0	10.6	17.7	6.6	20.9	1.0	18.5	19.3	15.3	10.0	21.1	15.3	13.4	5.7	3.6	8.1	9.5	7.5	13.1	14.8	18.7	15.9	11.9	14.2	13.8	21.1	20.6	11.4	4.2	4.0	4.6	17.0	18.9	8.9	16.6	1.5	21.9	9.5	24.4	15.6	12.9	8.0	19.0	4.8	16.2	6.3	21.7	4.3	10.4	21.1	13.0	13.6	9.8	17.8	56.0	23.4	43.5	3.4	18.4	14.4	37.1	56.9	98.3	45.9	28.1	4.0	40.9	9.0	18.9	88.1	59.4	34.0	1.3	73.5	39.7	4.0	1.3	0.0	16.2	10.3	33.1	0.4	0.2	17.3	79.5	47.5	159.7	44.1	51.1	1.1	1.6	0.3	125.7	8.6	1.0	0.2	13.6	24.5	79.7	3.7	62.7	1.3	120.4	70.1	1.5	3.6	27.4	29.1	36.1	16.8	32.9	2.2	60.8	67.3	17.5	29.2	76.0	4.5	2.1	1.2	10.1	0.2	25.2	2.0	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.0	0.3	1.6	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	17.7	20.9	19.3	15.3	14.8	18.7	21.1	20.6	18.9	19.0	21.7	17.8	26.9	3.2	7.2	72.5	10.2	9.8	149.0	11.3	2.8	0.9	7.9	13.5	7.1	11.5	11.7	14.7	0.0	27.5	2.5	30.8	27.4	11.3	11.3	13.3	2.6	17.9	14.9	0.4	5.2	6.3	75.0	6.3	15.8	16.6	3.8	33.7	5.7	10.3	11.9	21.9	11.2	20.7	8.2	5.3	12.7	12.8	10.2	8.3	19.6	64.6	9.4	4.0	0.0	3.0	2.1	28.0	22.0	1.2	8.9	36.3	25.8	23.7	18.1	0.4	72.3	23.8	19.9	4.2	3.7	4.8	10.2	18.9	3.7	8.3	10.3	106.1
BCAS4	"CNOL, FLJ20495"	ENSG00000124243	"Breast carcinoma amplified sequence 4"	Q8TDM0	20	50794894-50882676	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 71.6;B-cells: 76.0;granulocytes: 113.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 73.9;naive B-cell: 76.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 96.5;U-698: 88.7"					"Low region specificity"	"Detected in all"			HPA038812	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Intermediate filaments, Cytosol"		"HPA038812: AB_10795141"	"unprognostic (3.48e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.30e-2)"	1.6	1.2	7.6	7.7	8.2	2.2	3.0	4.8	14.9	5.0	7.2	3.7	1.0	4.1	4.1	2.7	2.8	2.0	1.8	15.4	6.0	5.8	0.8	2.1	21.3	4.8	5.6	2.0	2.0	4.8	4.0	2.2	5.3	6.0	0.7	2.3	2.8	4.0	1.0	1.2	7.6	1.8	3.3	9.4	3.5	3.6	6.4	11.7	4.3	0.8	23.1	5.3	2.8	6.8	12.3	21.8	1.7	9.3	3.3	8.7	3.7	15.8	14.2	11.1	7.8	10.4	7.3	96.5	5.8	6.7	22.3	18.2	10.8	22.9	6.3	6.2	9.4	0.4	8.3	8.7	4.7	0.1	0.5	2.8	13.0	8.5	4.2	13.7	0.6	7.5	0.3	0.6	4.0	42.9	3.7	0.3	7.6	1.8	17.6	30.5	2.9	0.9	5.1	11.0	9.5	9.9	24.5	23.2	0.5	8.1	45.9	1.1	0.5	11.8	17.3	12.1	3.9	1.4	7.4	88.7	4.9	0.7	1.1	2.2	0.3	0.2	15.3	0.2	8.7	73.9	9.4	19.0	0.2	76.1	32.2	25.4	1.4	20.0	0.2	18.8	8.9	13.3	7.6	8.2	4.8	14.9	15.4	6.0	4.8	5.6	5.3	3.3	6.4	6.8	1.2	22.4	71.6	6.5	76.0	2.0	27.5	28.9	2.2	6.2	12.6	8.3	17.7	4.3	35.3	9.2	2.1	29.1	16.1	0.3	41.1	11.8	4.0	6.0	6.4	23.7	33.6	5.2	11.5	3.1	4.8	26.6	3.1	7.7	113.5	9.4	2.2	0.4	3.2	8.4	14.3	3.7	44.7	1.3	2.8	1.1	1.5	6.2	5.4	0.0	1.9	10.6	21.6	8.5	0.8	8.9	0.1	3.0	6.1	15.0	0.7	5.2	40.0	6.6	6.6	4.9	35.7	3.2	11.0	1.2	2.4	10.9	35.7	1.5	1.1	25.5
BTN1A1	"BT, BTN, BTN1"	ENSG00000124557	"Butyrophilin subfamily 1 member A1"	Q13410	6	26501221-26510422	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	39	"breast: 32.5"	"Cell type enriched"	"Detected in some"	43	"Breast glandular cells: 111.9"	"Cancer enhanced"	"Detected in single"		"breast cancer: 0.6"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.1;naive B-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011126, CAB037340"	Supported				"Intracellular and membrane"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 5: Breast - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"			"CAB037340: , HPA011126: AB_1845491"	"unprognostic (4.07e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.77e-2)"		"unprognostic (5.50e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.35e-10)"	"unprognostic (4.62e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.31e-4)"	0.0	0.0	0.0	0.3	0.0	0.0	32.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	2.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	111.9	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0
BTNL9	"BTN8, FLJ32535"	ENSG00000165810	"Butyrophilin like 9"	Q6UXG8	5	181040225-181061521	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 250.8;breast: 200.0"	"Cell type enriched"	"Detected in many"	6	"Adipocytes: 900.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"OE19: 9.9;U-698: 37.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043429			Approved	"Nuclear membrane,Vesicles"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear membrane"	Vesicles	"HPA043429: AB_10961264"	"unprognostic (2.69e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.55e-9)"	"unprognostic (2.15e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.56e-2)"	250.8	13.3	18.3	3.0	13.1	1.0	200.0	14.9	24.2	12.7	11.2	11.7	1.9	11.0	5.4	5.9	20.0	9.3	104.5	20.6	13.1	22.4	7.9	102.3	7.1	21.9	14.6	5.3	11.9	5.9	4.8	10.5	21.8	8.3	3.6	1.2	6.9	2.6	46.6	11.8	10.8	4.0	12.7	57.3	12.8	4.4	32.2	9.8	29.6	20.7	13.8	10.5	10.4	12.7	0.0	0.2	0.1	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.4	0.1	0.2	1.4	0.0	0.0	0.2	0.7	0.1	0.0	0.2	3.7	1.5	0.4	0.2	0.0	0.7	4.2	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.9	0.3	0.0	0.1	0.1	0.2	0.1	9.9	2.3	0.0	0.1	0.1	0.1	0.6	0.2	0.1	0.2	0.1	0.0	0.2	0.6	0.0	0.0	0.1	5.5	0.1	0.0	0.3	0.1	37.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	18.3	13.1	14.9	24.2	20.6	13.1	21.9	14.6	21.8	12.7	32.2	12.7	900.4	0.0	3.8	1.3	9.8	2.3	0.6	0.1	0.6	0.6	2.4	3.6	40.6	0.0	0.8	0.0	0.0	0.1	3.9	1.0	3.9	0.0	0.7	1.1	0.5	127.0	4.2	0.4	8.4	0.2	0.1	10.2	0.5	3.4	1.3	7.0	144.9	0.6	0.1	0.0	1.2	3.5	0.0	8.3	1.1	1.4	2.1	1.7	3.6	54.4	0.1	0.3	0.0	1.0	0.6	0.1	1.2	0.4	1.2	0.4	0.0	0.1	2.4	0.3	13.1	8.4	37.5	4.0	9.8	5.5	2.3	0.1	2.2	88.9	1.5	0.5
CCDC24	MGC45441	ENSG00000159214	"Coiled-coil domain containing 24"	Q8N4L8	1	43991359-43996528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 36.4;Respiratory ciliated cells: 57.6;Spermatocytes: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 1.0;intermediate monocyte: 2.2;memory B-cell: 3.5;naive B-cell: 2.2;non-classical monocyte: 1.8"	"Group enriched"	"Detected in many"	5	"B-cells: 3.5;granulocytes: 1.0;monocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA035424, HPA061710"	Uncertain		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	"Nucleoli, Cytosol"	"HPA035424: AB_2674619, HPA061710: AB_2684591"	"prognostic favorable (3.06e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.65e-2)"	"prognostic favorable (3.18e-4)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.92e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.00e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.74e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.15e-3)"	1.6	4.8	11.8	1.3	11.9	0.4	3.3	11.3	15.9	5.9	12.3	3.8	1.9	3.2	1.9	2.1	11.2	3.1	1.3	11.8	12.0	11.8	3.6	2.9	1.4	11.6	11.8	2.4	5.6	6.2	12.9	1.0	11.7	7.2	2.1	6.6	4.4	5.0	0.8	1.1	2.4	1.3	11.8	2.4	3.8	19.1	12.3	0.9	9.1	0.2	1.0	4.1	2.4	11.5	4.7	2.8	1.2	1.4	1.2	0.8	2.7	0.2	1.9	1.4	2.4	1.8	13.4	3.8	5.0	0.5	4.0	4.7	0.7	6.5	1.3	3.9	1.6	1.9	1.7	0.5	1.3	0.6	3.2	0.3	0.6	4.5	0.4	4.3	1.1	1.4	0.8	1.4	2.0	4.0	0.2	1.4	2.7	4.2	2.2	1.3	0.0	0.7	5.5	1.8	2.9	2.6	4.0	2.3	2.6	2.5	6.7	0.1	0.3	2.1	5.9	1.5	0.7	0.5	1.8	0.8	5.3	0.5	1.7	0.0	0.4	1.0	0.3	2.2	0.2	3.5	0.1	0.1	0.4	2.2	0.0	0.0	0.4	0.3	1.8	0.3	0.0	0.2	11.8	11.9	11.3	15.9	11.8	12.0	11.6	11.8	11.7	11.8	12.3	11.5	1.7	3.2	7.2	17.0	2.3	1.1	7.9	26.5	9.1	8.9	13.3	12.1	1.0	12.8	22.0	9.2	6.2	5.6	0.9	11.3	21.5	9.4	20.7	30.9	2.4	2.1	36.4	1.3	17.7	7.2	2.2	2.5	21.9	6.9	2.5	1.6	2.5	2.6	3.3	3.3	10.0	13.6	14.2	2.0	2.2	11.7	2.1	3.6	3.6	1.9	2.7	10.2	0.0	5.0	2.4	6.5	8.3	3.0	1.8	5.7	6.3	11.5	57.6	15.4	0.0	2.9	3.8	50.6	19.9	3.9	0.9	2.5	1.3	3.9	10.2	11.4
CCR9	"CDw199, GPR-9-6, GPR28"	ENSG00000173585	"C-C motif chemokine receptor 9"	P51686	3	45886504-45903175	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"lymphoid tissue: 124.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 1.0;T-cells: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory B-cell: 24.0;naive B-cell: 15.6;T-reg: 8.1"	"Group enriched"	"Detected in many"	42	"B-cells: 24.0;T-cells: 8.1"	"Cell line enriched"	"Detected in some"	54	"MOLT-4: 112.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB006839	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"CAB006839: "	"unprognostic (3.08e-3)"	"unprognostic (3.37e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.65e-3)"	"unprognostic (7.88e-3)"	"unprognostic (4.54e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.34e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.20e-3)"	0.0	0.0	0.0	1.1	0.1	0.5	0.0	0.0	0.1	0.0	0.4	0.2	3.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	5.4	0.0	0.2	1.0	0.2	0.0	0.1	124.3	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	112.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	24.0	2.8	2.4	0.3	15.6	0.4	0.1	0.0	0.0	0.0	0.3	8.1	2.7	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1
CD40	"Bp50, p50, TNFRSF5"	ENSG00000101017	"CD40 molecule"	P25942	20	46118278-46129863	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 127.5;Basal respiratory cells: 126.0;Langerhans cells: 191.4;monocytes: 242.0;Prostatic glandular cells: 130.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 139.4;naive B-cell: 157.9"	"Group enriched"	"Detected in all"	6	"B-cells: 157.9;monocytes: 43.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 76.0;Daudi: 42.1;EFO-21: 131.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002495, HPA031567, HPA031568, CAB072868"	Enhanced				"Secreted to blood"	NA	NA	705000		"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"			"CAB002495: AB_563562, CAB072868: AB_2665719, HPA031567: AB_2673936, HPA031568: AB_2673937"	"unprognostic (6.41e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.08e-3)"	"unprognostic (6.21e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.25e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.15e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.04e-2)"	"prognostic unfavorable (4.48e-4)"	"unprognostic (1.22e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.28e-2)"	25.9	8.4	6.7	34.9	7.0	2.7	20.5	7.6	7.7	19.4	9.4	11.8	12.6	14.4	7.6	12.4	19.7	14.3	16.3	6.6	7.2	26.1	18.3	34.4	57.8	8.0	7.1	24.5	21.9	46.5	9.9	12.4	7.6	23.6	9.6	1.1	24.5	15.4	8.6	17.0	21.8	14.0	7.8	35.1	15.6	3.8	7.3	17.3	20.4	7.1	57.7	32.9	21.0	8.0	26.6	4.1	0.0	12.8	4.7	2.7	5.0	4.9	1.4	3.8	3.6	0.0	76.0	42.1	131.8	0.8	18.7	3.1	2.3	16.2	3.9	29.0	0.0	10.0	0.0	7.5	36.6	0.0	13.0	16.2	6.2	15.3	0.0	0.0	28.3	0.0	3.5	0.0	0.8	0.0	0.0	0.2	1.8	9.3	0.1	1.1	1.0	4.5	32.7	0.3	0.0	0.0	23.1	12.6	0.0	0.0	2.7	14.5	0.0	0.0	41.2	0.0	0.1	0.1	0.1	29.2	9.6	5.0	0.1	4.0	28.0	0.4	4.8	43.3	3.5	139.4	2.6	2.0	16.1	157.9	5.0	3.7	2.8	2.9	32.1	8.3	4.1	20.0	6.7	7.0	7.6	7.7	6.6	7.2	8.0	7.1	7.6	7.8	7.3	8.0	68.8	12.8	15.0	6.5	127.5	43.6	63.3	126.0	30.1	1.2	3.8	10.0	3.9	30.0	32.9	14.7	0.0	0.4	7.3	1.5	0.0	68.4	9.0	1.3	2.4	61.5	1.2	5.2	0.9	29.7	3.2	37.9	11.7	3.3	3.8	0.6	55.3	17.0	40.5	0.0	0.9	6.2	14.2	13.0	191.4	14.6	25.7	48.1	28.4	12.2	242.0	9.0	6.2	0.5	0.2	37.9	8.8	22.6	25.1	130.2	6.1	4.3	12.2	0.4	32.9	28.0	31.6	1.9	5.7	13.2	34.1	0.4	4.8	2.3	6.8	64.4
CHAD	SLRR4A	ENSG00000136457	Chondroadherin	O15335	17	50464496-50468906	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 36.2;pancreas: 32.6"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 4.6;Breast myoepithelial cells: 2.4;Distal enterocytes: 3.3;Gastric mucus-secreting cells: 4.6;Hepatocytes: 2.4;Intestinal goblet cells: 4.3;Oligodendrocyte precursor cells: 5.5;Paneth cells: 2.5;Proximal enterocytes: 2.6"	"Group enriched"	"Detected in many"	5	"breast cancer: 23.7;liver cancer: 10.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	53	"memory B-cell: 21.5;naive B-cell: 8.0"	"Lineage enriched"	"Detected in single"	76	"B-cells: 21.5"	"Cell line enhanced"	"Detected in some"		"RT4: 4.0;SCLC-21H: 8.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA018241	Enhanced				"Secreted to extracellular matrix"	NA	NA		22000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA018241: AB_1846612"	"prognostic favorable (7.68e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.92e-1)"	"unprognostic (3.06e-3)"	"prognostic favorable (1.59e-4)"	"unprognostic (1.51e-2)"	"unprognostic (4.75e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.41e-3)"	2.1	14.1	6.2	0.7	7.9	0.3	9.6	17.4	7.3	21.8	3.9	6.7	7.6	0.5	0.1	1.8	0.8	1.5	1.7	5.5	6.3	2.4	36.2	1.6	0.6	5.6	4.9	3.1	32.6	0.0	1.3	0.5	5.7	1.9	4.0	0.5	21.3	0.2	14.5	8.5	10.3	0.1	5.1	1.1	10.8	1.2	5.8	0.2	4.2	0.9	0.2	1.2	1.6	5.4	1.0	0.8	0.7	0.6	0.0	0.0	2.1	0.1	0.0	0.0	0.0	1.5	0.8	0.1	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.6	0.7	1.2	0.7	1.5	0.0	0.4	1.1	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.1	0.3	0.0	0.5	0.0	0.7	0.1	0.1	0.7	0.9	0.1	1.5	0.0	4.0	8.5	0.2	0.1	0.3	0.0	0.3	0.3	0.2	0.9	2.1	0.4	0.1	0.0	1.4	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.2	0.0	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	6.2	7.9	17.4	7.3	5.5	6.3	5.6	4.9	5.7	5.1	5.8	5.4	0.0	0.0	0.0	1.3	1.0	0.3	0.2	0.3	0.0	0.0	4.6	2.4	0.2	1.5	0.2	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	4.6	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.2	4.3	0.0	0.3	0.4	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	5.5	0.1	0.0	2.5	0.0	1.1	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.4
CHD8	"DUPLIN, HELSNF1, KIAA1564"	ENSG00000100888	"Chromodomain helicase DNA binding protein 8"	Q9HCK8	14	21385194-21456126	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Repressor"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052186, HPA076133"			Enhanced	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA052186: AB_2681754, HPA076133: "	"unprognostic (3.45e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (7.31e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.07e-3)"	12.5	11.9	11.2	13.5	12.5	35.3	14.8	16.3	13.2	12.4	10.5	14.0	9.4	14.8	11.1	14.9	12.9	10.1	12.0	11.1	12.2	11.7	9.6	13.7	18.0	11.4	11.6	17.1	13.6	22.3	13.1	11.7	11.1	13.2	12.3	14.8	13.6	12.1	15.7	22.3	14.7	14.8	11.5	15.8	14.2	12.9	12.5	25.4	14.8	12.7	17.5	12.8	12.9	13.6	31.2	39.6	43.6	20.7	27.7	23.6	24.9	24.4	28.4	36.5	35.4	35.0	26.3	51.4	14.8	33.1	28.4	37.2	54.9	35.1	46.0	39.3	24.2	46.3	27.6	43.5	25.7	64.6	40.4	32.8	27.2	40.9	29.7	28.6	33.4	40.2	32.4	26.7	28.0	33.9	46.1	26.0	33.4	30.9	34.3	42.0	32.9	17.4	27.3	57.9	30.9	30.7	37.5	29.8	21.8	39.7	20.7	30.5	36.4	29.2	23.0	17.8	29.1	30.3	38.4	50.3	12.1	23.2	29.6	9.1	3.8	9.8	5.5	3.8	6.4	4.2	4.9	5.6	2.7	11.2	5.0	4.4	7.9	7.8	6.7	6.1	4.7	2.7	11.2	12.5	16.3	13.2	11.1	12.2	11.4	11.6	11.1	11.5	12.5	13.6	27.6	38.5	56.3	27.4	32.2	12.6	11.3	15.9	23.3	33.3	21.9	22.6	19.6	24.3	32.6	33.1	27.1	14.7	40.0	16.8	1.9	21.8	3.4	32.5	37.9	25.5	27.1	27.8	41.0	23.6	12.3	24.0	27.5	39.5	28.4	41.7	13.9	14.9	17.5	23.5	40.2	16.0	8.2	20.1	9.3	4.1	16.1	25.3	10.6	20.6	27.1	18.9	32.0	29.7	33.1	26.5	13.9	17.7	32.4	16.1	12.0	7.4	28.8	24.3	0.0	32.1	26.2	29.2	25.1	24.6	16.6	12.3	31.4	34.1	16.8	12.7
CIPC	KIAA1737	ENSG00000198894	"CLOCK interacting pacemaker"	Q9C0C6	14	77098126-77117287	"Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 132.1"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000644			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA000644: AB_1079206"	"unprognostic (3.93e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.20e-1)"	"prognostic favorable (1.77e-10)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.21e-1)"	13.2	9.6	41.3	8.4	53.0	4.2	15.8	48.0	41.1	16.8	24.7	26.8	10.3	14.6	13.5	22.1	30.4	9.0	39.8	46.5	44.1	14.2	15.4	11.1	8.4	47.5	48.2	9.1	9.7	29.5	13.5	9.0	43.9	25.5	19.9	41.2	20.5	24.8	132.1	15.4	11.4	16.5	42.3	9.1	11.4	11.7	53.3	10.3	20.4	82.4	10.1	17.2	15.5	49.6	9.4	12.6	25.4	16.8	10.1	8.0	15.4	6.0	9.4	10.9	9.8	10.3	19.4	23.3	5.9	9.7	9.6	14.3	23.7	9.4	14.3	12.3	6.4	14.9	9.8	9.5	9.7	8.4	10.7	9.4	17.9	10.6	6.5	14.1	12.7	19.2	14.0	8.8	8.1	21.4	20.2	10.2	10.6	21.3	10.9	20.2	11.3	14.0	11.0	16.1	35.9	13.4	11.0	17.4	14.9	10.7	27.2	8.6	14.9	7.0	15.1	10.0	7.6	8.4	7.1	11.1	13.2	7.1	14.8	4.3	4.5	1.6	2.6	5.1	4.1	7.9	3.6	2.7	5.4	7.1	3.8	2.8	5.5	5.5	3.8	2.0	4.1	3.6	41.3	53.0	48.0	41.1	46.5	44.1	47.5	48.2	43.9	42.3	53.3	49.6	8.5	16.0	18.4	33.6	4.7	9.1	8.2	5.3	12.5	29.3	18.3	12.6	49.9	8.6	12.6	11.0	58.4	7.4	5.5	43.5	9.8	4.2	11.0	39.8	9.2	7.0	17.4	6.5	16.4	5.6	5.0	5.6	9.2	20.3	1.3	5.8	7.1	29.5	15.2	11.8	20.2	14.8	30.5	16.0	6.6	15.8	4.1	7.2	8.8	9.4	5.8	22.8	2.1	21.1	58.7	5.1	12.4	14.3	4.2	8.3	18.1	6.0	30.5	36.4	13.1	7.9	9.3	19.9	9.1	10.4	9.8	13.5	3.1	7.1	13.7	7.1
CLECL1	DCAL1	ENSG00000184293	"C-type lectin like 1"	Q8IZS7	12	9715860-9733299	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	5	"intestine: 9.9;lymphoid tissue: 31.1"	"Group enriched"	"Detected in some"	4	"B-cells: 87.0;dendritic cells: 24.0;Hofbauer cells: 22.2;Kupffer cells: 82.3;Langerhans cells: 64.6;Macrophages: 23.9;monocytes: 55.9;Plasma cells: 42.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 120.9"	"Lineage enriched"	"Detected in many"	5	"B-cells: 120.9"	"Group enriched"	"Detected in some"	5	"HEL: 49.7;Karpas-707: 66.2;U-698: 173.0;U-937: 95.6"					"Low region specificity"	"Detected in many"			HPA063928			Supported	"Plasma membrane,Centriolar satellite"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Centriolar satellite"		"HPA063928: "	"unprognostic (2.18e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.90e-3)"	"unprognostic (3.66e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.55e-4)"	"unprognostic (5.10e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-5)"	"unprognostic (3.31e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.10e-2)"	"unprognostic (7.39e-2)"	1.0	1.6	0.6	9.9	0.9	1.9	2.0	1.4	0.9	0.9	1.3	3.0	2.7	0.9	0.0	0.7	0.8	2.5	0.4	0.6	0.9	0.7	2.1	2.1	24.8	1.8	1.1	0.5	0.2	0.3	0.3	0.7	1.4	0.7	4.3	0.1	1.3	0.5	0.1	0.4	9.9	1.8	1.2	16.2	4.5	0.9	1.1	5.2	0.6	0.2	31.1	3.0	0.3	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.7	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.2	0.0	0.1	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.1	0.2	1.2	173.0	0.0	95.6	0.0	2.4	7.9	0.4	4.5	14.4	0.1	120.9	3.9	9.7	18.7	54.3	0.2	1.4	0.3	0.3	15.5	25.4	0.2	5.2	0.6	0.9	1.4	0.9	0.6	0.9	1.8	1.1	1.4	1.2	1.1	1.6	0.3	0.0	0.0	0.0	87.0	2.0	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.0	1.8	0.0	0.0	0.1	24.0	0.1	0.0	0.0	1.0	0.1	0.1	0.3	0.0	4.4	0.0	0.2	0.1	0.6	0.0	0.1	5.1	0.0	0.4	0.4	22.2	0.0	0.0	0.2	0.0	82.3	64.6	1.4	0.3	23.9	12.4	1.0	55.9	0.0	1.0	0.0	0.0	0.0	0.0	0.0	42.0	0.0	0.0	0.4	0.0	0.0	6.6	0.1	0.1	0.0	0.2	0.1	1.8	0.3	11.2	0.0	0.0	0.1
CNFN	PLAC8L2	ENSG00000105427	Cornifelin	Q9BYD5	19	42387019-42390297	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 952.0;esophagus: 3093.3;vagina: 1442.7"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 57.9;Breast myoepithelial cells: 51.6;Squamous epithelial cells: 71.8"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 367.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"memory B-cell: 61.2;naive B-cell: 70.2"	"Lineage enriched"	"Detected in many"	12	"B-cells: 70.2"	"Cell line enhanced"	"Detected in many"		"A549: 18.1;HEK 293: 25.7;MCF7: 12.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA049073, HPA053997"	Enhanced		Approved	"Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Microtubules	"Cytokinetic bridge"	"HPA049073: AB_2680620, HPA053997: AB_2682337"	"unprognostic (5.08e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.52e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.35e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.52e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.42e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.77e-3)"	"prognostic favorable (4.02e-5)"	"unprognostic (2.45e-1)"	4.3	5.3	1.8	0.4	4.2	0.6	12.9	1.9	2.2	952.0	1.3	3.2	0.4	1.5	7.3	3093.3	1.6	0.1	1.9	1.9	2.8	2.3	1.4	0.9	0.7	2.1	1.9	1.0	3.3	1.6	2.2	0.1	1.7	8.6	1.3	0.1	661.6	1.1	1.7	555.6	3.5	0.5	1.7	3.3	3.3	2.4	2.9	2.8	1.8	0.0	276.8	2.4	1442.7	1.6	6.0	18.1	0.4	1.6	0.8	0.9	0.2	1.0	0.3	0.4	0.4	1.0	1.6	5.1	8.0	0.2	1.2	2.4	1.5	2.3	0.1	0.0	25.7	0.4	6.9	1.9	0.0	0.0	0.1	1.8	4.0	1.0	0.0	0.1	0.0	4.7	1.1	0.2	0.0	12.6	0.1	0.1	6.6	8.1	5.4	2.2	0.3	2.9	1.6	2.3	2.7	7.7	3.4	5.1	2.5	2.7	6.2	2.6	0.0	0.0	5.3	0.2	0.1	5.8	7.6	3.6	0.1	2.2	0.3	0.1	4.6	0.1	1.7	3.9	0.4	61.2	1.3	1.2	5.9	70.2	0.6	0.9	1.3	0.0	0.9	1.3	0.1	2.2	1.8	4.2	1.9	2.2	1.9	2.8	2.1	1.9	1.7	1.7	2.9	1.6	32.7	3.2	2.2	0.0	24.6	4.6	16.8	28.5	14.8	0.1	57.9	51.6	0.8	2.8	20.2	33.1	0.0	0.2	2.1	24.5	7.9	13.1	1.5	20.6	3.9	9.3	32.5	3.6	0.1	2.5	0.3	2.3	4.6	23.9	4.5	7.2	3.9	0.7	5.7	0.0	0.2	33.4	14.2	3.8	7.7	3.9	5.3	6.3	3.6	0.0	6.4	0.3	7.2	0.0	0.1	2.4	39.4	4.5	0.5	11.5	43.8	12.3	10.5	0.1	0.0	0.9	8.0	0.4	17.4	71.8	12.9	0.3	1.3	1.1	41.8	27.0
CNKSR2	"CNK2, KIAA0902, KSR2"	ENSG00000149970	"Connector enhancer of kinase suppressor of Ras 2"	Q8WXI2	X	21372801-21654695	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 22.6;retina: 17.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.7;Excitatory neurons: 497.7;Inhibitory neurons: 143.6;Oligodendrocyte precursor cells: 93.5;Rod photoreceptor cells: 86.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.9;AF22: 4.0;NTERA-2: 8.9;PC-3: 4.8;RH-30: 8.2;U-251 MG: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001502			Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus, Plasma membrane"		"HPA001502: AB_1078542"	"unprognostic (1.33e-2)"	"unprognostic (1.00e-3)"	"unprognostic (5.35e-2)"	"unprognostic (4.90e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.40e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.13e-2)"	1.5	2.6	8.4	0.3	12.2	0.2	1.4	22.6	16.4	1.0	0.0	0.7	0.1	0.3	0.5	0.0	1.3	0.1	0.8	20.3	0.0	0.1	0.7	1.2	0.9	0.0	0.0	0.6	2.5	0.0	1.6	0.1	0.0	0.7	0.0	17.9	0.5	0.1	4.7	0.8	0.6	0.1	0.0	0.5	1.2	0.6	0.0	0.9	0.9	1.3	1.0	0.6	0.9	5.3	0.0	5.9	4.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	2.0	0.0	8.9	0.0	4.8	0.0	8.2	0.0	0.0	0.0	3.9	1.6	0.0	0.1	0.3	2.1	0.0	0.6	0.0	0.1	1.9	0.0	5.3	3.1	0.0	3.4	0.8	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.9	0.8	0.2	0.0	0.0	0.0	0.0	0.2	0.1	8.4	12.2	22.6	16.4	20.3	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.3	16.0	1.3	111.7	9.0	1.3	0.5	0.0	1.2	17.8	0.3	0.6	5.7	1.5	5.6	0.0	20.9	0.1	2.1	0.4	0.0	0.3	0.3	1.0	13.6	0.3	0.0	0.8	497.7	2.3	0.0	6.7	0.0	1.3	1.3	1.0	0.0	2.1	0.1	23.5	143.6	0.5	0.0	0.0	2.6	0.0	0.6	0.2	0.0	15.9	0.2	12.7	0.0	93.5	10.6	0.6	0.1	1.5	3.1	2.0	1.3	0.3	0.0	86.1	0.0	0.6	0.9	6.0	7.7	0.1	1.8	0.0	2.9	1.5	0.4	0.0
COBLL1	KIAA0977	ENSG00000082438	"Cordon-bleu WH2 repeat protein like 1"	Q53SF7	2	164653624-164843679	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 107.6"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 218.8;Cone photoreceptor cells: 250.2;Microglial cells: 351.3;Syncytiotrophoblasts: 331.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"memory B-cell: 15.0;naive B-cell: 9.4;plasmacytoid DC: 8.1"	"Group enriched"	"Detected in many"	13	"B-cells: 15.0;dendritic cells: 8.1"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 62.6;RPTEC TERT1: 63.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044933, HPA053344"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	"Cell Junctions"		"HPA044933: AB_2679148, HPA053344: AB_2682123"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (5.27e-13)"	"unprognostic (1.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.42e-1)"	35.1	51.4	9.5	7.4	8.5	4.1	13.8	6.4	9.2	10.1	28.7	8.0	10.7	4.6	15.6	32.6	4.8	12.3	7.2	6.6	7.1	68.8	107.6	18.2	12.8	8.9	7.9	12.5	43.7	10.9	5.0	50.9	9.4	27.4	7.8	56.8	17.9	28.0	3.3	16.9	7.8	7.4	6.8	9.9	30.0	2.0	12.8	4.8	18.4	7.2	16.2	22.6	16.4	6.3	10.7	2.2	5.9	0.0	7.1	1.3	11.9	34.0	13.3	4.7	5.6	8.9	4.3	1.0	6.9	3.2	5.0	38.4	26.2	21.3	5.6	2.9	10.7	10.5	9.5	36.3	10.2	0.0	0.0	1.8	19.8	1.0	27.6	5.8	21.1	1.3	0.0	62.6	7.5	12.5	0.3	0.1	2.9	25.9	12.8	1.3	22.4	10.4	63.1	36.0	14.4	5.8	16.1	14.7	4.6	11.4	10.7	0.0	9.5	11.3	9.7	3.8	8.3	24.3	10.0	3.6	4.7	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.8	0.0	8.1	0.0	0.4	9.5	8.5	6.4	9.2	6.6	7.1	8.9	7.9	9.4	6.8	12.8	6.3	56.4	70.5	66.5	7.5	102.5	97.3	54.3	14.5	30.7	21.6	22.4	22.4	9.3	30.0	26.0	218.8	250.2	52.1	40.8	11.3	62.6	25.5	0.1	24.6	12.2	47.1	22.2	22.5	23.7	33.8	71.3	35.0	53.5	19.5	34.1	9.0	6.1	127.9	8.7	3.3	30.9	11.0	24.4	3.9	9.0	1.3	14.6	3.7	19.6	351.3	0.7	144.5	0.0	5.0	1.6	29.8	4.9	7.9	154.8	46.0	12.6	28.6	12.4	190.2	46.0	8.6	71.2	0.6	2.7	69.0	70.3	331.4	8.3	8.0	10.0	75.6
COCH	"COCH-5B2, DFNA31, DFNA9"	ENSG00000100473	Cochlin	O43405	14	30874514-30895065	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Hearing		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"pancreas: 502.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 63.0;Horizontal cells: 84.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 71.3"	"Group enriched"	"Detected in some"	12	"memory B-cell: 38.3;naive B-cell: 17.7"	"Lineage enriched"	"Detected in many"	17	"B-cells: 38.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 95.7;Hep G2: 63.8;K-562: 129.1;NB-4: 105.5;SCLC-21H: 111.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 50.8"	HPA065086			Supported	Vesicles	"Secreted in other tissues"	NA	NA		160000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA065086: "	"unprognostic (8.36e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.91e-3)"	"unprognostic (5.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-1)"	3.2	3.7	7.3	2.8	71.3	4.0	3.4	1.4	20.9	17.4	19.0	3.2	0.8	0.6	2.2	0.9	6.2	2.9	1.9	5.6	8.0	5.2	0.5	0.6	11.0	2.9	7.9	0.8	502.0	3.4	10.1	1.9	3.7	48.3	2.2	12.1	3.6	73.4	1.3	15.2	2.6	1.1	6.2	2.6	1.7	5.2	12.5	1.3	1.3	5.0	7.7	2.0	23.0	1.7	0.0	35.3	3.1	0.0	0.6	0.1	21.8	0.2	0.0	6.4	17.1	20.9	1.2	0.4	1.7	0.0	1.3	0.1	22.2	0.0	10.6	0.0	95.7	18.1	7.6	63.8	0.0	1.8	7.3	1.3	0.0	0.6	0.0	0.0	0.3	39.9	129.1	5.1	1.6	0.8	9.2	105.5	11.9	0.1	3.7	26.7	0.0	0.9	1.1	3.4	111.8	30.4	2.6	0.6	0.2	12.1	0.0	48.7	0.9	0.0	0.0	0.3	0.1	5.7	15.8	11.2	0.0	0.0	4.7	0.0	0.6	0.0	0.0	0.0	0.0	38.3	0.3	0.0	0.1	17.7	0.0	0.1	0.2	0.0	0.0	0.0	2.2	1.0	7.3	71.3	1.4	20.9	5.6	8.0	2.9	7.9	3.7	6.2	12.5	1.7	2.0	0.0	0.5	3.6	13.4	19.1	2.3	0.3	0.0	2.7	7.9	1.5	0.8	2.8	0.9	0.0	4.2	6.5	1.3	0.6	1.9	0.5	1.5	2.2	0.8	3.1	17.0	7.4	14.3	63.0	14.3	22.0	1.1	1.0	1.3	1.8	5.0	5.0	3.8	84.1	24.2	0.3	6.1	5.0	25.2	2.0	1.5	2.4	19.6	7.5	2.8	14.5	0.0	6.0	16.5	3.7	4.3	6.0	10.0	3.5	0.2	11.7	0.5	4.0	0.0	2.8	9.0	22.1	20.3	0.1	13.5	6.6	3.3	0.1	0.6	1.7
CRACR2B	"EFCAB4A, MGC45840"	ENSG00000177685	"Calcium release activated channel regulator 2B"	Q8N4Y2	11	826144-831991	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 208.7;salivary gland: 223.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 180.4;Breast myoepithelial cells: 116.3;Gastric mucus-secreting cells: 178.9;Hepatic stellate cells: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 3.4;eosinophil: 3.7;memory B-cell: 3.9;naive B-cell: 3.0;NK-cell: 1.7"	"Group enriched"	"Detected in many"	6	"B-cells: 3.9;granulocytes: 3.7;NK-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"NB-4: 35.2;OE19: 29.6;SK-BR-3: 111.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046217	Approved					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"			"HPA046217: AB_10960833"	"unprognostic (8.87e-2)"	"unprognostic (4.89e-2)"	"prognostic unfavorable (1.81e-5)"	"unprognostic (4.47e-3)"	"unprognostic (8.20e-3)"	"unprognostic (5.27e-3)"	"unprognostic (7.31e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.61e-3)"	"unprognostic (3.49e-3)"	"unprognostic (9.25e-3)"	"unprognostic (5.28e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.03e-1)"	"unprognostic (3.65e-1)"	"unprognostic (5.15e-3)"	11.9	8.4	1.5	3.3	1.6	13.3	65.8	3.1	2.1	8.3	3.5	43.6	22.4	4.6	1.0	6.7	6.4	6.8	22.4	1.3	1.5	27.0	3.4	14.9	2.4	1.8	1.5	1.3	208.7	6.8	23.3	2.7	1.8	44.9	13.6	1.0	223.6	5.2	4.3	21.9	28.5	1.2	1.1	13.9	81.0	2.4	1.9	0.6	6.4	1.7	2.0	19.6	3.9	1.0	3.6	3.1	0.6	1.5	0.2	0.0	11.5	0.3	0.0	0.1	0.0	3.8	12.0	0.0	4.7	0.0	0.3	3.2	2.1	0.1	0.0	26.2	1.1	13.3	3.1	8.8	0.0	10.9	0.5	0.2	0.5	0.0	0.0	2.2	0.5	1.4	17.3	10.7	0.0	8.0	0.3	35.2	0.9	29.6	0.4	2.4	0.6	22.5	8.7	2.8	2.8	1.5	0.4	111.6	0.0	0.6	17.5	9.0	0.3	1.7	0.6	0.4	0.2	26.3	2.4	3.8	5.5	14.4	0.1	3.4	0.5	3.7	0.1	0.0	0.0	3.9	0.0	0.3	0.0	3.0	0.0	0.0	0.1	1.7	0.3	0.5	0.0	0.2	1.5	1.6	3.1	2.1	1.3	1.5	1.8	1.5	1.8	1.1	1.9	1.0	61.5	6.4	19.8	3.3	16.8	0.0	6.6	0.0	1.8	2.4	180.4	116.3	8.8	22.8	27.2	12.9	0.0	3.8	6.4	18.8	15.6	15.0	2.6	11.6	1.9	34.8	12.2	6.1	0.1	37.1	1.7	2.5	178.9	16.2	1.3	0.6	85.3	2.0	3.5	0.0	0.1	71.9	0.0	5.0	0.0	5.0	2.5	3.8	0.0	3.7	1.2	11.4	0.0	0.0	0.0	25.8	40.5	1.9	24.2	29.6	46.2	4.3	13.1	7.2	13.1	2.4	4.4	2.1	6.5	4.2	0.0	1.8	5.0	1.8	43.6	66.5
CTH		ENSG00000116761	"Cystathionine gamma-lyase"	P32929	1	70411218-70439851	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	"Calmodulin-binding, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 122.9;ovary: 34.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 38.0;Hepatocytes: 141.6"	"Group enriched"	"Detected in all"	5	"liver cancer: 30.0;testis cancer: 8.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 39.7;Karpas-707: 63.8;SK-MEL-30: 85.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021591, HPA023300"	Enhanced					NA	NA		220000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA021591: AB_1847321, HPA023300: AB_1847322"	"unprognostic (3.41e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.76e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.45e-3)"	"prognostic favorable (8.69e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.05e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.97e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.26e-1)"	4.3	12.9	3.4	1.3	3.1	3.4	2.9	3.3	4.0	2.5	4.5	5.1	5.2	2.2	1.6	4.5	3.8	1.8	2.4	3.3	3.6	13.5	122.9	3.1	0.9	3.4	3.7	34.4	17.0	1.4	2.9	1.1	3.4	4.3	6.2	8.1	2.5	2.1	3.6	1.2	5.3	1.3	2.7	1.0	7.4	4.1	3.7	0.6	7.7	2.9	1.3	2.2	1.9	3.2	10.2	1.5	7.1	10.0	8.5	4.8	15.0	4.3	4.1	3.8	15.7	3.2	6.4	5.8	3.4	3.1	9.3	4.9	27.3	3.1	7.2	17.3	5.9	7.0	5.1	9.4	39.7	7.8	1.7	7.5	24.4	7.5	8.8	1.5	3.2	11.9	14.0	63.8	2.2	3.2	2.7	1.9	7.2	4.2	5.9	3.0	3.7	16.2	7.3	0.1	3.9	3.3	6.6	7.7	85.7	13.3	2.6	4.6	1.1	1.2	7.7	5.7	4.1	23.8	15.3	3.1	9.8	16.1	3.1	0.8	0.3	0.1	1.2	0.2	2.1	2.2	1.1	1.7	0.5	1.7	3.2	1.5	0.4	0.2	0.2	0.7	0.3	0.6	3.4	3.1	3.3	4.0	3.3	3.6	3.4	3.7	3.4	2.7	3.7	3.2	2.8	6.4	5.6	16.6	6.7	2.5	8.0	2.2	6.2	9.4	6.2	5.8	1.9	5.7	2.5	5.5	10.4	0.8	5.5	16.1	11.7	1.8	27.2	38.0	6.4	3.3	3.0	7.4	7.8	4.2	1.8	13.6	14.8	19.7	0.0	1.9	3.9	141.6	1.2	0.0	7.4	7.9	2.0	3.5	5.7	5.2	1.2	4.7	19.6	1.9	0.0	4.4	0.0	7.1	4.2	6.4	12.9	4.1	10.8	4.0	11.1	29.2	0.7	11.6	0.0	2.8	17.7	1.4	0.6	4.8	2.0	0.8	11.2	4.5	9.1	3.8
CXXC5	"HSPC195, RINF, WID"	ENSG00000171604	"CXXC finger protein 5"	Q7LFL8	5	139647299-139683882	"Predicted intracellular proteins"	Transcription	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 317.0;Early spermatids: 714.2;Horizontal cells: 541.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"MAIT T-cell: 30.0;memory B-cell: 85.1;naive B-cell: 96.7;NK-cell: 71.9;plasmacytoid DC: 59.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 210.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036508, HPA058148"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA036508: AB_10673620, HPA058148: AB_2683621"	"unprognostic (3.08e-2)"	"unprognostic (9.03e-2)"	"prognostic favorable (2.40e-4)"	"prognostic unfavorable (4.10e-7)"	"unprognostic (2.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.63e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.57e-1)"	26.5	20.6	48.9	17.6	65.6	46.9	21.5	103.6	64.5	29.2	36.4	17.5	10.8	15.1	30.0	25.6	29.8	20.1	30.4	56.2	48.2	70.7	88.1	16.1	30.2	91.5	65.1	5.0	61.2	28.0	43.6	15.9	84.0	15.3	11.6	38.7	53.9	18.3	80.1	24.8	22.5	9.1	66.5	34.5	21.0	51.8	61.4	34.3	22.5	21.5	24.7	14.8	23.9	106.4	36.5	30.1	32.6	12.3	44.5	60.6	12.7	23.3	35.3	9.9	19.5	66.8	36.0	47.4	101.0	62.5	59.7	40.5	6.7	17.9	4.7	5.2	11.5	70.5	25.8	47.0	19.2	16.0	1.8	21.8	4.0	16.7	4.8	95.6	2.7	1.5	67.8	7.6	72.6	94.7	17.2	51.1	39.4	39.2	8.5	30.8	66.5	73.5	75.3	26.0	103.0	106.3	8.3	210.6	18.0	71.2	115.5	74.2	14.6	80.2	15.6	38.8	21.4	27.3	62.4	89.9	121.2	5.3	45.6	1.1	6.6	0.6	9.7	1.4	30.0	85.1	0.9	6.8	5.5	96.7	0.5	2.6	1.8	71.9	0.6	59.0	1.4	10.7	48.9	65.6	103.6	64.5	56.2	48.2	91.5	65.1	84.0	66.5	61.4	106.4	22.9	48.1	18.8	24.5	120.4	26.3	14.8	41.9	8.6	232.0	41.0	67.8	49.3	105.8	32.5	147.1	25.0	2.9	90.2	18.6	317.0	125.1	714.2	47.1	53.9	43.6	18.6	52.2	18.7	144.9	23.9	47.8	24.5	53.7	21.5	41.9	36.0	131.8	38.4	541.8	8.7	50.7	61.1	35.6	92.1	200.3	39.1	32.2	60.5	15.0	40.9	220.5	195.7	16.6	44.3	93.9	17.5	30.5	114.1	34.1	22.6	200.0	38.6	49.1	13.1	150.9	48.5	14.2	13.9	15.7	20.9	37.6	21.1	25.1	27.0	21.4
CYB5R2		ENSG00000166394	"Cytochrome b5 reductase 2"	Q6BCY4	11	7665100-7677222	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 139.2;testis: 133.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 268.0;Late spermatids: 601.1;Spermatocytes: 115.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"eosinophil: 6.1;memory B-cell: 10.6;naive B-cell: 2.8"	"Group enriched"	"Detected in many"	9	"B-cells: 10.6;granulocytes: 6.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 125.1;BJ hTERT+ SV40 Large T+: 65.9;BJ hTERT+ SV40 Large T+ RasG12V: 59.4;HBF TERT88: 52.0;NTERA-2: 69.8;WM-115: 96.3"	"Low region specificity"	"Detected in single"							"HPA038962, HPA061707"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA038962: AB_10675954, HPA061707: AB_2732668"	"unprognostic (1.47e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.41e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.60e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.01e-2)"	8.8	3.6	17.2	5.7	23.1	4.1	15.6	18.7	25.3	15.6	13.2	4.6	2.4	22.8	25.5	19.6	10.1	6.8	4.7	18.2	19.7	5.9	5.1	11.5	2.7	19.5	22.5	29.3	4.3	29.0	1.3	13.8	19.2	19.5	5.3	139.2	35.7	22.3	1.7	51.1	4.3	13.2	16.9	3.0	5.6	133.6	21.8	0.9	5.1	1.7	10.5	13.3	17.7	28.0	7.1	3.6	1.5	0.0	0.3	1.7	22.8	43.9	125.1	65.9	59.4	0.7	9.4	0.2	10.3	22.7	20.2	0.8	0.1	0.3	52.0	0.1	0.2	0.0	3.8	0.9	35.0	0.4	6.6	17.7	1.4	0.3	3.7	0.1	5.6	0.0	6.9	0.1	0.5	0.0	0.0	0.1	69.8	7.4	3.4	34.1	0.1	0.0	0.0	4.4	0.0	0.7	0.3	28.0	1.9	11.1	4.8	9.4	0.0	6.1	0.1	0.3	3.4	0.2	0.0	10.7	0.5	0.0	96.3	0.0	0.9	6.1	0.0	0.5	0.0	10.6	0.1	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.6	17.2	23.1	18.7	25.3	18.2	19.7	19.5	22.5	19.2	16.9	21.8	28.0	0.6	22.4	5.1	0.0	2.3	7.0	8.4	12.3	8.6	1.3	8.8	12.8	3.0	1.5	6.3	3.7	20.9	5.3	0.1	0.6	0.0	1.4	268.0	5.5	11.2	1.7	0.0	0.0	0.0	4.7	20.0	8.1	1.5	14.3	2.5	0.5	0.4	1.8	2.5	0.0	0.1	1.8	6.1	0.0	0.5	601.1	4.7	1.5	5.4	1.9	0.5	0.8	0.0	0.5	8.5	6.0	1.4	6.0	2.9	11.2	0.3	0.4	10.2	35.2	13.1	2.3	7.5	115.6	9.8	12.8	10.1	4.5	0.2	1.8	1.8	11.4
DCLK2	"DCAMKL2, DCDC3, DCDC3B, DCK2, MGC45428"	ENSG00000170390	"Doublecortin like kinase 2"	Q8N568	4	150078445-150257438	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.0"	"Group enriched"	"Detected in many"	6	"Astrocytes: 501.1;Excitatory neurons: 189.8;Inhibitory neurons: 173.2;Oligodendrocyte precursor cells: 172.4"	"Cancer enriched"	"Detected in many"	17	"glioma: 53.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 23.6;BJ: 11.8;BJ hTERT+: 24.9;fHDF/TERT166: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015770	Enhanced	Approved				NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA015770: AB_1847509"	"unprognostic (7.37e-2)"	"unprognostic (1.56e-3)"	"unprognostic (9.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.06e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.38e-3)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.25e-4)"	"prognostic favorable (2.48e-4)"	"unprognostic (6.87e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.74e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.45e-2)"	1.7	2.8	45.8	0.9	42.0	0.5	1.4	34.6	43.6	2.0	7.7	5.6	1.4	2.7	2.0	1.5	1.9	2.5	12.2	59.0	41.2	2.3	0.6	2.1	0.4	41.2	46.6	2.9	2.2	0.6	8.3	1.5	38.4	2.7	2.0	18.4	0.8	2.0	1.2	1.0	2.2	4.7	46.6	1.2	2.3	2.8	42.7	0.2	2.6	1.4	0.3	2.6	1.3	46.8	1.2	4.2	23.6	3.7	0.0	1.1	0.4	11.8	24.9	3.5	0.9	0.1	0.0	0.0	0.4	11.0	3.6	0.1	3.5	0.0	4.4	5.1	2.1	0.0	7.0	0.0	5.0	0.7	0.7	0.6	0.0	2.2	0.2	2.2	1.2	0.6	0.0	0.1	2.5	0.2	0.4	0.0	0.5	0.3	1.6	0.0	2.8	1.0	0.1	1.0	9.2	9.1	4.7	3.4	1.0	2.0	0.0	0.1	2.1	3.3	1.3	2.2	1.3	1.1	0.0	0.1	3.1	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	45.8	42.0	34.6	43.6	59.0	41.2	41.2	46.6	38.4	46.6	42.7	46.8	10.7	0.0	0.0	501.1	0.6	0.5	0.1	0.0	0.6	26.2	2.8	2.2	10.5	1.5	0.7	3.7	16.7	0.0	0.0	0.8	0.0	0.4	0.1	0.4	4.6	7.6	3.0	0.0	189.8	0.7	0.0	3.4	1.1	0.5	4.5	5.7	7.5	0.0	1.6	35.3	173.2	0.3	0.0	0.6	3.4	0.3	1.8	0.7	5.4	43.1	0.2	31.2	0.0	172.4	37.6	0.1	0.4	3.8	0.3	0.6	0.0	0.4	0.1	9.6	13.1	5.6	9.2	0.1	2.0	0.1	0.6	0.3	0.9	6.6	1.4	0.2
DEGS2	"C14orf66, DES2, FADS8"	ENSG00000168350	"Delta 4-desaturase, sphingolipid 2"	Q6QHC5	14	100143957-100159645	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.0;intestine: 34.8;skin 1: 54.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 82.8;Paneth cells: 77.0;Proximal enterocytes: 298.9;Respiratory ciliated cells: 144.8;Squamous epithelial cells: 86.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 3.5;eosinophil: 6.6;memory B-cell: 10.9;naive B-cell: 6.8"	"Group enriched"	"Detected in many"	5	"B-cells: 10.9;granulocytes: 6.6"	"Group enriched"	"Detected in some"	16	"OE19: 69.3;T-47d: 104.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046644			Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nucleoli"		"HPA046644: AB_2797231"	"unprognostic (8.18e-2)"	"unprognostic (3.83e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (7.94e-7)"	"unprognostic (1.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.66e-4)"	0.4	0.1	6.4	1.0	7.2	0.2	6.1	18.3	7.1	4.8	3.6	8.9	24.7	3.3	0.5	37.0	2.0	6.5	0.2	5.1	4.5	10.8	0.9	1.6	0.6	5.9	5.3	1.0	6.9	0.4	3.3	0.4	6.0	2.3	4.5	0.2	8.6	2.1	0.3	54.2	34.8	0.5	4.8	0.8	20.1	1.1	5.3	0.1	2.4	0.0	1.8	6.5	10.1	4.9	0.0	0.3	0.0	0.3	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.5	2.4	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.5	0.8	0.1	0.3	0.0	0.0	0.0	0.0	1.1	1.6	0.0	0.0	4.2	0.4	0.3	0.1	69.3	0.0	0.4	0.0	3.6	0.0	1.6	5.2	0.1	0.0	3.1	0.0	0.1	104.4	1.1	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.5	0.4	6.6	1.6	0.0	0.0	10.9	0.1	0.7	0.7	6.8	0.0	1.0	0.2	0.2	0.0	0.1	0.0	0.7	6.4	7.2	18.3	7.1	5.1	4.5	5.9	5.3	6.0	4.8	5.3	4.9	0.7	3.2	5.0	5.2	3.7	1.8	3.3	22.9	1.2	4.6	24.2	15.2	0.6	37.1	34.8	82.8	0.0	7.7	3.3	24.2	1.9	19.0	1.2	15.3	4.3	3.8	55.3	1.3	0.5	1.5	4.9	1.3	54.6	28.9	9.5	0.9	0.4	0.3	1.6	0.0	0.4	53.5	34.6	0.9	0.6	1.6	0.3	1.5	0.0	3.7	0.5	1.2	12.3	0.0	1.5	2.4	77.0	0.0	3.7	1.7	298.9	0.4	144.8	22.0	0.0	1.1	3.1	3.2	4.0	86.9	15.3	37.4	2.5	0.2	69.6	21.0
DENND5B	MGC24039	ENSG00000170456	"DENN domain containing 5B"	Q6ZUT9	12	31382226-31591136	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 152.8;Excitatory neurons: 217.3;Inhibitory neurons: 246.4;Oligodendrocyte precursor cells: 144.3;Oligodendrocytes: 121.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.4;naive B-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SuSa: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038865	Approved		Approved	Nucleoli,Microtubules		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Microtubules	Nucleoli	"HPA038865: AB_2676245"	"unprognostic (5.41e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.08e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.16e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.60e-2)"	4.0	6.4	6.3	5.4	7.8	2.1	3.2	20.1	12.3	4.8	2.9	4.2	9.2	6.9	2.0	2.4	3.9	4.2	10.9	6.1	8.4	7.6	12.5	2.6	7.3	7.7	5.2	21.7	5.7	2.7	4.7	4.9	7.7	2.9	4.3	15.9	2.0	3.1	7.1	1.3	10.4	7.2	2.0	6.7	5.0	16.1	7.1	2.4	2.9	13.1	8.4	3.7	3.1	6.1	2.8	27.9	20.1	7.7	7.1	8.8	3.0	6.8	7.4	16.9	12.1	18.9	11.1	10.4	11.1	14.8	18.5	0.8	4.0	1.9	16.7	0.0	8.5	0.1	21.2	11.3	6.5	9.6	0.2	5.5	6.0	11.3	18.5	15.5	15.7	5.7	4.0	20.6	10.6	2.6	5.7	10.0	20.4	6.5	4.9	5.4	27.8	0.2	14.2	3.6	6.4	9.5	17.0	1.9	15.0	57.3	2.8	5.2	16.5	6.3	16.0	11.4	14.4	10.9	13.0	10.5	10.7	1.1	10.7	0.1	0.1	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.2	1.6	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.1	6.3	7.8	20.1	12.3	6.1	8.4	7.7	5.2	7.7	2.0	7.1	6.1	6.7	3.2	0.5	152.8	43.9	2.9	3.5	0.9	2.8	42.4	5.3	4.1	44.0	17.2	2.1	7.3	31.3	0.6	7.0	13.3	3.9	1.8	19.6	6.1	10.1	7.4	8.4	6.3	217.3	9.3	2.9	13.0	4.6	4.4	0.0	45.0	25.0	34.2	4.5	28.6	246.4	3.1	2.0	4.5	5.8	8.3	8.4	3.8	23.2	74.9	2.5	12.9	1.0	144.3	121.0	7.9	3.6	10.5	72.6	2.4	33.2	12.0	2.2	26.8	6.6	12.9	10.0	32.0	18.2	0.2	1.4	0.7	2.3	15.5	4.4	1.2
DNAJC5B	"CSP-beta, MGC26226"	ENSG00000147570	"DnaJ heat shock protein family (Hsp40) member C5 beta"	Q9UF47	8	66021553-66101245	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 65.4"	"Group enriched"	"Detected in some"	71	"Early spermatids: 1010.5;Late spermatids: 2756.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 5.7"	"Lineage enriched"	"Detected in many"	5	"B-cells: 5.7"	"Group enriched"	"Detected in some"	5	"HDLM-2: 13.9;RPTEC TERT1: 20.4;THP-1: 12.9;U-266/70: 11.3;U-937: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (1.01e-1)"	"unprognostic (7.29e-3)"	"unprognostic (7.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.85e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.53e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.38e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.84e-2)"	0.3	0.0	0.1	3.0	0.1	0.4	0.6	0.0	0.7	0.3	0.1	1.1	1.1	0.2	0.2	0.3	0.4	0.6	0.4	0.1	0.0	0.3	1.7	6.1	7.7	0.4	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.3	1.3	0.0	0.3	0.3	0.7	0.0	1.5	0.1	0.1	1.5	0.7	65.4	0.3	1.1	0.1	3.2	3.8	1.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	12.9	0.0	0.5	0.0	0.0	0.0	11.3	0.0	0.4	0.2	11.1	0.0	0.0	0.6	0.0	0.0	0.5	0.0	5.7	0.0	0.0	1.2	1.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.1	0.0	0.7	0.1	0.0	0.4	0.1	0.2	0.1	0.3	0.6	0.2	0.0	0.0	0.7	7.5	0.1	1.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1010.5	0.0	0.0	1.3	0.0	2.7	0.3	0.0	0.1	0.4	0.5	0.2	1.3	0.0	0.4	0.3	6.8	0.0	1.0	0.0	2.0	10.1	1.0	2756.7	13.4	6.3	1.8	1.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	12.8	1.1	0.3	0.0	0.0	2.3	0.0	26.3	0.4	0.2	18.4	7.2	0.0	0.1	0.0	0.3	0.0	0.0	0.7
DOP1B	"C21orf5, DOPEY2, KIAA0933"	ENSG00000142197	"DOP1 leucine zipper like protein B"	Q9Y3R5	21	36156782-36294274	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 5.2;dendritic cells: 3.8;Extravillous trophoblasts: 11.4;Hofbauer cells: 16.7;Syncytiotrophoblasts: 8.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 19.8"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072065	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Mitochondria	"HPA072065: AB_2686486"	"prognostic unfavorable (7.08e-4)"	"unprognostic (7.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-1)"	3.5	1.7	2.9	5.6	4.8	24.2	5.8	19.8	8.0	4.6	0.0	15.4	12.6	2.3	3.0	11.8	4.2	4.1	4.5	3.6	1.0	3.2	9.1	4.9	4.7	3.6	1.1	1.6	4.6	30.4	2.3	3.1	4.5	12.1	15.1	1.6	19.3	3.4	15.9	7.1	11.7	3.8	0.1	5.5	20.5	3.5	2.1	6.5	4.0	13.5	6.3	4.0	5.9	3.4	25.9	5.4	4.0	6.8	4.4	8.4	38.2	12.0	14.2	16.7	10.4	3.8	2.0	4.8	1.8	9.0	12.7	5.2	7.8	2.8	13.5	8.8	7.0	11.0	1.2	1.4	3.9	10.8	5.5	2.9	5.5	10.9	2.9	10.0	7.1	11.2	3.5	7.6	5.0	29.0	8.7	11.1	3.3	30.4	5.6	15.4	2.3	23.7	8.8	10.2	10.7	6.1	8.0	35.9	10.1	5.5	13.1	13.2	12.2	6.4	1.7	8.4	9.8	5.7	15.0	2.2	9.2	23.0	3.7	1.0	3.0	6.1	2.6	2.7	1.4	7.3	1.7	1.5	1.9	10.5	1.1	0.9	4.8	1.0	2.4	5.9	1.4	1.4	2.9	4.8	19.8	8.0	3.6	1.0	3.6	1.1	4.5	0.1	2.1	3.4	2.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	1.9	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	11.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.1	0.6	0.0	0.0	0.0
DUS2	"DUS2L, FLJ20399, SMM1"	ENSG00000167264	"Dihydrouridine synthase 2"	Q9NX74	16	67987746-68079320	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 118.1;Late spermatids: 94.1;Spermatocytes: 53.1;Syncytiotrophoblasts: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042560, HPA043528"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA042560: AB_10965170, HPA043528: AB_10959753"	"unprognostic (2.21e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.23e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.18e-1)"	"prognostic favorable (3.50e-5)"	"unprognostic (1.44e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.81e-1)"	5.8	6.8	5.2	12.6	5.8	9.6	5.8	6.8	7.5	6.1	4.6	8.6	5.7	5.3	4.9	12.2	5.1	5.5	6.1	5.3	6.1	5.9	9.2	6.8	18.8	6.8	5.8	4.8	4.4	7.5	4.9	9.9	6.6	5.4	8.4	5.3	5.9	5.0	9.6	10.8	10.4	7.9	5.0	15.9	6.4	27.5	6.4	7.6	5.4	8.9	20.2	7.0	7.4	7.8	17.1	25.5	11.0	17.1	8.8	14.8	20.4	16.1	15.6	33.4	23.7	27.5	29.9	39.7	14.3	17.0	9.8	22.8	26.6	28.5	25.5	6.1	16.0	13.4	15.6	20.6	14.9	15.1	18.4	14.5	21.9	27.5	26.8	12.8	21.3	29.9	16.1	6.5	16.0	24.9	16.0	22.5	12.2	16.9	13.5	26.8	12.5	28.3	18.4	11.8	13.0	11.3	31.8	12.3	7.1	14.1	25.1	8.4	11.7	14.8	13.3	12.9	13.6	18.4	24.5	36.6	10.6	19.7	8.8	12.1	29.2	89.9	9.5	25.8	9.2	56.9	6.5	10.3	21.9	48.4	9.4	8.5	27.8	21.3	37.7	8.6	13.5	17.2	5.2	5.8	6.8	7.5	5.3	6.1	6.8	5.8	6.6	5.0	6.4	7.8	2.5	9.6	4.6	6.8	17.1	2.7	2.0	12.8	4.6	3.9	2.4	2.2	2.6	4.3	6.2	7.3	8.4	29.2	6.0	5.7	5.9	10.4	118.1	1.7	3.5	5.3	4.2	3.0	7.2	5.4	17.3	3.8	4.6	2.6	7.0	7.2	9.3	7.9	13.4	15.2	8.0	5.5	6.1	11.9	2.3	94.1	3.7	6.2	3.6	2.8	13.5	4.5	9.2	5.5	7.3	9.5	3.6	7.9	7.7	3.4	4.2	10.8	4.1	2.9	6.6	3.4	4.7	53.1	15.0	5.2	2.6	61.4	4.2	10.0	6.0	2.1
DYNC2I2	"bA216B9.3, CFAP133, DIC5, FAP133, MGC20486, WDR34"	ENSG00000119333	"Dynein 2 intermediate chain 2"	Q96EX3	9	128633653-128656847	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 20.4;Cytotrophoblasts: 89.8;Extravillous trophoblasts: 95.3;Hofbauer cells: 21.9;Syncytiotrophoblasts: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 35.8;naive B-cell: 52.9"	"Lineage enriched"	"Detected in all"	5	"B-cells: 52.9"	"Cell line enhanced"	"Detected in all"		"MCF7: 432.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040764, HPA041091"	Approved		Approved	Cytosol		NA	Yes			"Cluster 19: B-cells - Humoral immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"HPA040764: AB_10795625, HPA041091: AB_10796237"	"unprognostic (1.45e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (2.55e-1)"	"prognostic favorable (7.01e-5)"	"unprognostic (2.27e-1)"	"unprognostic (7.00e-3)"	"prognostic unfavorable (8.79e-4)"	"unprognostic (6.04e-2)"	"unprognostic (4.39e-1)"	"unprognostic (3.65e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.28e-1)"	14.4	49.9	15.7	11.4	15.4	33.2	20.1	14.3	20.1	28.2	30.5	26.7	22.2	22.4	8.9	37.9	30.5	11.1	41.4	15.4	18.9	61.8	39.1	25.1	12.0	17.0	19.4	19.1	36.7	21.2	36.1	11.0	16.4	31.0	10.3	4.5	31.9	14.0	11.1	24.0	27.7	6.3	16.5	23.6	26.3	69.8	16.6	23.8	55.6	4.3	9.5	19.2	23.7	14.7	112.7	202.8	49.8	78.8	11.4	16.1	141.4	46.2	32.9	66.5	42.8	96.6	197.3	40.4	32.4	30.8	62.0	169.4	47.5	50.8	16.6	93.5	40.1	24.0	134.8	52.0	13.9	41.5	39.4	8.0	25.0	66.3	18.9	24.0	46.5	112.6	83.5	34.0	36.4	432.4	151.3	106.1	63.7	97.3	121.0	157.2	66.6	136.8	42.1	36.0	125.1	100.1	143.9	135.9	36.8	13.7	230.5	40.7	28.3	75.9	114.8	95.6	90.7	34.6	100.7	39.6	71.4	41.9	74.0	1.7	1.1	0.4	1.4	1.6	2.3	35.8	2.9	3.9	2.8	52.9	1.1	1.7	0.8	4.5	5.7	11.0	5.7	3.8	15.7	15.4	14.3	20.1	15.4	18.9	17.0	19.4	16.4	16.5	16.6	14.7	2.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	89.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	95.3	6.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	37.4	0.2	0.0	0.0	0.0
EBI3	"IL27B, IL35B"	ENSG00000105246	"Epstein-Barr virus induced 3"	Q14213	19	4229523-4237528	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"placenta: 147.6"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 485.6;monocytes: 505.7;Syncytiotrophoblasts: 336.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"intermediate monocyte: 4.8;memory B-cell: 18.7;naive B-cell: 14.7;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	14	"B-cells: 18.7;monocytes: 6.3"	"Cell line enriched"	"Detected in some"	13	"HDLM-2: 218.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA046635	Enhanced				"Secreted to blood"	NA	NA	203000	1400000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA046635: AB_2679729"	"unprognostic (7.26e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.25e-3)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (1.04e-8)"	"unprognostic (1.97e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.67e-2)"	4.7	4.7	3.8	14.6	3.3	1.2	1.7	3.4	5.3	1.5	3.2	3.0	4.3	1.1	0.1	1.0	2.4	5.4	1.4	3.8	3.7	2.1	3.3	2.9	20.2	5.7	4.2	1.3	2.5	0.4	1.7	147.6	5.2	1.8	1.6	0.1	1.8	1.4	0.2	0.6	8.4	2.1	4.5	34.0	3.7	0.9	5.8	9.4	0.9	0.4	7.3	4.8	1.0	6.1	0.1	1.7	0.1	0.0	0.0	0.0	7.3	0.7	4.2	0.4	0.2	1.3	1.2	4.2	16.4	0.0	2.0	0.1	0.0	0.0	0.0	218.8	0.0	0.0	0.1	0.2	0.3	0.0	7.7	0.4	0.0	2.1	0.6	1.6	0.1	0.0	0.4	0.5	0.1	0.1	0.0	3.0	0.4	0.0	0.0	0.0	0.6	0.3	2.6	0.0	0.2	0.4	0.0	0.0	0.0	2.7	0.2	0.2	0.9	0.3	5.1	0.0	0.2	0.4	0.0	0.2	0.3	0.0	0.6	0.0	0.1	0.0	0.0	4.8	0.0	18.7	0.0	0.0	0.8	14.7	0.0	0.0	0.2	0.0	6.3	0.0	0.0	0.6	3.8	3.3	3.4	5.3	3.8	3.7	5.7	4.2	5.2	4.5	5.8	6.1	0.5	0.0	0.5	0.3	8.4	0.4	0.0	13.3	0.0	0.0	0.2	0.6	0.1	1.5	10.7	0.0	0.0	10.6	0.5	0.0	0.0	2.8	0.0	0.3	0.4	1.3	0.0	0.0	0.6	0.9	485.6	0.7	0.0	0.3	11.4	0.0	1.1	0.1	9.6	0.0	0.4	0.0	6.1	102.6	11.3	0.0	0.0	19.0	0.0	5.6	505.7	0.1	0.0	0.0	0.1	0.6	0.0	0.0	2.6	0.1	0.0	0.6	1.5	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.1	336.4	1.0	0.1	0.0	0.1
FANCL	"FAAP43, FLJ10335, PHF9, Pog"	ENSG00000115392	"FA complementation group L"	Q9NW38	2	58159243-58241372	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 81.4;Oligodendrocytes: 188.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033842, HPA036685, HPA036686"	Supported		Approved	"Nuclear bodies,Vesicles"		NA	Yes			"Cluster 19: B-cells - Humoral immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"	Vesicles	"CAB033842: AB_1122766, HPA036685: AB_10672474, HPA036686: AB_10670844"	"unprognostic (3.02e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.81e-7)"	"unprognostic (4.71e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.08e-3)"	"prognostic favorable (7.80e-5)"	8.5	35.3	39.4	11.0	49.5	15.1	19.5	35.3	39.4	18.6	27.2	12.1	11.5	19.9	18.4	11.5	13.9	12.0	13.0	34.1	45.1	12.2	21.7	9.6	14.8	51.6	40.3	24.8	14.5	14.0	44.3	12.5	55.4	14.7	14.8	24.6	18.7	10.7	9.1	17.9	12.8	13.5	40.9	16.8	13.1	19.1	41.2	13.2	17.1	9.1	12.6	11.7	14.6	68.6	48.6	35.0	69.4	34.0	11.9	15.1	36.9	34.8	21.5	33.8	43.5	30.9	59.4	33.4	43.8	11.4	46.3	27.5	39.0	26.4	56.0	78.8	61.7	54.8	49.5	42.1	13.0	53.3	29.0	11.8	12.4	24.8	9.7	29.9	27.0	23.5	51.9	29.6	23.2	24.6	18.9	65.8	75.2	77.4	7.2	35.2	52.5	26.1	29.9	47.2	78.1	39.3	49.5	20.2	33.8	37.0	18.7	35.4	15.9	30.0	45.0	22.3	39.0	30.4	20.6	19.7	63.7	35.7	46.6	3.2	3.0	4.9	3.7	5.6	3.0	9.1	3.2	4.2	5.9	9.3	1.0	2.3	0.8	7.6	4.3	5.3	4.8	2.2	39.4	49.5	35.3	39.4	34.1	45.1	51.6	40.3	55.4	40.9	41.2	68.6	16.7	19.2	20.0	18.6	9.4	10.3	13.9	26.1	11.4	16.6	12.5	15.4	16.4	8.6	16.1	9.2	4.2	29.1	4.8	7.2	11.7	9.7	2.5	11.1	15.8	14.8	9.0	14.5	45.0	4.2	14.0	12.2	15.3	6.2	10.8	25.8	13.2	12.5	10.9	8.4	38.4	15.0	30.5	6.3	4.6	3.6	10.8	7.0	26.6	34.7	6.8	22.8	3.1	81.4	188.9	4.6	13.3	14.3	9.7	6.2	21.7	5.7	23.2	18.7	13.1	10.8	12.4	52.6	37.9	9.5	6.8	7.4	5.6	13.2	16.0	9.3
FBXO10	FBX10	ENSG00000147912	"F-box protein 10"	Q9UK96	9	37510892-37576380	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 29.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 34.8;Excitatory neurons: 28.6;Inhibitory neurons: 28.2;Late spermatids: 45.7;Oligodendrocyte precursor cells: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 2.1;naive B-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"AF22: 24.0;HHSteC: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA002863, HPA072721"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA002863: AB_10965996, HPA072721: "	"unprognostic (2.40e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.49e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.93e-5)"	"unprognostic (1.91e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-1)"	2.9	8.0	5.9	3.2	6.2	0.8	2.4	2.6	7.4	3.3	3.9	7.4	1.8	4.5	10.7	3.2	2.5	2.7	3.9	9.0	6.4	3.8	3.6	2.3	5.5	3.6	5.1	2.5	6.6	3.8	16.4	2.0	4.4	3.3	1.8	1.6	8.5	2.9	29.8	1.9	4.7	3.2	3.6	10.0	3.2	9.4	6.8	2.0	7.6	13.9	5.3	3.0	2.7	5.6	2.3	5.6	24.0	6.2	11.1	3.9	2.0	4.2	7.6	5.3	7.7	3.2	1.5	14.4	1.4	4.6	2.1	0.2	8.8	2.1	3.8	8.2	5.8	2.9	5.3	2.8	33.8	7.9	1.0	9.0	1.7	4.7	3.1	3.4	7.5	1.4	10.4	3.9	9.4	2.0	3.0	2.6	11.2	3.3	2.1	5.5	10.4	1.8	3.0	1.5	5.1	12.8	2.8	3.4	3.2	7.1	1.4	8.0	6.1	3.7	6.3	3.4	3.1	4.5	3.9	2.3	3.1	3.0	3.5	0.0	0.0	0.0	0.2	0.0	0.2	2.1	0.4	0.2	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.2	5.9	6.2	2.6	7.4	9.0	6.4	3.6	5.1	4.4	3.6	6.8	5.6	0.7	0.0	1.1	12.4	6.7	0.3	0.1	0.4	0.6	3.9	1.2	0.8	1.7	2.8	0.5	1.8	4.2	0.3	0.3	0.1	0.0	1.1	34.8	1.1	4.3	1.4	5.4	0.4	28.6	1.5	0.8	1.8	0.5	1.3	0.0	1.9	3.9	1.2	4.1	3.3	28.2	0.5	2.0	0.3	0.0	45.7	0.9	0.6	1.8	4.7	0.7	1.6	0.0	16.6	7.0	1.2	0.2	1.5	5.7	0.9	0.2	1.3	1.1	1.0	0.0	3.1	1.0	4.2	1.9	0.7	0.6	0.3	1.3	5.0	0.3	0.3
FCRL2	"CD307b, FCRH2, IRTA4, SPAP1"	ENSG00000132704	"Fc receptor like 2"	Q96LA5	1	157745733-157777132	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"intestine: 20.9;lymphoid tissue: 34.3"	"Group enriched"	"Detected in some"	17	"B-cells: 84.7;Plasma cells: 40.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	34	"memory B-cell: 29.7;naive B-cell: 18.4"	"Lineage enriched"	"Detected in single"	42	"B-cells: 29.7"	"Group enriched"	"Detected in some"	4	"Daudi: 12.9;U-698: 10.5"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"				"unprognostic (3.94e-3)"	"unprognostic (1.47e-3)"	"unprognostic (3.49e-2)"	"unprognostic (3.69e-3)"		"unprognostic (5.11e-5)"	"unprognostic (1.67e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.19e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.19e-2)"	"unprognostic (4.60e-7)"	"unprognostic (2.89e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.48e-1)"	0.4	0.0	0.1	12.3	0.1	2.6	0.4	0.0	0.4	0.2	0.0	2.2	2.2	0.1	0.1	0.4	0.1	1.0	0.4	0.1	0.2	0.4	0.4	0.7	24.1	0.4	0.1	0.4	0.0	0.0	0.0	0.1	0.2	0.3	2.7	0.2	1.0	0.0	0.0	0.2	20.9	0.1	0.1	34.3	1.7	0.3	0.2	1.7	0.5	0.0	25.8	1.4	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	2.7	0.0	10.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	29.7	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.4	0.1	0.2	0.4	0.1	0.2	0.1	0.2	0.8	0.0	0.0	1.1	0.0	84.7	0.3	0.5	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.3	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.1	1.1	0.3	1.3	0.0	0.7	0.6	0.1	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	1.0	3.6	0.0	0.1	0.0	1.0	0.0	0.0	0.0	1.1	0.0	40.4	0.3	0.0	0.1	0.1	0.0	0.0	1.2	0.6	0.0	0.2	0.0	0.4	0.1	1.9	0.0	0.1	0.4
FNDC11	"C20orf195, MGC5356"	ENSG00000125531	"Fibronectin type III domain containing 11"	Q9BVV2	20	63547891-63556695	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"testis: 108.0"	"Cell type enhanced"	"Detected in some"		"Club cells: 1.3;Collecting duct cells: 1.8;Endometrial ciliated cells: 5.1;Respiratory ciliated cells: 6.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"memory B-cell: 1.5;naive B-cell: 3.3"	"Lineage enriched"	"Detected in single"	7	"B-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.2;EFO-21: 2.6;HaCaT: 1.5;OE19: 1.8;SH-SY5Y: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041341			Approved	Nucleoplasm,Vesicles,Aggresome		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Vesicles"	Aggresome	"HPA041341: AB_10794991"	"unprognostic (2.01e-1)"	"unprognostic (6.63e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.99e-3)"	"unprognostic (7.94e-2)"	"unprognostic (8.30e-4)"	"unprognostic (3.68e-1)"	"unprognostic (8.33e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.75e-1)"	"unprognostic (6.81e-2)"	0.4	0.1	0.2	0.3	0.1	0.5	0.6	0.1	0.3	0.8	0.3	0.3	0.1	0.4	2.3	0.2	1.2	0.3	0.2	0.1	1.1	1.2	0.1	0.9	0.6	0.5	0.5	0.4	0.1	0.0	0.9	0.1	0.3	0.6	0.0	0.0	0.4	0.1	0.1	0.4	0.6	0.0	0.4	1.0	0.4	108.0	0.5	0.3	0.5	0.0	0.4	0.7	0.6	0.2	0.2	0.0	0.9	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	5.2	0.3	2.6	0.0	0.1	1.5	0.1	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.6	0.0	0.1	0.4	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.5	0.0	0.1	0.1	1.8	0.4	0.0	0.0	0.0	0.9	0.0	0.2	3.3	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	1.5	0.1	0.2	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.1	0.1	0.3	0.1	1.1	0.5	0.5	0.3	0.4	0.5	0.2	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.2	6.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0
FRZB	"FRE, FRITZ, FRP-3, FRZB-1, FRZB-PEN, FRZB1, FZRB, hFIZ, SFRP3, SRFP3"	ENSG00000162998	"Frizzled related protein"	Q92765	2	182833275-182866637	"Disease related genes, Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 336.9"	"Cell type enriched"	"Detected in many"	13	"Muller glia cells: 3633.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 19.2;ASC diff: 9.4;NTERA-2: 7.4;SH-SY5Y: 6.5"	"Region enhanced"	"Detected in all"		"olfactory bulb: 56.9"	"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA		44000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 79: Retina - Phototransduction"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"				"unprognostic (5.39e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.64e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.67e-2)"	"unprognostic (8.58e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (3.53e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.04e-2)"	"unprognostic (3.21e-1)"	10.4	5.7	10.4	6.1	12.8	0.7	12.6	11.0	18.6	20.3	52.2	16.2	14.4	17.2	11.4	12.4	7.1	39.0	19.9	10.3	11.2	16.3	3.3	9.1	18.7	14.1	10.9	13.5	7.1	6.7	18.6	30.5	15.4	12.9	19.9	336.9	4.7	16.6	26.6	10.4	14.5	31.1	11.9	88.9	21.9	14.2	11.3	4.9	10.8	116.2	11.9	10.3	12.3	10.3	0.0	0.0	19.2	0.2	9.4	0.2	0.2	0.0	0.9	3.2	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.8	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	7.4	0.0	0.0	0.6	0.8	0.0	0.0	0.0	1.0	6.5	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	12.8	11.0	18.6	10.3	11.2	14.1	10.9	15.4	11.9	11.3	10.3	13.8	0.0	0.5	1.0	0.8	8.2	0.4	0.2	0.6	39.8	7.8	18.7	2.9	0.0	1.4	0.0	33.3	5.3	0.5	2.1	0.0	0.1	0.3	0.5	1.4	18.5	1.2	0.0	2.7	8.2	3.8	97.8	9.7	0.9	0.0	0.5	3.6	1.0	7.8	26.9	7.7	137.4	0.0	0.8	3.7	2.8	3.7	0.5	245.5	25.3	0.0	3633.8	0.0	8.5	1.7	0.2	0.8	14.7	5.8	1.8	1.3	0.2	0.2	124.4	276.1	41.9	157.1	0.2	0.1	0.6	3.1	12.4	1.5	22.9	3.4	0.6
GANC		ENSG00000214013	"Glucosidase alpha, neutral C"	Q8TET4	15	42273233-42356935	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 47.9;Oligodendrocytes: 86.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA016949, HPA051522"	Approved		Approved	Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA016949: AB_1849465, HPA051522: "	"unprognostic (8.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.51e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.49e-2)"	"prognostic favorable (9.76e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.74e-2)"	8.9	7.6	8.2	10.3	13.0	14.3	8.8	9.8	10.4	9.6	10.4	10.6	8.9	11.0	17.8	12.1	8.6	9.4	8.5	7.8	9.2	9.4	13.3	20.4	10.0	12.4	11.1	13.0	8.4	11.3	7.9	8.0	13.2	8.5	12.4	9.7	14.5	8.7	12.9	10.1	9.8	9.8	10.0	11.9	8.5	12.3	10.8	10.3	12.1	10.6	10.2	8.3	9.3	19.2	9.0	4.9	10.7	11.6	12.3	17.2	7.1	19.2	19.7	19.7	16.4	6.4	6.2	4.9	10.2	18.6	14.3	18.3	12.6	19.5	13.6	12.3	6.0	11.9	12.1	12.8	10.4	11.6	10.1	11.8	11.4	8.1	13.6	11.7	13.5	12.0	12.6	13.0	15.8	1.7	7.9	12.7	6.7	4.3	5.5	14.7	12.4	17.0	14.7	8.4	8.2	11.7	10.8	9.4	7.0	5.6	3.3	27.0	13.6	21.6	5.7	17.8	12.1	13.9	20.7	9.7	10.4	20.9	12.1	16.8	11.8	10.2	4.5	13.1	6.2	19.6	7.2	8.6	15.5	23.1	8.9	5.4	6.7	5.7	10.9	12.3	7.3	6.5	8.2	13.0	9.8	10.4	7.8	9.2	12.4	11.1	13.2	10.0	10.8	19.2	6.2	19.2	47.9	35.6	14.5	10.5	17.1	7.9	12.0	5.6	5.6	6.2	8.2	4.3	8.9	1.8	10.4	5.3	4.0	9.5	5.9	5.9	18.6	7.7	11.1	5.0	4.2	5.0	18.9	3.8	5.1	8.1	9.7	11.9	10.8	8.1	5.7	12.4	6.5	3.3	28.5	5.7	10.2	11.7	5.4	4.7	7.2	10.9	14.2	36.5	14.0	9.5	7.2	31.7	86.7	5.4	15.7	6.4	7.1	9.1	7.9	7.7	9.8	8.5	13.1	9.2	7.0	20.5	15.7	18.9	5.3	2.9	6.9	6.4	8.5	20.7
GDF7	BMP12	ENSG00000143869	"Growth differentiation factor 7"	Q7Z4P5	2	20667144-20679243	"Predicted secreted proteins"		"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 9.8;seminal vesicle: 22.4"	"Group enriched"	"Detected in some"	12	"Endometrial stromal cells: 137.0;Granulosa cells: 83.7"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.7;Hep G2: 4.4;RT4: 8.3;SH-SY5Y: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069106			Approved	Vesicles	"Secreted in other tissues"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 36: Stromal cells - Cell proliferation"	Vesicles		"HPA069106: "	"unprognostic (1.35e-1)"	"unprognostic (9.93e-3)"	"unprognostic (5.10e-1)"	"unprognostic (2.44e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.06e-3)"	"unprognostic (8.63e-3)"	"unprognostic (6.31e-3)"	"unprognostic (8.00e-3)"	"unprognostic (3.85e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.28e-3)"	"unprognostic (8.02e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.89e-3)"	0.4	0.4	0.2	1.0	0.5	0.2	0.1	0.0	2.5	9.8	0.0	0.5	0.2	7.2	3.3	0.9	0.7	0.6	0.8	0.4	0.1	3.6	5.0	0.4	2.3	0.3	0.1	0.3	0.6	0.1	0.3	0.8	0.0	3.8	0.2	0.1	0.1	22.4	0.0	1.3	1.6	1.1	0.0	1.3	0.7	0.2	0.3	0.2	0.2	0.6	1.8	1.1	6.6	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.7	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1	1.2	8.3	0.0	3.3	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	2.5	0.4	0.1	0.3	0.1	0.0	0.0	0.3	0.6	0.1	6.4	0.0	0.0	2.6	0.0	0.6	0.0	0.0	0.5	0.0	0.0	8.8	2.8	3.1	5.5	0.0	0.0	0.1	0.1	1.9	0.1	0.1	3.5	137.0	1.8	0.0	2.7	0.2	0.0	0.1	1.3	0.0	2.9	0.0	83.7	0.0	8.2	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.7	0.0	4.1	0.7	0.0	0.0	0.3	7.1	0.5	1.0	0.0	0.0	0.0	0.8	0.0	0.0	1.5
GGA2	"KIAA1080, VEAR"	ENSG00000103365	"Golgi associated, gamma adaptin ear containing, ARF binding protein 2"	Q9UJY4	16	23463542-23521995	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 153.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 159.9;U-698: 170.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB034422, HPA043313, HPA063634"	Approved		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus"		"CAB034422: AB_2110748, HPA043313: AB_2678421, HPA063634: AB_2685067"	"unprognostic (1.27e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (8.53e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.91e-2)"	"prognostic favorable (9.70e-5)"	"unprognostic (1.68e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (7.82e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.15e-3)"	"unprognostic (8.55e-2)"	"prognostic favorable (3.91e-5)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (3.89e-2)"	"unprognostic (2.08e-1)"	15.1	36.3	13.0	32.0	13.1	37.6	19.9	18.6	14.8	20.7	25.2	16.5	10.0	16.1	19.6	17.9	18.4	13.4	18.5	13.8	15.3	26.9	16.4	34.1	72.9	11.7	12.9	34.0	54.3	29.2	26.0	17.6	11.9	27.4	15.8	79.3	37.6	21.3	25.5	21.1	33.6	14.9	10.8	44.2	25.7	12.4	17.8	37.2	36.2	19.0	87.3	16.3	18.7	12.3	18.8	22.9	29.6	26.1	16.5	17.9	25.3	19.7	20.0	15.2	19.3	32.1	18.9	159.9	31.4	21.1	4.3	28.7	49.1	25.8	19.4	25.1	45.6	28.8	29.5	51.2	16.2	48.0	18.2	18.7	22.7	20.8	9.7	22.1	22.0	12.8	50.3	23.0	19.8	29.8	17.0	31.9	39.6	18.3	20.2	108.3	38.4	41.2	24.8	25.6	21.1	25.3	18.3	27.0	27.1	31.5	23.7	59.7	24.5	18.1	19.6	20.3	18.5	42.0	41.8	170.8	16.5	32.2	20.6	0.2	4.2	7.0	3.1	4.3	3.2	16.2	3.9	3.7	4.9	21.6	4.0	4.0	0.5	3.1	4.0	15.9	4.5	3.1	13.0	13.1	18.6	14.8	13.8	15.3	11.7	12.9	11.9	10.8	17.8	12.3	11.7	48.1	41.4	28.7	102.3	34.2	33.6	16.5	39.3	73.2	25.0	26.0	27.3	21.5	17.6	22.0	114.7	23.0	80.6	7.3	25.4	19.3	22.0	25.4	17.6	19.0	17.6	9.9	44.2	18.9	40.7	17.3	15.3	37.3	9.5	88.5	12.5	16.1	69.1	6.7	61.5	12.6	12.2	26.1	19.7	30.8	24.5	37.7	26.6	36.5	87.9	23.8	23.7	26.2	8.3	16.2	6.1	26.4	36.1	20.7	8.7	21.5	16.2	153.3	19.7	16.0	16.3	30.5	60.5	25.4	14.6	22.7	34.8	56.8	11.9	18.6
GINM1	"C6orf72, dJ12G14.2"	ENSG00000055211	"Glycoprotein integral membrane 1"	Q9NU53	6	149566294-149591748	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 369.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017210, HPA041679"	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane"		NA	NA		35000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center, Plasma membrane"		"HPA017210: AB_1845743, HPA041679: AB_2677611"	"unprognostic (6.09e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.79e-3)"	56.0	44.0	25.7	24.0	31.4	41.2	45.0	33.9	36.1	47.8	38.5	43.0	25.9	46.4	44.6	32.2	39.2	38.2	58.6	25.0	28.9	92.7	45.7	36.0	26.1	30.6	29.0	50.5	36.8	55.3	24.7	62.6	30.6	40.3	34.8	21.9	32.2	47.4	47.1	36.4	28.1	50.5	29.3	35.1	34.1	48.0	26.9	21.7	73.9	42.3	24.7	42.2	34.0	38.9	27.2	19.5	30.5	41.4	162.6	96.1	48.3	89.0	107.5	68.1	85.1	25.4	35.7	19.4	46.9	87.6	62.9	53.8	20.1	46.0	89.0	33.6	39.6	18.9	17.5	30.5	62.0	37.2	17.2	107.8	39.1	58.0	39.6	74.7	74.7	27.0	24.6	31.8	65.1	35.3	22.9	27.9	10.1	40.2	20.1	25.2	54.0	15.1	97.7	23.9	19.2	18.1	90.1	53.2	18.9	33.5	32.9	38.4	51.3	35.9	37.0	92.9	60.9	30.6	38.6	24.5	67.4	33.1	34.3	21.0	18.5	25.1	8.8	17.8	10.5	22.8	10.2	9.7	13.9	17.0	9.8	8.0	32.1	11.4	23.4	16.9	10.7	10.6	25.7	31.4	33.9	36.1	25.0	28.9	30.6	29.0	30.6	29.3	26.9	38.9	120.5	80.1	53.7	10.1	44.6	46.8	58.6	75.1	46.7	21.3	50.1	50.3	54.1	38.6	53.4	66.2	29.2	81.1	31.4	64.5	39.2	92.7	191.0	42.2	77.3	78.9	26.8	32.2	11.9	80.7	77.1	103.4	18.3	60.7	29.1	48.2	104.6	41.9	45.6	16.8	13.9	23.1	46.8	56.0	47.7	369.6	129.5	46.6	42.7	5.6	75.7	86.5	18.6	17.1	25.0	67.8	33.5	112.8	45.3	65.0	49.8	132.1	33.8	22.6	98.6	85.9	71.1	166.5	82.8	48.7	47.0	122.7	32.0	65.7	22.4	64.0
GNG3		ENSG00000162188	"G protein subunit gamma 3"	P63215	11	62707676-62709201	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 295.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 39.8;Early spermatids: 27.6;Excitatory neurons: 23.3;Inhibitory neurons: 20.7;Late spermatids: 123.0"	"Cancer enriched"	"Detected in some"	14	"glioma: 12.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	30	"memory B-cell: 16.9;naive B-cell: 17.1"	"Lineage enriched"	"Detected in single"	31	"B-cells: 17.1"	"Group enriched"	"Detected in many"	7	"Karpas-707: 149.4;SCLC-21H: 292.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (2.43e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.68e-4)"	"unprognostic (2.73e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.37e-5)"	"unprognostic (3.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.00e-1)"	0.3	14.8	168.3	1.9	183.3	1.1	0.3	132.0	295.7	0.3	62.2	8.3	1.3	0.2	1.0	0.4	0.2	0.3	0.6	203.9	207.0	0.6	0.8	0.4	0.4	146.2	148.2	0.6	0.7	0.9	48.4	0.1	179.5	0.7	2.6	35.3	0.6	0.7	0.6	0.6	3.2	1.2	106.6	0.3	1.5	11.3	152.4	0.0	0.4	0.1	0.2	0.3	1.2	201.3	0.5	1.0	7.3	0.5	0.0	0.0	3.2	0.6	0.0	0.5	0.0	2.4	1.4	0.4	0.8	0.0	0.3	1.0	0.0	0.0	0.0	2.2	0.5	0.8	0.9	2.1	0.2	1.3	0.6	0.3	0.0	0.1	0.0	1.3	0.0	1.1	1.7	149.4	0.0	1.3	0.3	3.9	33.2	0.7	0.1	2.0	1.3	0.8	0.5	2.4	292.9	2.5	0.8	1.0	0.2	1.5	1.7	0.7	0.4	1.7	2.9	0.9	0.5	0.9	2.4	0.8	1.5	1.1	0.4	0.0	0.1	0.5	0.0	0.0	0.0	16.9	0.1	0.1	0.1	17.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.4	168.3	183.3	132.0	295.7	203.9	207.0	146.2	148.2	179.5	106.6	152.4	201.3	0.1	0.0	0.0	5.9	1.2	0.0	0.4	0.0	0.0	39.8	0.4	0.9	0.1	0.0	0.0	0.0	4.2	0.2	0.0	0.2	0.0	0.1	27.6	0.5	0.0	0.1	0.0	0.0	23.3	0.4	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.3	5.0	20.7	0.2	0.0	0.0	0.4	123.0	0.9	0.1	0.0	2.8	0.6	5.3	0.0	8.0	7.4	0.0	1.2	0.0	0.0	0.0	0.1	0.3	0.0	14.1	0.0	0.0	0.1	4.4	3.0	0.0	0.3	0.0	0.1	0.4	0.1	0.2
GPM6A	GPM6	ENSG00000150625	"Glycoprotein M6A"	P51674	4	175632934-176002664	"Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"brain: 577.8;choroid plexus: 249.3;retina: 147.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 3712.4;Excitatory neurons: 833.0;Inhibitory neurons: 581.3;Muller glia cells: 459.6;Oligodendrocyte precursor cells: 1341.6"	"Cancer enriched"	"Detected in many"	107	"glioma: 110.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"memory B-cell: 34.8;naive B-cell: 16.6"	"Lineage enriched"	"Detected in many"	12	"B-cells: 34.8"	"Group enriched"	"Detected in some"	10	"AF22: 49.9;Daudi: 43.0;HAP1: 17.4;U-251 MG: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017338	Supported					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA017338: AB_1849933"	"unprognostic (1.36e-4)"	"unprognostic (3.35e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.82e-5)"	"unprognostic (2.24e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.60e-3)"	3.8	4.2	366.9	1.4	455.6	0.5	2.5	422.6	577.8	6.8	249.3	25.4	1.9	7.7	2.9	1.9	7.5	4.4	2.8	469.8	268.7	7.1	13.4	20.1	2.6	225.0	265.4	12.3	1.8	0.7	7.7	0.3	222.4	5.7	6.0	147.3	0.9	6.9	0.6	0.8	3.4	11.1	257.9	15.8	1.1	1.5	281.9	0.3	11.9	0.6	1.3	2.6	2.9	336.4	0.3	0.7	49.9	0.5	0.0	0.0	0.2	0.1	0.5	0.2	0.4	1.1	0.7	43.0	0.2	0.2	1.8	0.9	17.4	1.5	0.1	0.2	4.0	0.5	3.7	1.4	0.1	0.4	0.7	0.1	0.0	0.1	0.2	2.0	0.0	0.1	0.4	1.7	0.0	1.2	1.6	0.6	1.2	0.0	0.6	0.2	0.2	0.3	0.1	2.1	0.5	0.4	0.2	0.9	0.2	0.3	0.6	0.1	0.2	0.9	0.6	0.6	50.8	1.6	0.1	2.6	1.8	0.4	1.1	0.8	0.1	0.1	0.1	0.1	0.1	34.8	0.1	0.0	0.2	16.6	0.1	0.1	0.4	0.1	0.2	2.9	0.1	0.8	366.9	455.6	422.6	577.8	469.8	268.7	225.0	265.4	222.4	257.9	281.9	336.4	0.6	96.1	8.7	3712.4	9.6	1.8	5.3	0.0	0.0	220.3	0.2	0.1	0.7	1.5	0.6	0.0	14.6	0.0	0.0	0.1	1.9	0.0	11.7	0.4	0.1	29.0	0.0	5.3	833.0	0.2	0.2	2.4	0.0	0.2	0.0	0.2	116.0	2.1	0.3	124.5	581.3	0.0	0.0	4.4	0.4	3.6	3.4	1.6	0.0	208.0	0.0	459.6	0.0	1341.6	37.3	0.0	0.0	1.5	0.1	9.0	0.0	3.4	0.0	30.5	0.0	15.3	3.3	0.5	0.4	0.2	0.9	0.1	1.2	3.0	0.0	6.5
GPRC5D		ENSG00000111291	"G protein-coupled receptor class C group 5 member D"	Q9NZD1	12	12940775-12952147	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"skin 1: 47.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 6.8;Gastric mucus-secreting cells: 5.6;Late spermatids: 6.2;Melanocytes: 5.4;Plasma cells: 16.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"memory B-cell: 21.9;naive B-cell: 7.5"	"Lineage enriched"	"Detected in many"	14	"B-cells: 21.9"	"Group enriched"	"Detected in many"	9	"Karpas-707: 84.5;RPMI-8226: 85.9;U-266/84: 25.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071909	Approved					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 61: Skin - Cornification"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA071909: AB_2686470"	"unprognostic (4.27e-2)"	"unprognostic (8.58e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.34e-2)"	"prognostic favorable (5.09e-4)"	"unprognostic (3.00e-5)"	"unprognostic (4.06e-2)"	"unprognostic (3.06e-2)"	"unprognostic (5.53e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.54e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.63e-2)"	0.9	0.6	0.2	0.4	0.4	0.6	3.0	0.1	0.2	1.2	2.0	2.7	1.8	0.2	0.0	2.5	0.3	0.8	0.8	0.2	0.4	0.6	1.0	7.2	0.7	1.1	1.2	0.5	2.1	0.0	1.5	0.3	0.5	1.2	2.3	0.3	4.5	0.0	0.2	47.8	2.7	0.0	0.3	1.6	2.3	2.7	0.6	0.1	1.2	0.0	1.1	0.7	1.0	0.3	1.3	1.4	0.0	1.5	0.0	0.0	3.3	0.4	0.0	0.0	0.3	1.3	3.2	0.1	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	7.6	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	4.1	84.5	0.2	3.1	0.0	0.0	0.8	3.9	0.1	0.1	0.0	85.9	0.0	3.4	2.6	0.5	1.9	1.4	0.0	3.5	0.0	0.0	2.3	0.0	3.9	0.1	0.0	4.4	25.2	1.1	0.0	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	21.9	0.2	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.2	0.4	0.1	0.2	0.2	0.4	1.1	1.2	0.5	0.3	0.6	0.3	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.1	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.1	5.6	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.3	0.0	6.2	0.0	0.1	5.4	1.9	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1
GPT2	ALT2	ENSG00000166123	"Glutamic--pyruvic transaminase 2"	Q8TD30	16	46884362-46931289	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 267.4;skeletal muscle: 176.4;tongue: 184.5"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 64.3;Hepatocytes: 123.9;Syncytiotrophoblasts: 83.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.3;naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Hep G2: 159.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051514	Approved		Approved	Mitochondria		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA051514: AB_2681516"	"unprognostic (1.65e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.12e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.86e-1)"	"unprognostic (3.54e-3)"	"unprognostic (3.18e-1)"	56.8	10.4	51.6	4.0	49.9	3.8	17.0	49.1	56.9	5.2	38.4	7.7	1.7	3.7	31.4	77.8	7.6	9.8	7.9	51.3	45.7	23.5	103.7	2.1	4.3	69.8	45.9	2.3	267.4	8.3	13.0	3.1	63.9	24.2	4.9	6.9	48.8	10.9	176.4	37.8	3.9	3.1	60.2	2.3	58.6	15.0	54.9	7.7	7.6	184.5	13.4	2.7	7.7	64.5	42.6	19.0	23.8	90.6	32.7	7.0	43.1	28.9	10.9	30.7	19.2	65.3	17.6	29.9	24.7	20.7	15.6	33.6	43.3	42.8	20.4	14.0	21.1	10.5	10.8	159.9	22.4	75.6	9.5	15.2	37.0	30.0	46.3	20.3	15.1	56.1	8.7	23.3	10.3	75.8	15.1	62.9	25.3	52.2	54.2	0.3	26.3	71.1	12.4	21.0	73.7	37.7	14.9	76.4	39.0	9.4	19.6	67.6	11.3	21.1	40.9	14.2	23.4	110.2	36.9	87.1	32.6	48.3	11.7	0.4	0.2	0.0	0.1	0.0	0.0	1.3	0.0	0.1	0.4	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	51.6	49.9	49.1	56.9	51.3	45.7	69.8	45.9	63.9	60.2	54.9	64.5	1.3	6.4	3.4	54.9	4.8	15.9	4.9	6.8	64.3	14.5	6.7	8.4	14.9	8.6	9.1	18.4	22.9	9.2	0.3	10.2	11.7	7.0	9.6	12.2	7.2	2.3	13.1	5.2	16.7	30.2	44.8	7.5	37.2	37.5	3.8	14.9	5.0	123.9	3.8	6.7	18.8	13.4	6.1	3.2	7.3	22.9	4.7	2.3	8.8	1.0	1.1	42.5	1.0	13.6	26.0	25.6	5.2	15.4	7.9	12.4	2.0	38.6	5.4	5.9	0.0	5.2	3.6	2.5	17.3	53.1	16.3	83.3	1.4	2.6	6.3	4.2
GRAMD1C	DKFZp434C0328	ENSG00000178075	"GRAM domain containing 1C"	Q8IYS0	3	113828182-113947174	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 181.8;Early spermatids: 97.1;Late spermatids: 80.5;Oligodendrocyte precursor cells: 82.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"memory B-cell: 2.7;naive B-cell: 2.9;neutrophil: 2.1"	"Group enriched"	"Detected in many"	13	"B-cells: 2.9;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.5;HUVEC TERT2: 10.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA012316	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane, Cytosol"		"HPA012316: AB_1849949"	"unprognostic (2.73e-3)"	"unprognostic (6.16e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.50e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.43e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.49e-2)"	"prognostic favorable (4.22e-15)"	"unprognostic (8.48e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.09e-2)"	1.4	1.9	13.0	1.7	12.0	0.1	8.8	11.9	15.3	3.1	9.0	5.0	7.6	2.2	2.0	5.5	10.7	2.6	0.7	11.6	12.1	24.0	27.7	4.9	2.0	13.9	15.4	0.8	12.7	10.6	8.1	6.1	11.8	2.6	3.9	14.3	12.0	2.1	0.8	12.1	16.7	0.7	12.3	1.3	9.0	16.8	14.5	1.1	3.9	3.2	3.9	2.0	3.7	10.0	1.6	0.0	4.0	3.0	0.7	1.8	5.2	3.5	3.1	0.7	2.1	0.0	13.5	0.4	1.0	2.0	1.4	1.3	0.7	1.5	1.8	1.9	0.6	0.3	0.1	0.0	1.4	0.2	0.0	3.0	1.0	0.6	0.1	7.1	10.2	4.5	0.0	0.1	1.1	0.4	1.6	0.2	0.3	1.4	0.5	0.0	0.8	2.4	4.2	1.9	0.8	1.1	1.0	5.2	3.4	1.6	3.6	0.0	2.2	1.5	2.8	0.0	0.3	2.2	1.3	1.9	2.2	0.1	1.8	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.1	0.2	0.0	2.9	0.1	0.1	2.1	0.1	0.0	0.0	0.0	0.0	13.0	12.0	11.9	15.3	11.6	12.1	13.9	15.4	11.8	12.3	14.5	10.0	4.5	12.8	10.5	181.8	15.6	1.0	6.9	3.0	5.2	0.2	9.9	7.0	0.9	15.7	7.1	14.7	37.5	17.5	0.3	10.1	31.3	4.4	97.1	33.3	8.5	4.7	4.9	2.7	29.7	2.7	3.7	1.5	6.6	51.9	0.0	1.4	5.7	17.0	1.5	11.8	4.3	5.5	4.1	0.3	0.8	80.5	2.8	0.9	1.8	9.4	0.1	13.4	0.0	82.4	1.7	2.3	9.3	1.5	6.3	2.8	34.3	14.0	27.9	19.7	0.0	1.2	1.7	28.2	6.7	6.8	4.7	42.4	1.9	5.0	5.3	7.0
GUCY2C	"GUC2C, STAR"	ENSG00000070019	"Guanylate cyclase 2C"	P25092	12	14612632-14696599	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"cGMP biosynthesis"	"Lyase, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"intestine: 68.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 34.4;Enteroendocrine cells: 176.7;Intestinal goblet cells: 56.0;Paneth cells: 97.9;Proximal enterocytes: 81.5;Undifferentiated cells: 47.6"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.9;stomach cancer: 9.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.4;CACO-2: 1.1;CAPAN-2: 1.7;SiHa: 1.6"	"Region enhanced"	"Detected in some"		"midbrain: 1.8"	"Low region specificity"	"Detected in all"			"HPA037655, HPA073759"	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"HPA037655: AB_10672388, HPA073759: "	"unprognostic (1.08e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.67e-3)"	"prognostic unfavorable (1.37e-5)"	"unprognostic (9.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.35e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.98e-1)"	0.5	0.2	0.1	3.4	0.3	0.5	0.0	0.2	0.1	0.0	3.0	37.2	68.2	0.3	0.0	1.9	0.0	0.9	2.2	0.2	0.3	0.4	0.3	0.2	0.4	0.4	0.3	0.0	2.2	0.0	0.0	0.2	0.4	0.3	41.4	0.1	0.6	0.0	0.7	1.0	66.5	1.4	0.5	0.2	1.9	0.4	0.3	0.0	0.5	0.0	0.3	0.5	0.2	0.5	0.4	0.0	0.0	1.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.1	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	1.6	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.3	1.1	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.2	0.1	0.3	0.2	0.1	0.2	0.3	0.4	0.3	0.4	0.5	0.3	0.5	0.0	0.0	0.0	1.3	6.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	34.4	0.0	0.0	0.1	0.1	0.0	0.0	176.7	0.0	1.4	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	56.0	0.0	0.3	0.3	0.2	0.0	0.3	0.0	1.0	0.3	0.0	0.0	1.0	0.2	0.4	97.9	0.0	0.1	0.0	81.5	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	47.6	0.0
HRK	DP5	ENSG00000135116	"Harakiri, BCL2 interacting protein"	O00198	12	116856144-116881441	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.4;choroid plexus: 4.5"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 14.6;Early spermatids: 11.3;Endometrial ciliated cells: 10.3;Enteroendocrine cells: 11.3;Excitatory neurons: 9.5;Paneth cells: 10.1"	"Cancer enhanced"	"Detected in many"		"melanoma: 2.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	30	"eosinophil: 1.3;memory B-cell: 3.6;naive B-cell: 3.9"	"Group enriched"	"Detected in many"	27	"B-cells: 3.9;granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 11.1;SCLC-21H: 9.1;SH-SY5Y: 7.8;SK-MEL-30: 22.0;U-698: 37.0"	"Low region specificity"	"Detected in all"							CAB025973	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"CAB025973: "	"unprognostic (9.38e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.54e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.24e-3)"	"unprognostic (5.21e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.42e-2)"	0.2	0.7	4.5	0.4	6.1	0.7	0.1	0.6	7.4	0.0	4.5	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.1	14.4	3.4	0.1	0.0	0.1	0.8	1.5	2.1	0.0	0.0	0.0	2.8	0.0	1.1	0.0	0.1	0.3	0.2	0.0	0.5	0.2	0.1	0.0	1.3	0.2	0.0	0.5	3.9	3.5	3.8	0.0	0.7	0.0	0.0	2.8	0.2	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	11.1	0.4	0.0	0.2	4.5	2.4	0.0	0.0	0.0	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.2	0.0	2.1	0.1	0.0	0.0	0.1	0.5	0.0	1.0	0.0	0.1	1.0	0.0	1.5	0.1	0.0	9.1	7.8	0.5	0.0	22.0	0.4	0.6	0.2	0.0	0.0	1.8	0.2	0.0	1.0	0.5	37.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	3.6	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.5	6.1	0.6	7.4	14.4	3.4	1.5	2.1	1.1	1.3	3.9	2.8	1.1	0.0	0.0	0.0	7.0	0.1	0.1	0.1	0.0	4.5	3.2	3.0	2.4	0.0	0.8	0.0	14.6	0.1	0.1	2.2	0.0	0.1	11.3	10.3	0.1	1.4	11.3	0.0	9.5	0.0	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.4	4.5	0.0	0.2	3.6	5.6	0.6	0.2	0.0	6.6	0.3	0.0	10.1	0.0	1.1	0.3	0.0	0.2	6.6	0.6	0.0	0.1	0.7	0.4	3.0	0.7	0.0	0.1	0.3	0.0	1.0	0.1
IGHA1		ENSG00000211895	"Immunoglobulin heavy constant alpha 1"	P01876	14	105703995-105708665	"Disease related genes, Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 7411.2;lymphoid tissue: 6397.6;salivary gland: 8904.9;stomach 1: 6664.9"	"Group enriched"	"Detected in many"	10	"B-cells: 17763.5;Plasma cells: 34095.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	203	"memory B-cell: 2571.8;naive B-cell: 1114.6"	"Lineage enriched"	"Detected in many"	284	"B-cells: 2571.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.4;RPMI-8226: 34.7;SH-SY5Y: 22.3;U-266/70: 78.2;U-266/84: 24.0"									"HPA001217, HPA006013"	Approved				"Immunoglobulin genes"	NA	NA		130000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA001217: AB_1079120, HPA006013: AB_1079119"	"prognostic favorable (8.87e-5)"	"unprognostic (5.36e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.75e-2)"	"prognostic favorable (3.81e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.86e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.83e-7)"	"unprognostic (8.10e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.99e-2)"	200.6	41.7	1.4	1121.1	1.0	918.5	953.5	0.7	6.5	214.3	4.2	5973.6	7411.2	79.9	3.5	641.9	203.5	662.9	73.8	0.6	1.3	278.5	327.7	1305.3	1420.6	3.5	1.1	40.6	115.1	3.5	38.3	6.7	1.1	202.5	1338.5	0.0	8904.9	69.0	10.8	56.7	3788.8	69.5	1.4	6397.6	6664.9	23.2	1.0	131.0	447.3	0.4	1949.0	1616.2	302.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.8	0.0	0.0	3.6	0.0	0.0	0.0	17.4	0.0	3.7	0.0	0.0	0.0	5.4	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.1	0.0	0.0	4.1	14.4	5.5	0.0	0.0	3.8	4.3	34.7	0.0	0.0	9.7	22.3	2.6	0.0	0.0	0.0	0.0	1.6	5.1	0.0	3.9	4.2	3.2	78.2	24.0	2.2	0.0	2.4	0.0	3.8	3.0	0.6	1.3	0.3	1.0	2571.8	0.7	1.1	1.5	1114.6	0.4	1.0	9.0	0.9	0.9	1.7	1.0	508.3	1.4	1.0	0.7	6.5	0.6	1.3	3.5	1.1	1.1	1.4	1.0	1.9	11.8	131.4	783.5	0.0	17763.5	0.0	26.0	0.0	1.2	0.0	22.4	4.6	4.7	22.8	46.4	0.0	0.0	0.7	55.5	20.8	0.0	0.0	0.0	0.1	0.1	26.5	28.4	167.0	0.0	0.0	0.5	56.5	99.4	0.1	584.8	0.0	353.8	225.1	1.6	0.0	0.0	13.6	0.0	57.8	0.0	0.0	0.0	34.6	0.0	0.0	6.7	0.0	11.3	0.0	0.0	0.0	12.8	0.0	34095.8	33.2	0.0	1.4	16.0	0.0	0.0	2.0	13.6	0.0	0.0	0.8	0.0	6.0	2514.2	0.0	27.9	1.2
IGHA2		ENSG00000211890	"Immunoglobulin heavy constant alpha 2 (A2m marker)"	P01877	14	105583731-105588395	"Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 5017.7;salivary gland: 3728.4"	"Group enriched"	"Detected in many"	22	"B-cells: 3713.4;Plasma cells: 10918.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	876	"memory B-cell: 279.6;naive B-cell: 123.8"	"Lineage enriched"	"Detected in single"	1214	"B-cells: 279.6"	"Group enriched"	"Detected in some"	42	"U-266/70: 181.9;U-266/84: 63.9"	"Not detected"	"Not detected"							"HPA001217, HPA006013"	Approved				"Immunoglobulin genes"	NA	NA		67000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA001217: AB_1079120, HPA006013: AB_1079119"	"prognostic favorable (1.98e-9)"	"unprognostic (3.20e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (8.40e-5)"	"unprognostic (4.56e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (7.50e-6)"	"unprognostic (2.12e-1)"	"unprognostic (3.28e-2)"	"unprognostic (9.70e-2)"	"unprognostic (4.47e-1)"	24.3	3.7	0.0	14.2	0.0	12.4	329.7	0.0	0.0	47.6	0.0	5017.7	15.3	8.9	0.0	219.7	35.0	0.9	4.8	0.0	0.0	49.7	35.1	134.2	6.8	0.0	0.0	5.3	30.3	0.0	4.9	0.3	0.0	37.7	8.8	0.0	3728.4	0.1	2.1	17.8	2261.3	1.0	0.0	700.9	670.1	1.1	0.0	22.4	59.8	0.0	13.0	93.4	67.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	2.8	2.8	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.1	0.0	0.9	181.9	63.9	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	279.6	0.0	0.1	0.1	123.8	0.0	0.1	0.2	0.0	0.1	0.1	0.1	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.2	12.4	0.0	3713.4	0.0	2.4	0.0	2.8	0.0	1.4	0.3	1.2	5.7	0.6	0.0	0.0	0.1	3.2	3.7	0.0	0.0	0.0	0.0	0.0	15.6	8.5	56.2	0.0	0.0	0.0	8.0	10.7	0.0	15.2	0.0	78.9	6.0	0.3	0.0	0.0	2.9	0.0	10.8	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.0	10918.5	0.3	0.0	0.1	0.0	0.0	0.0	0.1	23.6	0.0	0.0	12.3	0.0	0.4	325.4	0.0	4.8	0.2
IGHD2-15	"D2, IGHD215"	ENSG00000211918	"Immunoglobulin heavy diversity 2-15"		14	105897957-105897987	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"bone marrow: 2.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"endometrial cancer: 3.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	8	"naive B-cell: 39.9"	"Lineage enriched"	"Detected in single"	400	"B-cells: 39.9"	"Cell line enriched"	"Detected in single"	28	"HEL: 2.7"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"																						0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHG2		ENSG00000211893	"Immunoglobulin heavy constant gamma 2 (G2m marker)"	P01859	14	105639559-105644790	"FDA approved drug targets, Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"lymphoid tissue: 4319.4"	"Group enriched"	"Detected in some"	8	"B-cells: 2050.1;Plasma cells: 2918.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	447	"memory B-cell: 339.0;naive B-cell: 119.3"	"Lineage enriched"	"Detected in single"	661	"B-cells: 339.0"	"Group enriched"	"Detected in some"	4	"RH-30: 9.6;RPMI-8226: 25.1"									HPA001245	Approved				"Immunoglobulin genes"	NA	NA		250000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA001245: AB_1079121"	"prognostic favorable (3.53e-4)"	"unprognostic (6.88e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.40e-2)"	"prognostic favorable (3.30e-6)"	"unprognostic (1.06e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (4.30e-8)"	"unprognostic (4.72e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.40e-2)"	109.5	11.0	1.3	170.0	1.4	34.8	56.0	0.2	4.1	59.9	0.8	202.8	7.5	55.8	0.8	90.2	51.5	20.7	15.2	0.2	1.1	157.5	98.2	171.0	65.4	0.9	0.2	16.3	8.0	0.1	8.2	0.0	0.5	64.2	9.4	0.0	201.2	1.2	3.5	13.3	330.7	1.0	1.5	4319.4	87.2	2.3	0.3	16.7	134.4	0.0	226.0	100.4	104.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	25.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	339.0	0.5	0.0	0.3	119.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	34.5	1.3	1.4	0.2	4.1	0.2	1.1	0.9	0.2	0.5	1.5	0.3	1.8	0.2	54.5	305.3	0.0	2050.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	2.8	13.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.2	4.1	0.0	32.5	0.0	0.0	0.0	3.1	0.0	0.0	126.1	0.0	8.2	5.1	0.1	0.0	0.0	0.9	0.0	12.4	0.0	0.2	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2918.6	0.7	0.0	3.5	0.0	0.0	0.0	0.3	0.9	0.1	0.0	0.0	0.0	0.1	305.5	0.0	0.7	0.0
IGHG4		ENSG00000211892	"Immunoglobulin heavy constant gamma 4 (G4m marker)"	P01861	14	105620506-105626066	"FDA approved drug targets, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 2478.2"	"Group enriched"	"Detected in some"	10	"B-cells: 964.5;Plasma cells: 2099.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	457	"memory B-cell: 122.7;naive B-cell: 73.7"	"Lineage enriched"	"Detected in single"	571	"B-cells: 122.7"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 339.7"									HPA001245	Approved				"Immunoglobulin genes"	NA	NA		170000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA001245: AB_1079121"	"unprognostic (7.29e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.16e-4)"	"unprognostic (4.58e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.49e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.74e-2)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (9.09e-8)"	"unprognostic (2.84e-2)"	"unprognostic (4.23e-1)"	"unprognostic (9.24e-2)"	"unprognostic (7.72e-2)"	80.0	2.1	0.4	2478.2	0.6	42.2	5.8	0.5	1.0	33.9	0.3	40.6	85.5	10.8	0.2	401.2	28.5	101.3	19.2	0.3	0.4	44.0	43.7	49.4	136.5	0.6	0.4	3.9	4.2	0.5	1.9	0.2	1.3	31.2	44.3	0.1	16.4	4.1	0.8	4.7	186.2	1.8	1.1	831.6	57.4	2.2	0.4	49.9	108.3	0.0	872.5	588.7	29.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	43.2	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.3	0.6	339.7	0.0	0.0	3.5	3.7	0.3	0.2	0.0	0.0	0.1	0.0	1.0	0.0	0.9	0.3	1.5	0.6	0.1	57.5	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	122.7	0.0	0.0	0.1	73.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	19.6	0.4	0.6	0.5	1.0	0.3	0.4	0.6	0.4	1.3	1.1	0.4	0.3	1.3	6.4	118.8	0.0	964.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	7.0	8.6	3.7	0.0	0.0	0.0	0.3	11.5	0.0	0.0	0.2	0.0	0.4	2.5	27.8	26.7	0.0	0.0	0.0	4.3	0.0	0.0	50.4	0.0	16.4	36.7	0.0	0.0	0.0	10.5	0.0	51.9	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.3	0.0	2099.3	0.2	0.0	10.6	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	152.3	0.0	12.8	0.1
IGHJ1		ENSG00000211905	"Immunoglobulin heavy joining 1"	A0A0C4DH62	14	105865407-105865458	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	4	"intestine: 354.8;lymphoid tissue: 414.0;salivary gland: 120.1;stomach 1: 305.5"	"Cell type enriched"	"Detected in single"	18	"Plasma cells: 1.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 1.9"	"Group enriched"	"Detected in some"	72	"memory B-cell: 276.3;naive B-cell: 180.8;plasmacytoid DC: 99.0"	"Group enriched"	"Detected in many"	73	"B-cells: 276.3;dendritic cells: 99.0"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.7;U-698: 1.8"														"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (5.28e-3)"	"unprognostic (2.05e-2)"	"unprognostic (6.81e-2)"	"unprognostic (9.53e-2)"		"prognostic favorable (3.55e-4)"		"unprognostic (2.51e-1)"			"unprognostic (2.45e-1)"			"unprognostic (3.00e-2)"	"unprognostic (2.90e-2)"			8.6	5.3	0.1	196.9	0.1	35.6	72.8	0.0	1.9	18.6	0.2	260.2	354.8	3.3	0.0	15.7	5.2	12.6	1.4	0.1	0.1	2.3	6.1	28.5	46.8	1.3	0.0	8.2	3.1	0.4	0.0	0.7	0.5	4.3	182.6	0.0	120.1	0.5	0.0	0.0	171.1	12.0	0.3	100.2	305.5	1.0	0.2	14.6	2.9	0.0	414.0	61.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.2	276.3	0.6	2.5	0.2	180.8	0.3	0.3	0.0	0.1	0.1	99.0	0.2	29.1	0.1	0.1	0.0	1.9	0.1	0.1	1.3	0.0	0.5	0.3	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHJ4		ENSG00000240041	"Immunoglobulin heavy joining 4"		14	105864215-105864260	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 416.7;lymphoid tissue: 1568.0;urinary bladder: 551.2"	"Cell type enriched"	"Detected in single"	148	"Plasma cells: 103.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	187	"memory B-cell: 6029.7;naive B-cell: 2618.0"	"Lineage enriched"	"Detected in all"	261	"B-cells: 6029.7"	"Cell line enriched"	"Detected in some"	87	"U-698: 3990.3"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"																					0.0	0.0	7.2	0.0	2.9	0.0	240.0	0.9	10.8	0.0	3.6	377.5	0.0	0.0	0.0	200.2	7.4	4.1	12.3	0.9	2.5	0.0	39.1	0.0	0.0	8.9	30.7	0.0	0.0	13.6	0.0	2.5	22.3	7.0	416.7	0.0	0.0	0.0	0.0	20.7	0.0	0.0	2.0	45.4	7.3	3.7	3.1	32.3	3.9	0.0	1568.0	551.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	14.0	17.5	0.0	0.0	0.0	0.0	6.8	3.6	0.0	0.0	0.0	0.0	0.0	8.9	0.0	45.8	0.0	0.0	6.2	0.0	3990.3	0.0	12.2	0.0	13.9	3.6	5.4	5.0	1.3	3.0	6029.7	13.2	4.0	23.1	2618.0	1.5	6.0	20.1	3.3	6.0	0.0	6.6	1048.2	7.2	2.9	0.9	10.8	0.9	2.5	8.9	30.7	22.3	2.0	3.1	1.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV1-2	V35	ENSG00000211934	"Immunoglobulin heavy variable 1-2"	P23083	14	105986582-105987083	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 462.7;lymphoid tissue: 1157.3"	"Cell type enriched"	"Detected in some"	38	"Plasma cells: 609.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	52	"memory B-cell: 285.2;naive B-cell: 347.4"	"Lineage enriched"	"Detected in many"	57	"B-cells: 347.4"	"Cell line enriched"	"Detected in some"	8	"U-266/70: 14302.7"														"Immunoglobulin genes"	NA	NA		4000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.63e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.46e-2)"	"unprognostic (5.78e-2)"	"prognostic favorable (1.67e-5)"	"unprognostic (9.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (2.17e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.17e-2)"	16.7	43.1	0.3	364.1	0.2	76.0	84.1	0.0	1.2	41.5	0.5	462.7	223.7	13.1	1.3	34.5	58.5	54.4	26.2	0.0	0.1	13.7	18.9	60.7	404.9	0.4	0.0	36.5	3.0	0.6	1.3	0.6	0.2	23.2	283.8	0.0	222.4	52.5	0.4	4.5	121.9	7.5	0.2	393.2	216.1	35.0	0.1	72.1	33.7	0.0	1157.3	255.5	8.9	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	4.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.8	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	2.6	0.0	0.0	2.3	0.4	2.8	0.0	0.0	3.1	0.6	0.5	0.0	0.0	1.3	1.8	0.1	0.0	0.6	0.0	0.0	0.2	0.3	0.0	1.5	0.0	1.3	14302.7	1755.5	0.5	0.0	0.4	0.0	0.3	0.6	0.1	0.3	0.0	0.2	285.2	1.6	0.7	0.2	347.4	1.5	0.6	6.1	0.2	0.3	0.5	1.1	34.0	0.3	0.2	0.0	1.2	0.0	0.1	0.4	0.0	0.2	0.2	0.1	0.6	0.0	0.0	1.3	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	4.6	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	609.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0
IGHV1-69D		ENSG00000280411	"Immunoglobulin heavy variable 1-69D"	A0A0B4J2H0	14	106762092-106762588	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 2878.6;stomach 1: 989.1"	"Group enriched"	"Detected in some"	6	"Plasma cells: 5.8;T-cells: 1.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	225	"memory B-cell: 184.5;naive B-cell: 433.4"	"Lineage enriched"	"Detected in many"	316	"B-cells: 433.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.8;HL-60: 2.3;MOLT-4: 4.2;RPMI-8226: 2.5;U-266/70: 3.3;U-698: 7.9"														"Immunoglobulin genes"	NA	NA		1200000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"				"unprognostic (3.32e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.49e-4)"	"prognostic favorable (2.88e-4)"	"unprognostic (1.66e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (2.72e-8)"	"unprognostic (5.14e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.08e-2)"	26.1	95.3	0.1	462.7	0.1	113.1	146.7	0.0	0.7	37.5	1.0	628.2	491.2	15.0	16.8	98.6	16.0	78.0	20.2	0.0	0.1	17.5	46.6	149.6	2878.6	1.1	0.0	35.9	3.3	0.6	1.1	0.4	0.1	16.5	406.2	0.0	385.0	100.0	0.5	5.2	121.3	43.8	0.2	452.7	989.1	6.8	0.0	135.7	38.3	0.0	2219.2	295.4	11.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	4.2	0.3	1.3	0.0	0.0	0.9	0.8	2.5	0.0	0.0	0.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.6	0.4	3.3	0.1	7.9	0.0	0.7	0.0	0.8	0.3	0.1	0.0	0.0	0.2	184.5	0.3	0.0	0.2	433.4	0.4	0.1	0.4	0.2	0.4	1.3	0.2	33.5	0.1	0.1	0.0	0.7	0.0	0.1	1.1	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0
IGHV1OR21-1	IGHV1/OR21-1	ENSG00000277282	"Immunoglobulin heavy variable 1/OR21-1 (non-functional)"		21	10649400-10649835	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"intestine: 3.3;lymphoid tissue: 6.3;stomach 1: 3.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"lung cancer: 2.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"memory B-cell: 2.0;naive B-cell: 1.7"	"Lineage enriched"	"Detected in single"	15	"B-cells: 2.0"	"Cell line enhanced"	"Detected in single"		"U-266/70: 1.1"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"					"unprognostic (3.93e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.28e-2)"			"unprognostic (8.48e-5)"		"unprognostic (2.59e-1)"			"unprognostic (3.45e-1)"			"unprognostic (1.53e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.32e-1)"		0.0	0.6	0.0	3.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	3.3	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	1.4	0.6	0.0	0.9	3.4	0.1	0.0	0.5	0.0	0.0	6.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV3-7		ENSG00000211938	"Immunoglobulin heavy variable 3-7"	P01780	14	106062151-106062683	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 461.3;lymphoid tissue: 971.3"	"Cell type enriched"	"Detected in some"	255	"Plasma cells: 20463.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 18.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	147	"memory B-cell: 134.0;naive B-cell: 107.0"	"Lineage enriched"	"Detected in single"	163	"B-cells: 134.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.6;HL-60: 3.1;K-562: 3.0;NB-4: 3.0;RPMI-8226: 5.8;SH-SY5Y: 4.8;TIME: 2.9"														"Immunoglobulin genes"	NA	NA		39000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.29e-2)"	"unprognostic (5.57e-3)"	"unprognostic (1.37e-2)"			"prognostic favorable (1.47e-6)"	"unprognostic (1.00e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (4.35e-5)"	"unprognostic (5.18e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.70e-2)"	47.8	10.1	0.7	50.1	1.0	71.1	202.7	0.3	0.8	87.4	0.6	461.3	154.1	37.7	8.2	17.8	13.4	37.0	2.2	0.2	0.4	17.6	20.3	56.4	102.5	1.6	2.8	24.7	4.8	2.9	1.8	0.3	2.3	9.2	303.5	0.0	265.5	22.9	1.3	9.6	206.0	3.6	3.9	610.4	230.4	13.2	0.4	0.0	21.1	0.1	971.3	42.9	14.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.0	0.0	0.0	0.0	0.0	3.0	0.5	0.0	0.0	0.4	2.6	5.8	0.0	0.0	2.3	4.8	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.7	0.0	1.2	1.6	0.0	0.1	0.0	0.6	0.0	0.4	0.8	0.2	0.1	0.0	0.2	134.0	0.2	0.2	0.3	107.0	0.1	0.1	0.1	0.1	0.2	0.6	0.2	12.6	0.7	1.0	0.3	0.8	0.2	0.4	1.6	2.8	2.3	3.9	0.4	1.3	0.0	0.0	0.0	0.0	80.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	30.5	0.0	5.3	0.0	0.0	0.0	4.4	31.1	0.0	0.0	0.0	2.2	1.9	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20463.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	0.0	7.4	0.0	0.5	0.0
IGHV3-72		ENSG00000225698	"Immunoglobulin heavy variable 3-72"	A0A0B4J1Y9	14	106790691-106791233	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 75.7;lymphoid tissue: 121.6;urinary bladder: 101.3"	"Cell type enriched"	"Detected in some"	271	"Plasma cells: 3507.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	5	"memory B-cell: 52.4"	"Lineage enriched"	"Detected in many"	50	"B-cells: 52.4"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.3;RH-30: 1.3;RPMI-8226: 1.2;TIME: 2.2;U-698: 5.8"														"Immunoglobulin genes"	NA	NA		9600000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (9.10e-6)"	"unprognostic (2.18e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.93e-2)"		"prognostic favorable (8.57e-5)"	"unprognostic (9.14e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.27e-2)"	"prognostic unfavorable (4.40e-4)"	"unprognostic (9.29e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.32e-1)"	4.8	2.6	0.1	18.4	0.1	15.5	7.0	0.0	0.6	5.2	0.1	75.7	28.4	3.0	2.9	17.4	3.4	0.3	0.3	0.0	0.0	1.9	5.3	8.6	2.7	0.5	0.0	2.3	3.4	0.1	0.2	0.1	0.1	1.9	47.6	0.0	46.6	0.9	0.1	0.3	58.2	5.4	0.1	121.6	29.4	0.0	0.0	2.6	2.2	0.5	12.1	101.3	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	1.3	0.2	0.0	0.0	0.1	1.3	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.1	0.0	0.3	0.0	5.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	52.4	0.1	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.1	0.1	0.0	0.6	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.1	7.1	0.0	0.0	0.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3507.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0
IGHV3-73		ENSG00000211976	"Immunoglobulin heavy variable 3-73"	A0A0B4J1V6	14	106802694-106803233	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 141.8;lymphoid tissue: 83.0;urinary bladder: 81.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 6.1;Cholangiocytes: 1.5;Erythroid cells: 5.3;Plasma cells: 3.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	86	"memory B-cell: 69.9;naive B-cell: 42.9"	"Lineage enriched"	"Detected in single"	107	"B-cells: 69.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.4;HEL: 1.1;HL-60: 1.1;K-562: 1.7"														"Immunoglobulin genes"	NA	NA		3200000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 57: B-cells - Immune response"				"prognostic favorable (7.89e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.79e-2)"		"prognostic favorable (7.25e-7)"	"unprognostic (4.23e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.40e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.37e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (4.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.25e-2)"	"unprognostic (4.37e-2)"	4.4	13.3	0.0	9.4	0.0	15.8	10.5	0.0	0.5	4.7	0.3	76.9	141.8	5.1	0.0	4.0	3.9	19.1	10.4	0.0	0.0	3.0	9.8	12.3	0.0	0.1	0.0	1.5	5.9	0.0	0.5	0.1	0.2	4.3	58.0	0.0	30.6	3.9	0.4	0.2	23.6	0.4	0.1	83.0	47.5	0.4	0.0	0.0	4.1	0.0	0.2	81.7	2.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	69.9	0.1	0.0	0.0	42.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0
IGHV3OR16-9	IGHV3/OR16-9	ENSG00000270472	"Immunoglobulin heavy variable 3/OR16-9 (non-functional)"		16	32066065-32066358	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 73.2;lymphoid tissue: 88.5;stomach 1: 79.0;urinary bladder: 54.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	136	"memory B-cell: 20.0;naive B-cell: 7.1"	"Lineage enriched"	"Detected in single"	200	"B-cells: 20.0"	"Not detected"	"Not detected"																	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"						"unprognostic (1.32e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.49e-3)"			"prognostic favorable (1.29e-4)"		"unprognostic (2.29e-1)"		"unprognostic (5.22e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.55e-1)"	11.1	9.8	0.1	32.9	0.0	13.7	17.1	0.3	0.6	8.3	0.0	73.2	45.8	0.9	0.0	26.5	1.5	8.3	2.9	0.0	0.1	0.8	3.7	9.1	13.0	0.6	0.0	6.2	1.3	0.1	0.0	0.0	0.4	1.1	37.7	0.0	49.3	0.0	0.0	0.0	38.6	0.3	0.4	27.0	79.0	0.3	0.1	8.6	0.1	0.0	88.5	54.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.3	0.6	0.0	0.1	0.6	0.0	0.4	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV7-4-1		ENSG00000282122	"Immunoglobulin heavy variable 7-4-1"	A0A0J9YVY3	14	106025145-106025630	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 97.4;lymphoid tissue: 133.9"	"Cell type enriched"	"Detected in some"	4	"Plasma cells: 4.7"					"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	109	"memory B-cell: 8.3;naive B-cell: 13.5"	"Lineage enriched"	"Detected in single"	136	"B-cells: 13.5"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 5.4"														"Immunoglobulin genes"	NA	NA		560000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"																					3.9	2.9	0.3	58.3	0.0	39.0	21.1	0.0	0.6	7.7	0.2	60.8	8.3	0.5	0.0	4.7	0.8	3.1	0.8	0.0	0.0	2.1	2.8	49.1	7.5	0.0	0.0	0.9	0.7	0.0	0.2	0.0	0.0	2.6	97.4	0.0	42.2	8.7	0.3	0.2	42.9	0.2	0.1	68.5	24.2	0.2	0.0	45.6	5.9	0.0	133.9	10.4	2.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV7-81		ENSG00000211979	"Immunoglobulin heavy variable 7-81 (non-functional)"	A0A0B4J1V7	14	106874583-106875071	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 12.7;lymphoid tissue: 18.3;stomach 1: 12.3"	"Group enriched"	"Detected in some"	12	"B-cells: 1.5;Plasma cells: 1.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"memory B-cell: 5.5;naive B-cell: 3.9"	"Lineage enriched"	"Detected in single"	14	"B-cells: 5.5"	"Cell line enhanced"	"Detected in some"		"A549: 1.1;Daudi: 6.1;OE19: 1.2;U-698: 2.0"														"Immunoglobulin genes"	NA	NA		270000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"				"unprognostic (5.71e-4)"	"unprognostic (3.87e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.85e-2)"		"unprognostic (2.67e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.07e-1)"		"unprognostic (1.14e-2)"	"unprognostic (6.16e-5)"	"unprognostic (1.69e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.63e-2)"	0.1	0.1	0.0	8.4	0.0	4.6	3.6	0.0	0.0	0.3	0.0	7.6	6.4	0.4	0.0	0.6	0.3	7.9	0.2	0.0	0.0	0.3	0.2	1.8	4.2	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	2.3	12.7	0.0	5.0	0.1	0.0	0.2	6.2	0.4	0.0	2.3	12.3	0.1	0.0	1.4	0.0	0.0	18.3	1.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.2	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.5	0.3	0.1	0.0	3.9	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKC	HCAK1	ENSG00000211592	"Immunoglobulin kappa constant"		2	88857161-88857683	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in all"		"intestine: 35196.7;lymphoid tissue: 63075.6"	"Group enriched"	"Detected in many"	12	"B-cells: 72318.1;Plasma cells: 96515.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	21	"memory B-cell: 39143.0;naive B-cell: 35081.5"	"Lineage enriched"	"Detected in all"	23	"B-cells: 39143.0"	"Group enriched"	"Detected in many"	6	"Daudi: 9909.1;U-266/70: 10337.6;U-266/84: 3927.9;U-698: 12154.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB015377	Uncertain				"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB015377: AB_2251264"	"prognostic favorable (6.59e-4)"	"unprognostic (1.04e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.06e-2)"	"unprognostic (8.82e-3)"	"prognostic favorable (1.18e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.81e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (2.17e-9)"	"unprognostic (1.85e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.59e-1)"	1025.4	2379.8	13.1	20500.0	13.3	6315.2	11287.7	11.3	33.6	3649.2	26.7	35196.7	24515.5	877.3	474.1	5708.4	1137.6	5995.3	810.4	11.4	16.7	1176.6	1580.5	5824.2	21356.1	25.1	18.2	2214.9	462.9	72.6	101.8	22.2	15.3	843.6	30618.3	4.0	19606.1	2123.2	32.9	250.8	17061.1	1259.7	43.5	26904.1	22740.5	1083.9	13.4	8576.0	2151.1	8.1	63075.6	24817.5	705.0	20.2	17.1	0.0	0.0	0.0	0.0	0.0	103.7	0.0	0.0	0.1	0.0	0.0	0.0	9909.1	15.3	0.0	1.0	22.2	0.0	0.0	0.0	510.2	0.0	30.9	0.0	0.0	0.0	67.8	29.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.8	0.4	0.0	0.0	18.3	83.2	28.8	0.0	0.0	16.7	56.4	1509.5	0.6	0.0	79.6	146.1	19.6	1.5	6.0	0.5	0.5	17.2	66.7	0.0	56.9	24.3	44.0	10337.6	3927.9	12154.4	0.0	28.9	0.0	47.5	55.6	31.6	24.6	11.2	21.7	39143.0	28.3	18.3	46.6	35081.5	15.2	16.8	65.2	24.1	29.1	1735.4	23.7	8567.0	13.1	13.3	11.3	33.6	11.4	16.7	25.1	18.2	15.3	43.5	13.4	20.2	58.6	336.5	1863.8	0.0	72318.1	0.0	189.2	0.0	2.2	0.0	8.8	7.0	5.7	163.0	88.5	0.0	0.0	48.0	452.1	39.8	3.9	0.0	2.8	0.7	0.3	72.8	77.8	1658.9	0.0	0.2	37.3	186.5	64.7	0.4	849.0	15.5	340.2	334.8	8.9	0.0	0.0	35.1	0.0	496.3	0.0	11.0	0.0	64.4	0.0	0.0	26.4	0.0	59.8	0.0	0.0	0.0	25.9	0.4	96515.7	193.2	0.3	45.2	12.4	0.0	0.0	3.7	38.4	0.3	0.2	5.9	0.0	49.4	6505.3	0.1	50.2	1.9
IGKJ1	J1	ENSG00000211597	"Immunoglobulin kappa joining 1"	A0A0A0MT89	2	88861886-88861923	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	5	"intestine: 3082.3;lymphoid tissue: 3301.5;salivary gland: 1202.6;stomach 1: 2816.8;urinary bladder: 1106.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	418	"memory B-cell: 38345.4;naive B-cell: 32121.1;plasmacytoid DC: 14778.6"	"Group enriched"	"Detected in all"	390	"B-cells: 38345.4;dendritic cells: 14778.6"	"Cell line enriched"	"Detected in many"	4	"U-266/70: 21925.7"														"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"																					70.6	227.2	1.9	3301.5	1.5	424.8	363.1	1.3	9.2	71.7	5.0	1960.8	3082.3	41.6	0.0	278.0	18.1	157.4	31.0	3.2	2.2	31.7	92.0	382.5	839.3	3.4	2.4	127.7	50.3	2.0	0.0	6.3	2.9	50.4	1743.7	0.2	1202.6	16.4	6.9	8.8	2231.5	61.2	3.4	1516.0	2816.8	31.2	2.1	115.3	6.2	0.0	2770.1	1106.5	0.0	2.9	22.9	0.0	0.0	0.0	0.0	0.0	62.7	0.0	0.0	0.0	0.0	7.4	0.0	9.9	2.5	0.0	0.0	14.6	0.0	0.0	0.0	851.1	0.0	10.1	0.0	0.0	0.0	34.5	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	10.3	12.1	11.8	0.0	0.0	23.1	0.0	4365.8	0.0	0.0	10.3	18.7	0.0	0.0	4.9	0.0	0.0	31.0	0.0	0.0	9.7	2.4	34.6	21925.7	5461.9	93.7	0.0	6.3	0.0	48.3	44.8	22.7	19.1	17.9	25.4	38345.4	27.2	13.8	57.2	32121.1	20.1	20.9	68.0	38.9	26.9	14778.6	29.9	3897.0	1.9	1.5	1.3	9.2	3.2	2.2	3.4	2.4	2.9	3.4	2.1	2.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKJ2	J2	ENSG00000211596	"Immunoglobulin kappa joining 2"		2	88861525-88861563	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 2670.6;lymphoid tissue: 2226.1;salivary gland: 1187.7;stomach 1: 1719.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	50	"memory B-cell: 22200.6;naive B-cell: 20663.6"	"Lineage enriched"	"Detected in all"	52	"B-cells: 22200.6"	"Group enriched"	"Detected in many"	7	"HDLM-2: 213.9;RPMI-8226: 179.1"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"																					67.9	154.0	0.6	1862.6	0.9	296.5	312.9	0.1	4.0	158.7	0.7	1762.7	2670.6	37.5	0.0	308.3	14.3	114.1	19.6	0.6	0.6	27.0	61.7	236.7	693.3	4.3	1.4	71.6	72.5	1.9	0.0	1.1	1.2	46.0	1364.3	0.0	1187.7	20.2	2.9	5.2	1974.3	28.2	1.5	1097.1	1719.7	44.8	0.9	73.5	5.1	0.0	2226.1	494.7	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.1	0.0	0.0	3.5	0.0	0.0	0.0	213.9	0.0	9.7	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	8.0	3.6	0.0	0.0	7.4	2.5	179.1	0.0	0.0	3.2	17.5	4.8	0.0	0.0	0.0	0.0	29.6	10.7	0.0	3.4	3.7	7.6	5.3	0.0	29.0	0.0	1.8	0.0	19.7	33.6	12.8	10.3	7.7	12.8	22200.6	15.0	8.1	23.3	20663.6	9.5	9.6	42.6	10.8	18.6	430.3	17.4	2451.2	0.6	0.9	0.1	4.0	0.6	0.6	4.3	1.4	1.2	1.5	0.9	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
IGKJ4		ENSG00000211594	"Immunoglobulin kappa joining 4"		2	88860886-88860922	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 3282.9;lymphoid tissue: 2905.5;stomach 1: 2295.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	42	"memory B-cell: 36413.7;naive B-cell: 27723.7"	"Lineage enriched"	"Detected in all"	48	"B-cells: 36413.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 16.9;Daudi: 23.5;HDLM-2: 58.4;RPMI-8226: 43.3;SH-SY5Y: 27.6;U-698: 25.7"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 44: HDLM-2 - Immune response"																						80.0	268.7	0.6	2905.5	0.7	407.6	414.6	0.3	4.1	110.0	0.5	1844.1	3282.9	29.5	62.5	433.0	33.3	138.1	34.8	0.6	1.1	48.2	104.6	481.3	932.6	2.9	0.7	117.5	29.3	1.7	0.0	1.3	1.3	56.4	1849.6	0.3	1142.3	54.8	3.9	17.3	2184.0	78.1	2.6	1246.0	2295.9	39.7	1.8	113.5	11.4	0.0	2661.5	645.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.0	0.0	0.0	0.0	9.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	2.0	10.4	0.0	0.0	0.0	0.0	9.1	43.3	0.0	0.0	6.7	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	7.3	8.5	3.3	0.0	25.7	0.0	0.0	0.0	114.4	64.9	20.3	24.9	9.5	16.8	36413.7	15.8	15.2	32.5	27723.7	22.7	16.1	60.0	21.5	25.4	759.9	22.8	3519.3	0.6	0.7	0.3	4.1	0.6	1.1	2.9	0.7	1.3	2.6	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1-16	"IGKV116, L1"	ENSG00000240864	"Immunoglobulin kappa variable 1-16"	P04430	2	89099859-89100361	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 279.7;lymphoid tissue: 597.8;urinary bladder: 260.3"	"Cell type enriched"	"Detected in some"	559	"Plasma cells: 18463.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	523	"memory B-cell: 164.7;naive B-cell: 112.8"	"Lineage enriched"	"Detected in single"	621	"B-cells: 164.7"	"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.0"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		10000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (2.63e-4)"	"unprognostic (7.81e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.61e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.35e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (2.84e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.84e-2)"	"unprognostic (5.82e-2)"	11.8	4.7	0.1	159.1	0.1	40.0	75.9	0.0	0.8	76.0	0.6	279.7	199.4	6.3	0.5	34.3	6.6	99.0	11.4	0.0	0.1	9.2	14.9	40.5	155.0	0.2	0.0	17.7	2.0	0.1	3.6	0.1	0.1	5.6	235.6	0.0	126.9	30.9	0.8	0.7	143.6	11.8	0.1	315.4	158.9	2.0	0.1	45.7	18.4	0.0	597.8	260.3	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.1	0.2	1.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	164.7	0.0	0.0	0.1	112.8	0.0	0.1	0.2	0.0	0.0	0.0	0.0	16.9	0.1	0.1	0.0	0.8	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.6	21.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18463.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0
IGKV1-17	"A30, IGKV117"	ENSG00000240382	"Immunoglobulin kappa variable 1-17"	P01599	2	89117342-89117844	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 375.0;lymphoid tissue: 454.4"	"Cell type enriched"	"Detected in some"	113	"Plasma cells: 4510.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	425	"memory B-cell: 105.7;naive B-cell: 82.2"	"Lineage enriched"	"Detected in single"	478	"B-cells: 105.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.9;K-562: 1.2;RPMI-8226: 2.0;SH-SY5Y: 1.4"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		8400000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"unprognostic (7.72e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.37e-3)"	"unprognostic (1.78e-2)"	"unprognostic (5.08e-3)"	"prognostic favorable (4.11e-4)"	"unprognostic (8.04e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (3.44e-7)"	"unprognostic (3.12e-3)"	"unprognostic (8.83e-2)"	"unprognostic (3.80e-1)"	"unprognostic (7.28e-2)"	12.8	26.5	0.1	183.7	0.2	27.7	87.1	0.0	0.7	11.9	0.4	358.5	294.8	6.6	4.1	54.7	12.4	55.7	10.9	0.0	0.1	10.3	14.2	36.5	95.7	0.6	0.0	12.4	3.3	1.1	1.0	0.1	0.2	5.5	375.0	0.0	134.3	31.0	1.3	1.2	152.7	4.7	0.1	306.1	159.7	2.4	0.3	45.6	25.8	0.0	454.4	182.6	6.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.8	2.0	0.0	0.0	0.5	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	105.7	0.0	0.0	0.1	82.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	12.6	0.1	0.2	0.0	0.7	0.0	0.1	0.6	0.0	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	39.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	11.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4510.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0
IGKV1-27	"A20, IGKV127"	ENSG00000244575	"Immunoglobulin kappa variable 1-27"	A0A075B6S5	2	89213423-89213928	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 268.0;lymphoid tissue: 347.1;salivary gland: 177.6"	"Cell type enriched"	"Detected in some"	126	"Plasma cells: 4951.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	683	"memory B-cell: 152.7;naive B-cell: 185.3"	"Lineage enriched"	"Detected in single"	748	"B-cells: 185.3"	"Cell line enhanced"	"Detected in single"		"BEWO: 1.8"					"Not detected"	"Not detected"			HPA048721	Approved				"Immunoglobulin genes"	NA	NA		8300000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (2.56e-5)"	"unprognostic (6.50e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.72e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (9.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.99e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (8.84e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.67e-2)"	17.2	9.2	0.0	133.5	0.0	28.5	70.0	0.0	0.4	16.8	0.1	268.0	183.3	6.2	7.7	30.4	6.9	37.5	10.7	0.1	0.1	11.8	9.7	55.2	124.7	0.7	0.3	8.8	4.9	0.2	1.0	0.0	0.1	6.4	212.3	0.0	177.6	8.8	0.6	0.9	200.2	5.1	0.2	276.9	91.9	1.0	0.0	46.9	19.4	0.0	347.1	87.7	6.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.4	0.6	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	152.7	0.1	0.1	0.1	185.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	15.8	0.0	0.0	0.0	0.4	0.1	0.1	0.7	0.3	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.3	12.2	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4951.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0
IGKV1-37	"IGKV137, O14"	ENSG00000239862	"Immunoglobulin kappa variable 1-37 (non-functional)"	A0A075B6S9	2	89297264-89297785	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 8.2;lymphoid tissue: 17.2;urinary bladder: 5.6"	"Cell type enriched"	"Detected in some"	24	"Plasma cells: 73.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	247	"memory B-cell: 21.2;naive B-cell: 28.2"	"Lineage enriched"	"Detected in single"	283	"B-cells: 28.2"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "								"unprognostic (3.47e-1)"						"unprognostic (1.17e-1)"				0.1	0.2	0.0	2.9	0.0	0.8	2.4	0.0	0.0	0.5	0.0	4.5	3.1	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.4	1.2	2.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	2.6	0.6	0.0	0.0	2.0	0.2	0.0	3.7	1.5	0.0	0.0	0.9	0.1	0.0	17.2	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1-39		ENSG00000242371	"Immunoglobulin kappa variable 1-39"	P01597	2	89319625-89320146	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 108.5;lymphoid tissue: 254.9;salivary gland: 151.2;stomach 1: 83.2"	"Cell type enriched"	"Detected in some"	151	"Plasma cells: 16225.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 13.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	388	"memory B-cell: 1069.8;naive B-cell: 935.1"	"Lineage enriched"	"Detected in many"	415	"B-cells: 1069.8"	"Cell line enriched"	"Detected in some"	21	"Daudi: 194.2"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		8000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (1.76e-4)"	"unprognostic (5.10e-3)"	"unprognostic (4.71e-2)"			"prognostic favorable (1.70e-5)"		"unprognostic (2.38e-1)"		"unprognostic (7.33e-2)"	"unprognostic (1.78e-1)"		"unprognostic (6.62e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.27e-1)"	"unprognostic (2.25e-1)"	10.9	9.1	0.0	54.7	0.1	14.2	17.7	0.0	0.1	21.8	0.0	108.5	70.5	5.7	0.0	11.6	12.5	14.3	1.5	0.2	0.0	10.9	6.8	27.2	36.5	0.0	0.0	1.8	3.2	0.0	0.5	0.0	0.2	4.2	13.3	0.0	151.2	0.9	0.2	1.3	74.4	1.2	0.0	254.9	83.2	0.3	0.0	5.9	31.0	0.0	42.5	17.5	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	194.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	1.8	0.0	9.0	0.0	0.0	0.0	0.9	1.0	0.7	0.3	0.3	0.3	1069.8	0.5	0.4	1.1	935.1	0.3	0.6	2.5	0.4	0.6	1.3	0.8	136.4	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	10.7	0.0	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16225.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	4.9	0.0	0.3	0.0
IGKV1-5		ENSG00000243466	"Immunoglobulin kappa variable 1-5"	P01602	2	88947301-88947957	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 777.1;lymphoid tissue: 1459.2;urinary bladder: 945.2"	"Cell type enriched"	"Detected in some"	240	"Plasma cells: 39194.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	364	"memory B-cell: 859.0;naive B-cell: 860.5"	"Lineage enriched"	"Detected in many"	364	"B-cells: 860.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.0;HL-60: 2.4;RPMI-8226: 5.0;SCLC-21H: 2.9;SH-SY5Y: 4.5"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		8400000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (1.19e-4)"	"unprognostic (1.26e-2)"	"unprognostic (3.12e-3)"	"unprognostic (5.00e-3)"	"unprognostic (1.59e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (7.60e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (4.36e-8)"	"unprognostic (1.14e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.17e-2)"	35.8	82.0	0.2	639.7	0.2	115.4	233.9	0.1	1.6	115.8	0.6	777.1	528.7	17.1	2.0	146.2	86.9	124.8	18.7	0.1	0.5	36.2	32.0	125.3	387.2	1.0	0.2	60.8	10.8	0.5	3.0	0.4	0.3	16.7	745.0	0.0	392.2	34.8	0.9	3.2	429.7	24.4	1.3	915.4	456.3	11.5	0.2	155.3	58.4	0.0	1459.2	945.2	28.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.4	1.6	0.5	0.0	0.0	0.3	1.0	5.0	0.0	0.0	2.9	4.5	0.2	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.4	0.7	0.4	0.6	0.1	0.4	0.0	0.6	0.0	0.7	1.2	1.3	0.5	0.2	0.4	859.0	2.3	0.3	1.0	860.5	0.2	0.3	1.4	0.4	0.6	0.7	0.6	113.5	0.2	0.2	0.1	1.6	0.1	0.5	1.0	0.2	0.3	1.3	0.2	0.5	0.0	0.0	0.6	0.0	163.2	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	7.0	89.7	0.0	0.0	0.0	0.7	3.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39194.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	11.8	0.0	0.2	0.0
IGKV1-6		ENSG00000239855	"Immunoglobulin kappa variable 1-6"	A0A0C4DH72	2	88966262-88966767	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 155.5;lymphoid tissue: 606.3"	"Cell type enriched"	"Detected in some"	33	"Plasma cells: 877.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	801	"memory B-cell: 123.6;naive B-cell: 85.7"	"Lineage enriched"	"Detected in single"	946	"B-cells: 123.6"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA		12000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (3.44e-5)"	"unprognostic (5.25e-3)"	"unprognostic (3.78e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.23e-2)"	"prognostic favorable (1.81e-4)"	"unprognostic (3.86e-3)"	"unprognostic (3.86e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (4.37e-6)"	"unprognostic (5.23e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.54e-1)"	8.2	1.7	0.1	84.1	0.1	37.0	50.3	0.0	0.4	16.5	0.1	155.5	110.5	4.0	4.1	23.5	5.0	18.1	5.3	0.0	0.0	7.7	6.3	20.0	82.3	0.1	0.1	4.0	1.8	0.0	1.1	0.0	0.0	4.3	145.9	0.0	95.0	2.2	0.2	0.6	59.1	5.1	0.2	209.5	130.3	0.7	0.0	22.7	16.4	0.0	606.3	144.8	8.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	123.6	0.0	0.0	0.1	85.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.1	0.1	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	877.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0
IGKV1-9	"IGKV19, L8"	ENSG00000241755	"Immunoglobulin kappa variable 1-9"	A0A0C4DH69	2	89009982-89010515	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 428.1;lymphoid tissue: 671.3;stomach 1: 283.7"	"Cell type enriched"	"Detected in some"	116	"Plasma cells: 7178.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Group enriched"	"Detected in some"	705	"memory B-cell: 300.5;naive B-cell: 296.8"	"Lineage enriched"	"Detected in single"	709	"B-cells: 300.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.2;NB-4: 1.0;RPMI-8226: 2.9;TIME: 1.2"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		4500000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (2.10e-7)"	"unprognostic (1.30e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.70e-2)"	"prognostic favorable (4.91e-4)"	"unprognostic (3.30e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (6.04e-8)"	"unprognostic (4.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.40e-1)"	12.6	12.6	0.2	184.3	0.4	53.6	202.8	0.0	1.3	15.8	0.4	428.1	267.0	8.3	0.8	52.9	78.3	30.0	13.9	0.1	0.1	15.4	17.9	40.1	201.8	0.3	0.1	20.7	2.5	0.5	1.3	0.1	0.2	12.8	348.6	0.0	221.3	13.3	0.5	1.6	182.8	13.3	0.4	313.1	283.7	35.1	0.1	85.1	34.2	0.0	671.3	187.5	8.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	1.0	0.3	0.0	0.0	0.0	0.9	2.9	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.1	0.0	0.5	0.0	0.2	0.0	0.2	0.0	0.2	0.4	0.1	0.2	0.0	0.1	300.5	0.1	0.0	0.3	296.8	0.0	0.1	0.3	0.2	0.2	0.1	0.3	34.5	0.2	0.4	0.0	1.3	0.1	0.1	0.3	0.1	0.2	0.4	0.1	0.3	0.0	0.0	0.0	0.0	61.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.7	0.0	0.0	0.0	1.8	0.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7178.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0
IGKV1D-13		ENSG00000276566	"Immunoglobulin kappa variable 1D-13"	"A0A0B4J2D9, P0DP09"	2	90154073-90154574	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 103.7;lymphoid tissue: 317.6"	"Cell type enriched"	"Detected in some"	141	"Plasma cells: 6195.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	733	"memory B-cell: 480.8;naive B-cell: 331.6"	"Lineage enriched"	"Detected in single"	868	"B-cells: 480.8"	"Cell line enhanced"	"Detected in single"		"Daudi: 1.0"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		370000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (4.68e-6)"	"unprognostic (4.10e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.71e-3)"		"unprognostic (3.01e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.68e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.60e-2)"	4.8	0.4	0.0	101.2	0.0	34.8	34.3	0.0	0.0	46.6	0.0	85.6	21.7	5.4	0.0	17.9	10.2	2.5	3.5	0.0	0.0	8.1	6.4	39.4	317.6	0.0	0.0	1.0	1.9	0.0	0.4	0.0	0.1	3.1	78.3	0.0	54.2	1.4	0.0	1.1	103.7	6.8	0.0	102.8	20.3	2.7	0.0	29.0	7.2	0.0	223.2	45.9	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.3	0.1	0.1	0.2	480.8	0.2	0.1	0.5	331.6	0.0	0.0	0.4	0.1	0.1	0.2	0.1	42.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.1	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6195.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1D-17		ENSG00000242766	"Immunoglobulin kappa variable 1D-17"	A0A075B6S4	2	90082635-90083291	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 6.8;lymphoid tissue: 12.5;salivary gland: 5.7"	"Cell type enriched"	"Detected in some"	13	"Plasma cells: 36.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	60	"memory B-cell: 7.7;naive B-cell: 4.1"	"Lineage enriched"	"Detected in single"	78	"B-cells: 7.7"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA		1000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"		"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (1.47e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.44e-1)"		"prognostic favorable (5.68e-4)"		"unprognostic (1.19e-1)"		"unprognostic (6.18e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.74e-5)"	"unprognostic (1.38e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.04e-3)"	1.3	0.1	0.1	5.1	0.1	0.9	0.8	0.1	0.2	0.3	0.8	6.8	1.5	0.2	0.0	0.5	0.8	0.6	0.0	0.1	0.1	0.3	0.4	1.5	0.8	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	2.2	0.0	5.7	0.3	0.0	0.4	4.7	0.4	0.1	12.5	2.0	0.0	0.1	0.3	0.5	0.0	4.5	1.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1OR2-108	"IGKV1/OR2-108, IGKV1OR2108, IGO1"	ENSG00000231292	"Immunoglobulin kappa variable 1/OR2-108 (non-functional)"		2	113406396-113406872	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 38.2;lymphoid tissue: 56.7"	"Cell type enriched"	"Detected in single"	652	"Plasma cells: 65.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	55	"memory B-cell: 13.5;naive B-cell: 12.2"	"Lineage enriched"	"Detected in single"	58	"B-cells: 13.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.6;HBEC3-KT: 7.2;hTEC/SVTERT24-B: 4.1;REH: 4.1"	"Not detected"	"Not detected"							HPA048721	Approved					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (1.53e-6)"	"unprognostic (2.73e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.37e-1)"		"unprognostic (3.64e-3)"	"unprognostic (3.57e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (9.96e-6)"	"unprognostic (6.95e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.95e-1)"	0.5	1.4	0.1	23.3	0.4	11.2	16.7	0.0	0.3	4.8	5.6	38.2	21.8	0.3	0.0	6.8	0.4	5.5	0.2	0.8	0.0	0.1	1.4	6.9	14.0	0.1	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.9	22.1	0.1	15.2	0.5	0.1	4.8	13.9	0.8	0.0	12.7	16.9	0.0	0.1	3.8	1.3	0.0	56.7	21.7	0.1	0.0	2.1	0.7	0.3	0.0	0.0	0.0	0.4	0.0	2.2	0.3	1.5	3.0	1.2	6.6	0.0	0.9	1.1	0.3	0.0	7.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	4.1	2.4	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.6	0.4	0.0	1.6	4.1	0.6	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.6	0.0	1.3	0.2	0.2	0.1	1.2	0.1	0.4	0.4	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	13.5	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.1	0.4	0.0	0.3	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV2-40		ENSG00000273962	"Immunoglobulin kappa variable 2-40"	A0A087WW87	2	89330110-89330429	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 42.8;urinary bladder: 34.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	48	"memory B-cell: 15.4;naive B-cell: 7.1"	"Lineage enriched"	"Detected in single"	66	"B-cells: 15.4"	"Cell line enhanced"	"Detected in single"		"Daudi: 1.7"														"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"												"unprognostic (3.31e-1)"						"unprognostic (1.94e-2)"				0.4	0.1	0.0	9.3	0.0	1.1	6.7	0.0	0.1	10.2	0.0	9.7	42.8	0.9	0.0	10.5	15.5	0.1	0.1	0.0	0.0	0.3	1.4	10.9	0.9	0.0	0.0	3.2	0.0	0.0	0.1	0.0	0.0	1.1	7.1	0.0	5.9	2.0	0.0	0.1	6.2	0.0	0.0	17.8	19.6	0.2	0.0	1.9	1.2	0.1	6.2	34.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV2D-28		ENSG00000242534	"Immunoglobulin kappa variable 2D-28"	P01615	2	89959979-89960754	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 221.6;lymphoid tissue: 462.7;salivary gland: 259.7"	"Cell type enriched"	"Detected in some"	98	"Plasma cells: 4332.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	224	"memory B-cell: 3054.0;naive B-cell: 2203.9"	"Lineage enriched"	"Detected in all"	260	"B-cells: 3054.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.0;RPMI-8226: 2.0;SCLC-21H: 1.9;SH-SY5Y: 4.3;U-698: 4.4"														"Immunoglobulin genes"	NA	NA		3500000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (3.88e-3)"	"unprognostic (2.68e-2)"				"unprognostic (2.51e-3)"		"unprognostic (1.22e-1)"		"unprognostic (1.13e-1)"	"unprognostic (4.17e-1)"			"unprognostic (1.13e-1)"	"unprognostic (2.66e-1)"			9.9	4.8	0.1	162.1	0.2	23.3	35.2	0.0	1.5	7.6	0.3	203.7	221.6	8.3	1.2	113.5	14.0	26.1	4.8	0.3	0.4	11.5	13.3	40.6	166.6	0.7	0.2	2.8	1.9	0.1	0.9	0.4	0.4	11.1	65.9	0.0	259.7	19.2	0.3	1.4	143.3	8.7	0.2	462.7	186.4	5.7	0.2	40.9	37.8	0.3	192.0	157.9	8.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	1.1	0.0	0.0	0.0	5.0	0.0	1.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.4	0.1	0.0	0.0	0.7	0.0	2.0	0.0	0.0	1.9	4.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.6	1.3	0.0	4.4	0.0	1.1	0.0	11.7	7.8	1.2	1.2	0.5	1.3	3054.0	1.3	0.9	2.0	2203.9	0.2	0.9	2.2	1.0	1.5	1.4	1.3	248.7	0.1	0.2	0.0	1.5	0.3	0.4	0.7	0.2	0.4	0.2	0.2	0.3	0.0	0.0	0.0	0.0	44.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4332.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	31.5	0.0	0.1	0.0
IGKV2D-30		ENSG00000239571	"Immunoglobulin kappa variable 2D-30"	A0A075B6S6	2	89936859-89937679	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.3;lymphoid tissue: 33.5;stomach 1: 22.2"	"Cell type enriched"	"Detected in some"	222	"Plasma cells: 1314.8"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	379	"memory B-cell: 124.9;naive B-cell: 164.0"	"Lineage enriched"	"Detected in single"	430	"B-cells: 164.0"	"Cell line enriched"	"Detected in some"	6	"U-698: 51.7"														"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.17e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.58e-1)"			"unprognostic (2.98e-4)"		"unprognostic (5.74e-3)"		"unprognostic (3.19e-2)"	"unprognostic (1.10e-1)"			"unprognostic (4.12e-2)"	"unprognostic (3.55e-1)"			0.4	0.4	0.0	6.4	0.0	4.3	5.9	0.0	0.1	0.8	0.0	15.3	11.8	0.4	0.0	1.0	0.4	0.8	0.8	0.1	0.1	1.4	0.7	2.8	6.7	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.1	0.5	11.2	0.0	13.0	4.6	0.0	1.2	8.5	2.0	0.0	29.3	22.2	0.1	0.0	1.6	0.8	0.0	33.5	5.6	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	51.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	124.9	0.0	0.1	0.1	164.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	19.3	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1314.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0
IGKV3-15		ENSG00000244437	"Immunoglobulin kappa variable 3-15"	P01624	2	89085177-89085787	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 785.8;lymphoid tissue: 1996.3;urinary bladder: 784.8"	"Cell type enriched"	"Detected in some"	85	"Plasma cells: 22923.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	561	"memory B-cell: 2243.8;naive B-cell: 1651.4"	"Lineage enriched"	"Detected in all"	646	"B-cells: 2243.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.7;K-562: 1.3;NB-4: 1.9;RH-30: 1.2;RPMI-8226: 2.2;SCLC-21H: 1.4;SH-SY5Y: 2.5"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		7200000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (1.57e-4)"	"unprognostic (1.29e-2)"	"unprognostic (7.02e-3)"	"unprognostic (3.89e-3)"	"unprognostic (9.06e-3)"	"unprognostic (2.06e-3)"	"unprognostic (5.36e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (3.15e-7)"	"unprognostic (2.00e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.17e-1)"	47.9	114.5	0.0	603.8	0.1	131.0	174.3	0.0	1.5	141.8	0.3	785.8	431.4	19.4	34.7	120.0	30.0	144.4	14.8	0.1	0.3	35.2	36.7	184.8	500.9	0.7	0.3	55.4	9.3	2.5	3.0	0.5	0.3	18.3	649.4	0.0	399.3	114.2	1.0	2.7	335.8	29.5	1.5	1020.7	629.8	64.8	0.2	250.2	77.7	0.0	1996.3	784.8	28.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.4	1.9	0.6	0.0	0.0	0.0	1.2	2.2	0.0	0.0	1.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.4	0.7	0.5	0.0	0.0	0.0	1.0	0.0	1.8	3.4	0.8	1.0	0.4	0.8	2243.8	1.0	1.1	1.8	1651.4	1.0	1.1	1.9	1.0	1.3	1.7	1.5	193.1	0.0	0.1	0.0	1.5	0.1	0.3	0.7	0.3	0.3	1.5	0.2	1.0	0.0	0.0	0.0	0.0	269.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	2.6	73.4	0.0	0.0	0.0	1.4	1.1	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	22923.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	252.5	0.0	0.0	0.2	0.0	0.0	28.2	0.0	0.0	0.0
IGKV3-20		ENSG00000239951	"Immunoglobulin kappa variable 3-20"	P01619	2	89142574-89143160	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 3080.6;lymphoid tissue: 5246.5"	"Cell type enriched"	"Detected in some"	138	"Plasma cells: 52154.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	329	"memory B-cell: 1602.7;naive B-cell: 1222.4"	"Lineage enriched"	"Detected in many"	373	"B-cells: 1602.7"	"Group enriched"	"Detected in many"	215	"U-266/70: 3769.9;U-266/84: 1732.3"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		20000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (1.86e-4)"	"unprognostic (4.16e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.93e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.07e-6)"	"unprognostic (7.35e-2)"	"unprognostic (5.08e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.70e-2)"	104.8	56.4	0.9	1791.2	0.9	380.3	736.4	0.5	4.2	326.9	2.6	3080.6	1714.2	59.0	7.8	302.1	105.2	637.2	55.7	0.5	1.6	106.2	113.5	454.0	2815.6	2.1	8.4	153.5	32.8	5.8	9.6	1.8	1.4	56.1	2731.8	0.2	1270.5	224.5	3.3	13.4	1355.8	82.8	10.4	2699.1	1412.9	24.7	1.2	671.5	224.3	1.8	5246.5	1644.0	70.0	1.5	2.5	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.5	0.0	0.0	2.3	0.0	0.0	0.0	0.5	0.0	2.1	0.0	0.0	0.0	6.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	2.0	5.9	2.8	0.0	0.0	3.0	6.0	10.4	0.0	0.0	7.7	12.8	1.4	0.0	0.1	0.0	0.0	0.8	4.4	0.0	2.0	1.5	4.3	3769.9	1732.3	1.8	0.0	2.3	0.0	4.0	1.2	0.7	0.7	0.4	0.8	1602.7	0.8	0.6	3.5	1222.4	0.4	0.7	4.2	0.8	1.0	0.9	0.8	196.9	0.9	0.9	0.5	4.2	0.5	1.6	2.1	8.4	1.4	10.4	1.2	1.5	0.1	3.2	1.3	0.0	376.9	0.0	0.0	0.0	5.2	0.0	0.1	0.1	0.0	4.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	9.4	0.0	0.0	0.0	55.3	124.4	0.0	1.3	0.0	3.6	5.0	0.1	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	52154.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.0	0.0	0.0	26.7	0.0	0.2	0.0
IGKV3-7		ENSG00000243063	"Immunoglobulin kappa variable 3-7 (non-functional)"	A0A075B6H7	2	88978468-88979081	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.6;lymphoid tissue: 22.2;salivary gland: 15.9;stomach 1: 10.2"	"Group enriched"	"Detected in some"	37	"B-cells: 1.5;Plasma cells: 5.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	61	"memory B-cell: 27.8;naive B-cell: 24.3"	"Lineage enriched"	"Detected in single"	65	"B-cells: 27.8"	"Not detected"	"Not detected"											HPA047702	Approved				"Immunoglobulin genes"	NA	NA		850000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (1.17e-4)"	"unprognostic (3.07e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.28e-2)"		"unprognostic (1.20e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (1.27e-5)"	"unprognostic (1.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.64e-2)"	0.3	0.4	0.0	15.0	0.0	4.2	3.9	0.0	0.0	2.1	0.0	18.6	15.1	0.3	0.1	1.5	0.1	1.3	0.0	0.0	0.0	0.2	0.5	1.8	2.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	13.6	0.0	15.9	0.1	0.0	0.0	11.2	0.7	0.0	4.9	10.2	0.0	0.0	1.4	0.1	0.0	22.2	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.8	0.0	0.0	0.0	24.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV3D-11		ENSG00000211632	"Immunoglobulin kappa variable 3D-11"	A0A0A0MRZ8	2	90172802-90173414	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.6;lymphoid tissue: 58.5;stomach 1: 27.7"	"Cell type enriched"	"Detected in some"	34	"Plasma cells: 196.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	468	"memory B-cell: 152.5;naive B-cell: 146.1"	"Lineage enriched"	"Detected in single"	478	"B-cells: 152.5"	"Cell line enhanced"	"Detected in single"		"U-266/70: 2.1"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		6700000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (6.40e-5)"	"unprognostic (7.90e-3)"	"unprognostic (1.91e-2)"	"unprognostic (2.24e-3)"		"prognostic favorable (5.58e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.61e-1)"	"prognostic unfavorable (2.20e-6)"	"unprognostic (1.12e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.24e-2)"	1.3	0.7	0.3	35.9	0.2	8.9	6.4	0.0	0.1	1.7	0.0	38.6	32.2	0.8	0.0	2.4	2.1	2.7	0.5	0.0	0.1	2.1	1.3	12.4	13.0	0.1	0.3	1.5	0.5	0.0	0.1	0.0	0.1	0.7	26.6	0.0	18.8	0.3	0.0	0.1	23.6	0.7	0.2	29.9	27.7	0.2	0.0	4.2	2.3	0.0	58.5	17.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.8	0.4	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	152.5	0.0	0.0	0.1	146.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	30.2	0.3	0.2	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	196.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0
IGKV3D-15		ENSG00000224041	"Immunoglobulin kappa variable 3D-15"	A0A087WSY6	2	90114838-90115402	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 126.7;lymphoid tissue: 203.0;salivary gland: 54.1;stomach 1: 87.4;urinary bladder: 58.0"	"Cell type enriched"	"Detected in some"	622	"Plasma cells: 3673.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	191	"memory B-cell: 181.1;naive B-cell: 155.6"	"Lineage enriched"	"Detected in single"	206	"B-cells: 181.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.0;HL-60: 2.6;SiHa: 1.7"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		4800000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (6.11e-4)"	"prognostic favorable (7.46e-4)"	"unprognostic (9.16e-3)"	"unprognostic (1.74e-1)"		"unprognostic (1.90e-3)"	"unprognostic (7.20e-2)"	"unprognostic (9.19e-2)"	"unprognostic (4.93e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (1.82e-6)"	"unprognostic (8.99e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.04e-1)"	3.1	4.4	0.1	93.5	0.4	11.1	17.1	0.1	0.5	5.9	0.3	111.6	63.0	1.0	0.0	16.4	5.2	10.1	2.3	0.1	0.2	3.6	2.0	18.0	43.6	0.4	0.2	17.9	4.0	0.3	0.1	0.0	0.2	1.7	126.7	0.0	54.1	1.1	0.1	0.6	46.7	4.3	0.3	56.3	87.4	0.2	0.1	13.0	4.5	0.0	203.0	58.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.6	0.0	0.6	0.0	0.1	0.8	0.0	0.0	0.0	0.0	181.1	0.0	0.0	0.1	155.6	0.0	0.0	0.0	0.1	0.1	0.0	0.1	27.5	0.1	0.4	0.1	0.5	0.1	0.2	0.4	0.2	0.2	0.3	0.1	0.3	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3673.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
IGKV4-1	"B3, IGKV41"	ENSG00000211598	"Immunoglobulin kappa variable 4-1"	P06312	2	88885397-88886153	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1805.7;lymphoid tissue: 3169.0"	"Cell type enriched"	"Detected in some"	219	"Plasma cells: 46306.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	588	"memory B-cell: 3036.3;naive B-cell: 3070.9"	"Lineage enriched"	"Detected in all"	591	"B-cells: 3070.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 14.9;RPMI-8226: 10.4;SH-SY5Y: 6.9;U-266/70: 7.5"														"Immunoglobulin genes"	NA	NA		8500000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (6.41e-5)"	"unprognostic (9.19e-2)"	"unprognostic (4.29e-3)"	"unprognostic (5.42e-3)"	"unprognostic (2.08e-2)"	"prognostic favorable (8.25e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.32e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.19e-1)"	55.9	296.3	0.4	1054.1	0.9	342.1	665.2	0.4	3.4	145.2	2.4	1805.7	1769.7	46.8	19.4	195.7	41.3	188.2	51.9	0.4	1.2	35.0	76.1	302.3	816.8	1.9	0.8	86.5	28.3	2.5	2.8	1.0	3.5	43.9	1318.2	0.1	701.8	89.6	1.0	8.6	1023.0	66.4	3.6	972.3	1125.7	125.7	0.7	405.1	51.0	0.1	3169.0	758.2	19.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.9	0.0	1.7	0.0	0.0	0.0	3.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.6	3.6	0.3	0.0	0.0	1.4	2.2	10.4	0.0	0.0	4.0	6.9	2.3	0.0	0.0	0.0	0.0	0.7	2.6	0.0	0.8	1.1	1.0	7.5	0.2	0.8	0.0	1.2	0.0	3.9	3.2	5.1	1.6	0.9	1.7	3036.3	1.9	1.1	2.8	3070.9	2.1	1.3	2.4	1.6	2.4	2.3	1.7	344.9	0.4	0.9	0.4	3.4	0.4	1.2	1.9	0.8	3.5	3.6	0.7	1.5	0.0	0.0	0.0	0.0	210.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	8.0	0.0	0.0	0.0	17.0	40.2	0.0	0.0	0.0	2.2	2.8	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	46306.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	15.7	0.0	0.1	0.0
IGKV6D-21	"A10, IGKV6D21"	ENSG00000225523	"Immunoglobulin kappa variable 6D-21 (non-functional)"	A0A0A0MT36	2	90021567-90022185	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	7	"intestine: 67.0;lymphoid tissue: 152.7;urinary bladder: 227.3"	"Cell type enriched"	"Detected in some"	7	"Plasma cells: 234.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	154	"memory B-cell: 14.2;naive B-cell: 16.5"	"Lineage enriched"	"Detected in single"	166	"B-cells: 16.5"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (1.95e-4)"	"unprognostic (5.47e-3)"	"unprognostic (2.85e-3)"			"prognostic favorable (5.25e-5)"		"unprognostic (1.51e-1)"		"unprognostic (1.86e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (3.45e-7)"	"unprognostic (7.23e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.07e-1)"	1.1	0.4	0.0	17.2	0.0	17.2	11.8	0.0	0.1	5.4	0.0	67.0	38.8	1.6	0.0	22.1	0.8	2.7	2.1	0.2	0.0	1.6	2.4	6.3	19.8	0.6	0.0	1.1	1.1	0.0	0.0	0.0	0.1	0.8	31.8	0.0	21.1	17.3	0.0	1.2	37.8	1.0	0.0	45.3	13.4	3.4	0.0	9.1	1.4	0.0	152.7	227.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	234.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IGKV6D-41		ENSG00000211626	"Immunoglobulin kappa variable 6D-41 (non-functional)"	A0A0C4DH26	2	90069662-90070238	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 4.7;intestine: 3.4;lymphoid tissue: 2.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"lung cancer: 0.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	40	"memory B-cell: 3.0;naive B-cell: 4.9"	"Lineage enriched"	"Detected in single"	49	"B-cells: 4.9"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		32000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"											"unprognostic (3.64e-2)"						"unprognostic (4.43e-1)"				0.0	1.3	0.0	1.3	0.0	0.0	0.1	0.0	0.0	4.7	0.0	3.4	0.9	0.0	0.0	0.3	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.5	1.1	0.2	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLC1	IGLC	ENSG00000211675	"Immunoglobulin lambda constant 1"		22	22895375-22895834	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 3264.2;lymphoid tissue: 5586.9;stomach 1: 2335.3"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 37.3;granulocytes: 15.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	743	"memory B-cell: 5729.2;naive B-cell: 5821.4"	"Lineage enriched"	"Detected in all"	749	"B-cells: 5821.4"	"Cell line enriched"	"Detected in many"	5	"U-266/70: 600.3"														"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"																					132.3	163.1	2.2	1208.8	1.9	641.9	903.4	1.7	7.0	190.8	4.4	3038.0	3264.2	63.1	2.1	535.0	113.2	640.0	104.5	1.7	2.2	148.2	114.7	470.6	2372.4	3.9	1.7	135.6	69.8	8.0	13.2	1.9	2.2	71.5	2133.6	0.7	2047.0	124.0	4.9	28.8	1389.9	78.0	2.6	3332.0	2335.3	23.7	2.3	873.2	224.5	0.0	5586.9	1948.8	79.3	3.4	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.4	0.0	0.0	0.0	1.0	0.0	1.9	0.2	0.0	0.0	6.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	9.1	0.0	0.0	1.1	10.2	2.0	0.0	0.0	2.3	8.9	33.4	0.0	0.0	6.3	11.1	1.4	0.0	0.0	0.0	0.0	0.3	2.5	0.0	1.3	4.3	2.6	600.3	119.9	36.5	0.0	3.5	0.0	4.2	7.7	2.0	3.7	1.7	2.9	5729.2	3.8	2.5	6.0	5821.4	0.9	2.2	7.6	2.8	4.8	5.2	3.4	897.2	2.2	1.9	1.7	7.0	1.7	2.2	3.9	1.7	2.2	2.6	2.3	3.4	0.0	6.4	37.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0
IGLC2	IGLC	ENSG00000211677	"Immunoglobulin lambda constant 2"	P0DOY2	22	22900976-22901437	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Bence-Jones protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 9734.6;lymphoid tissue: 19988.7;stomach 1: 10849.9"	"Group enriched"	"Detected in many"	40	"B-cells: 24632.2;Plasma cells: 18795.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	36	"memory B-cell: 11361.1;naive B-cell: 10650.3"	"Lineage enriched"	"Detected in all"	37	"B-cells: 11361.1"	"Group enriched"	"Detected in many"	190	"RPMI-8226: 62032.1;U-266/70: 102644.1;U-266/84: 83511.6"														"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (5.76e-5)"	"unprognostic (2.29e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.46e-2)"	"unprognostic (4.02e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (1.96e-2)"	"unprognostic (7.52e-2)"	"unprognostic (7.15e-2)"	"unprognostic (7.69e-3)"	"unprognostic (2.83e-1)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (4.47e-9)"	"unprognostic (2.00e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	386.6	782.7	7.7	3871.2	6.2	2741.4	2183.6	4.6	14.9	815.5	11.4	8217.0	9734.6	194.3	207.0	1690.0	231.5	2091.8	318.3	4.6	5.7	301.6	382.3	1442.8	5543.4	11.1	5.0	540.2	112.7	16.8	31.0	7.5	6.6	264.0	5055.4	0.7	5934.2	384.9	8.6	74.2	5290.6	306.2	6.6	7090.0	10849.9	256.0	5.4	2071.4	491.7	0.6	19988.7	6482.1	176.7	10.7	120.6	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	221.4	12.0	0.0	0.0	61.9	0.0	0.0	0.0	30.5	0.0	7.7	0.0	0.0	0.0	19.2	343.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	64.7	0.0	0.0	70.1	27.7	52.3	0.0	0.0	45.3	436.2	62032.1	0.0	0.0	46.7	45.7	5.6	43.0	17.3	0.0	17.7	57.2	11.7	0.0	38.9	23.4	78.2	102644.1	83511.6	298.8	0.7	21.9	0.7	9.9	18.6	5.6	5.8	3.0	5.7	11361.1	5.8	4.5	10.9	10650.3	3.5	4.7	118.0	5.8	8.7	303.3	6.5	2385.6	7.7	6.2	4.6	14.9	4.6	5.7	11.1	5.0	6.6	6.6	5.4	10.7	4.1	32.1	121.0	0.0	24632.2	0.0	0.3	0.0	1.2	0.0	16.1	3.0	3.9	44.3	8.1	0.0	0.0	0.3	8.0	28.0	0.0	0.0	0.0	0.0	0.1	86.3	62.5	222.4	0.0	0.0	0.3	42.5	14.8	0.0	65.6	0.0	222.8	539.9	2.1	0.0	0.0	21.5	0.0	134.5	0.0	0.0	0.0	8.5	0.0	0.0	11.4	0.0	15.5	0.0	0.0	0.0	20.6	0.0	18795.5	0.0	0.0	1.4	1.5	0.0	0.0	0.2	10.2	0.0	0.0	2.8	0.0	0.1	538.6	0.0	23.7	0.0
IGLC3	IGLC	ENSG00000211679	"Immunoglobulin lambda constant 3 (Kern-Oz+ marker)"	P0DOY3	22	22906342-22906803	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Bence-Jones protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 4115.7;lymphoid tissue: 8175.8;stomach 1: 4130.0;urinary bladder: 3726.3"	"Group enriched"	"Detected in many"	35	"B-cells: 12202.8;Plasma cells: 5357.3;T-cells: 3582.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	34	"memory B-cell: 7254.6;naive B-cell: 6119.2"	"Lineage enriched"	"Detected in all"	37	"B-cells: 7254.6"	"Cell line enriched"	"Detected in many"	15	"RPMI-8226: 10741.3"									"CAB000050, CAB016533"	Supported				"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB000050: , CAB016533: AB_629719"	"prognostic favorable (2.32e-4)"	"unprognostic (1.18e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.54e-2)"	"unprognostic (8.41e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (5.45e-2)"	"unprognostic (4.59e-2)"	"unprognostic (8.77e-2)"	"prognostic favorable (4.58e-4)"	"unprognostic (9.71e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.04e-9)"	"unprognostic (1.21e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.97e-2)"	156.2	550.9	2.6	2377.2	2.7	840.6	1388.6	1.4	9.1	220.4	7.1	4115.7	4046.3	115.2	33.2	508.5	88.0	707.7	63.7	1.3	2.8	178.6	171.7	1081.6	2745.8	7.2	1.4	247.8	47.6	7.0	19.0	3.2	2.0	134.0	2268.4	0.3	2264.0	177.1	5.8	20.7	2373.2	113.9	3.4	4261.5	4130.0	55.4	2.1	426.9	232.0	0.9	8175.8	3726.3	111.5	6.4	0.6	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	60.1	0.7	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	18.3	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	338.0	0.0	0.0	10.8	15.0	2.8	0.0	0.0	700.2	9.3	10741.3	0.0	0.0	16.6	25.1	4.4	20.8	0.0	0.0	4.9	0.8	11.1	0.0	6.3	7.2	5.0	88.0	103.4	36.1	1.2	5.3	0.5	6.4	9.1	3.9	6.0	2.0	27.3	7254.6	5.1	3.6	6.9	6119.2	2.6	3.3	60.7	4.3	4.6	195.3	4.7	1415.5	2.6	2.7	1.4	9.1	1.3	2.8	7.2	1.4	2.0	3.4	2.1	6.4	2.0	22.4	97.3	0.0	12202.8	0.0	0.7	0.0	0.0	0.0	5.4	0.5	15.3	8.6	3.7	0.0	0.0	0.2	8.8	5.0	0.0	0.0	0.0	0.0	0.1	7.4	12.2	54.8	0.0	0.0	0.0	22.1	5.6	0.1	47.9	0.0	195.9	127.7	0.2	0.0	0.0	3.5	0.0	23.1	0.0	0.0	0.0	5.6	0.0	0.0	2.0	0.0	2.1	0.0	0.0	0.0	3.1	0.0	5357.3	0.2	0.0	1.1	2.2	0.0	0.0	0.0	4.2	0.0	0.0	0.8	0.0	0.1	3582.0	0.0	6.3	0.9
IGLJ3		ENSG00000211678	"Immunoglobulin lambda joining 3"		22	22904850-22905025	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	7	"intestine: 552.2;lymphoid tissue: 227.6;salivary gland: 149.1;stomach 1: 462.5;urinary bladder: 147.8"	"Group enriched"	"Detected in some"	44	"B-cells: 4.5;Plasma cells: 4.3"	"Group enriched"	"Detected in some"	13	"colorectal cancer: 5.1;endometrial cancer: 10.3"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.5"	"Group enriched"	"Detected in many"	24	"memory B-cell: 1223.9;naive B-cell: 1139.6"	"Lineage enriched"	"Detected in many"	25	"B-cells: 1223.9"	"Group enriched"	"Detected in some"	7	"Daudi: 53.6;REH: 69.6;U-266/70: 42.8;U-266/84: 22.5"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"						"unprognostic (1.19e-1)"	"unprognostic (2.06e-3)"				"unprognostic (2.05e-1)"						"unprognostic (1.37e-1)"	"unprognostic (5.00e-1)"			5.7	29.4	0.4	212.4	0.3	37.4	32.5	0.1	1.5	9.7	0.4	130.1	552.2	3.2	0.0	40.0	4.0	32.7	3.1	0.1	0.1	2.9	9.9	41.7	132.1	0.4	0.2	31.1	1.9	0.0	0.0	0.1	0.1	9.6	71.4	0.0	149.1	1.6	0.0	1.5	205.9	6.1	0.0	207.6	462.5	6.1	0.1	23.2	0.8	0.0	227.6	147.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	53.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	69.6	2.5	6.7	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	1.0	42.8	22.5	4.3	0.0	0.0	0.0	0.8	1.6	0.7	0.9	0.3	4.3	1223.9	0.8	0.5	1.3	1139.6	0.4	0.5	8.5	0.6	1.2	49.2	0.8	193.9	0.4	0.3	0.1	1.5	0.1	0.1	0.4	0.2	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLL5		ENSG00000254709	"Immunoglobulin lambda like polypeptide 5"	B9A064	22	22887780-22896111	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 408.3;lymphoid tissue: 674.1;stomach 1: 308.1"	"Cell type enriched"	"Detected in some"	55	"Melanocytes: 93931.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	226	"memory B-cell: 515.9;naive B-cell: 615.5"	"Lineage enriched"	"Detected in many"	246	"B-cells: 615.5"	"Group enriched"	"Detected in some"	7	"Daudi: 637.2;U-266/70: 386.4;U-698: 441.1"														"Secreted to blood"	NA	NA		53000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"				"prognostic favorable (6.10e-4)"	"unprognostic (7.64e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.82e-2)"	"prognostic favorable (3.41e-5)"	"unprognostic (1.76e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (5.94e-8)"	"unprognostic (1.85e-1)"	"unprognostic (4.63e-1)"	"unprognostic (8.52e-2)"	"unprognostic (6.50e-2)"	16.3	25.1	0.3	164.8	0.2	94.4	139.3	0.1	1.2	32.8	0.4	405.6	408.3	7.8	0.0	50.4	14.7	67.3	11.2	0.1	0.1	17.0	15.9	65.7	308.5	0.4	0.1	18.6	11.0	1.5	1.5	0.2	0.2	8.3	249.4	0.1	279.3	22.2	0.5	2.7	181.5	8.8	0.4	458.8	308.1	4.3	0.2	123.6	26.2	0.2	674.1	223.5	10.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	637.2	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.3	3.6	0.9	0.0	0.0	0.6	1.0	0.4	0.0	0.1	0.0	0.0	0.9	1.4	0.0	1.9	0.1	0.2	386.4	68.5	441.1	0.0	0.3	0.0	0.4	0.7	0.2	0.3	0.1	0.2	515.9	0.2	0.2	0.8	615.5	0.1	0.2	1.0	0.2	0.4	2.5	0.3	68.1	0.3	0.2	0.1	1.2	0.1	0.1	0.4	0.1	0.2	0.4	0.2	0.5	0.0	3.2	30.9	0.0	222.5	108.6	0.0	0.0	0.0	0.0	1.4	0.1	0.0	1.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.7	0.0	0.0	12.7	1.2	5.7	0.0	0.0	0.0	7.7	3.1	0.0	11.4	0.1	1.1	4.2	0.0	0.0	0.0	0.1	0.0	0.8	113.1	3.8	0.0	0.9	93931.2	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.1	0.0	1680.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	93.5	0.0	49.3	0.0	2.4	0.0
IGLV1-40		ENSG00000211653	"Immunoglobulin lambda variable 1-40"	P01703	22	22409766-22410282	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 1291.5;stomach 1: 1287.4"	"Cell type enriched"	"Detected in some"	358	"Plasma cells: 43406.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.0"	"Group enriched"	"Detected in some"	496	"memory B-cell: 666.4;naive B-cell: 576.7"	"Lineage enriched"	"Detected in many"	532	"B-cells: 666.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.5;RPMI-8226: 2.2;SH-SY5Y: 3.4;TIME: 2.3"														"Immunoglobulin genes"	NA	NA		2300000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.64e-3)"	"unprognostic (4.68e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.37e-3)"	"unprognostic (9.60e-3)"	"prognostic favorable (5.74e-6)"	"unprognostic (2.39e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.43e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (5.44e-6)"	"unprognostic (1.51e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.57e-2)"	43.4	13.0	0.8	203.5	0.5	114.3	138.5	0.1	3.0	68.1	1.1	553.8	551.6	14.8	0.6	125.4	21.5	236.0	15.2	0.2	0.2	28.8	28.3	115.4	282.5	0.3	0.2	56.6	10.0	1.1	3.4	0.6	0.6	46.1	336.7	4.2	413.8	19.7	1.2	3.1	287.2	14.3	0.2	1029.8	1287.4	7.2	0.3	179.2	61.2	0.0	1291.5	464.8	19.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	1.0	1.1	0.0	0.0	0.2	0.8	2.2	0.0	0.0	1.3	3.4	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.4	0.7	0.7	1.1	1.1	0.8	0.0	0.3	0.0	0.4	0.7	0.2	0.3	0.1	0.6	666.4	0.3	0.3	0.6	576.7	0.1	0.2	1.2	0.3	0.3	0.6	0.4	53.7	0.8	0.5	0.1	3.0	0.2	0.2	0.3	0.2	0.6	0.2	0.3	1.0	0.0	0.0	0.0	0.0	121.0	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	1.2	8.0	0.0	0.0	0.0	28.6	64.2	0.0	0.0	0.0	1.8	0.9	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.7	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	43406.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	7.4	0.0	0.1	0.0
IGLV1-44		ENSG00000211651	"Immunoglobulin lambda variable 1-44"	P01699	22	22380766-22381347	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 589.7;lymphoid tissue: 1918.7;stomach 1: 534.3"	"Cell type enriched"	"Detected in some"	108	"Plasma cells: 12023.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	840	"memory B-cell: 968.8;naive B-cell: 850.4"	"Lineage enriched"	"Detected in many"	894	"B-cells: 968.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 21.3;RPMI-8226: 5.5;SCLC-21H: 4.1;U-698: 15.2"														"Immunoglobulin genes"	NA	NA		4000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.88e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.81e-3)"	"prognostic favorable (4.71e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (6.55e-8)"	"unprognostic (1.85e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.48e-2)"	"unprognostic (5.49e-2)"	33.9	2.0	0.1	297.2	0.0	133.4	110.2	0.0	0.8	14.3	0.0	378.7	589.7	11.8	0.0	80.1	19.5	78.7	17.5	0.0	0.0	18.7	17.1	122.2	519.5	1.3	0.2	15.3	3.6	0.0	2.6	0.0	0.4	13.8	263.1	0.0	273.0	9.4	0.7	2.4	236.5	21.4	0.0	608.7	534.3	11.6	0.1	117.8	35.1	0.0	1918.7	240.5	16.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	5.5	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	968.8	0.0	0.0	0.7	850.4	0.0	0.0	0.0	0.0	0.1	1.0	0.1	100.0	0.1	0.0	0.0	0.8	0.0	0.0	1.3	0.2	0.4	0.0	0.1	0.8	0.0	0.0	0.6	0.0	111.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.7	0.0	0.0	0.0	3.5	48.4	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12023.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.3	0.0
IGLV2-14		ENSG00000211666	"Immunoglobulin lambda variable 2-14"	P01704	22	22758700-22759218	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 2622.2;lymphoid tissue: 5374.9;stomach 1: 2530.1"	"Cell type enriched"	"Detected in some"	179	"Plasma cells: 58316.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	50	"memory B-cell: 3655.3;naive B-cell: 2657.4"	"Lineage enriched"	"Detected in all"	58	"B-cells: 3655.3"	"Cell line enriched"	"Detected in many"	5	"RPMI-8226: 22672.4"														"Immunoglobulin genes"	NA	NA		2200000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (3.23e-4)"	"unprognostic (9.05e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.00e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (3.69e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.83e-2)"	"unprognostic (9.11e-2)"	"unprognostic (4.97e-1)"	"prognostic unfavorable (5.74e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.87e-2)"	83.9	192.1	0.8	754.9	1.7	357.8	749.8	0.5	6.4	119.7	3.8	2622.2	2470.7	47.8	20.7	245.2	49.0	442.1	45.2	0.6	1.0	54.3	102.1	399.3	3320.0	1.6	0.6	75.3	52.1	4.5	5.6	1.2	1.0	71.0	1074.1	0.1	797.3	119.4	2.7	21.3	1262.7	62.0	1.4	1580.6	2530.1	13.9	1.3	586.1	116.5	0.5	5374.9	1165.2	35.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.4	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	5.8	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	4453.2	0.0	0.0	8.7	8.0	1.7	0.0	0.0	4.9	3.7	22672.4	0.0	0.0	11.8	11.1	0.4	17.3	0.0	0.0	7.1	0.0	5.1	0.0	4.1	5.7	1.1	20.4	37.7	1.4	12.1	1.7	5.0	3.9	5.3	1.7	47.1	1.0	28.8	3655.3	9.6	53.9	3.3	2657.4	1.4	12.7	11.6	62.5	2.4	2.2	2.1	451.3	0.8	1.7	0.5	6.4	0.6	1.0	1.6	0.6	1.0	1.4	1.3	2.1	0.0	0.0	0.0	0.0	324.1	0.0	0.0	0.0	1.2	0.0	0.3	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	14.7	0.0	0.0	0.0	9.9	121.8	0.0	0.0	0.0	1.4	1.7	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	58316.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	36.6	0.0	0.8	0.0
IGLV2-18		ENSG00000211664	"Immunoglobulin lambda variable 2-18"	A0A075B6J9	22	22734607-22735089	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 271.5;lymphoid tissue: 224.4"	"Cell type enriched"	"Detected in some"	210	"Plasma cells: 2488.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	44	"memory B-cell: 321.2;naive B-cell: 126.9"	"Lineage enriched"	"Detected in many"	64	"B-cells: 321.2"	"Group enriched"	"Detected in some"	7	"RPMI-8226: 13.4;U-266/70: 22.3;U-266/84: 7.2"														"Immunoglobulin genes"	NA	NA		570000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (6.06e-5)"	"unprognostic (2.81e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.13e-2)"		"prognostic favorable (7.75e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.58e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (1.86e-7)"	"unprognostic (1.95e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-2)"	3.4	0.3	0.0	73.0	0.0	23.7	67.1	0.0	0.3	6.7	0.1	271.5	262.0	4.2	0.0	39.6	10.8	36.3	12.5	0.0	0.0	2.0	2.8	12.6	37.6	0.1	0.0	4.1	1.1	2.1	0.2	0.1	0.4	1.7	138.6	0.0	64.3	4.9	0.1	0.3	150.2	6.5	0.0	95.8	72.5	0.5	0.0	22.1	2.8	0.0	224.4	18.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	13.4	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	22.3	7.2	0.1	0.1	0.1	0.0	0.2	1.8	0.0	1.6	0.0	0.8	321.2	0.3	1.3	0.1	126.9	0.7	0.6	0.5	5.0	0.1	0.2	0.1	69.7	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	7.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2488.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
IGLV2-33		ENSG00000211656	"Immunoglobulin lambda variable 2-33 (non-functional)"	A0A075B6J2	22	22588155-22588688	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 4.3;lymphoid tissue: 2.7;salivary gland: 2.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"memory B-cell: 2.9;naive B-cell: 1.9"	"Lineage enriched"	"Detected in single"	30	"B-cells: 2.9"	"Group enriched"	"Detected in some"	9	"RPMI-8226: 1.5;U-266/70: 5.1;U-266/84: 3.4"														"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"					"unprognostic (1.29e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.30e-1)"		"unprognostic (2.64e-3)"		"unprognostic (2.47e-2)"			"unprognostic (2.06e-1)"			"unprognostic (6.68e-2)"				0.0	0.1	0.0	1.5	0.0	1.3	0.4	0.0	0.0	0.0	0.0	2.2	4.3	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	2.6	0.0	0.0	0.0	2.3	0.2	0.0	1.5	1.5	0.0	0.0	0.1	0.0	0.0	2.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLV3-1		ENSG00000211673	"Immunoglobulin lambda variable 3-1"	P01715	22	22880706-22881396	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1234.9;lymphoid tissue: 3325.7;stomach 1: 1460.4"	"Cell type enriched"	"Detected in some"	321	"Plasma cells: 56277.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	725	"memory B-cell: 779.5;naive B-cell: 1038.5"	"Lineage enriched"	"Detected in many"	828	"B-cells: 1038.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 14.4;RPMI-8226: 4.5;SCLC-21H: 9.1;SH-SY5Y: 9.9"									HPA003285	Approved				"Immunoglobulin genes"	NA	NA		4300000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA003285: AB_1079122"	"prognostic favorable (9.70e-5)"	"unprognostic (9.06e-2)"	"unprognostic (5.39e-3)"	"unprognostic (2.37e-2)"	"unprognostic (8.13e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (9.06e-9)"	"unprognostic (2.70e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	44.5	70.9	0.3	485.2	0.2	332.4	317.1	0.2	2.0	192.0	0.9	1234.9	643.4	39.2	0.0	217.7	19.2	310.4	28.1	0.1	0.4	26.3	70.1	176.2	1117.0	1.0	0.3	34.1	7.6	2.7	2.0	0.7	1.5	21.9	684.4	0.2	627.3	19.6	1.2	4.1	481.7	37.2	0.4	654.2	1460.4	56.0	0.3	335.5	35.9	0.0	3325.7	679.7	30.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.1	0.0	0.0	1.1	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.0	0.0	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.2	2.4	0.8	0.0	0.0	0.5	3.0	4.5	0.0	0.0	9.1	9.9	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	0.6	1.7	1.8	1.2	2.8	0.0	0.3	0.0	0.7	1.1	0.5	0.3	0.4	0.4	779.5	0.6	0.2	1.2	1038.5	0.2	0.3	0.6	0.4	0.8	0.5	0.5	52.3	0.3	0.2	0.2	2.0	0.1	0.4	1.0	0.3	1.5	0.4	0.3	0.9	0.0	3.2	0.0	0.0	111.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	122.5	0.0	0.0	0.0	0.0	0.0	10.7	174.8	0.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56277.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	11.7	0.0	0.2	0.0
IGLV3-12		ENSG00000211667	"Immunoglobulin lambda variable 3-12"	A0A075B6K2	22	22771824-22772582	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 4.2;memory B-cell: 9.2;memory CD8 T-cell: 4.0;naive B-cell: 6.7;NK-cell: 5.6"	"Group enriched"	"Detected in many"	64	"B-cells: 9.2;NK-cells: 5.6;T-cells: 4.2"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		850000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"		"Cluster 57: B-cells - Immune response"				"unprognostic (1.92e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.03e-2)"		"prognostic favorable (8.39e-6)"		"unprognostic (8.44e-2)"		"unprognostic (4.62e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.15e-4)"	"unprognostic (3.62e-2)"	"unprognostic (4.71e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.52e-1)"	0.8	1.2	0.0	3.9	0.0	2.7	1.9	0.0	0.3	0.3	0.1	7.3	5.5	0.5	0.0	1.0	0.6	3.3	0.0	0.0	0.0	0.1	0.5	2.7	15.3	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.5	3.8	0.0	5.1	1.7	0.0	0.2	2.7	0.1	0.0	4.6	8.2	0.9	0.0	3.9	0.2	0.0	30.1	1.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	1.1	9.2	1.0	4.0	0.0	6.7	0.0	0.2	0.0	5.6	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLV3-25		ENSG00000211659	"Immunoglobulin lambda variable 3-25"	P01717	22	22686726-22687271	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 2440.7;stomach 1: 1015.7"	"Cell type enriched"	"Detected in some"	41	"Plasma cells: 17441.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	45	"memory B-cell: 545.0;naive B-cell: 794.2"	"Lineage enriched"	"Detected in many"	53	"B-cells: 794.2"	"Cell line enhanced"	"Detected in some"		"HL-60: 2.6;RPMI-8226: 2.7;SCLC-21H: 4.6;SH-SY5Y: 5.1"									HPA003285	Approved				"Immunoglobulin genes"	NA	NA		3200000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA003285: AB_1079122"	"prognostic favorable (5.55e-4)"	"unprognostic (8.28e-2)"	"unprognostic (4.28e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.88e-2)"	"prognostic favorable (1.43e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (3.78e-7)"	"unprognostic (1.25e-1)"	"unprognostic (4.78e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.72e-1)"	56.8	163.2	0.2	293.2	0.2	243.2	430.9	0.1	1.7	151.9	1.3	847.4	338.9	20.8	2.1	161.5	49.8	177.1	29.8	0.2	0.3	17.1	45.7	870.5	1024.7	1.8	0.2	21.8	14.5	1.7	1.7	0.5	0.6	18.9	467.5	0.0	532.3	116.5	0.7	2.4	228.9	34.1	0.4	543.5	1015.7	59.8	0.5	155.9	23.1	0.0	2440.7	779.6	20.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	1.7	0.4	1.7	0.0	0.0	1.6	1.5	2.7	0.0	0.0	4.6	5.1	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.0	0.1	0.8	1.8	0.2	0.7	0.0	1.3	0.0	0.8	0.4	0.3	0.7	0.1	0.2	545.0	0.4	0.1	0.5	794.2	0.2	0.1	14.9	0.3	0.6	0.3	0.3	76.5	0.2	0.2	0.1	1.7	0.2	0.3	1.8	0.2	0.6	0.4	0.5	0.6	0.0	0.0	0.0	0.0	84.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.0	1.9	40.8	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17441.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	417.4	0.0	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0
IGLV5-48		ENSG00000211647	"Immunoglobulin lambda variable 5-48 (non-functional)"	A0A075B6I7	22	22352940-22353433	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.3;lymphoid tissue: 5.5;urinary bladder: 2.7"	"Cell type enriched"	"Detected in some"	8	"Plasma cells: 19.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	61	"memory B-cell: 5.4;naive B-cell: 6.7"	"Lineage enriched"	"Detected in single"	68	"B-cells: 6.7"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (3.76e-3)"	"unprognostic (1.91e-2)"	"unprognostic (9.43e-2)"			"unprognostic (3.36e-4)"		"unprognostic (1.38e-1)"			"unprognostic (1.90e-1)"			"unprognostic (1.74e-2)"	"unprognostic (2.97e-1)"			0.0	0.0	0.0	0.9	0.0	1.3	0.9	0.0	0.6	0.4	0.0	3.3	3.3	0.0	0.0	0.3	0.1	0.3	0.1	0.0	0.0	0.1	0.1	0.3	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.5	0.0	0.0	0.0	1.3	0.2	0.0	5.5	0.7	0.0	0.0	2.5	0.1	0.0	5.3	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLV5-52		ENSG00000211643	"Immunoglobulin lambda variable 5-52"	A0A0A0MRZ9	22	22318727-22319226	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"B-cells: 1.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 11.7;naive B-cell: 10.3"	"Lineage enriched"	"Detected in many"	6	"B-cells: 11.7"	"Low cell line specificity"	"Detected in all"																"Immunoglobulin genes"	NA	NA		1200000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 57: B-cells - Immune response"				"unprognostic (7.26e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.61e-5)"		"unprognostic (1.22e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.25e-3)"	"unprognostic (7.75e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.46e-2)"	11.5	10.4	10.7	18.0	11.7	14.6	23.8	16.4	14.1	16.5	13.2	26.6	20.1	28.4	44.2	22.5	22.7	22.5	16.6	11.9	11.1	11.5	9.5	14.9	44.1	9.4	9.4	21.6	8.0	13.9	8.6	11.2	11.0	15.9	23.5	22.5	17.9	15.0	10.1	37.7	15.3	22.3	9.2	21.8	29.2	12.9	10.8	17.7	21.4	15.6	53.5	31.1	6.3	13.9	12.1	7.7	18.8	29.2	22.3	25.1	14.4	7.7	19.0	17.3	22.0	15.6	5.0	38.4	8.5	22.5	10.1	16.9	36.0	25.6	24.0	9.4	27.3	13.4	21.4	14.8	8.7	20.8	22.9	24.0	24.0	19.5	34.5	14.2	35.2	13.9	40.7	3.3	32.3	14.5	7.0	13.9	10.5	22.5	5.7	9.4	9.4	6.4	22.6	16.1	21.2	13.2	9.9	10.6	10.9	15.7	21.0	4.8	21.0	40.9	25.7	4.2	9.0	6.7	21.9	18.2	14.0	15.4	12.2	0.0	1.3	1.9	1.1	0.7	1.3	11.7	1.2	1.3	1.5	10.3	0.8	0.8	0.7	0.7	0.8	1.4	0.6	3.1	10.7	11.7	16.4	14.1	11.9	11.1	9.4	9.4	11.0	9.2	10.8	13.9	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0
IL12A	"CLMF, IL-12A, NFSK, NKSF1, p35"	ENSG00000168811	"Interleukin 12A"	P29459	3	159988835-159996019	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 4.1"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 3.9;Ionocytes: 4.1;Oligodendrocyte precursor cells: 4.0;Respiratory ciliated cells: 6.1;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 8.1;HDLM-2: 13.2;SK-BR-3: 17.6"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.8"	"Not detected"	"Not detected"			HPA001886	Uncertain				"Secreted to blood"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA001886: AB_1079132"	"unprognostic (6.23e-2)"	"unprognostic (7.82e-5)"	"unprognostic (1.25e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.22e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.18e-5)"	"unprognostic (2.22e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.57e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.61e-2)"	0.3	0.4	0.9	0.6	0.9	1.5	0.7	0.9	2.0	0.2	0.3	0.8	0.5	0.3	0.1	4.1	2.1	0.2	0.8	0.8	0.8	0.4	0.1	2.1	0.8	0.9	1.1	0.5	0.5	0.0	0.5	0.1	1.0	0.3	0.4	0.1	0.3	0.1	0.2	0.1	0.8	0.2	0.7	1.2	0.5	0.3	0.9	0.4	0.2	0.7	0.5	0.7	0.6	1.1	3.1	0.3	0.4	2.6	0.0	0.2	0.2	3.3	2.1	3.9	8.1	1.2	0.1	0.0	0.2	0.5	4.5	0.3	0.8	0.5	3.6	13.2	4.1	0.1	0.2	0.9	2.5	0.7	6.1	0.6	1.0	6.9	2.7	2.7	1.2	0.3	0.0	2.1	2.4	0.1	0.1	0.0	0.4	0.1	1.8	2.4	0.0	0.4	0.4	0.2	0.1	1.2	0.0	17.6	0.5	0.6	0.9	1.4	0.9	0.8	0.8	2.3	6.3	1.4	0.0	0.0	1.5	5.9	0.8	0.0	0.0	0.5	0.3	0.1	0.5	0.5	0.1	0.6	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.9	0.9	0.9	2.0	0.8	0.8	0.9	1.1	1.0	0.7	0.9	1.1	1.0	0.0	0.6	1.0	3.4	0.1	2.1	1.0	1.2	0.0	1.6	2.2	0.4	0.0	1.1	0.0	0.0	0.1	0.7	0.3	0.0	1.5	0.0	3.9	0.2	1.4	2.4	0.8	0.1	0.0	0.0	0.4	0.0	1.5	0.0	0.1	0.0	0.0	0.1	0.0	1.9	0.9	4.1	0.3	0.3	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	4.0	1.3	0.4	0.2	0.0	2.1	2.9	0.1	0.0	6.1	0.0	6.6	1.5	0.3	0.4	2.9	2.6	0.1	0.0	0.7	0.1	0.5	1.3
IL7	IL-7	ENSG00000104432	"Interleukin 7"	P13232	8	78675743-78805523	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 108.8;Late spermatids: 145.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 9.7;naive B-cell: 8.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 7.6;HDLM-2: 15.4;HEL: 18.2;HMC-1: 25.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA019590	Approved				"Secreted to blood"	NA	NA	60700		"Cluster 19: B-cells - Humoral immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA019590: AB_10794621"	"unprognostic (3.19e-3)"	"unprognostic (1.44e-1)"	"unprognostic (9.57e-3)"	"unprognostic (5.45e-2)"	"unprognostic (9.37e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (2.69e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.11e-4)"	2.3	1.2	0.2	4.1	0.3	2.1	1.5	0.4	0.2	2.3	0.3	5.1	6.7	1.1	0.3	3.5	4.8	3.1	0.6	0.3	0.5	1.4	4.2	3.3	8.7	0.6	0.4	0.9	1.0	0.0	0.5	0.3	0.5	1.8	4.4	0.7	1.1	0.9	0.1	8.8	8.7	1.1	0.4	3.5	3.8	1.7	1.2	0.8	1.3	0.1	4.2	2.8	1.5	0.2	0.3	0.0	0.1	0.0	0.4	0.4	0.0	1.4	1.4	1.3	1.9	0.0	7.6	0.1	0.0	4.4	4.5	4.2	0.1	0.0	0.0	15.4	0.0	18.2	0.6	2.1	0.1	0.1	25.4	1.3	0.0	0.2	0.6	4.9	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.1	0.0	5.4	3.2	0.0	2.4	2.6	0.3	0.2	0.0	0.1	0.0	0.2	0.8	0.9	0.0	2.0	0.3	0.0	0.0	3.4	0.0	1.9	5.2	0.3	0.0	0.4	0.2	0.0	9.7	1.0	1.0	2.2	8.7	0.2	0.3	0.0	0.5	0.8	0.3	7.3	0.6	0.2	0.3	0.4	0.2	0.3	0.5	0.6	0.4	0.5	0.4	1.2	0.2	0.6	0.0	3.6	5.9	12.2	6.0	3.2	1.2	10.8	0.1	1.3	0.9	0.7	5.7	2.4	1.8	0.0	0.0	1.3	7.8	9.8	1.2	108.8	22.9	0.8	4.9	3.0	10.5	16.0	5.1	0.0	2.5	11.2	0.6	0.0	0.1	1.8	2.4	0.9	0.0	11.0	6.2	2.0	1.0	3.3	145.5	0.6	1.9	0.0	1.0	3.4	2.0	0.0	20.1	6.0	2.6	11.5	1.2	1.0	1.2	12.4	9.5	24.2	0.4	0.0	2.2	0.5	2.3	0.9	5.2	6.5	0.0	1.6	0.1	4.6	1.7
INKA1	"C3orf54, FAM212A"	ENSG00000185614	"Inka box actin regulator 1"		3	49803261-49805030	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"skin 1: 24.1"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 19.9;Breast myoepithelial cells: 9.7;Endothelial cells: 8.4;Hofbauer cells: 54.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 59.6;memory B-cell: 65.9;naive B-cell: 64.4"	"Group enriched"	"Detected in many"	7	"B-cells: 65.9;granulocytes: 59.6"	"Cell line enhanced"	"Detected in many"		"HEL: 68.5;HMC-1: 45.1;NB-4: 38.5;THP-1: 42.1;U-937: 34.9"	"Low region specificity"	"Detected in all"							HPA041879	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Vesicles"		"HPA041879: AB_10797269"	"unprognostic (1.36e-1)"	"unprognostic (2.99e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.96e-4)"	"unprognostic (2.70e-2)"	"unprognostic (4.35e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.35e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.90e-3)"	"unprognostic (4.95e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.40e-2)"	5.1	2.3	4.8	2.0	5.0	3.5	4.1	5.2	7.6	6.2	2.8	3.2	0.8	4.7	1.4	19.7	2.8	1.5	5.2	5.3	5.5	5.8	1.1	5.4	4.1	6.2	5.3	2.2	1.3	0.5	2.1	3.1	5.7	6.4	0.5	0.2	4.9	2.1	11.7	24.1	4.3	1.8	5.8	6.7	2.4	2.9	6.5	1.6	2.1	2.3	3.9	5.5	10.3	7.0	1.3	1.1	1.5	1.1	1.8	4.1	0.0	3.0	1.9	1.4	1.7	0.1	0.0	14.9	0.4	2.2	1.5	8.7	0.5	10.4	0.1	2.6	0.0	68.5	0.7	0.2	2.6	10.4	45.1	5.4	14.5	2.9	2.6	0.9	6.1	1.0	4.7	1.2	1.2	0.6	0.9	38.5	1.1	0.0	5.8	13.9	0.8	3.3	0.1	16.9	0.8	5.3	2.7	0.5	1.5	0.4	0.3	42.1	3.8	7.3	0.9	3.4	1.3	1.7	1.7	1.2	3.2	34.9	1.8	59.6	2.4	11.6	1.3	5.9	0.3	65.9	1.5	1.8	0.7	64.4	2.2	3.6	1.3	0.0	8.5	9.3	1.6	6.4	4.8	5.0	5.2	7.6	5.3	5.5	6.2	5.3	5.7	5.8	6.5	7.0	19.9	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	1.0	9.7	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.7	0.0	0.5	1.6	8.4	0.0	0.0	0.0	1.2	0.7	3.0	0.0	0.1	0.0	0.1	0.0	0.0	54.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.1	0.4	0.5	0.0	0.0
JCHAIN	"IGCJ, IGJ, JCH"	ENSG00000132465	"Joining chain of multimeric IgA and IgM"	P01591	4	70655541-70681817	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 3028.0;intestine: 7979.6;stomach 1: 5916.2"	"Cell type enriched"	"Detected in many"	16	"Plasma cells: 101294.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	121	"memory B-cell: 4173.0;naive B-cell: 2555.1;plasmacytoid DC: 3578.1"	"Group enriched"	"Detected in all"	137	"B-cells: 4173.0;dendritic cells: 3578.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 3953.8;Karpas-707: 2117.6;RPMI-8226: 4469.2;U-266/70: 8794.0;U-266/84: 3519.2;U-698: 4949.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034436, HPA044132"	Enhanced				"Secreted to blood"	NA	NA		2200000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB034436: AB_2233368, HPA044132: AB_2678826"	"prognostic favorable (1.81e-6)"	"unprognostic (1.45e-3)"	"unprognostic (7.44e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (7.56e-7)"	"unprognostic (2.37e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.96e-1)"	130.2	76.6	0.7	1089.0	0.8	76.3	3028.0	0.4	3.0	205.2	3.1	7979.6	6145.8	94.2	25.0	654.4	115.0	492.4	45.6	0.4	1.4	43.3	116.8	620.2	1033.5	1.9	1.0	183.5	78.3	2.1	2.0	2.4	0.8	90.2	6426.5	0.3	2420.5	258.4	4.2	13.2	4277.1	200.3	7.0	819.4	5916.2	40.0	0.8	155.3	19.4	0.8	1746.7	1059.4	11.6	2.8	8.9	0.0	0.0	0.0	0.0	0.0	15.5	8.2	1.5	0.1	0.1	0.0	0.0	3953.8	3.3	12.7	0.1	6.6	0.0	0.0	0.6	2.1	0.0	3.3	0.0	0.0	0.0	3.3	9.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	5.4	2117.6	0.1	0.0	6.1	14.9	4.9	0.0	0.0	4.8	2.6	4469.2	0.0	0.0	3.3	15.7	3.7	2.6	2.7	0.0	0.8	6.8	3.9	9.9	11.8	4.9	6.3	8794.0	3519.2	4949.0	2.1	5.2	1.2	25.1	7.5	2.6	4.0	1.5	19.1	4173.0	2.5	3.8	6.6	2555.1	2.1	2.1	28.3	4.5	2.5	3578.1	2.6	1310.4	0.7	0.8	0.4	3.0	0.4	1.4	1.9	1.0	0.8	7.0	0.8	2.8	3.0	22.4	101.3	0.0	6154.9	0.0	28.2	0.0	8.6	0.0	11.7	1.9	2.2	15.7	8.1	0.0	0.0	0.1	700.0	5.1	0.0	0.0	0.5	0.0	0.1	38.1	7.3	139.0	0.0	0.0	0.1	48.8	228.8	0.0	79.5	0.1	66.4	24.6	0.3	0.0	0.0	5.3	0.0	35.8	0.0	0.3	0.0	42.0	0.0	0.0	3.9	0.0	6.2	0.0	0.0	0.0	5.1	0.0	101294.9	32.7	0.0	5.4	3.6	0.0	0.0	0.6	88.4	1.4	0.3	24.3	0.0	0.3	1487.8	0.0	3.5	0.6
KCNN4	"hIKCa1, hKCa4, hSK4, IK, KCa3.1"	ENSG00000104783	"Potassium calcium-activated channel subfamily N member 4"	O15554	19	43766533-43781257	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 130.8"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 231.1;Syncytiotrophoblasts: 763.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 85.7;WM-115: 258.6"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.9"	"Not detected"	"Not detected"			"HPA013367, HPA053841, HPA059622"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Cytosol"		"HPA013367: , HPA053841: AB_2682278, HPA059622: AB_2684085"	"unprognostic (1.23e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.29e-1)"	"unprognostic (3.74e-3)"	"prognostic unfavorable (2.68e-4)"	"unprognostic (1.98e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (9.96e-3)"	"prognostic unfavorable (1.05e-14)"	"unprognostic (3.70e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (1.75e-4)"	3.6	0.7	1.7	11.8	1.9	18.3	12.4	1.3	1.8	11.8	1.4	18.5	6.4	1.6	1.8	6.5	5.8	3.5	1.1	1.5	1.6	1.4	0.8	7.3	12.5	1.6	1.6	0.6	1.0	0.0	0.7	14.3	1.7	28.6	6.2	0.2	130.8	7.5	0.4	29.1	26.0	0.7	1.9	20.5	35.1	2.7	2.0	5.0	2.1	0.2	9.2	18.2	6.5	2.3	22.4	35.2	0.1	0.2	0.0	2.2	55.0	0.8	1.7	0.7	0.1	0.5	85.7	6.7	9.8	0.9	9.1	13.6	0.0	28.8	1.7	40.9	0.0	29.8	48.6	0.5	0.0	0.3	0.3	0.0	2.9	1.3	6.6	52.7	0.0	0.3	2.6	2.3	0.3	18.7	4.8	17.9	0.2	43.1	42.4	16.8	0.7	21.0	13.0	55.3	0.2	0.1	62.2	70.1	32.6	1.7	0.3	15.1	1.5	12.6	75.9	0.4	45.3	0.1	1.4	2.6	45.9	5.1	258.6	5.8	21.1	0.0	0.5	35.3	0.7	37.3	10.4	5.0	30.7	21.6	6.6	6.3	1.1	0.0	20.1	0.9	15.2	11.2	1.7	1.9	1.3	1.8	1.5	1.6	1.6	1.6	1.7	1.9	2.0	2.3	1.6	0.0	1.9	1.3	24.7	2.8	45.7	79.5	3.4	0.2	69.7	56.6	0.4	7.2	18.4	1.8	4.2	231.1	4.1	22.0	0.0	5.9	1.2	1.7	0.2	4.0	0.0	32.4	1.5	3.9	14.1	2.3	57.1	4.2	0.0	0.0	0.4	0.0	43.7	0.0	1.1	8.9	2.0	7.2	78.2	0.3	0.0	23.3	21.4	1.0	2.5	0.1	1.0	0.5	0.8	63.8	22.3	0.0	22.4	63.5	1.0	0.1	2.2	0.5	0.0	0.3	1.4	0.4	1.4	2.1	2.3	763.3	9.5	0.0	51.1	65.6
KDM2B	"CXXC2, Fbl10, FBXL10, JHDM1B, PCCX2"	ENSG00000089094	"Lysine demethylase 2B"	Q8NHM5	12	121429096-121581023	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071257			Supported	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA071257: "	"unprognostic (7.67e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (6.74e-6)"	"unprognostic (1.16e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (8.64e-4)"	"unprognostic (1.77e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.82e-2)"	9.7	8.4	7.1	18.9	8.7	16.9	10.0	12.9	10.7	15.6	7.4	12.2	8.2	11.5	5.5	20.2	12.4	7.0	8.7	7.3	5.6	11.1	15.6	13.1	22.9	8.3	6.3	15.2	11.6	10.8	9.4	7.3	9.2	9.5	7.6	9.7	12.6	6.1	15.2	28.0	18.9	8.3	5.4	21.4	10.9	14.0	7.8	23.1	11.2	6.1	21.6	12.3	16.9	9.0	15.2	19.1	31.3	9.8	8.7	7.6	34.8	12.4	19.1	17.8	14.9	24.0	7.7	69.3	20.6	11.2	9.9	13.1	34.3	13.7	14.4	29.3	24.0	38.0	15.9	19.4	10.3	44.0	29.5	6.9	7.4	16.9	12.3	19.1	12.7	33.6	31.4	8.8	8.5	20.4	54.5	51.8	55.8	11.0	15.1	61.0	16.4	34.1	9.8	24.5	37.1	21.4	23.8	14.0	14.4	29.5	25.0	49.2	17.3	19.0	15.4	19.2	13.9	23.9	21.3	64.5	17.6	35.2	12.3	4.5	2.8	2.4	6.3	2.3	4.9	9.5	4.9	3.5	3.9	9.3	4.3	5.8	0.4	2.0	1.7	3.5	4.6	3.4	7.1	8.7	12.9	10.7	7.3	5.6	8.3	6.3	9.2	5.4	7.8	9.0	6.8	0.0	10.6	28.1	36.8	17.0	7.1	4.0	13.6	20.1	10.3	6.7	14.6	14.3	5.4	11.0	12.5	6.7	43.3	3.8	11.7	7.5	57.0	13.0	7.0	8.8	5.4	22.5	36.2	5.8	11.2	8.3	9.2	12.0	14.0	16.5	9.7	15.4	24.4	15.2	41.6	6.1	6.1	21.1	61.0	60.1	7.8	25.5	16.0	26.2	48.0	4.1	24.7	31.2	44.1	5.8	4.7	7.2	34.1	11.2	6.5	4.2	5.7	16.1	19.7	6.5	8.1	11.4	18.3	13.9	15.2	6.6	24.8	6.2	7.4	6.3
KLK1	Klk6	ENSG00000167748	"Kallikrein 1"	P06870	19	50819146-50823787	"Enzymes, Metabolic proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	84	"pancreas: 9557.9;salivary gland: 5487.3"	"Group enriched"	"Detected in many"	7	"Exocrine glandular cells: 788.4;Intestinal goblet cells: 1317.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 50.9;renal cancer: 84.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"memory B-cell: 9.5;naive B-cell: 4.0"	"Lineage enriched"	"Detected in single"	13	"B-cells: 9.5"	"Cell line enriched"	"Detected in some"	4	"RPMI-8226: 43.8"									HPA059690	Approved				"Secreted to digestive system"	NA	NA		10000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA059690: "	"unprognostic (1.51e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.49e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.23e-2)"	1.4	2.4	0.1	4.0	0.0	0.4	1.8	0.0	0.4	1.9	0.0	68.8	9.6	2.0	0.0	1.3	0.6	0.1	3.0	0.3	0.0	89.4	0.6	0.5	0.5	0.0	0.0	4.7	9557.9	0.4	0.2	1.1	0.0	2.7	53.0	0.0	5487.3	0.1	0.2	26.3	9.7	2.8	0.0	3.3	1.4	0.1	0.0	0.2	2.9	0.2	1.5	0.2	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.4	0.2	0.3	0.5	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	1.1	0.1	0.4	0.2	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.1	0.0	0.0	9.7	0.0	0.1	0.0	43.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.8	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	9.5	0.0	0.0	0.1	4.0	0.0	0.0	0.1	0.0	0.2	0.7	0.0	0.1	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	18.9	19.5	1.2	2.9	1.2	0.0	1.0	1.1	0.3	0.0	2.5	0.0	0.0	0.0	0.2	62.2	45.0	3.3	0.6	0.1	1.4	0.4	117.1	0.0	0.0	788.4	0.0	7.7	1.5	0.0	8.9	8.8	0.4	0.0	0.6	0.0	0.0	1317.5	14.2	1.6	5.3	0.3	6.2	1.5	5.4	0.0	6.2	0.0	0.0	0.0	0.0	125.8	134.4	0.0	10.9	9.8	57.1	0.3	0.3	0.0	0.0	0.0	1.1	0.3	0.9	1.7	54.0	0.0	2.1	2.5	148.5	3.8
LCN8	LCN5	ENSG00000204001	"Lipocalin 8"	Q6JVE9	9	136754386-136758543	"Predicted intracellular proteins, Predicted secreted proteins"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	99	"epididymis: 83.7"	"Group enriched"	"Detected in some"	11	"B-cells: 17.9;Plasma cells: 5.6"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	60	"memory B-cell: 4.1;naive B-cell: 8.1"	"Lineage enriched"	"Detected in single"	79	"B-cells: 8.1"	"Cell line enriched"	"Detected in single"	6	"REH: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 14: REH - Unknown function"	"Cluster 57: B-cells - Immune response"							"unprognostic (1.64e-2)"	"unprognostic (1.00e-1)"					"unprognostic (6.71e-2)"			"unprognostic (2.11e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.00e-1)"		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	83.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LRCH1	"CHDC1, KIAA1016"	ENSG00000136141	"Leucine rich repeats and calponin homology domain containing 1"	Q9Y2L9	13	46553168-46753040	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 89.2;Inhibitory neurons: 117.6;Microglial cells: 183.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 37.1"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021536	Approved		Approved	"Nucleoli,Actin filaments,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Actin filaments, Cytosol"	Nucleoli	"HPA021536: AB_1853258"	"unprognostic (7.13e-3)"	"prognostic unfavorable (6.24e-4)"	"unprognostic (3.59e-2)"	"unprognostic (8.93e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.04e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.98e-2)"	15.1	5.0	4.7	10.7	4.7	8.9	14.6	37.1	6.2	15.9	4.2	15.2	7.9	16.3	7.7	10.0	11.8	12.6	8.4	5.7	6.1	14.9	12.2	13.8	16.3	6.5	7.0	10.1	5.6	5.4	5.8	18.2	7.8	10.8	10.0	10.3	10.0	12.0	3.9	17.9	11.6	17.6	7.9	14.6	13.0	4.6	6.8	18.5	6.5	7.5	15.7	13.5	9.7	7.5	7.4	10.4	9.2	9.6	6.6	12.5	23.6	12.4	16.1	15.0	14.2	23.5	12.3	23.4	3.4	11.7	9.8	10.4	7.1	12.5	21.6	24.2	6.6	21.0	4.3	11.1	8.2	13.8	34.5	7.9	9.7	13.9	16.8	12.3	13.1	15.6	4.2	6.9	11.2	14.2	14.8	17.3	5.2	46.3	5.5	8.0	10.0	6.3	28.1	7.5	14.5	14.6	7.0	6.8	18.8	16.2	5.3	18.3	12.5	8.8	6.0	11.0	11.9	1.3	3.7	10.6	10.3	11.9	10.8	0.6	0.9	0.9	1.5	0.7	0.8	2.2	1.1	1.0	0.8	2.7	0.8	0.9	0.3	2.5	0.5	1.0	0.8	0.9	4.7	4.7	37.1	6.2	5.7	6.1	6.5	7.0	7.8	7.9	6.8	7.5	61.5	6.4	6.1	24.8	26.7	37.5	10.5	6.2	27.3	8.3	12.0	11.8	7.2	17.2	6.5	22.0	22.9	13.4	8.4	6.8	9.8	8.3	1.6	5.4	6.5	32.5	1.8	9.9	89.2	4.2	12.7	14.3	18.8	13.7	27.9	2.8	17.5	9.3	13.4	3.3	117.6	10.6	8.2	16.9	30.7	2.1	13.1	12.3	30.2	183.6	8.4	5.5	8.2	64.8	9.7	13.5	5.5	17.0	12.4	12.9	8.0	8.4	2.6	8.5	13.1	15.6	18.6	1.7	4.1	15.9	33.2	9.7	14.7	15.3	7.8	9.2
MAP9	"ASAP, FLJ21159"	ENSG00000164114	"Microtubule associated protein 9"	Q49MG5	4	155342658-155376970	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.3;parathyroid gland: 33.9"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 114.4;Respiratory ciliated cells: 125.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (8.00e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.11e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.05e-2)"	"unprognostic (9.54e-2)"	4.2	5.8	20.5	3.9	21.4	1.8	4.4	26.4	46.3	5.8	26.2	3.1	0.9	7.3	7.6	2.9	9.6	7.9	7.0	23.5	35.1	9.7	0.7	5.0	3.2	31.6	23.9	6.0	5.5	33.9	7.8	5.1	31.3	12.4	1.8	16.3	2.4	8.9	0.2	0.5	1.6	5.7	20.9	2.4	6.1	12.8	28.7	3.4	15.5	0.8	2.4	3.2	1.6	22.1	0.0	10.3	11.0	9.6	11.7	14.0	2.2	11.3	10.2	6.6	5.7	0.1	0.0	7.5	14.7	8.3	24.6	0.0	11.7	12.0	10.8	0.0	9.4	4.7	0.1	0.0	8.6	0.0	0.0	12.0	6.5	9.3	5.7	20.2	0.0	2.9	0.1	0.0	7.5	4.6	8.8	0.1	8.7	3.7	13.3	0.0	0.0	0.2	22.2	8.9	15.1	43.4	0.0	19.4	0.6	7.3	15.7	0.1	1.6	8.8	15.6	0.2	8.4	9.1	0.0	8.2	25.8	0.0	14.3	0.0	0.0	0.0	2.7	0.3	2.1	2.9	1.5	2.5	0.1	4.8	1.3	1.8	0.1	0.8	0.0	2.6	1.0	0.5	20.5	21.4	26.4	46.3	23.5	35.1	31.6	23.9	31.3	20.9	28.7	22.1	3.8	16.0	37.4	34.6	17.0	1.3	13.4	18.7	12.5	67.0	15.2	20.8	33.1	17.2	25.7	25.8	79.2	9.0	10.2	0.4	33.2	35.4	39.3	114.4	44.8	3.5	21.1	5.0	59.0	16.0	3.4	24.5	13.7	24.7	2.5	16.5	1.8	0.6	1.0	72.3	58.3	0.7	26.4	0.9	0.8	14.1	45.7	2.0	5.4	14.0	1.3	53.5	9.2	23.6	27.4	15.9	0.2	49.2	3.8	11.7	0.0	49.1	125.0	92.5	13.1	28.0	31.1	69.4	53.1	2.8	1.1	2.3	14.2	40.1	0.6	4.1
MBD4	MED1	ENSG00000129071	"Methyl-CpG binding domain 4, DNA glycosylase"	O95243	3	129430947-129440179	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002031	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nuclear speckles"		"HPA002031: AB_1079319"	"unprognostic (2.70e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.18e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (2.18e-4)"	"prognostic unfavorable (4.75e-4)"	"prognostic unfavorable (2.73e-6)"	"unprognostic (9.27e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.35e-2)"	18.6	18.4	16.8	34.0	18.4	44.2	21.6	19.6	20.7	33.2	16.8	19.3	23.7	23.3	24.8	16.4	19.3	21.3	25.3	17.0	17.4	25.4	38.0	22.9	66.5	17.5	17.2	30.3	22.9	18.1	19.3	19.7	17.7	18.7	22.9	19.6	19.5	17.8	25.8	23.7	27.5	19.7	17.3	39.2	27.8	17.3	18.4	30.0	19.3	22.3	74.0	18.5	17.5	20.6	46.2	27.4	32.5	36.5	36.8	32.8	37.5	39.0	36.9	36.7	43.3	33.8	30.1	64.6	31.1	24.5	33.7	40.7	25.2	24.1	44.2	37.0	16.6	38.9	32.0	24.6	58.7	71.2	49.2	39.1	33.8	31.2	27.4	36.5	35.1	37.2	43.9	47.1	27.5	43.3	41.4	50.0	28.7	38.8	23.5	38.7	19.2	44.7	40.9	22.7	36.5	20.3	49.3	25.3	42.5	28.0	32.3	62.5	23.6	34.5	26.3	37.6	26.2	31.9	20.9	111.9	29.4	40.1	29.2	80.3	25.0	35.2	31.1	23.1	24.0	116.5	33.2	30.9	21.0	110.8	40.6	33.3	43.0	28.9	30.0	25.2	31.5	25.6	16.8	18.4	19.6	20.7	17.0	17.4	17.5	17.2	17.7	17.3	18.4	20.6	36.5	19.2	52.9	15.3	111.2	17.3	32.5	38.4	29.6	37.0	26.7	29.6	35.9	27.1	36.4	44.1	18.8	49.2	61.4	22.4	45.0	32.1	19.8	49.6	41.2	33.5	33.6	46.3	18.1	69.0	46.2	35.6	55.0	45.0	58.9	33.1	31.4	32.1	71.8	21.9	12.8	27.5	40.7	41.8	24.7	10.6	32.9	48.0	21.4	24.4	62.9	21.2	54.6	14.1	22.0	39.3	23.4	36.5	75.5	31.1	29.4	55.5	39.5	46.3	39.5	39.6	30.9	49.5	71.6	30.4	19.6	37.1	54.2	33.2	26.3	35.6
MYL2	CMH10	ENSG00000111245	"Myosin light chain 2"	P10916	12	110910819-110921443	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	72	"heart muscle: 27910.5;skeletal muscle: 28967.7;tongue: 19823.2"	"Cell type enriched"	"Detected in some"	80	"Cardiomyocytes: 27611.5"	"Group enriched"	"Detected in some"	46	"head and neck cancer: 31.5;prostate cancer: 25.5"	"Region enriched"	"Detected in some"	6	"hypothalamus: 6.0"	"Group enriched"	"Detected in some"	12	"memory B-cell: 1.1;naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 4.2;HSkMC: 8.8;U-2 OS: 17.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA019763, HPA039262"	Supported		Uncertain	Microtubules		NA	NA		180000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Microtubules		"HPA019763: AB_1854243, HPA039262: AB_2676418"	"unprognostic (2.07e-2)"	"unprognostic (1.37e-1)"		"unprognostic (1.39e-1)"		"prognostic unfavorable (2.60e-4)"		"unprognostic (1.32e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.20e-1)"		"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.55e-1)"		7.3	4.5	0.0	0.1	0.0	0.7	29.4	0.0	0.0	1.5	0.0	4.7	0.6	2.2	0.0	357.0	0.5	9.5	27910.5	0.0	6.0	3.0	5.4	5.0	15.2	0.6	1.0	2.4	5.8	0.0	2.5	0.1	0.3	249.8	0.1	0.0	108.7	0.2	28967.7	19.3	3.2	0.3	0.0	2.1	3.5	2.1	0.0	1.0	13.3	19823.2	1.1	2.2	4.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	4.2	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	17.7	0.0	0.1	0.0	0.0	1.7	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.6	1.0	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	27611.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	235.7	0.0	0.0	0.0	0.0	0.0	53.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	4.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	342.2	138.8	0.1	0.1	0.0	0.0	0.0	3.3	0.0	0.1	0.0
NDUFAF6	"C8orf38, MGC40214"	ENSG00000156170	"NADH:ubiquinone oxidoreductase complex assembly factor 6"	Q330K2	8	94895767-95116455	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047148, HPA050545"	Approved					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA047148: AB_2679954, HPA050545: AB_2681166"	"unprognostic (1.97e-3)"	"unprognostic (1.62e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.29e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.45e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.52e-2)"	"unprognostic (9.61e-2)"	"unprognostic (3.85e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.35e-2)"	"unprognostic (4.04e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.32e-3)"	4.7	3.1	6.9	4.1	7.7	5.5	5.3	8.8	8.1	1.9	5.1	4.4	2.1	3.2	5.7	4.3	4.2	1.9	8.8	6.4	7.8	4.4	10.9	2.6	4.9	6.9	7.6	3.9	3.1	3.5	2.6	3.6	7.3	3.5	5.5	7.4	2.2	3.4	14.6	5.6	3.0	3.2	6.7	3.1	4.3	4.0	7.6	4.7	6.3	13.8	5.2	2.5	1.7	8.9	7.7	4.5	5.4	5.1	3.5	4.3	11.1	8.0	5.0	6.6	4.8	3.6	3.7	14.8	5.3	3.7	2.0	6.3	7.8	5.4	4.9	3.7	15.1	13.7	10.0	6.7	5.4	5.1	6.9	6.5	9.0	3.8	6.1	3.0	3.8	12.1	9.9	8.0	8.0	6.8	13.0	16.5	5.9	10.0	10.6	8.6	4.3	11.3	6.1	7.3	10.1	5.5	4.1	2.5	10.8	6.5	10.1	4.2	4.8	4.7	3.7	3.7	5.8	10.7	8.5	12.4	3.9	13.5	2.7	1.9	1.8	3.0	2.3	1.1	2.9	5.8	3.2	2.2	2.4	5.4	3.1	2.3	0.9	2.9	2.2	2.1	2.9	1.9	6.9	7.7	8.8	8.1	6.4	7.8	6.9	7.6	7.3	6.7	7.6	8.9	23.4	12.8	15.9	35.3	23.6	9.7	10.1	21.5	19.4	22.7	25.7	27.4	32.0	28.6	21.2	12.9	16.7	24.0	14.3	18.5	43.0	15.8	28.5	13.5	9.1	14.8	12.5	23.3	31.8	34.7	30.2	9.4	10.7	9.8	31.8	21.5	12.1	28.3	22.6	25.2	37.0	15.3	24.4	7.3	5.6	8.1	10.5	10.1	14.2	33.7	12.0	25.6	6.2	43.2	58.3	19.3	18.2	13.9	53.1	11.2	23.2	38.2	24.7	23.6	13.1	11.9	21.4	28.4	43.9	17.9	11.9	10.9	13.0	16.5	19.4	9.5
NEK6	SID6-1512	ENSG00000119408	"NIMA related kinase 6"	Q9HC98	9	124257606-124353307	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 121.0;Hofbauer cells: 112.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 250.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045993, HPA056828"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Cytosol"	"Centriolar satellite"	"CAB045993: AB_2150651, HPA056828: AB_2683250"	"unprognostic (6.27e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.53e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (5.27e-2)"	"unprognostic (4.77e-3)"	18.0	6.1	33.5	32.6	34.3	19.6	14.7	28.1	32.4	26.1	26.5	22.3	17.5	12.2	3.4	8.5	11.2	25.4	7.4	31.8	37.0	17.2	68.2	24.3	27.4	49.8	41.2	9.0	16.7	1.9	6.1	30.2	33.9	19.6	22.5	11.3	20.6	16.7	8.2	5.4	25.8	18.7	34.4	16.6	27.1	7.8	44.2	10.2	7.3	3.1	31.7	24.3	6.4	30.4	31.8	50.0	47.8	18.8	88.3	113.9	59.3	38.8	61.1	58.4	48.4	47.7	57.0	38.2	61.0	74.6	133.2	5.9	24.7	111.7	39.4	43.7	21.8	104.4	42.1	85.4	105.2	19.4	250.0	152.8	17.8	55.4	56.9	152.3	64.3	17.6	19.5	1.7	105.6	32.6	0.9	20.8	12.2	163.7	45.5	40.6	35.6	19.6	62.6	11.4	21.4	7.5	12.6	23.6	54.5	48.3	51.4	76.4	127.5	42.2	42.8	29.5	26.7	8.4	11.4	21.6	53.5	42.3	57.5	28.1	47.6	76.4	9.2	32.1	5.9	52.5	5.5	7.8	29.0	30.2	0.9	3.8	58.8	23.3	41.4	26.9	7.6	21.6	33.5	34.3	28.1	32.4	31.8	37.0	49.8	41.2	33.9	34.4	44.2	30.4	8.4	9.6	4.7	37.9	24.5	2.4	13.8	18.9	4.6	1.0	9.4	6.5	3.3	18.6	8.8	3.7	0.0	47.1	11.3	8.5	1.9	41.3	18.2	9.4	17.7	8.4	6.0	4.0	8.3	23.3	121.0	11.1	19.4	22.2	22.2	1.1	5.0	43.5	112.0	0.0	5.3	18.2	18.3	10.4	22.5	20.0	5.0	31.2	7.2	12.2	57.7	34.6	8.2	15.1	2.4	30.6	11.9	3.8	5.5	17.1	17.2	38.0	3.3	2.1	0.0	4.9	6.4	1.3	17.1	2.4	1.1	36.1	4.5	2.1	18.7	10.2
NPIPA1	"morpheus, NPIP"	ENSG00000183426	"Nuclear pore complex interacting protein family member A1"	Q9UND3	16	14922802-14952060	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 938.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.4;Excitatory neurons: 37.7;Respiratory ciliated cells: 37.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	15	"cerebral cortex: 938.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 76.6"									HPA053611	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (2.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.29e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.82e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.74e-7)"	"unprognostic (2.28e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.66e-5)"	55.4	49.4	43.3	10.7	42.1	12.7	54.6	60.6	938.3	69.6	30.2	88.8	5.7	57.1	0.0	47.1	74.6	7.7	60.4	43.7	39.7	43.0	44.6	51.5	14.6	43.1	36.3	102.2	49.3	13.9	157.0	8.3	44.1	70.5	9.1	38.4	41.1	26.6	69.7	63.6	49.2	30.0	34.9	55.8	50.0	96.8	37.8	17.0	57.3	23.6	12.0	67.6	56.9	39.3	0.4	12.5	56.7	22.0	0.1	0.9	9.9	22.0	15.3	19.9	17.5	8.6	13.6	3.6	30.4	30.5	23.5	9.9	26.4	3.0	20.1	11.3	10.0	0.0	20.9	47.0	76.6	28.3	6.4	42.8	42.6	16.6	29.6	11.6	9.7	19.0	3.2	15.2	22.7	26.9	0.0	14.5	0.6	0.0	0.6	10.8	0.3	5.2	32.1	26.7	2.4	21.0	11.6	1.4	29.1	6.7	4.4	24.2	2.0	26.4	1.2	0.4	7.2	8.3	6.7	7.5	0.9	1.8	14.0	0.3	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	43.3	42.1	60.6	938.3	43.7	39.7	43.1	36.3	44.1	34.9	37.8	39.3	6.8	6.4	20.0	22.2	4.4	9.3	1.0	3.7	12.5	9.0	8.1	7.4	2.0	7.2	17.6	9.2	6.2	2.6	6.5	5.1	0.0	5.3	64.4	5.2	7.3	6.2	4.9	9.1	37.7	2.0	1.8	9.9	3.6	4.0	22.1	5.3	6.8	3.3	2.3	6.7	27.2	5.3	4.1	4.7	4.1	22.3	21.5	3.9	0.0	5.6	6.1	3.2	4.1	24.1	17.5	4.4	4.3	19.2	14.7	1.5	4.1	1.0	37.4	6.3	19.7	6.8	5.5	14.9	10.8	9.6	4.0	1.2	5.1	2.3	6.1	1.0
ODC1	ODC	ENSG00000115758	"Ornithine decarboxylase 1"	P11926	2	10439968-10448327	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Polyamine biosynthesis"	"Decarboxylase, Lyase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 560.8;Late spermatids: 834.9;Prostatic glandular cells: 412.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001536, CAB035996"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Cytosol"		"CAB035996: , HPA001536: AB_1079521"	"unprognostic (2.33e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.25e-3)"	"unprognostic (5.21e-3)"	"unprognostic (4.22e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (3.06e-2)"	"unprognostic (4.18e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.86e-2)"	47.2	23.2	31.0	69.3	31.5	172.9	33.0	30.5	32.2	33.5	48.5	64.8	32.4	66.0	49.2	29.4	56.3	43.7	55.9	29.9	33.0	132.2	92.1	52.4	111.0	32.4	33.0	54.8	61.8	99.6	92.5	20.0	30.6	91.1	72.0	46.2	27.0	55.1	163.3	29.2	41.6	71.2	34.1	42.9	51.5	133.3	34.0	77.1	58.5	73.5	149.1	113.6	26.9	35.7	166.8	130.6	177.1	211.4	31.1	92.4	410.1	234.6	114.9	216.3	99.9	697.3	75.4	870.2	114.6	143.6	208.6	30.2	549.1	265.5	261.2	334.0	231.5	398.1	212.2	429.9	250.8	680.1	91.8	62.5	70.5	490.1	608.3	111.4	176.3	237.6	674.2	274.3	121.7	109.0	680.1	267.3	324.9	228.3	418.8	478.5	556.0	586.3	130.9	119.5	246.6	209.9	293.6	88.8	121.8	135.7	60.0	300.5	124.7	174.4	362.6	227.9	511.7	128.0	416.1	780.8	156.7	443.6	109.9	0.0	1.5	3.0	2.9	2.9	3.3	14.8	4.1	4.8	3.4	15.0	2.8	4.5	0.5	1.4	1.8	12.2	4.4	3.2	31.0	31.5	30.5	32.2	29.9	33.0	32.4	33.0	30.6	34.1	34.0	35.7	78.2	44.8	161.4	7.5	228.9	58.0	123.7	48.8	19.4	36.8	53.2	68.3	55.1	81.5	33.9	40.5	31.3	1.5	188.1	77.7	72.4	50.6	560.8	90.9	66.2	52.2	271.0	111.3	7.5	27.6	70.0	63.2	204.4	127.6	58.9	103.8	14.6	50.3	46.8	6.7	4.1	234.1	22.4	32.1	22.4	834.9	15.5	191.8	23.2	8.4	22.1	126.3	37.0	4.5	2.4	28.6	64.5	11.3	287.4	412.4	31.6	154.1	21.9	77.4	0.0	223.0	79.9	186.5	75.8	52.2	87.5	3.4	133.0	30.2	180.5	142.2
OSTN		ENSG00000188729	Osteocrin	P61366	3	191199241-191265615	"Predicted secreted proteins"	Differentiation	"Developmental protein, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 4.2;Excitatory neurons: 1.0;Inhibitory neurons: 5.9;Late spermatids: 1.4;Oligodendrocyte precursor cells: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"memory B-cell: 4.0;naive B-cell: 1.3"	"Lineage enriched"	"Detected in single"	9	"B-cells: 4.0"	"Cell line enriched"	"Detected in some"	24	"U-2197: 39.1"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.0"	"Low region specificity"	"Detected in single"			"CAB024997, CAB025649, HPA030878"	Uncertain				"Secreted in other tissues"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB024997: , CAB025649: , HPA030878: AB_2673642"					"unprognostic (2.35e-2)"		"unprognostic (9.12e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.45e-1)"			0.3	0.1	0.6	0.7	0.9	0.0	0.1	0.1	1.2	1.2	0.2	0.1	0.0	0.1	1.6	0.0	0.7	0.8	0.4	0.8	0.8	0.1	0.6	0.2	0.6	0.5	0.2	0.2	0.0	0.0	0.0	0.4	0.5	0.6	0.0	0.1	0.2	0.1	0.8	1.2	0.1	0.0	0.4	0.2	0.3	0.4	0.3	0.1	0.1	1.0	0.0	1.3	0.2	0.5	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.1	0.0	1.6	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.9	0.1	1.2	0.8	0.8	0.5	0.2	0.5	0.4	0.3	0.5	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	5.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PARM1	"Cipar1, DKFZP564O0823, WSC4"	ENSG00000169116	"Prostate androgen-regulated mucin-like protein 1"	Q6UWI2	4	74933095-75050115	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 181.9;Distal enterocytes: 398.3;Intestinal goblet cells: 109.7;Paneth cells: 132.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 56.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	15	"memory B-cell: 8.1;myeloid DC: 4.0;naive B-cell: 5.6"	"Group enriched"	"Detected in many"	15	"B-cells: 8.1;dendritic cells: 4.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 44.6;Karpas-707: 44.9;U-266/70: 49.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038236	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles, Cytosol"		"HPA038236: AB_10675789"	"unprognostic (2.57e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.26e-3)"	"unprognostic (8.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.49e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.74e-2)"	"unprognostic (9.44e-2)"	"unprognostic (3.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (2.23e-1)"	45.1	51.8	4.1	27.7	5.4	0.4	29.3	0.0	19.3	43.3	2.1	91.3	7.0	34.7	14.0	13.5	23.3	28.6	103.6	10.4	26.0	55.9	1.3	33.7	18.2	1.3	3.9	19.6	34.1	73.1	41.0	40.7	21.2	83.8	113.4	6.0	39.4	64.5	21.0	11.1	15.7	48.2	0.0	15.3	13.4	12.0	4.1	17.3	123.7	18.1	20.9	44.9	25.0	0.0	1.1	1.9	1.7	0.0	44.6	0.3	0.2	0.0	0.2	0.0	0.0	3.9	0.3	0.0	0.2	0.0	0.1	0.1	15.1	0.0	0.0	0.2	3.3	0.0	0.0	0.0	7.4	0.0	1.3	1.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	44.9	0.8	0.5	5.2	0.2	4.3	0.0	2.7	0.0	4.1	11.8	0.2	9.5	2.8	0.1	0.1	0.3	0.0	1.8	0.0	0.0	0.0	2.7	2.9	0.3	4.2	49.8	5.1	12.9	4.7	0.0	0.7	0.0	0.1	0.0	0.0	0.3	0.0	8.1	0.0	0.0	4.0	5.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.5	4.1	5.4	0.0	19.3	10.4	26.0	1.3	3.9	21.2	0.0	4.1	0.0	44.8	16.0	84.1	2.9	11.6	3.2	27.2	6.5	4.0	7.0	4.0	3.4	181.9	31.5	10.4	0.0	0.0	0.3	0.1	398.3	3.9	0.5	10.1	3.0	73.5	6.4	19.9	2.7	51.3	49.2	0.7	13.2	2.0	2.8	1.3	61.9	2.9	0.0	1.5	0.0	77.8	109.7	14.2	0.3	34.7	28.6	36.7	4.9	8.8	1.0	0.7	0.1	0.0	6.0	3.6	23.5	132.1	74.4	42.9	32.6	2.5	27.7	7.2	1.7	46.0	5.4	61.5	1.6	3.2	0.3	1.8	0.8	1.9	14.9	81.6	9.1
PFKM	"PFK-1, PFKX, PPP1R122"	ENSG00000152556	"Phosphofructokinase, muscle"	P08237	12	48105139-48146404	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 1570.1;tongue: 1393.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 345.9;Horizontal cells: 121.1;Muller glia cells: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002117	Approved		Approved	"Endoplasmic reticulum"		NA	NA		410000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Endoplasmic reticulum"		"HPA002117: AB_1855245"	"unprognostic (4.60e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (5.85e-6)"	"unprognostic (4.97e-1)"	"prognostic unfavorable (7.91e-5)"	"unprognostic (5.93e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.29e-3)"	"unprognostic (6.73e-2)"	"prognostic favorable (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.30e-2)"	18.7	54.2	50.4	11.0	50.9	8.0	15.0	58.1	59.3	28.2	50.1	34.2	10.4	36.1	14.3	38.6	29.2	15.9	298.6	49.4	63.3	46.0	8.4	14.9	8.0	54.5	51.1	45.1	10.9	136.2	36.5	12.0	58.7	29.0	16.1	85.5	29.2	39.0	1570.1	14.4	16.0	35.1	46.1	11.8	23.0	50.7	62.1	9.3	21.5	1393.9	10.2	27.7	19.2	43.4	32.9	30.6	98.4	87.5	97.2	72.5	20.2	85.4	80.2	77.1	54.4	76.3	40.5	192.9	69.6	44.1	44.9	36.0	90.1	91.2	70.9	5.5	43.9	54.7	64.7	1.9	54.3	2.9	30.9	102.1	50.4	69.2	107.3	125.1	85.9	3.7	64.6	91.7	71.5	25.8	69.5	5.1	67.7	36.0	93.9	115.7	55.7	141.3	48.4	32.5	111.5	82.6	51.0	75.9	86.5	78.7	80.3	11.2	75.8	34.0	46.5	49.5	72.1	52.8	145.3	106.4	62.4	6.8	28.5	0.3	2.9	7.8	2.1	2.5	0.9	8.8	3.5	2.1	5.6	8.3	4.3	2.4	0.7	2.1	2.1	0.9	3.5	3.1	50.4	50.9	58.1	59.3	49.4	63.3	54.5	51.1	58.7	46.1	62.1	43.4	8.6	16.0	8.4	30.3	6.9	7.4	21.7	22.1	15.9	43.3	5.6	9.1	345.9	12.8	10.8	22.0	43.8	2.8	0.9	3.4	66.5	10.6	43.1	5.5	18.0	17.3	9.1	8.6	23.2	2.5	3.8	27.1	6.6	2.4	1.3	17.3	13.9	2.7	4.1	121.1	30.0	9.1	34.6	3.8	3.7	27.0	30.7	4.3	55.2	3.7	11.3	125.7	4.1	15.6	3.4	3.5	1.9	47.8	4.6	7.9	2.7	30.6	11.2	51.1	26.3	37.6	24.5	52.1	14.4	9.2	5.3	2.5	3.3	24.0	10.1	9.7
PHKB		ENSG00000102893	"Phosphorylase kinase regulatory subunit beta"	Q93100	16	47461123-47701523	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	Calmodulin-binding	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 159.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073380			Approved	"Golgi apparatus"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA073380: AB_2686598"	"unprognostic (2.87e-3)"	"unprognostic (2.41e-1)"	"prognostic favorable (3.69e-4)"	"unprognostic (3.98e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.01e-2)"	"prognostic favorable (3.89e-9)"	"unprognostic (3.56e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (2.53e-2)"	29.7	42.4	15.8	21.9	16.2	28.2	36.1	18.3	19.5	33.8	34.1	39.0	37.8	26.8	32.8	34.5	25.6	30.6	32.7	14.3	21.3	47.2	30.1	30.0	26.2	15.8	16.0	24.2	26.6	56.7	21.6	37.1	18.6	36.2	41.5	18.9	46.1	32.2	159.0	18.9	38.0	32.1	13.8	29.0	40.4	30.6	18.9	31.0	54.1	80.7	29.0	26.5	21.2	16.6	36.7	53.3	60.3	39.1	41.2	38.8	74.9	42.8	41.2	30.1	15.0	29.4	62.2	44.5	63.5	62.7	23.7	50.6	57.0	66.9	42.3	13.8	29.8	42.1	45.4	98.3	37.0	46.2	47.7	35.1	33.4	20.3	38.2	65.4	59.8	53.5	58.8	27.4	43.7	26.3	45.2	44.1	25.5	61.1	39.8	75.7	73.3	74.3	59.2	31.1	31.5	35.8	70.9	92.4	12.0	66.1	36.0	37.7	66.5	54.4	25.4	28.0	22.9	31.1	24.6	57.2	34.5	30.2	22.7	11.1	21.0	18.4	11.8	18.9	15.3	30.6	12.2	9.7	20.6	34.7	11.8	11.7	10.4	18.5	23.7	13.9	15.8	12.6	15.8	16.2	18.3	19.5	14.3	21.3	15.8	16.0	18.6	13.8	18.9	16.6	49.3	19.2	38.0	66.9	46.8	8.9	17.5	28.8	18.8	34.9	28.7	23.4	61.2	32.9	39.9	42.3	100.1	48.5	29.3	43.1	23.5	19.6	64.7	33.5	31.1	42.9	30.5	40.1	109.8	15.6	26.3	28.8	47.9	38.3	18.3	52.6	39.3	30.9	28.4	23.5	149.0	37.8	20.3	58.7	17.0	89.8	25.4	45.1	8.8	104.0	72.2	25.8	32.0	133.2	118.4	27.2	26.4	35.7	28.1	30.2	48.9	35.9	26.7	71.8	26.3	33.3	30.6	53.9	19.5	47.2	7.2	33.8	24.7	74.9	38.6	26.7
PIKFYVE	"FAB1, KIAA0981, MGC40423, p235, PIP5K, PIP5K3, ZFYVE29"	ENSG00000115020	"Phosphoinositide kinase, FYVE-type zinc finger containing"	Q9Y2I7	2	208266255-208358746	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 82.0;Oligodendrocyte precursor cells: 80.9;Oligodendrocytes: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042604	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"HPA042604: AB_10796580"	"unprognostic (1.00e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.04e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (6.82e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.05e-2)"	10.4	7.9	7.6	12.0	7.6	28.8	8.1	14.3	9.3	9.1	10.5	6.1	6.0	9.3	11.9	6.3	6.4	7.2	7.4	7.7	7.3	10.6	10.5	7.8	17.4	8.0	7.4	10.0	22.2	11.1	6.0	9.7	6.9	11.5	7.4	17.3	6.5	8.0	6.5	8.2	7.3	8.9	7.4	15.1	8.0	14.0	8.9	19.3	12.2	9.0	16.1	8.2	5.8	11.1	8.0	7.9	18.3	14.3	18.1	21.4	8.5	9.6	19.5	11.1	15.0	11.3	6.6	9.2	9.8	16.6	21.7	8.0	16.1	10.8	18.8	7.9	10.1	33.0	15.6	10.2	13.7	29.5	28.5	16.0	11.5	13.0	24.1	18.5	18.3	24.1	22.7	16.1	14.0	3.4	26.9	22.1	15.2	6.1	5.9	9.9	14.2	12.7	14.2	11.5	5.8	13.8	10.6	6.8	19.2	21.4	4.3	31.3	21.2	13.8	9.2	9.4	9.0	11.2	14.2	19.2	11.1	25.2	13.9	0.9	0.5	0.4	0.9	0.4	0.5	4.4	1.2	1.4	0.5	3.2	0.9	1.1	0.7	3.2	0.7	1.2	0.9	0.3	7.6	7.6	14.3	9.3	7.7	7.3	8.0	7.4	6.9	7.4	8.9	11.1	18.8	25.6	16.2	58.8	82.0	15.3	6.7	7.8	25.6	21.9	10.5	6.6	17.5	11.5	10.6	11.0	16.7	8.1	14.4	8.1	5.9	5.4	10.4	11.3	19.4	18.8	18.6	25.5	72.6	4.3	5.7	15.7	16.3	21.7	36.1	18.0	18.2	19.4	14.4	10.1	67.9	9.6	4.1	29.9	32.5	8.3	18.6	28.5	10.6	48.7	19.1	13.5	16.5	80.9	81.7	8.5	5.9	13.5	10.3	18.1	14.3	9.9	9.2	19.7	13.1	15.4	18.9	30.5	23.0	14.8	15.3	7.3	21.5	13.3	8.8	11.4
PLA2G2D	sPLA2S	ENSG00000117215	"Phospholipase A2 group IID"	Q9UNK4	1	20111939-20119566	"Enzymes, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"lymphoid tissue: 106.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 1.6;dendritic cells: 1.3;Kupffer cells: 2.4;Melanocytes: 5.4;Plasma cells: 8.1"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 25.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory B-cell: 3.7;naive B-cell: 3.6;plasmacytoid DC: 2.0"	"Group enriched"	"Detected in many"	6	"B-cells: 3.7;dendritic cells: 2.0"	"Cell line enriched"	"Detected in some"	7	"RPMI-8226: 8.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (4.35e-4)"	"prognostic favorable (8.15e-5)"	"unprognostic (3.88e-3)"	"prognostic favorable (9.74e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.82e-5)"	"unprognostic (7.51e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.60e-1)"	0.7	0.1	0.1	15.8	0.1	0.8	0.9	0.3	0.2	0.3	0.0	2.3	1.4	0.4	0.1	0.4	0.4	1.7	0.2	0.1	0.0	0.1	0.7	2.4	106.4	0.1	0.0	1.0	0.3	0.0	0.0	0.1	0.1	0.4	3.3	0.1	1.2	0.4	0.0	0.2	4.5	0.2	0.0	11.0	2.3	0.4	0.1	3.1	0.3	0.0	59.1	4.5	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.2	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.4	0.4	0.0	0.0	0.6	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3
PLAAT2	"FLJ20556, HRASLS2, PLAAT-2"	ENSG00000133328	"Phospholipase A and acyltransferase 2"	Q9NWW9	11	63552770-63563379	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 67.9"	"Cell type enhanced"	"Detected in single"		"dendritic cells: 2.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	8	"memory B-cell: 17.3;naive B-cell: 8.2"	"Lineage enriched"	"Detected in many"	10	"B-cells: 17.3"	"Cell line enriched"	"Detected in some"	8	"U-266/70: 128.9"									HPA058997	Approved		Approved	Mitochondria		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA058997: AB_2683874"	"unprognostic (4.76e-2)"	"prognostic favorable (6.87e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	"unprognostic (9.69e-2)"	"unprognostic (3.91e-3)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.57e-2)"	0.3	0.0	0.6	0.8	0.6	0.1	9.1	0.5	0.9	0.9	0.3	11.2	67.9	0.3	1.2	1.5	4.7	0.6	0.2	0.5	0.5	8.6	4.6	3.6	0.3	0.7	0.6	0.2	0.0	0.0	0.2	0.2	0.6	0.4	13.7	0.0	0.9	0.5	0.0	0.3	42.5	0.3	0.5	0.7	12.4	0.5	0.6	0.3	0.9	0.0	0.3	1.3	0.2	1.1	0.4	1.7	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.4	0.1	0.3	15.6	0.0	0.9	0.0	0.4	1.0	0.6	0.2	0.1	0.2	0.0	0.1	1.0	0.1	0.2	0.0	0.1	0.1	1.2	0.3	0.0	0.7	0.0	0.0	0.0	6.7	0.0	0.0	0.2	0.3	0.1	8.7	1.9	0.0	0.0	1.5	0.6	0.0	0.0	0.2	0.1	4.0	0.0	0.1	2.2	0.1	0.0	0.0	0.0	0.1	0.0	128.9	16.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.9	17.3	0.2	1.0	0.1	8.2	0.2	0.7	0.1	1.6	0.0	0.9	0.0	3.9	0.6	0.6	0.5	0.9	0.5	0.5	0.7	0.6	0.6	0.5	0.6	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0
PLEKHG7	"C12orf74, FLJ46688"	ENSG00000187510	"Pleckstrin homology and RhoGEF domain containing G7"	Q32Q52	12	92702843-92772455	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 1.8;epididymis: 1.9;fallopian tube: 2.8"	"Cell type enriched"	"Detected in some"	4	"Respiratory ciliated cells: 72.0"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"memory B-cell: 1.9;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	20	"B-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.8;SK-BR-3: 1.5"									HPA060632	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA060632: AB_2684333"	"unprognostic (4.47e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.80e-2)"	"unprognostic (9.91e-5)"	"unprognostic (1.38e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.75e-1)"		"unprognostic (3.27e-5)"	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.5	0.3	0.3	1.9	0.0	2.8	0.4	0.0	0.0	0.0	0.3	0.2	0.8	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.4	0.0	0.0	0.6	0.0	0.0	0.4	1.7	0.0	0.0	0.2	0.0	0.0	1.6	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.8	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	6.9	0.1	0.3	6.1	0.0	0.4	0.0	0.0	0.7	0.0	16.3	1.8	0.0	0.0	0.0	0.2	0.0	0.6	1.0	13.7	0.3	0.1	1.2	0.0	0.1	0.2	0.0	0.0	1.1	1.6	1.3	0.1	0.0	0.0	0.0	0.0	0.1	0.2	4.1	0.0	0.0	0.9	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.3	0.3	0.2	0.1	72.0	0.6	0.0	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	1.3
PLPP3	"LPP3, PAP-2b, PPAP2B"	ENSG00000162407	"Phospholipid phosphatase 3"	O14495	1	56494761-56645301	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 392.7;Hepatic stellate cells: 779.6;Leydig cells: 1092.6;Peritubular cells: 398.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 168.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.4;naive B-cell: 2.3"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 710.0;ASC TERT1: 351.8;HSkMC: 438.1;U-2197: 660.4"					"Low region specificity"	"Detected in all"			HPA072751	Approved		Supported	"Golgi apparatus"		NA	Yes			"Cluster 19: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA072751: AB_2686555"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.09e-1)"	168.4	53.0	93.9	33.6	94.2	13.1	139.8	87.3	105.9	294.6	50.7	56.7	24.0	107.2	56.2	51.3	122.5	66.3	84.6	88.3	90.6	91.4	182.0	87.0	22.4	107.5	108.1	81.9	36.8	130.2	23.1	225.5	87.7	102.8	41.8	19.0	76.2	169.7	50.9	82.1	45.8	65.6	86.8	23.3	66.0	37.3	113.2	29.8	327.6	63.0	19.9	139.2	142.8	88.6	3.3	10.8	14.1	1.5	710.0	351.8	34.5	39.3	39.7	35.5	17.4	31.8	6.2	5.2	4.6	59.3	39.4	5.9	2.1	0.8	7.4	0.0	9.4	1.3	4.4	44.5	17.3	0.1	0.0	438.1	3.0	34.2	28.6	25.1	34.1	0.4	2.9	0.1	39.0	3.2	0.1	0.5	43.3	9.2	42.6	0.1	0.1	1.7	6.1	32.6	0.4	28.1	12.4	16.1	4.2	42.6	5.2	0.0	21.6	176.2	14.4	660.4	1.8	0.0	0.0	0.0	31.0	1.7	12.7	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.3	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	93.9	94.2	87.3	105.9	88.3	90.6	107.5	108.1	87.7	86.8	113.2	88.6	148.5	25.6	18.9	0.0	7.2	0.0	19.8	0.0	35.3	3.9	12.2	31.2	0.0	44.3	13.0	22.0	0.0	127.0	1.1	8.1	21.5	21.5	7.9	13.9	139.4	148.3	2.4	8.0	0.0	9.2	9.8	392.7	5.6	16.3	3.8	8.1	779.6	132.6	38.8	0.0	0.0	8.5	0.0	35.2	0.0	28.3	1092.6	14.9	0.0	0.0	0.9	136.0	0.0	0.0	0.0	7.9	5.9	398.7	7.1	20.8	15.5	21.3	4.4	4.1	138.1	179.7	107.2	4.5	3.4	16.4	0.0	214.9	5.0	22.4	7.2	20.1
PNOC	"N/OFQ, NOP, PPNOC"	ENSG00000168081	Prepronociceptin	Q13519	8	28316986-28343355	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Neuropeptide, Neurotransmitter, Opioid peptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.3;fallopian tube: 18.2;lymphoid tissue: 25.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 61.5;dendritic cells: 12.6;Inhibitory neurons: 23.3;Melanocytes: 14.2;Plasma cells: 80.4"	"Cancer enriched"	"Detected in many"	8	"ovarian cancer: 32.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	20	"memory B-cell: 231.2;naive B-cell: 260.3;plasmacytoid DC: 194.0"	"Group enriched"	"Detected in many"	20	"B-cells: 260.3;dendritic cells: 194.0"	"Group enriched"	"Detected in some"	6	"Daudi: 38.3;Karpas-707: 29.2;RPMI-8226: 11.2;U-698: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA044507, HPA056724"	Enhanced				"Secreted to blood"	NA	NA	12300		"Cluster 19: B-cells - Humoral immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA044507: AB_10795043, HPA056724: AB_2683216"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (2.94e-6)"	"unprognostic (3.71e-2)"	"unprognostic (5.16e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.81e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.99e-3)"	"unprognostic (7.57e-9)"	"unprognostic (2.19e-2)"	"unprognostic (5.45e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.40e-1)"	0.2	0.8	5.4	9.9	5.1	2.7	0.6	1.3	10.8	0.2	1.3	2.9	4.3	0.1	0.0	0.6	18.2	1.1	0.1	2.9	9.9	0.7	0.2	1.0	25.1	10.4	6.3	0.4	0.0	0.0	0.0	0.0	9.9	0.2	1.5	0.0	1.6	0.1	0.0	0.1	5.8	0.5	14.3	14.4	3.2	0.6	4.3	2.7	0.4	0.0	23.6	3.7	0.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	4.0	4.4	23.0	0.1	0.1	0.0	0.2	11.5	2.3	0.2	7.7	0.1	231.2	0.2	0.1	1.1	260.3	0.1	0.1	1.3	1.2	3.2	194.0	0.5	11.1	5.4	5.1	1.3	10.8	2.9	9.9	10.4	6.3	9.9	14.3	4.3	3.0	0.1	0.0	1.9	1.3	61.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	3.9	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.5	0.0	0.0	0.0	1.4	0.4	0.2	0.0	23.3	0.1	0.0	0.0	0.3	2.8	0.3	1.7	14.2	1.0	3.0	0.0	1.0	0.0	0.9	0.1	0.0	0.0	80.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	1.1	0.0	0.3	0.5
POF1B	"FLJ22792, POF"	ENSG00000124429	"POF1B actin binding protein"	Q8WVV4	X	85277396-85379717	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.2;skin 1: 123.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 129.8;Gastric mucus-secreting cells: 48.9;Intestinal goblet cells: 61.1;Paneth cells: 62.5;Proximal enterocytes: 73.6;Squamous epithelial cells: 39.2;Undifferentiated cells: 51.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 44.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.9;naive B-cell: 2.1"	"Lineage enriched"	"Detected in single"	7	"B-cells: 2.9"	"Group enriched"	"Detected in some"	5	"OE19: 179.0;RT4: 78.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002033, HPA050027"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		200000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA002033: AB_1079650, HPA050027: "	"unprognostic (2.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.54e-3)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.57e-4)"	"unprognostic (1.01e-2)"	0.7	0.3	0.1	6.1	0.1	0.2	11.0	0.8	0.3	6.4	0.0	54.2	34.4	0.2	0.5	33.1	6.2	9.0	10.6	0.1	0.0	1.4	0.4	1.8	0.5	0.0	0.0	0.1	6.9	0.0	0.3	1.0	0.0	2.9	50.9	0.4	8.5	1.3	0.8	123.9	43.4	2.0	0.0	3.5	23.7	0.2	0.0	0.5	0.5	0.0	12.0	14.3	14.7	0.0	3.7	22.9	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.5	23.9	12.0	3.3	0.0	0.1	23.7	5.1	0.4	0.0	2.4	0.1	4.4	0.1	0.1	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.3	0.7	3.9	0.0	9.6	0.1	0.2	0.0	179.0	0.0	0.2	1.0	0.1	0.0	78.2	0.1	0.1	0.0	6.0	0.0	1.8	2.4	1.0	0.2	0.1	0.1	0.2	0.3	2.0	4.8	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.2	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.7	1.2	9.1	4.9	7.9	12.0	0.0	2.5	0.8	24.2	8.6	10.2	5.5	0.0	3.2	0.0	129.8	0.0	13.8	0.0	0.3	0.0	1.7	22.8	0.0	0.4	15.6	0.6	3.4	48.9	0.2	0.0	0.0	0.4	0.2	0.3	0.0	0.4	61.1	6.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.4	24.8	62.5	0.0	0.2	3.9	73.6	0.1	9.5	0.0	0.0	0.1	0.9	0.0	0.1	39.2	28.6	5.3	0.3	0.0	51.1	17.1
PWP1	IEF-SSP-9502	ENSG00000136045	"PWP1 homolog, endonuclein"	Q13610	12	107685799-107713162	"Predicted intracellular proteins"	"Ribosome biogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038708			Approved	"Nucleoli rim,Golgi apparatus"		Yes	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli rim"	"Golgi apparatus"	"HPA038708: AB_2676163"	"unprognostic (7.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (9.65e-4)"	"prognostic unfavorable (1.40e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.00e-1)"	"unprognostic (6.95e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.10e-2)"	29.7	20.9	18.6	26.4	19.0	31.9	33.7	18.8	23.6	24.9	29.5	27.7	17.7	30.3	24.8	28.7	24.7	20.4	17.3	18.9	19.1	30.4	32.2	21.4	32.0	17.4	18.0	32.8	25.8	33.0	17.8	29.5	20.0	25.2	26.0	26.9	24.4	27.5	22.9	28.8	21.7	32.3	18.1	23.7	23.1	30.1	18.8	33.2	25.9	17.6	37.4	31.4	24.5	19.0	71.0	86.9	51.8	49.4	70.9	77.2	68.5	72.9	81.9	100.8	84.8	88.5	32.9	108.8	38.4	112.9	68.4	60.7	70.8	77.0	99.2	54.7	80.6	82.9	50.5	103.2	72.7	101.8	56.9	70.2	69.1	93.5	83.0	79.0	119.8	66.0	110.8	29.8	109.1	78.3	71.6	99.3	62.0	64.8	141.2	58.3	61.2	101.4	62.7	98.3	58.4	46.9	59.6	42.4	104.1	64.8	75.3	49.7	94.9	76.7	38.9	63.0	84.1	42.5	62.8	84.9	34.3	55.3	68.7	29.4	20.8	16.2	41.7	27.8	37.8	68.5	40.6	43.9	35.0	64.1	34.5	47.9	6.6	44.2	34.4	47.3	48.6	29.7	18.6	19.0	18.8	23.6	18.9	19.1	17.4	18.0	20.0	18.1	18.8	19.0	44.1	41.7	38.1	13.7	80.1	48.4	52.3	70.6	36.5	50.4	41.0	41.3	22.1	25.8	48.9	27.6	37.5	69.1	48.4	14.6	58.7	69.7	24.4	34.5	47.3	52.0	21.0	52.2	15.6	63.0	74.5	51.6	30.5	35.8	57.6	41.5	43.5	52.0	46.2	33.7	19.0	31.9	26.4	34.3	28.0	11.1	50.4	33.2	30.2	4.7	75.2	41.4	38.1	15.1	16.7	68.0	19.8	44.0	46.0	50.2	24.5	70.8	42.8	46.2	26.3	41.8	50.9	124.3	79.2	41.9	49.7	45.7	44.0	45.8	34.1	40.5
QSOX2	"DKFZp762A2013, QSCN6L1, SOXN"	ENSG00000165661	"Quiescin sulfhydryl oxidase 2"	Q6ZRP7	9	136206333-136245812	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012716, HPA017280"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		9600000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA012716: AB_2173315, HPA017280: AB_2669565"	"unprognostic (7.29e-2)"	"unprognostic (7.35e-3)"	"unprognostic (6.23e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.06e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (9.64e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.10e-2)"	7.5	7.6	7.3	11.2	7.6	15.9	5.9	12.9	8.1	7.3	5.9	6.7	5.1	8.3	10.6	5.3	8.6	4.6	7.6	7.3	7.6	7.5	8.6	7.0	17.5	7.3	7.6	9.5	18.8	8.1	32.3	4.9	6.9	6.4	5.4	12.3	5.9	3.7	5.6	11.1	11.8	6.7	6.0	15.7	7.1	10.8	8.0	8.1	11.7	3.4	14.6	6.3	5.8	7.3	14.7	35.0	28.6	38.2	15.8	19.0	35.9	18.3	20.4	34.9	31.9	26.4	31.1	22.6	29.5	24.7	64.1	46.7	34.2	26.5	28.0	33.5	17.2	12.1	59.8	29.3	22.5	36.4	17.8	15.3	26.3	34.8	41.8	15.4	25.9	23.3	29.8	59.1	18.8	25.0	13.6	24.2	34.0	44.2	22.3	24.8	37.1	37.2	12.0	13.1	30.5	23.1	28.9	22.6	15.9	18.5	16.3	21.1	15.0	42.2	30.4	35.1	42.6	20.9	29.9	49.7	28.3	18.9	40.5	0.4	0.0	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	7.3	7.6	12.9	8.1	7.3	7.6	7.3	7.6	6.9	6.0	8.0	7.3	8.8	9.6	7.9	13.7	17.7	5.7	2.8	2.2	1.8	24.4	2.3	2.9	4.3	0.0	4.4	5.5	18.8	1.3	5.8	1.6	1.9	3.4	6.7	5.7	7.4	6.6	16.3	14.5	10.1	4.0	2.8	5.2	4.1	5.6	1.3	7.1	2.9	4.4	2.3	5.0	11.1	3.8	0.0	3.7	8.2	7.3	5.9	3.3	0.0	8.4	4.3	2.6	4.1	6.0	10.7	3.4	0.7	7.2	5.4	7.9	0.9	2.3	9.0	8.8	6.6	9.2	4.7	19.4	24.2	1.8	11.5	1.0	5.1	7.3	3.9	3.6
RABEP2	"FLJ23282, FRA"	ENSG00000177548	"Rabaptin, RAB GTPase binding effector protein 2"	Q9H5N1	16	28904421-28936526	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047641	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 57: B-cells - Immune response"	"Vesicles, Cytosol"		"HPA047641: AB_2680111"	"unprognostic (4.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (5.84e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.41e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.26e-3)"	"unprognostic (5.86e-2)"	"prognostic favorable (1.24e-6)"	"unprognostic (7.50e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.92e-3)"	7.3	21.5	7.3	25.1	8.8	11.5	9.3	8.2	9.2	11.0	10.7	15.0	16.8	8.4	2.7	18.7	7.0	6.6	16.8	6.5	7.9	19.2	10.6	10.1	46.7	10.7	8.5	6.3	17.9	11.5	16.4	5.3	8.4	28.6	4.6	3.5	17.5	7.0	6.5	23.6	28.3	3.4	7.9	47.9	14.4	6.2	8.2	5.3	13.9	3.2	9.4	12.5	12.3	8.5	13.5	21.1	5.6	10.5	3.3	4.7	10.1	15.5	9.2	10.9	10.7	15.9	12.0	27.7	23.7	6.5	4.4	17.8	2.2	9.9	2.1	9.5	9.9	10.5	17.0	21.7	6.5	7.7	32.1	7.9	8.0	13.5	2.4	6.3	15.5	7.4	4.9	9.7	8.5	31.9	9.5	17.8	7.3	5.4	11.4	33.6	5.1	17.4	7.5	17.5	8.6	11.1	7.6	34.8	7.0	1.2	27.6	15.9	27.5	16.4	8.4	12.1	15.6	15.3	5.0	20.7	17.3	18.2	12.6	0.9	2.8	2.4	3.5	2.9	2.4	12.1	2.5	3.2	3.7	15.0	2.2	2.1	0.7	5.5	3.3	2.2	2.2	2.8	7.3	8.8	8.2	9.2	6.5	7.9	10.7	8.5	8.4	7.9	8.2	8.5	11.5	3.2	10.0	4.9	42.4	5.1	14.7	14.6	17.6	11.1	13.3	11.0	1.9	11.5	12.9	20.2	35.5	26.1	21.0	35.0	17.6	16.0	0.7	9.2	8.2	14.2	17.3	6.5	4.8	20.9	7.1	9.0	23.0	10.0	18.4	12.1	7.9	4.2	12.4	15.2	6.5	33.7	18.3	8.4	11.3	1.3	4.1	10.5	10.6	9.4	11.6	8.6	22.6	5.0	8.4	20.0	44.1	6.4	21.4	15.4	32.3	11.6	8.0	43.4	13.1	7.9	9.6	4.3	6.0	16.6	8.4	22.0	14.5	22.6	26.7	19.0
RNGTT	"hCAP, HCE, HCE1"	ENSG00000111880	"RNA guanylyltransferase and 5'-phosphatase"	O60942	6	88609897-88963618	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA capping, mRNA processing"	"Hydrolase, Multifunctional enzyme, Nucleotidyltransferase, Protein phosphatase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 108.6;Inhibitory neurons: 110.2;Oligodendrocyte precursor cells: 96.5;Oligodendrocytes: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003750	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA003750: AB_1856383"	"unprognostic (5.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.82e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (4.48e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-3)"	"unprognostic (9.83e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-3)"	5.3	6.7	4.9	8.2	4.9	9.5	5.6	9.1	5.7	5.2	2.6	4.6	4.2	5.2	3.6	7.2	4.1	3.7	5.3	5.1	7.0	5.3	6.9	4.4	17.2	4.6	5.2	4.8	2.9	6.4	4.9	5.0	5.1	5.3	5.4	10.6	3.5	4.9	5.2	4.4	5.2	6.1	4.6	7.6	4.2	9.3	7.3	14.7	5.6	6.4	17.3	6.2	4.8	5.3	9.2	14.0	21.1	26.2	12.0	12.6	12.4	20.2	13.4	16.4	20.4	15.9	6.8	23.1	16.2	14.9	21.5	11.1	24.7	16.5	29.7	31.8	19.0	30.5	11.4	12.2	9.5	33.2	16.6	7.7	13.8	16.8	15.9	13.6	14.7	12.7	30.9	18.1	23.8	12.0	14.6	22.8	12.5	15.0	11.7	28.6	32.0	13.3	14.0	14.2	12.3	17.3	16.8	9.8	11.1	19.7	10.8	31.8	11.5	13.0	12.0	14.7	27.9	16.1	31.6	13.2	18.9	23.8	24.1	5.2	4.1	7.6	7.8	5.9	7.8	22.9	8.6	9.7	5.8	22.8	9.7	10.1	3.4	10.9	5.5	4.0	9.0	5.4	4.9	4.9	9.1	5.7	5.1	7.0	4.6	5.2	5.1	4.6	7.3	5.3	8.9	0.0	16.2	54.5	60.4	8.3	10.7	6.0	10.8	22.4	6.5	6.1	10.7	7.2	12.9	12.9	39.6	10.4	19.7	8.0	0.0	6.3	17.9	7.9	12.1	7.0	9.1	7.6	108.6	4.9	9.9	9.7	15.8	12.4	8.8	11.0	7.5	10.3	7.8	15.2	110.2	7.0	4.1	9.1	7.3	5.2	5.9	13.6	3.6	69.3	9.8	7.2	18.6	96.5	94.3	7.2	5.1	7.9	42.3	8.6	4.6	6.3	10.1	43.4	6.6	15.8	9.5	23.3	20.1	10.7	8.7	11.8	24.6	8.0	6.7	7.4
SAMD12	FLJ39458	ENSG00000177570	"Sterile alpha motif domain containing 12"	Q8N8I0	8	118189455-118622112	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Excitatory neurons: 537.6;Inhibitory neurons: 531.7;Oligodendrocytes: 1158.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 34.6;U-266/70: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024634	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus, Cytosol"		"HPA024634: AB_1856549"	"unprognostic (6.96e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (4.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.94e-3)"	"unprognostic (2.01e-1)"	"prognostic favorable (1.52e-6)"	"unprognostic (3.31e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.35e-3)"	0.7	1.4	2.4	1.1	4.9	0.4	3.0	0.7	8.8	2.3	0.0	4.0	3.7	1.1	4.0	4.1	5.3	3.6	6.9	7.5	0.8	5.2	1.6	4.2	0.7	1.4	0.5	0.9	1.9	9.6	3.3	0.1	2.6	3.7	4.7	5.9	2.4	5.0	0.8	0.8	2.0	0.7	0.9	2.6	5.7	1.3	2.1	1.0	10.2	0.1	2.0	4.4	1.1	8.4	10.2	0.7	0.9	0.0	0.0	0.0	2.1	3.4	10.4	7.8	4.3	1.1	12.1	3.4	0.8	8.2	1.6	1.9	2.0	4.7	11.9	0.1	1.1	0.0	5.7	0.0	0.0	0.0	0.2	0.0	2.3	4.6	0.4	2.8	0.2	5.9	0.0	6.0	6.0	2.0	1.6	0.0	0.8	13.2	1.3	0.0	0.0	9.7	5.4	13.5	4.0	0.0	2.8	34.6	0.0	2.1	0.5	0.0	0.0	0.1	3.8	1.4	1.2	14.9	10.2	0.4	1.8	0.0	1.1	0.1	0.0	0.0	0.1	0.0	1.0	1.5	0.8	0.5	0.0	1.0	1.0	0.6	0.1	0.6	0.0	0.3	0.8	0.2	2.4	4.9	0.7	8.8	7.5	0.8	1.4	0.5	2.6	0.9	2.1	8.4	4.7	112.2	95.0	53.5	8.0	1.7	10.1	10.3	13.1	16.8	10.9	5.1	12.1	12.8	57.5	29.5	43.8	0.0	3.3	10.5	19.6	12.9	5.2	12.1	1.5	13.0	14.3	2.1	537.6	12.4	0.1	9.1	26.5	16.4	56.8	4.4	7.5	5.2	0.1	30.3	531.7	11.2	14.2	0.3	0.0	6.1	0.3	6.5	7.2	163.0	0.7	4.5	4.1	122.6	1158.0	13.0	3.5	0.4	16.9	5.0	8.6	17.4	68.0	26.9	0.0	0.5	0.9	0.5	2.4	15.9	1.7	0.0	8.9	4.5	11.9	13.6
SDR16C5	"EPHD-2, RDH-E2, RDHE2"	ENSG00000170786	"Short chain dehydrogenase/reductase family 16C member 5"	Q8N3Y7	8	56300005-56320776	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.9;lung: 34.4;skin 1: 62.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 155.9;Basal respiratory cells: 325.1;Club cells: 141.9;Ionocytes: 120.1;Pancreatic endocrine cells: 99.5;Respiratory ciliated cells: 82.5;Suprabasal keratinocytes: 72.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	35	"memory B-cell: 4.7;naive B-cell: 2.3"	"Lineage enriched"	"Detected in single"	47	"B-cells: 4.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 20.8;HaCaT: 10.3;hTCEpi: 16.7;OE19: 24.8;T-47d: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA025224	Enhanced					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA025224: AB_1856163"	"unprognostic (1.66e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.46e-2)"	"unprognostic (4.18e-4)"	"unprognostic (8.83e-3)"	"prognostic favorable (7.88e-4)"		"unprognostic (1.66e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.48e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.71e-1)"	0.3	0.2	1.7	3.0	1.8	0.0	9.1	1.6	4.4	15.6	0.5	2.2	2.3	0.0	0.0	51.9	0.2	0.4	0.2	2.2	1.5	0.1	0.0	34.4	0.4	4.8	2.0	0.2	0.4	0.0	0.5	0.0	4.9	0.3	3.9	1.1	16.8	0.0	0.3	62.6	15.7	0.2	0.9	0.0	18.1	0.8	2.8	0.3	0.0	0.2	21.9	6.3	24.9	1.8	4.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	10.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.7	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	24.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	8.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.8	1.6	4.4	2.2	1.5	4.8	2.0	4.9	0.9	2.8	1.8	1.7	48.1	155.9	0.0	1.7	51.1	6.2	325.1	4.6	0.3	5.5	2.4	0.2	5.7	141.9	0.0	0.0	0.0	0.0	7.1	0.0	0.7	0.4	0.0	0.1	2.3	0.0	0.0	4.3	1.4	0.0	0.9	10.2	0.1	3.8	0.0	0.0	0.0	0.0	0.0	1.1	19.7	120.1	0.0	3.6	0.4	0.6	0.4	3.6	0.0	0.6	12.3	0.0	0.0	0.3	99.5	3.4	0.0	0.0	9.5	0.3	0.0	82.5	1.6	0.0	0.1	4.9	0.3	5.5	36.6	72.2	0.0	0.6	0.0	5.3	26.0
SEMA4B	"KIAA1745, MGC131831, SEMAC, SemC"	ENSG00000185033	"Semaphorin 4B"	Q9NPR2	15	90160604-90229679	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 124.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 16.9;naive B-cell: 14.9;neutrophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 182.4;RPTEC TERT1: 111.1;RT4: 124.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013372	Approved		Approved	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA		61000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"	"Nucleoplasm, Vesicles"	"HPA013372: AB_1856670"	"unprognostic (3.33e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.50e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.34e-3)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (3.33e-8)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.57e-2)"	"unprognostic (7.09e-2)"	11.9	37.6	20.3	18.0	21.9	9.8	22.5	18.8	21.6	35.1	12.8	50.2	30.2	17.1	8.2	124.4	22.6	17.1	24.9	17.3	21.0	47.7	43.2	20.5	12.0	23.5	24.0	21.6	38.5	18.1	18.6	18.3	21.4	31.4	12.1	27.1	41.2	17.6	7.8	50.9	34.7	13.3	21.0	30.3	32.2	10.7	22.9	13.2	34.2	7.9	13.0	42.2	59.8	26.8	21.2	56.3	4.2	13.2	3.8	2.6	30.4	6.4	13.9	7.8	8.3	7.0	182.4	14.9	69.2	4.7	45.0	97.8	3.7	91.2	6.4	85.4	11.7	19.7	13.5	9.4	15.1	2.6	8.7	10.8	39.1	8.5	17.5	32.5	8.8	4.4	9.6	23.0	4.3	15.6	5.4	8.4	18.7	46.8	51.1	6.4	3.1	33.1	111.1	124.0	13.3	13.5	22.3	35.4	8.5	9.3	24.7	6.0	20.0	6.3	11.4	13.1	14.5	33.0	43.2	7.5	58.8	16.1	6.3	0.0	2.4	0.3	0.9	1.4	0.6	16.9	0.5	0.5	1.2	14.9	0.5	0.6	5.1	0.4	2.8	0.2	0.2	1.5	20.3	21.9	18.8	21.6	17.3	21.0	23.5	24.0	21.4	21.0	22.9	26.8	1.8	16.0	22.5	67.3	29.2	65.0	40.0	51.4	23.9	5.7	29.1	18.9	7.8	8.6	44.6	16.5	25.0	13.9	2.4	47.8	3.9	27.3	0.9	15.6	19.6	4.4	4.2	4.0	23.5	35.5	74.5	6.4	34.1	28.3	0.0	8.6	4.6	16.8	13.3	16.8	28.2	17.5	18.3	6.9	7.5	1.2	13.1	5.5	5.4	2.8	5.3	25.1	1.0	8.0	8.3	44.7	26.1	12.0	8.0	46.9	19.6	4.5	22.6	48.3	19.7	5.7	15.3	0.7	3.2	65.3	57.1	12.4	4.3	5.2	20.2	52.0
SETBP1	"KIAA0437, SEB"	ENSG00000152217	"SET binding protein 1"	Q9Y6X0	18	44680173-45068510	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Excitatory neurons: 349.0;Inhibitory neurons: 548.3;Oligodendrocyte precursor cells: 170.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 11.6"	"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.0;plasmacytoid DC: 2.8"	"Group enriched"	"Detected in many"	5	"B-cells: 3.0;dendritic cells: 2.8;monocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"AF22: 16.1;Karpas-707: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049022, HPA057259"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		66000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA049022: AB_2680602, HPA057259: AB_2683384"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.71e-3)"	"unprognostic (6.52e-2)"	"prognostic favorable (6.34e-8)"	"unprognostic (2.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.06e-2)"	"unprognostic (7.81e-5)"	7.3	1.9	2.0	3.7	3.7	1.8	6.3	11.6	5.7	11.6	0.0	10.9	1.7	8.3	7.2	4.5	7.2	5.0	4.3	2.6	0.2	7.4	4.7	6.6	5.3	0.0	0.1	7.7	5.8	3.7	2.7	7.2	0.1	7.8	3.5	3.0	4.3	9.2	10.7	4.4	4.6	7.4	0.0	3.7	5.6	1.8	0.0	4.4	5.1	9.7	4.7	8.1	8.5	3.8	0.0	2.4	16.1	0.0	4.1	1.2	1.0	1.3	3.0	1.5	1.3	0.2	0.0	1.0	0.5	1.8	1.0	4.8	1.8	4.9	1.0	1.4	0.8	0.0	1.8	1.2	0.0	0.0	0.0	3.8	2.0	0.0	3.0	2.7	0.5	0.0	0.1	44.7	0.4	0.8	0.0	0.1	2.0	0.0	1.1	5.6	0.0	5.5	4.9	3.9	8.2	4.2	0.0	0.0	0.9	7.1	2.2	0.0	0.0	9.5	3.3	0.0	7.7	8.6	0.5	0.0	5.8	0.2	5.5	0.1	0.0	0.0	0.4	0.6	0.0	2.0	0.0	0.2	0.0	3.0	0.0	0.1	0.0	0.0	1.0	2.8	0.0	0.1	2.0	3.7	11.6	5.7	2.6	0.2	0.0	0.1	0.1	0.0	0.0	3.8	7.6	0.0	1.8	85.5	42.4	15.4	8.6	8.3	7.4	12.5	11.0	12.6	3.9	14.3	4.2	16.5	18.8	1.5	25.5	1.6	3.9	4.5	1.3	12.9	15.6	8.3	12.0	0.8	349.0	3.5	1.4	29.3	4.1	14.8	0.0	0.7	17.9	16.5	2.0	3.3	548.3	4.4	10.2	2.4	8.7	3.7	62.7	4.6	3.6	88.1	1.5	10.7	6.2	170.4	62.9	3.7	9.1	39.9	29.6	8.1	0.4	10.5	5.8	18.2	6.6	18.4	28.6	0.3	0.8	4.0	15.2	0.8	5.9	0.1	4.7	1.5
SGCE	DYT11	ENSG00000127990	"Sarcoglycan epsilon"	O43556	7	94524204-94656572	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 116.6;Oligodendrocyte precursor cells: 133.2;Oligodendrocytes: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"gdT-cell: 2.1;memory B-cell: 4.4;naive B-cell: 6.6"	"Group enriched"	"Detected in many"	4	"B-cells: 6.6;T-cells: 2.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074790			Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Plasma membrane"		Yes	No		170000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA074790: AB_2686713"	"unprognostic (3.16e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (1.19e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.80e-3)"	"unprognostic (9.69e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	43.2	63.4	19.9	9.4	21.6	0.4	36.5	22.1	31.6	45.1	20.9	51.6	8.0	43.2	27.1	13.3	40.7	27.6	38.9	19.6	21.0	19.5	14.4	30.5	16.7	23.2	20.6	92.2	21.5	10.9	30.9	52.7	22.4	18.0	12.8	16.8	21.1	31.6	8.5	8.2	19.2	41.8	21.9	25.1	23.8	18.5	20.4	12.8	23.9	19.8	7.2	35.6	34.6	26.7	13.5	42.5	39.6	61.8	63.7	110.8	7.1	51.3	92.3	40.7	60.4	24.9	78.0	12.8	70.4	86.5	83.7	9.4	60.0	21.6	49.1	2.2	32.7	1.4	36.9	28.3	44.0	4.3	0.0	95.5	31.1	64.8	79.3	104.9	30.8	0.0	0.1	93.7	43.5	42.6	0.0	0.0	32.8	8.0	29.0	19.8	51.0	25.8	78.6	13.6	26.2	20.8	0.0	52.2	65.1	44.2	17.6	0.8	0.0	131.1	45.1	11.8	81.7	50.8	67.9	14.8	51.4	0.2	74.2	0.7	0.0	0.1	2.1	0.0	0.8	4.4	0.6	1.0	0.0	6.6	0.2	0.7	0.3	1.0	0.1	0.2	0.2	0.3	19.9	21.6	22.1	31.6	19.6	21.0	23.2	20.6	22.4	21.9	20.4	26.7	39.2	70.5	33.3	66.9	6.1	5.0	18.4	16.8	1.8	18.6	9.7	44.4	18.6	30.0	28.3	20.2	4.2	90.2	1.4	0.0	5.9	42.5	1.6	4.0	17.1	18.8	1.2	0.4	85.2	4.3	26.1	116.6	1.5	6.6	2.5	37.3	58.2	11.2	6.3	20.2	68.5	0.1	12.2	2.5	7.3	3.7	75.5	1.4	51.6	15.9	0.0	31.5	0.0	133.2	116.3	2.1	0.0	58.3	2.6	5.5	0.0	14.1	13.7	30.3	85.5	68.0	60.7	17.1	13.0	0.9	4.0	82.8	2.7	44.0	0.0	2.2
SH3GLB2	KIAA1848	ENSG00000148341	"SH3 domain containing GRB2 like, endophilin B2"	Q9NR46	9	129007036-129028331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 127.9;Syncytiotrophoblasts: 149.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 234.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021438, HPA024734"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA021438: AB_1856820, HPA024734: AB_1856821"	"unprognostic (2.59e-1)"	"prognostic favorable (1.56e-6)"	"unprognostic (1.88e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (5.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.25e-2)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-3)"	"prognostic favorable (4.28e-4)"	32.7	49.1	86.7	19.2	93.6	59.4	46.0	69.4	127.6	60.5	63.5	56.3	42.1	47.9	17.1	101.4	52.7	22.0	32.4	95.0	74.5	63.9	25.3	35.4	24.9	81.3	71.1	45.2	71.5	69.1	88.4	37.7	82.2	71.8	16.1	11.7	60.8	50.2	50.0	116.7	47.9	18.5	68.8	42.1	71.2	24.4	78.0	37.2	45.9	19.0	22.6	72.6	66.8	93.1	49.7	41.2	19.9	27.1	11.7	14.8	59.2	17.0	37.8	33.0	30.0	25.8	83.2	51.9	13.3	30.1	25.5	119.2	6.3	36.7	9.3	34.0	27.5	13.2	70.5	22.9	24.4	11.9	30.7	10.6	41.1	16.8	14.9	36.2	28.0	66.8	17.8	67.2	16.9	121.5	68.4	31.5	17.8	83.2	28.7	136.3	37.2	234.3	36.7	59.1	62.0	50.3	24.7	62.6	26.3	16.4	90.5	17.5	25.8	15.3	26.1	39.3	37.7	65.6	34.0	33.8	35.6	14.7	8.3	2.1	1.6	3.5	1.9	0.8	2.3	3.5	2.2	1.8	1.3	2.0	1.6	1.3	1.3	2.6	2.5	3.7	2.0	1.5	86.7	93.6	69.4	127.6	95.0	74.5	81.3	71.1	82.2	68.8	78.0	93.1	36.3	16.0	28.4	28.1	20.3	20.8	27.5	11.6	9.6	26.9	59.7	62.9	10.6	18.6	19.8	47.8	8.4	127.9	29.4	58.2	15.6	14.5	11.2	36.3	19.6	15.6	25.3	29.5	24.4	26.0	19.2	23.3	84.6	63.6	6.3	29.9	12.1	9.9	20.7	47.1	14.2	35.9	12.2	11.9	11.6	24.4	19.0	14.3	14.2	17.8	6.9	36.0	6.2	23.6	95.6	24.6	50.3	20.3	25.9	23.0	39.4	7.6	21.5	20.6	13.1	32.0	39.7	8.6	6.6	27.6	53.6	149.5	16.3	18.3	34.6	58.3
SHCBP1	"FLJ22009, PAL"	ENSG00000171241	"SHC binding and spindle associated 1"	Q8NEM2	16	46578591-46621379	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.4;lymphoid tissue: 10.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 36.2;Extravillous trophoblasts: 28.7;Plasma cells: 38.3;Spermatocytes: 33.7;Spermatogonia: 23.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA048876	Uncertain		Approved	"Nuclear bodies,Microtubules,Midbody,Mitotic spindle"		Yes	Yes			"Cluster 19: B-cells - Humoral immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies"	"Microtubules, Midbody, Mitotic spindle"	"HPA048876: AB_2680542"	"unprognostic (2.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.96e-4)"	"unprognostic (2.26e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.47e-5)"	"unprognostic (4.81e-2)"	"unprognostic (2.22e-16)"	"unprognostic (3.59e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.66e-1)"	0.7	0.5	0.5	5.1	0.5	17.4	0.9	1.2	0.6	0.6	0.4	1.9	1.2	0.6	0.6	3.5	0.2	0.6	1.0	0.4	0.2	5.4	0.2	1.0	9.8	0.4	0.3	0.3	0.2	0.2	0.2	2.4	0.4	0.3	2.2	0.2	0.8	0.2	1.5	3.3	1.5	1.7	0.1	4.4	0.9	5.2	0.5	8.8	0.3	0.2	10.6	1.2	1.2	0.7	33.8	30.8	11.9	15.3	3.1	6.2	16.2	60.7	24.6	59.2	26.8	14.6	20.8	28.0	30.2	28.8	26.8	21.0	29.3	21.7	73.8	17.7	17.2	28.2	25.8	30.3	0.1	28.5	35.4	1.2	1.6	45.9	18.1	5.9	33.0	14.9	12.7	28.3	69.7	21.5	24.0	23.7	10.0	17.2	31.6	45.4	89.9	44.8	13.7	9.4	5.0	7.2	46.0	23.7	11.1	11.4	13.0	23.4	16.1	43.9	28.7	43.5	54.0	24.9	36.7	46.7	21.4	31.3	45.8	0.2	0.3	0.6	0.2	0.5	0.0	1.7	0.3	0.1	0.3	1.2	0.0	0.1	0.4	0.1	2.4	0.7	1.2	1.1	0.5	0.5	1.2	0.6	0.4	0.2	0.4	0.3	0.4	0.1	0.5	0.7	0.2	0.0	1.1	1.3	7.1	1.7	0.7	1.2	0.0	0.3	0.6	1.1	1.9	1.5	1.4	0.0	0.0	11.3	0.8	1.9	0.0	0.2	8.4	0.7	1.7	1.7	0.0	36.2	2.1	0.0	28.7	3.7	4.1	1.5	0.0	7.6	1.8	0.3	12.6	0.0	0.7	2.2	2.0	4.5	3.3	2.3	0.6	4.0	1.8	2.8	2.8	0.8	0.0	1.0	0.5	0.1	0.1	0.4	38.3	0.5	0.4	0.1	0.1	0.3	0.0	0.5	6.3	33.7	23.7	3.6	0.6	3.7	2.2	0.8	3.4	1.1
SMAGP	"hSMAGP, MGC149453, MGC149454"	ENSG00000170545	"Small cell adhesion glycoprotein"	Q0VAQ4	12	51244558-51270415	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 139.8;placenta: 102.1"	"Group enriched"	"Detected in many"	7	"Cytotrophoblasts: 1219.9;Syncytiotrophoblasts: 842.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 131.2;OE19: 163.9"	"Low region specificity"	"Detected in all"							HPA039711	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA039711: AB_10674985"	"unprognostic (2.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (3.01e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.46e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.52e-1)"	14.0	17.2	2.7	9.9	2.7	3.5	16.1	5.2	3.2	33.8	3.4	57.5	17.6	6.5	20.7	139.8	8.3	16.2	10.3	3.0	2.5	43.0	10.2	17.7	6.0	2.8	2.9	11.4	16.5	11.1	4.3	102.1	2.8	10.5	59.3	1.0	24.1	8.6	3.4	34.8	19.6	8.5	2.6	13.7	35.9	8.1	3.3	1.5	8.7	6.8	27.6	17.5	67.9	3.0	81.6	24.2	2.9	2.7	10.5	40.9	131.2	61.1	60.9	30.6	18.7	48.9	83.2	1.0	10.5	37.9	11.6	28.3	17.1	23.5	42.6	4.1	14.2	10.9	3.3	16.5	28.8	2.7	10.1	26.7	17.8	66.3	59.4	69.4	74.6	20.6	8.7	4.7	49.9	71.4	13.4	9.8	12.3	163.9	93.9	0.8	0.8	3.1	44.0	18.5	3.3	4.1	13.4	53.2	10.2	31.3	45.0	4.2	26.1	33.9	32.7	1.7	37.8	1.7	2.4	1.6	49.8	26.3	18.7	4.6	6.6	12.0	15.4	4.6	10.0	36.9	6.8	11.1	4.7	38.1	6.3	11.0	16.0	19.8	5.4	2.9	5.3	6.8	2.7	2.7	5.2	3.2	3.0	2.5	2.8	2.9	2.8	2.6	3.3	3.0	44.1	0.0	25.7	0.3	26.3	21.7	74.3	35.5	12.0	1.3	23.4	25.8	1.7	55.8	44.7	16.5	0.0	1219.9	21.7	85.0	49.0	43.6	11.7	4.8	2.3	60.9	20.4	8.6	0.6	108.7	108.0	11.4	47.9	8.7	12.7	19.7	51.4	6.7	96.8	1.7	0.5	121.5	26.4	6.3	11.2	3.2	13.1	6.1	14.2	6.5	7.9	4.1	38.1	0.0	0.5	142.5	88.1	9.8	5.7	73.7	35.0	22.6	17.4	1.7	26.3	4.8	11.1	6.2	31.3	80.7	29.7	842.5	13.8	9.8	121.7	105.2
SMKR1		ENSG00000240204	"Small lysine rich protein 1"	H3BMG3	7	129502531-129512918	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	19	"testis: 123.6"	"Group enriched"	"Detected in many"	50	"Early spermatids: 1894.5;Late spermatids: 6100.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 19.7;SCLC-21H: 32.8"					"Low region specificity"	"Detected in all"			HPA078358			Approved	Nucleoli		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoli		"HPA078358: AB_2686883"	"unprognostic (5.08e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.13e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.02e-1)"	"unprognostic (9.24e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.72e-6)"	"unprognostic (1.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.67e-2)"	0.3	1.1	5.2	0.4	5.9	0.1	1.9	4.2	5.8	0.5	4.1	0.1	0.4	0.3	1.4	0.4	6.6	0.2	0.1	5.4	5.5	0.8	0.1	0.3	0.9	4.5	5.0	0.2	2.3	6.4	6.1	0.2	4.7	0.4	0.2	0.7	0.2	0.3	0.1	0.4	0.4	0.1	4.5	0.5	0.4	123.6	6.4	0.3	0.7	0.1	0.8	0.1	0.2	5.2	13.4	13.0	0.4	11.1	0.0	0.0	0.1	0.0	0.4	1.1	1.1	0.1	3.4	0.0	1.1	0.7	7.2	1.6	2.3	0.1	1.6	12.6	1.3	0.0	2.5	0.0	2.3	0.2	8.2	0.1	5.5	3.3	2.3	1.4	0.4	7.9	0.7	0.3	0.6	19.7	2.5	1.2	1.5	3.4	11.2	1.3	0.0	2.9	4.7	0.0	32.8	9.0	9.6	1.1	0.8	2.1	3.0	1.7	0.1	0.0	0.3	7.3	2.8	3.2	4.5	0.2	4.5	0.5	0.9	0.0	0.0	0.0	1.3	0.0	0.6	1.0	0.2	0.7	0.0	0.8	0.5	0.5	0.0	0.4	0.0	0.0	0.0	0.1	5.2	5.9	4.2	5.8	5.4	5.5	4.5	5.0	4.7	4.5	6.4	5.2	0.1	3.2	0.0	1.0	6.4	0.1	2.2	1.1	2.2	1.4	8.9	10.9	0.3	0.0	1.4	5.5	0.0	0.0	7.7	0.1	9.8	2.3	1894.5	21.1	0.3	1.9	9.0	0.4	2.9	6.2	0.3	1.0	1.5	0.9	0.0	2.1	0.7	0.0	0.1	0.0	2.3	0.0	4.1	0.3	0.4	6100.1	37.6	2.3	1.8	0.0	0.8	1.1	40.2	0.5	0.3	3.0	0.0	27.4	2.4	5.3	0.0	1.9	12.6	0.6	0.0	1.1	0.7	78.8	29.7	1.4	0.3	0.1	5.3	0.1	0.2	1.2
SPACA9	"C9orf9, Mast"	ENSG00000165698	"Sperm acrosome associated 9"	Q96E40	9	132878027-132890201	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 74.0;testis: 131.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 23.9;Distal tubular cells: 33.2;Endometrial ciliated cells: 99.8;Proximal tubular cells: 23.9;Respiratory ciliated cells: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"JURKAT: 48.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA022243, HPA051600"	Enhanced		Approved	Mitochondria		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria		"HPA022243: AB_1845844, HPA051600: AB_2681546"	"unprognostic (2.69e-1)"	"unprognostic (2.14e-3)"	"unprognostic (8.00e-3)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.73e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-2)"	"unprognostic (9.51e-2)"	"prognostic favorable (8.31e-4)"	"unprognostic (5.11e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-2)"	5.0	7.6	17.4	1.3	17.7	1.5	5.2	17.4	19.5	9.7	18.2	11.5	1.3	8.3	74.0	9.5	39.2	5.4	10.4	16.8	19.0	12.2	2.3	7.4	2.2	20.3	22.2	11.3	5.2	3.8	11.5	3.2	19.1	7.0	1.9	8.2	9.8	7.1	1.7	11.9	3.7	4.9	21.3	3.6	6.5	131.2	18.5	7.9	15.6	1.8	3.2	6.1	8.1	19.0	3.0	3.2	4.8	3.9	6.6	8.4	5.7	1.9	3.5	2.6	2.8	0.8	9.1	0.7	4.3	8.7	5.4	4.2	2.0	5.4	2.3	3.5	3.9	0.8	2.3	1.0	9.6	2.2	0.3	9.6	11.4	6.4	6.9	10.6	3.0	48.5	0.8	2.4	7.1	6.4	7.6	8.6	1.0	5.6	3.0	3.6	1.0	2.1	10.5	1.1	1.2	4.7	8.0	1.3	6.3	3.6	10.3	0.7	2.9	5.5	3.7	5.3	0.8	1.0	1.7	2.6	10.2	0.8	2.7	4.0	1.1	1.9	1.1	1.1	1.3	3.0	1.2	0.6	1.6	2.6	1.3	1.3	1.5	4.4	1.9	0.5	2.0	0.9	17.4	17.7	17.4	19.5	16.8	19.0	20.3	22.2	19.1	21.3	18.5	19.0	3.6	3.2	2.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	10.3	17.9	0.0	0.0	5.0	23.9	0.0	18.2	0.8	0.0	33.2	8.6	0.0	99.8	7.1	1.9	0.0	0.0	0.0	7.1	12.4	3.9	0.0	8.1	0.0	6.7	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	23.9	63.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	7.3	0.8	7.7	0.0	0.0
SSPN	"KRAG, SPN1, SPN2"	ENSG00000123096	Sarcospan	Q14714	12	26121991-26299290	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 79.0"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 140.8;Leydig cells: 185.8;Peritubular cells: 267.4;Skeletal myocytes: 139.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"memory B-cell: 57.4;naive B-cell: 16.9"	"Lineage enriched"	"Detected in many"	19	"B-cells: 57.4"	"Group enriched"	"Detected in many"	4	"ASC diff: 24.4;hTERT-RPE1: 91.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066432			Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear membrane"	Nucleoplasm	"HPA066432: AB_2685669"	"unprognostic (4.82e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.03e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (2.64e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.21e-1)"	21.3	10.7	18.0	6.4	26.5	0.1	20.1	26.2	15.4	39.5	8.6	21.2	4.4	23.9	17.8	18.3	25.2	21.9	46.0	16.1	30.1	6.1	1.4	8.9	7.0	26.5	29.1	33.8	8.0	3.2	3.8	4.6	27.9	22.4	12.7	2.9	9.4	34.4	60.7	4.4	7.7	24.3	31.5	8.7	7.7	8.3	21.5	8.7	17.1	79.0	12.1	19.2	15.4	38.4	0.8	1.6	4.0	0.0	24.4	14.5	0.2	6.9	10.8	1.1	3.1	0.1	9.5	0.0	1.8	11.0	6.0	3.0	0.0	0.5	2.1	0.1	0.0	0.0	0.1	0.0	2.9	0.1	0.0	9.3	1.0	3.5	0.8	91.6	0.4	0.0	0.0	0.1	8.4	1.9	0.6	1.9	7.9	0.6	2.7	0.3	10.7	3.2	2.4	8.3	0.4	6.3	2.7	0.6	7.0	4.0	0.9	0.3	3.0	2.5	1.8	3.4	1.8	0.3	1.2	0.2	5.3	0.0	8.6	0.0	0.0	2.7	0.0	0.0	0.5	57.4	0.0	0.0	0.1	16.9	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.7	18.0	26.5	26.2	15.4	16.1	30.1	26.5	29.1	27.9	31.5	21.5	38.4	10.8	3.2	3.2	39.2	30.7	13.6	23.1	21.6	30.1	2.1	21.8	89.2	95.4	10.0	14.8	18.4	0.0	74.0	1.4	36.0	5.9	11.4	4.0	12.4	52.1	10.2	4.9	1.3	3.5	7.1	7.5	140.8	3.6	6.0	0.0	10.7	9.7	0.2	15.3	6.7	5.8	10.1	0.0	0.6	11.1	5.8	185.8	6.6	19.6	18.7	18.6	41.2	0.0	41.7	18.4	2.8	7.3	267.4	41.2	19.4	0.6	3.1	7.9	2.7	39.5	139.9	56.3	0.7	3.8	7.7	7.1	27.8	2.1	30.7	7.7	24.7
STPG1	"C1orf201, FLJ33340, MAPO2"	ENSG00000001460	"Sperm tail PG-rich repeat containing 1"	Q5TH74	1	24356999-24416934	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 27.5"	"Group enriched"	"Detected in many"	8	"Early spermatids: 282.7;Late spermatids: 660.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA024301			Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA024301: AB_1845634"	"unprognostic (2.63e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (1.33e-4)"	"unprognostic (6.06e-4)"	"unprognostic (5.14e-2)"	"unprognostic (2.91e-3)"	"unprognostic (5.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (2.31e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.42e-1)"	4.6	4.1	10.0	2.1	9.2	1.1	4.0	9.2	11.5	3.3	15.7	6.4	3.5	3.8	5.4	5.0	16.8	3.2	3.2	8.6	10.5	5.5	1.6	4.9	2.1	9.9	11.2	4.2	3.9	9.2	8.8	1.0	10.0	4.3	5.3	14.6	3.4	3.2	1.3	4.5	4.4	4.9	9.4	1.8	4.0	27.5	11.6	2.7	4.5	2.5	2.7	4.0	4.2	11.1	7.9	4.7	0.6	8.5	5.9	8.5	4.5	11.5	10.8	10.6	11.0	2.1	11.6	1.0	7.6	11.9	8.9	3.3	7.3	8.0	12.2	9.4	7.2	1.4	2.4	2.2	12.2	3.9	1.9	5.1	15.9	15.4	20.2	11.2	8.5	0.0	2.9	0.0	8.1	2.9	0.0	3.3	6.9	8.3	7.7	2.1	0.0	0.3	14.3	2.6	6.9	4.6	6.2	2.5	18.1	7.0	6.2	6.9	5.8	4.0	4.5	1.6	3.4	4.9	5.0	2.8	4.3	0.4	6.3	0.0	0.0	0.5	0.6	0.6	0.1	2.2	0.5	1.9	0.3	1.7	0.5	0.7	0.0	0.0	0.1	1.3	1.2	0.8	10.0	9.2	9.2	11.5	8.6	10.5	9.9	11.2	10.0	9.4	11.6	11.1	7.6	9.6	9.6	3.9	4.1	4.6	13.0	12.0	7.4	14.9	5.5	6.0	5.3	0.0	13.5	11.0	14.6	3.9	1.6	22.9	15.6	7.5	282.7	32.1	2.3	5.0	4.8	5.7	11.0	7.1	7.8	4.1	4.1	8.5	12.0	3.2	6.8	1.7	3.7	10.1	5.9	5.9	8.2	1.6	6.7	660.7	6.5	2.4	16.0	4.7	3.0	7.1	0.0	4.0	16.1	11.3	14.0	4.5	5.0	6.2	21.0	8.4	55.9	20.0	6.6	2.4	4.8	37.0	11.3	13.0	5.5	4.5	3.7	3.1	6.3	54.2
SWAP70	"KIAA0640, SWAP-70"	ENSG00000133789	"Switching B cell complex subunit SWAP70"	Q9UH65	11	9664077-9752993	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 183.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 80.6;naive B-cell: 84.8"	"Group enriched"	"Detected in all"	7	"B-cells: 84.8;granulocytes: 48.6;monocytes: 29.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 161.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006810, HPA006929"	Supported		Supported	"Plasma membrane,Actin filaments"		NA	NA		21000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	"Actin filaments"	"HPA006810: AB_1857683, HPA006929: "	"unprognostic (4.16e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.79e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.44e-1)"	39.3	10.4	12.8	37.5	13.7	20.9	31.9	13.6	15.9	22.6	17.2	15.0	15.4	17.8	10.4	17.8	16.3	22.0	16.2	12.2	14.1	17.2	10.0	24.9	66.1	16.7	13.6	10.2	15.0	19.4	5.7	39.0	16.7	14.1	12.8	3.9	18.0	15.3	9.8	26.4	20.3	19.7	16.5	59.5	15.9	4.8	14.3	17.3	22.3	14.7	75.3	31.2	17.6	16.5	40.6	22.2	30.8	0.1	62.9	54.6	54.0	43.4	52.6	40.3	44.1	24.7	31.3	161.0	41.6	83.5	57.9	47.7	37.9	24.2	51.6	14.8	15.2	42.6	25.7	12.1	35.2	33.3	76.2	38.4	29.6	29.5	52.3	32.6	124.4	20.2	3.9	0.6	42.4	6.4	10.0	16.1	28.4	10.7	11.3	23.6	28.9	4.7	33.6	106.1	1.5	15.5	41.3	52.6	35.2	42.9	20.9	25.1	143.6	70.3	25.1	59.4	41.2	4.2	12.4	111.5	27.9	36.6	29.3	19.7	5.7	48.6	1.2	13.5	0.5	80.6	1.4	1.1	8.2	84.8	1.2	1.3	1.1	7.9	29.6	2.3	4.2	5.4	12.8	13.7	13.6	15.9	12.2	14.1	16.7	13.6	16.7	16.5	14.3	16.5	154.0	67.3	60.8	33.0	183.7	35.6	68.1	40.1	36.5	3.4	35.1	28.3	17.6	22.8	57.7	20.2	0.0	82.6	9.9	11.3	13.7	47.4	1.6	66.5	18.6	136.0	13.1	9.7	9.0	21.6	128.0	39.1	15.8	71.6	137.8	10.3	53.2	7.2	65.0	26.9	14.5	8.7	18.3	61.9	50.8	2.9	29.8	58.5	28.4	77.8	88.8	9.2	6.2	22.1	22.4	37.0	15.1	34.6	20.7	63.0	22.4	11.7	50.9	2.3	19.7	46.2	35.5	5.5	10.8	17.4	31.3	140.1	15.5	33.4	9.0	78.8
SYNPO	KIAA1029	ENSG00000171992	Synaptopodin	Q8N3V7	5	150601080-150659207	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 369.6;skeletal muscle: 1296.3;tongue: 502.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 264.7;Distal enterocytes: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 88.4;EFO-21: 72.8;HUVEC TERT2: 72.7;TIME: 178.0;U-87 MG: 152.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033265, HPA034631, CAB037325, HPA071347"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB033265: AB_2201163, CAB037325: , HPA034631: AB_10669994, HPA071347: AB_2732179"	"unprognostic (2.09e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (1.53e-6)"	"unprognostic (1.23e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.35e-2)"	91.8	112.1	103.5	21.3	60.7	0.3	48.6	0.0	88.9	23.2	0.8	37.4	31.4	38.7	20.9	31.0	30.8	32.2	369.6	91.2	5.2	60.6	38.5	72.1	10.6	18.2	8.5	34.6	32.9	17.1	21.6	23.8	5.2	46.0	17.5	10.0	21.6	29.1	1296.3	15.4	39.6	38.9	20.6	38.9	34.9	17.0	5.1	6.6	31.1	502.1	11.1	56.8	22.3	34.9	0.5	24.2	0.2	0.3	3.5	3.2	88.4	13.8	18.9	4.6	3.7	21.6	9.7	0.1	72.8	19.9	29.2	8.9	0.1	13.5	1.9	0.2	0.2	0.0	37.4	4.7	19.6	0.0	0.9	3.7	21.3	5.2	3.7	27.5	72.7	0.2	0.2	0.2	4.4	1.6	0.1	0.7	2.8	9.3	11.6	0.5	0.7	0.2	3.4	1.9	8.5	39.3	19.9	21.6	0.7	31.1	1.6	6.6	178.0	17.4	53.2	0.4	3.6	0.8	0.2	1.3	152.5	0.3	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.5	60.7	0.0	88.9	91.2	5.2	18.2	8.5	5.2	20.6	5.1	34.9	51.1	35.3	12.2	1.3	4.8	4.6	3.0	32.6	1.8	1.9	6.4	2.5	264.7	27.1	17.0	7.3	2.1	14.8	0.5	70.5	0.0	43.7	1.7	0.4	0.4	56.3	13.8	2.7	22.5	34.5	6.0	19.9	4.6	0.5	0.0	40.9	62.8	40.0	2.1	0.0	5.7	8.4	2.0	10.8	5.1	3.4	2.8	0.9	5.4	6.5	24.0	7.2	0.0	2.5	1.3	35.6	24.4	27.8	0.6	5.7	52.6	4.4	7.6	0.8	46.0	18.0	29.2	1.2	0.8	1.4	2.3	25.9	1.6	8.6	11.8	3.6
SYPL1	SYPL	ENSG00000008282	"Synaptophysin like 1"	Q16563	7	106090505-106112576	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 633.6;Spermatocytes: 536.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014141	Approved					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA014141: AB_1857716"	"unprognostic (8.88e-2)"	"unprognostic (8.10e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.61e-2)"	"unprognostic (8.74e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.32e-1)"	"prognostic favorable (1.25e-9)"	"unprognostic (2.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.17e-1)"	78.7	70.1	35.3	49.2	50.2	51.2	98.3	55.5	63.5	93.6	34.8	83.1	60.4	100.0	88.9	147.2	104.1	70.1	73.3	33.4	41.1	127.2	66.6	66.9	86.0	71.6	50.8	72.1	54.3	125.8	26.3	84.1	69.5	96.8	77.1	13.0	135.8	119.8	149.6	94.0	58.2	109.4	56.2	59.8	81.7	97.6	44.8	56.7	117.4	101.6	121.4	107.5	94.8	82.8	187.1	85.3	44.9	74.4	188.8	142.9	65.0	115.0	128.3	105.8	128.5	58.5	323.6	187.0	150.9	144.2	179.5	154.9	72.4	186.0	174.8	51.6	85.5	82.6	49.5	57.4	148.0	140.7	65.5	107.5	236.7	111.1	142.8	140.9	147.9	69.5	85.5	0.4	212.7	161.3	149.3	167.1	49.8	214.5	112.6	18.4	75.7	97.7	224.4	300.4	22.1	50.1	111.3	266.4	115.6	106.8	81.6	111.0	133.2	210.3	107.3	226.0	132.4	82.1	102.2	193.7	92.6	239.8	121.0	66.9	39.8	44.8	13.6	37.9	28.2	130.3	36.3	27.3	32.5	125.1	53.5	34.3	15.2	71.3	31.2	31.3	33.9	40.9	35.3	50.2	55.5	63.5	33.4	41.1	71.6	50.8	69.5	56.2	44.8	82.8	186.9	54.5	63.4	27.1	238.6	171.7	285.3	326.6	252.6	8.9	111.5	70.4	69.7	181.6	172.9	187.6	16.7	211.6	45.9	51.6	113.5	167.0	633.6	96.6	57.3	153.3	37.8	81.2	8.4	107.5	144.7	125.1	88.7	87.7	91.4	47.9	152.4	96.5	90.5	20.2	7.6	82.7	175.0	83.4	95.3	170.3	95.1	69.4	145.9	16.9	39.4	103.9	15.5	8.5	70.8	130.0	66.2	94.0	23.8	213.6	61.0	221.4	131.2	12.8	157.8	76.3	144.4	536.4	126.3	309.0	173.0	184.0	79.5	113.6	101.1	271.8
SYT1	"P65, SVP65, SYT"	ENSG00000067715	"Synaptotagmin 1"	P21579	12	78863993-79452008	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"brain: 403.3;retina: 197.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 1287.6;Cone photoreceptor cells: 894.5;Excitatory neurons: 3753.2;Inhibitory neurons: 2910.4;Rod photoreceptor cells: 905.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"amygdala: 113.1;basal ganglia: 153.7;cerebral cortex: 403.3;hippocampal formation: 134.2;white matter: 146.0"	"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.0;naive B-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 39.4;hTERT-RPE1: 37.1;LHCN-M2: 31.9;SH-SY5Y: 30.9;WM-115: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008394, HPA064788"	Enhanced	Supported				NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA008394: AB_1857696, HPA064788: AB_2685351"	"unprognostic (1.02e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.77e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.68e-5)"	"unprognostic (2.78e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.14e-3)"	"unprognostic (3.05e-8)"	"unprognostic (2.89e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	0.5	21.7	113.1	2.2	153.7	0.6	0.7	19.7	403.3	1.4	0.0	4.4	1.5	9.9	0.7	0.7	0.8	1.3	0.2	134.2	2.0	1.9	1.9	0.9	0.3	0.0	0.0	5.2	0.3	0.0	6.4	2.6	3.0	6.6	2.8	197.7	0.2	5.5	0.2	0.2	3.4	25.2	0.0	2.6	1.3	0.7	12.5	0.5	0.3	0.5	0.3	1.6	2.5	146.0	0.0	19.2	14.2	0.0	1.4	4.0	0.0	1.4	1.7	1.0	1.1	1.0	0.5	0.0	2.8	0.2	5.0	0.6	0.3	2.2	1.6	0.3	0.7	1.0	0.5	0.0	3.6	0.0	0.3	1.1	1.4	5.2	39.4	37.1	13.6	0.7	0.7	2.2	31.9	3.1	1.8	0.0	10.3	2.1	5.3	0.0	14.3	0.0	0.0	5.5	18.8	30.9	0.0	2.4	0.3	9.5	6.8	0.0	5.4	2.0	0.7	0.0	6.2	3.4	8.0	0.1	4.5	0.0	29.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	113.1	153.7	19.7	403.3	134.2	2.0	0.0	0.0	3.0	0.0	12.5	146.0	2.2	0.0	0.6	124.7	9.0	0.9	0.1	0.0	0.0	1287.6	0.2	3.4	0.6	0.0	1.3	0.0	894.5	5.6	0.1	0.1	0.0	0.0	1.4	0.6	20.2	10.4	96.9	1.3	3753.2	0.2	2.2	5.9	0.0	0.7	0.0	0.7	1.8	0.1	13.9	62.2	2910.4	0.1	0.0	4.7	7.2	2.9	69.3	1.6	1.8	137.7	0.0	337.7	0.0	126.2	105.1	0.1	7.6	4.5	8.5	11.5	0.1	0.1	0.0	905.8	0.0	0.0	6.7	1.5	5.7	0.2	0.6	5.9	0.4	1.8	0.1	0.3
TAF1A	"SL1, TAFI48"	ENSG00000143498	"TATA-box binding protein associated factor, RNA polymerase I subunit A"	Q15573	1	222557902-222589933	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054334	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA054334: AB_2682453"	"unprognostic (3.01e-1)"	"prognostic unfavorable (9.26e-6)"	"unprognostic (7.98e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.98e-3)"	"unprognostic (3.88e-3)"	"unprognostic (3.10e-3)"	"unprognostic (4.79e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-4)"	"unprognostic (8.43e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.35e-3)"	"unprognostic (9.06e-2)"	3.0	3.4	2.0	4.8	2.1	2.7	3.2	2.3	2.3	3.0	1.6	2.0	2.5	4.1	3.0	2.6	2.8	2.7	1.9	1.7	2.8	2.1	1.8	2.8	6.5	2.4	2.0	6.8	1.9	1.9	2.5	4.4	2.3	3.2	2.6	4.0	2.0	2.7	1.2	2.1	2.4	2.5	2.1	4.4	3.4	6.4	2.1	4.4	5.1	1.3	5.6	5.3	2.5	3.0	13.8	7.3	19.5	6.8	6.6	5.8	17.2	9.1	7.0	10.8	13.2	7.8	14.8	12.6	17.4	3.2	8.6	13.7	13.1	5.6	15.2	8.3	9.9	7.5	6.3	7.5	7.4	18.2	3.3	3.0	6.0	12.1	15.4	5.1	4.5	8.7	23.4	5.6	14.9	5.0	21.6	13.0	39.5	15.8	21.0	13.2	39.1	12.2	4.5	7.3	11.1	23.1	14.0	8.1	10.1	9.9	4.6	9.1	6.1	10.9	10.9	19.4	23.2	6.8	6.6	16.5	9.7	11.7	14.7	1.8	1.5	2.1	3.2	2.5	4.7	5.2	2.8	2.9	1.5	7.4	3.3	4.1	0.3	3.0	2.5	5.3	2.5	1.7	2.0	2.1	2.3	2.3	1.7	2.8	2.4	2.0	2.3	2.1	2.1	3.0	3.1	0.0	1.1	6.5	8.6	8.5	6.4	3.9	6.8	10.2	3.1	3.6	1.5	2.8	1.9	3.7	6.2	7.2	4.6	2.4	1.9	2.9	2.5	3.0	6.1	2.7	1.2	3.8	5.2	0.7	6.7	6.0	4.1	3.0	1.3	7.7	1.1	2.0	4.4	6.7	7.1	3.0	0.0	3.8	1.0	1.3	5.6	4.7	0.0	3.7	2.7	3.8	2.1	8.0	8.0	1.3	1.8	2.2	4.4	8.0	0.9	1.3	2.6	8.5	6.6	4.5	4.3	11.5	12.1	4.9	2.8	5.9	4.7	4.2	3.2	8.8
TAL2	bHLHa19	ENSG00000186051	"TAL bHLH transcription factor 2"	Q16559	9	105662457-105663124	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 13.7"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Distal tubular cells: 7.9;Enteroendocrine cells: 3.5;Muller glia cells: 2.7;Proximal tubular cells: 2.3"	"Group enriched"	"Detected in some"	4	"renal cancer: 1.6;testis cancer: 0.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 6.9;naive B-cell: 7.3"	"Lineage enriched"	"Detected in many"	4	"B-cells: 7.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.1;HAP1: 2.9;K-562: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030886	Uncertain		Approved	Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA030886: AB_10601596"	"unprognostic (3.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.00e-4)"	"unprognostic (2.84e-2)"	"prognostic favorable (2.69e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.39e-2)"	0.1	0.2	0.4	0.1	0.5	0.0	0.1	0.3	0.9	0.2	1.3	0.1	0.0	0.1	0.6	0.1	0.2	0.0	0.2	0.5	0.5	3.0	0.2	0.1	0.2	0.5	0.6	0.3	0.1	0.0	0.4	0.1	0.6	0.1	0.1	0.5	0.1	0.1	13.7	0.1	0.1	0.0	0.4	0.2	0.1	0.3	0.4	0.1	0.1	2.4	0.3	0.1	0.1	0.7	0.0	0.4	1.5	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.2	2.1	0.1	0.0	0.1	0.0	0.4	0.0	2.9	0.0	0.1	0.4	0.3	0.7	0.0	0.0	0.1	0.3	1.1	0.1	0.3	0.1	0.1	0.1	0.0	0.5	8.2	0.2	0.2	0.2	0.5	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.7	0.7	0.1	0.1	0.1	0.0	0.2	1.3	0.3	0.2	0.4	0.4	0.6	0.6	1.2	0.0	0.1	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.1	0.4	0.5	0.3	0.9	0.5	0.5	0.5	0.6	0.6	0.4	0.4	0.7	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.0	0.4	0.1	0.2	0.0	0.0	0.0	4.2	0.0	0.1	0.0	7.9	0.1	0.1	0.0	0.2	0.0	3.5	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.2	0.2	0.0	0.4	0.1	0.0	0.0	2.3	0.0	1.0	0.0	0.8	0.1	0.6	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0
TBC1D9	"GRAMD9, KIAA0882, MDR1"	ENSG00000109436	"TBC1 domain family member 9"	Q6ZT07	4	140620782-140756385	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 91.6"	"Cancer enriched"	"Detected in all"	7	"breast cancer: 85.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 5.9"	"Group enriched"	"Detected in many"	37	"B-cells: 5.9;dendritic cells: 3.2;monocytes: 1.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000262, HPA006503"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 19: Lung - Lung function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 35: Glandular cells - Unknown function"	Cytosol		"HPA000262: AB_2665956, HPA006503: AB_2667604"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.77e-2)"	"prognostic favorable (1.61e-6)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.16e-2)"	18.2	9.2	7.2	15.2	7.9	2.0	48.7	22.5	9.4	12.9	35.2	7.3	8.2	8.3	7.8	9.1	10.0	13.8	8.5	8.4	15.3	15.7	12.6	16.3	15.1	7.9	9.6	15.9	9.1	9.8	6.3	20.5	15.4	14.6	6.6	21.0	8.8	21.3	2.2	3.2	12.8	7.7	6.4	33.7	16.8	3.3	12.9	5.6	5.8	6.9	19.4	15.8	7.1	3.3	0.9	11.9	10.9	9.4	26.0	24.3	22.3	15.3	16.3	10.8	13.7	2.4	10.4	0.1	9.5	19.9	13.4	2.4	13.7	10.8	10.1	0.0	7.7	7.0	8.5	10.4	9.4	0.9	1.1	20.1	17.7	9.4	37.2	31.2	30.3	3.7	0.0	0.0	10.2	12.0	1.6	0.1	1.7	12.7	10.4	7.7	17.9	18.1	12.3	22.0	16.0	11.4	15.8	27.4	10.5	18.4	6.4	0.4	47.7	28.3	8.5	18.6	13.3	0.0	0.0	0.1	17.2	1.3	15.7	0.0	1.7	0.0	0.0	1.3	0.0	5.9	0.0	0.0	2.9	2.9	0.0	0.0	0.0	0.0	0.5	3.2	0.0	0.7	7.2	7.9	22.5	9.4	8.4	15.3	7.9	9.6	15.4	6.4	12.9	3.3	49.4	54.5	9.3	4.6	42.1	4.6	10.6	21.4	4.0	35.4	91.6	39.4	8.1	17.2	15.1	55.2	4.2	14.1	14.0	8.3	7.9	13.6	0.5	49.4	20.9	32.6	7.7	0.4	54.8	17.2	4.7	15.1	8.2	61.4	0.0	8.0	17.2	23.9	18.3	10.1	66.2	6.6	24.4	39.3	30.3	1.3	13.1	44.8	8.8	78.7	39.5	43.5	1.0	27.6	2.6	12.2	5.8	26.7	25.0	16.3	6.1	5.7	15.9	7.6	0.0	2.8	11.1	0.8	1.7	10.4	3.8	43.2	3.7	16.0	3.1	16.0
TCEA1	"GTF2S, SII, TCEA, TF2S, TFIIS"	ENSG00000187735	"Transcription elongation factor A1"	P23193	8	53966552-54022456	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043786	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA043786: AB_10959468"	"unprognostic (5.35e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (3.75e-5)"	"unprognostic (3.80e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	52.7	46.0	44.1	56.5	47.5	81.2	62.2	44.7	58.3	55.3	42.5	49.7	47.1	55.6	45.8	53.9	52.4	42.6	35.9	42.0	46.0	59.8	90.4	46.7	98.3	47.2	44.6	61.9	68.4	80.0	28.2	49.3	47.0	59.0	50.7	49.0	56.5	54.2	42.0	49.8	46.9	52.4	47.5	49.5	52.2	36.8	44.2	72.4	124.2	41.7	112.6	54.6	41.4	55.1	161.3	157.9	138.1	145.7	99.3	121.8	100.9	122.1	147.3	143.5	160.2	91.4	131.0	392.5	136.9	147.0	152.5	120.9	182.3	116.6	212.9	225.0	88.5	293.6	71.5	139.5	309.7	116.8	122.7	88.5	308.1	137.4	606.2	121.3	128.2	132.9	191.1	334.0	135.5	75.6	245.8	83.3	229.1	265.0	47.1	185.1	48.2	72.5	204.0	107.0	129.9	95.5	101.9	91.0	356.3	132.2	129.6	132.6	110.6	106.1	96.3	120.6	114.5	201.1	134.4	260.9	184.9	133.2	152.1	82.3	64.1	78.7	103.9	63.1	98.3	213.8	107.0	96.7	81.8	174.1	93.9	99.3	23.1	97.5	60.6	116.7	153.0	73.5	44.1	47.5	44.7	58.3	42.0	46.0	47.2	44.6	47.0	47.5	44.2	55.1	94.7	89.8	106.2	24.2	253.2	135.5	128.3	98.9	257.2	77.0	129.2	124.3	23.9	82.9	109.4	99.3	89.6	115.5	143.8	61.0	168.3	121.0	86.4	126.9	145.4	92.5	87.2	330.7	17.7	109.9	125.1	118.8	111.6	124.4	98.7	75.7	66.4	160.7	87.7	57.2	20.1	96.6	118.0	89.5	134.2	191.0	134.8	124.2	117.4	17.8	132.5	166.0	170.0	22.1	29.7	121.1	71.6	132.8	341.1	146.0	72.2	207.6	110.6	104.5	78.9	102.6	130.4	94.9	103.1	237.2	150.6	112.1	154.8	108.5	88.1	148.6
TEAD2	"ETF, TEF-4, TEF4"	ENSG00000074219	"TEA domain transcription factor 2"	Q15562	19	49340595-49362457	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 51.1;Early spermatids: 76.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"memory B-cell: 1.7;naive B-cell: 2.7"	"Lineage enriched"	"Detected in single"	27	"B-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"AF22: 135.3;AN3-CA: 147.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066292, HPA069963"			Supported	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"HPA066292: AB_2685651, HPA069963: AB_2686222"	"unprognostic (2.69e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.58e-3)"	"unprognostic (4.39e-1)"	"prognostic unfavorable (8.66e-4)"	"unprognostic (2.91e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.78e-2)"	32.8	17.8	7.5	15.4	7.1	0.2	31.6	6.6	7.9	41.8	16.2	50.4	7.6	39.6	12.4	11.0	34.2	15.5	55.5	7.5	6.8	34.5	11.9	35.7	9.0	8.7	8.3	33.5	26.8	19.4	9.2	17.7	7.7	26.5	11.2	3.4	18.5	22.7	12.9	10.7	18.5	38.4	7.6	14.8	31.3	26.6	8.3	3.1	16.9	22.1	7.3	27.2	24.4	6.6	12.5	28.6	135.3	147.6	14.2	20.8	24.3	22.8	23.9	25.6	29.7	2.3	6.8	1.2	29.6	38.5	13.1	13.9	37.5	7.7	14.1	0.1	17.5	0.0	27.2	19.3	24.6	0.1	0.3	24.8	17.8	17.4	8.4	50.6	92.1	0.1	22.0	0.0	36.1	15.3	0.0	0.2	45.4	35.2	36.2	0.0	40.8	0.2	23.3	0.2	0.2	82.0	38.1	5.6	10.1	46.1	40.5	3.5	55.0	45.9	28.1	9.9	1.8	0.1	0.1	4.8	1.7	0.6	18.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	7.1	6.6	7.9	7.5	6.8	8.7	8.3	7.7	7.6	8.3	6.6	26.1	3.2	3.2	0.0	3.8	3.3	6.9	5.9	8.6	0.4	21.1	9.5	1.0	8.6	3.4	12.9	0.0	0.6	0.4	1.3	1.9	51.1	76.6	7.3	20.7	29.5	7.1	3.2	0.1	26.2	23.7	15.0	9.7	6.5	0.0	14.7	21.4	2.8	0.6	0.0	0.1	6.6	8.2	0.9	3.6	29.6	15.2	0.7	5.4	1.9	0.0	15.9	0.0	0.0	0.1	22.7	4.9	22.2	0.1	7.2	0.1	0.2	1.2	0.4	32.9	7.6	28.7	2.1	2.4	2.0	1.6	1.2	0.5	4.4	6.8	2.8
TERF2	"TRBF2, TRF2"	ENSG00000132604	"Telomeric repeat binding factor 2"	Q15554	16	69355567-69408571	"Predicted intracellular proteins"	"Cell cycle"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001907, HPA002735, CAB010451"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"CAB010451: AB_2201333, HPA001907: AB_1080246, HPA002735: AB_1857898"	"unprognostic (2.61e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.04e-1)"	15.2	14.4	19.8	17.2	20.6	18.5	14.1	22.7	29.1	15.3	9.1	15.5	13.4	17.9	15.1	15.0	15.4	13.7	15.1	21.8	21.0	13.0	14.8	12.6	35.6	17.6	19.9	19.2	16.7	18.3	12.4	16.1	16.8	13.3	14.4	21.0	11.9	14.1	31.9	15.9	14.0	19.1	14.5	15.8	12.6	16.4	18.4	21.0	16.6	22.1	44.7	15.6	13.4	23.3	21.6	34.4	30.5	30.8	28.5	20.9	26.0	21.5	26.9	50.1	38.7	31.7	28.6	98.2	28.6	26.7	17.9	34.0	37.8	26.4	46.7	18.6	29.3	28.8	18.2	29.1	24.2	28.6	23.0	21.5	26.2	40.2	48.7	22.2	35.0	38.4	54.8	14.2	32.8	29.2	57.0	36.4	35.1	23.6	16.7	78.5	20.2	56.8	21.6	15.8	34.4	27.0	71.4	16.1	19.6	27.5	30.6	32.8	21.5	31.3	27.4	21.9	25.9	36.8	42.1	124.9	27.1	25.5	30.8	14.9	3.5	4.3	5.9	3.3	4.3	13.0	5.6	5.0	3.7	8.4	6.3	6.2	4.2	4.6	3.5	5.0	5.0	2.8	19.8	20.6	22.7	29.1	21.8	21.0	17.6	19.9	16.8	14.5	18.4	23.3	16.2	16.0	10.2	15.0	20.9	12.5	12.8	5.0	5.7	25.3	13.4	8.5	17.2	5.7	5.1	9.2	18.8	8.3	13.0	15.5	1.9	5.3	33.4	15.5	20.8	17.9	10.2	8.6	18.3	7.5	7.7	13.5	8.6	20.5	14.0	14.9	14.3	18.2	12.5	45.4	19.9	11.6	2.0	15.4	12.3	19.5	9.3	11.0	3.6	16.9	8.9	19.3	16.5	18.6	26.5	7.9	7.3	14.3	11.2	14.8	9.5	8.4	8.3	13.9	19.7	18.8	12.1	8.8	13.1	9.6	12.9	8.3	12.1	17.0	11.1	12.8
TEX9		ENSG00000151575	"Testis expressed 9"	Q8N6V9	15	56244009-56445997	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.1;Endometrial ciliated cells: 86.2;Respiratory ciliated cells: 125.6;Spermatocytes: 74.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"basophil: 4.3;memory B-cell: 14.4;naive B-cell: 11.4"	"Group enriched"	"Detected in many"	12	"B-cells: 14.4;granulocytes: 4.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039415	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Plasma membrane"	"HPA039415: AB_10672775"	"unprognostic (3.27e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	1.8	6.1	4.1	4.6	3.9	3.4	10.1	7.4	3.9	8.8	17.0	3.6	11.6	5.2	8.4	4.4	28.0	5.2	1.1	3.2	4.2	10.8	1.5	4.4	6.0	9.4	8.6	5.4	5.4	14.2	9.9	1.6	4.5	4.5	4.8	18.0	10.5	3.4	1.2	5.6	8.0	2.2	5.3	3.2	12.2	16.4	6.6	3.7	17.4	1.5	10.6	2.7	1.6	5.7	7.8	7.1	15.3	13.7	3.7	10.8	2.0	1.7	6.3	4.8	5.7	1.7	6.9	15.5	7.0	1.2	8.2	6.6	6.6	7.4	5.5	1.7	7.8	9.1	6.7	5.2	1.1	3.3	1.3	5.9	13.3	5.4	4.1	6.9	0.2	11.1	5.2	1.4	2.6	4.5	6.5	1.2	7.2	13.2	3.0	2.6	7.1	5.5	15.9	4.4	24.3	9.8	8.7	4.9	5.5	11.2	14.6	3.0	0.7	20.3	5.8	6.5	6.4	2.1	16.5	11.7	8.0	1.7	3.9	4.3	0.1	0.1	0.4	0.6	0.1	14.4	0.4	0.3	0.2	11.4	0.2	0.8	0.3	0.4	0.4	0.4	0.6	0.7	4.1	3.9	7.4	3.9	3.2	4.2	9.4	8.6	4.5	5.3	6.6	5.7	1.5	6.4	7.5	38.8	21.0	4.2	7.3	13.2	20.5	6.4	11.3	11.7	0.8	5.7	23.5	11.0	12.5	1.8	0.3	2.3	21.5	15.6	89.1	86.2	5.1	3.2	7.7	5.9	14.3	7.0	0.5	5.0	17.3	4.8	1.3	5.1	1.8	0.4	1.3	1.7	20.4	3.7	16.2	0.0	2.1	40.9	4.7	2.7	3.6	4.7	1.2	6.8	1.0	14.6	15.1	4.5	5.4	3.8	15.8	3.7	12.3	21.7	125.6	37.5	0.0	4.6	6.0	74.6	36.6	6.9	2.3	0.3	1.0	6.2	6.7	4.9
TLCD4	"FLJ31842, TMEM56"	ENSG00000152078	"TLC domain containing 4"	Q96MV1	1	95117355-95197607	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 130.0"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 77.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 22.4;RH-30: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046762			Approved	"Nuclear speckles"		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles"		"HPA046762: AB_2679792"	"unprognostic (1.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.82e-3)"	"unprognostic (3.63e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.69e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.15e-2)"	5.3	9.9	9.4	2.1	10.6	20.5	2.6	19.5	15.1	2.4	0.0	13.6	5.5	3.4	2.5	2.3	2.4	4.2	25.7	10.6	6.3	5.7	130.0	3.7	0.4	4.9	5.7	1.7	7.4	6.4	3.4	4.4	4.2	5.3	10.2	3.1	8.3	2.9	13.0	1.6	8.5	3.6	6.9	0.7	5.0	4.8	9.9	0.3	7.3	9.7	0.5	4.7	1.3	12.6	22.4	12.6	1.7	2.6	0.8	0.0	2.9	0.8	0.5	2.8	6.5	9.1	10.4	0.0	10.7	0.4	20.0	0.2	7.4	1.1	4.8	15.5	4.1	0.5	9.2	2.0	0.8	0.4	0.6	1.2	0.4	2.1	0.0	4.4	0.0	1.2	19.8	1.2	0.6	1.9	1.3	0.1	1.7	0.7	6.9	0.0	35.7	0.6	12.0	14.4	4.5	3.6	15.6	10.8	6.7	1.8	11.7	0.4	0.2	0.3	9.0	1.1	7.9	3.8	8.0	0.0	1.5	0.1	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.4	10.6	19.5	15.1	10.6	6.3	4.9	5.7	4.2	6.9	9.9	12.6	5.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.9	0.0	0.0	0.0	0.0	8.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.5	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0
TMEM156	FLJ23235	ENSG00000121895	"Transmembrane protein 156"	Q8N614	4	38966744-39032922	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 26.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 99.8;Microglial cells: 68.4;NK-cells: 28.8;Plasma cells: 123.1;T-cells: 30.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 74.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 39.6;GAMG: 29.6;HBEC3-KT: 84.8;hTERT-HME1: 64.0;NB-4: 35.2;PC-3: 37.3;U-698: 45.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 57: B-cells - Immune response"				"prognostic favorable (4.09e-4)"	"unprognostic (7.36e-3)"	"unprognostic (3.31e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.17e-2)"	"unprognostic (8.73e-4)"	"unprognostic (3.89e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.92e-4)"	"unprognostic (9.06e-2)"	0.4	1.7	1.7	9.0	1.6	1.9	1.1	2.0	1.8	0.5	1.7	1.7	1.8	0.5	0.2	0.5	0.5	1.9	0.3	1.9	1.9	0.5	2.8	0.9	23.6	2.7	2.2	0.4	0.3	0.2	0.1	0.1	2.8	0.6	1.9	0.5	0.9	0.5	0.5	0.4	5.1	0.4	2.3	11.1	2.6	0.2	1.9	5.1	0.4	0.0	26.8	3.0	0.2	3.4	2.4	23.9	0.2	0.2	0.0	0.6	0.2	0.1	6.4	0.0	0.0	0.2	0.3	39.6	0.3	0.0	29.6	0.2	0.2	84.8	0.3	0.4	0.0	2.1	7.7	0.5	13.3	16.8	0.3	0.1	4.2	1.7	64.0	4.9	7.3	6.5	5.8	0.2	2.8	0.2	3.1	35.2	0.1	0.9	37.3	0.8	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.1	1.2	17.9	2.9	0.5	0.2	0.7	0.2	0.1	45.3	5.0	15.2	0.1	16.8	0.8	48.6	12.2	0.3	14.3	74.8	20.7	12.2	8.4	59.9	8.0	10.4	1.8	12.5	0.3	12.4	15.4	8.3	1.7	1.6	2.0	1.8	1.9	1.9	2.7	2.2	2.8	2.3	1.9	3.4	0.6	0.0	1.8	0.7	99.8	0.5	0.8	0.5	0.0	0.6	2.3	2.4	0.3	17.2	1.9	0.0	0.0	0.1	22.1	0.0	0.0	0.5	1.3	0.3	1.1	3.3	0.0	4.2	0.6	0.0	1.2	0.8	1.5	0.2	0.0	0.0	2.9	0.4	1.6	1.7	0.7	0.2	2.0	22.8	2.7	2.8	0.0	8.4	10.6	68.4	2.7	0.1	28.8	0.5	2.5	1.1	0.0	0.0	123.1	0.8	0.0	0.4	1.5	0.5	0.0	1.4	0.6	0.8	0.1	0.0	0.6	0.3	30.2	0.1	0.3	0.8
TMEM38B	"bA219P18.1, C9orf87, D4Ertd89e, FLJ10493, TRIC-B"	ENSG00000095209	"Transmembrane protein 38B"	Q9NVV0	9	105694541-105776629	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 77.4;tongue: 62.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 267.0;Late spermatids: 488.4;Spermatocytes: 157.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018465	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA018465: AB_1858116"	"unprognostic (3.34e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.80e-2)"	"prognostic favorable (7.96e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.89e-3)"	"unprognostic (9.98e-2)"	7.6	14.0	6.2	7.1	11.6	19.1	4.7	19.5	9.2	7.6	6.3	12.5	6.4	8.3	17.3	7.2	7.2	6.8	30.7	7.4	12.9	29.2	15.3	5.7	8.1	8.3	8.4	18.3	4.9	9.2	5.8	4.6	10.6	8.0	11.8	10.4	4.0	6.8	77.4	6.0	10.7	8.1	5.9	6.3	6.7	28.6	9.0	4.9	28.8	62.1	5.1	5.0	4.0	19.6	16.7	25.6	19.6	30.9	110.5	24.3	40.8	23.4	15.3	22.6	23.3	40.0	22.5	38.4	11.8	8.5	36.4	11.6	28.4	13.5	24.4	29.0	37.8	15.8	16.2	24.7	15.1	48.1	32.7	23.0	11.8	15.5	21.6	7.1	9.1	26.6	84.3	33.2	14.0	46.4	33.6	14.5	15.1	48.7	27.1	22.3	61.4	18.4	10.3	13.2	34.1	8.3	24.2	39.4	17.9	13.0	49.2	33.5	4.9	20.5	20.2	78.9	24.7	40.7	109.8	19.1	38.2	52.2	41.7	15.6	20.2	53.8	13.2	29.6	17.7	56.6	18.3	15.8	23.3	56.6	38.9	24.9	3.1	28.2	26.8	51.7	18.0	24.2	6.2	11.6	19.5	9.2	7.4	12.9	8.3	8.4	10.6	5.9	9.0	19.6	9.2	0.0	2.7	7.5	27.8	30.3	24.9	6.2	15.9	12.9	8.9	3.9	55.5	15.7	8.4	25.8	29.2	12.0	16.4	19.1	66.5	8.9	267.0	2.2	7.2	9.9	31.8	7.2	12.4	6.9	19.0	24.2	9.2	3.0	15.8	11.3	3.6	24.4	30.9	11.8	28.6	12.9	18.3	7.9	33.2	488.4	85.1	21.4	32.0	6.5	18.3	30.6	3.1	65.4	30.6	6.3	12.2	44.8	20.2	55.1	10.9	47.0	7.6	12.3	118.3	18.2	58.1	157.8	47.6	13.0	32.7	21.2	13.8	39.7	19.0	20.2
TMEM64	DKFZp762C1112	ENSG00000180694	"Transmembrane protein 64"	Q6YI46	8	90621995-90791632	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"choroid plexus: 42.5;epididymis: 144.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 62.0;Hepatocytes: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB034221	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB034221: AB_1567653"	"unprognostic (3.61e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.55e-3)"	"unprognostic (4.84e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.97e-1)"	17.1	12.0	5.2	9.3	9.3	3.4	8.4	7.1	7.1	15.4	42.5	10.5	9.6	10.9	144.9	10.5	8.8	10.4	7.2	4.9	6.8	13.6	20.8	9.5	12.9	9.4	7.4	16.3	15.3	6.8	4.7	10.3	7.8	11.4	5.5	1.0	17.8	17.3	8.9	6.4	9.8	16.3	7.5	8.9	7.1	12.2	7.4	5.1	22.9	7.1	12.1	10.6	7.8	14.5	26.5	20.3	10.0	5.4	45.7	33.0	5.5	19.2	18.2	14.8	16.3	5.7	17.8	17.2	7.5	11.8	6.4	9.0	26.9	13.0	19.5	34.8	9.8	32.1	7.3	12.8	16.1	1.9	5.1	43.4	14.0	6.1	13.8	17.1	15.1	4.1	14.8	36.9	25.1	35.3	0.1	4.6	1.5	13.6	10.6	3.8	22.1	8.7	29.2	50.6	7.1	20.0	12.6	10.9	23.5	13.3	10.9	1.5	15.1	14.9	13.1	10.8	15.8	24.3	0.4	18.8	13.4	3.9	20.0	2.7	0.1	0.1	1.5	0.3	1.9	3.1	1.6	1.7	0.3	2.0	0.7	1.1	0.0	3.2	0.4	0.2	0.8	0.9	5.2	9.3	7.1	7.1	4.9	6.8	9.4	7.4	7.8	7.5	7.4	14.5	16.7	9.6	12.5	5.2	15.7	24.1	12.7	5.4	62.0	0.7	7.3	11.4	20.4	7.2	3.7	22.0	0.0	25.3	18.6	2.5	1.9	3.9	3.7	3.3	9.6	9.0	7.8	18.7	9.9	10.2	6.2	18.1	6.1	4.6	14.0	13.5	6.1	51.7	4.0	1.7	14.1	4.5	8.2	9.7	11.6	3.2	46.9	11.1	24.9	9.4	1.9	4.0	4.1	8.0	46.8	8.8	2.4	21.4	12.6	19.7	16.7	30.6	3.7	0.0	0.0	10.5	11.9	3.4	2.2	17.4	23.4	15.7	13.3	23.7	7.2	8.6
TNFRSF13B	"CD267, IGAD2, TACI"	ENSG00000240505	"TNF receptor superfamily member 13B"	O14836	17	16929816-16972118	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 18.9;lymphoid tissue: 33.0;skeletal muscle: 62.9"	"Group enriched"	"Detected in some"	4	"B-cells: 117.3;Plasma cells: 143.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	41	"memory B-cell: 130.9;naive B-cell: 51.8"	"Lineage enriched"	"Detected in many"	59	"B-cells: 130.9"	"Group enriched"	"Detected in some"	9	"Karpas-707: 167.2;RPMI-8226: 106.7;U-266/70: 72.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030453	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"			"HPA030453: AB_10601700"	"unprognostic (3.94e-5)"	"unprognostic (1.11e-3)"	"unprognostic (4.88e-2)"	"unprognostic (4.30e-3)"		"unprognostic (1.23e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.61e-4)"	"unprognostic (2.22e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.59e-5)"	"unprognostic (1.20e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.05e-1)"	0.4	0.1	0.3	8.9	0.4	1.1	0.7	0.0	0.5	0.3	0.0	3.4	4.1	0.1	0.0	1.3	0.4	0.5	5.3	0.1	0.3	0.3	0.3	0.8	17.3	0.4	0.3	0.4	0.0	0.0	0.0	0.0	0.9	0.4	2.5	0.3	2.1	0.3	62.9	0.0	18.9	0.1	0.2	33.0	5.2	0.1	0.4	2.0	0.5	0.0	21.6	2.6	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	167.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.2	106.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.6	0.0	13.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	130.9	0.0	0.0	0.0	51.8	0.0	0.1	0.5	0.0	0.0	0.0	2.2	2.7	0.3	0.4	0.0	0.5	0.1	0.3	0.4	0.3	0.9	0.2	0.4	1.2	0.0	0.0	0.0	0.0	117.3	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.1	0.0	0.0	0.4	1.1	0.0	0.0	0.0	1.1	0.8	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.5	32.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	143.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.6	0.0	6.2	0.0	0.0	0.0
TNFRSF17	"BCM, BCMA, CD269, TNFRSF13A"	ENSG00000048462	"TNF receptor superfamily member 17"	Q02223	16	11965210-11968068	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 29.0;lymphoid tissue: 47.9;stomach 1: 24.4"	"Cell type enriched"	"Detected in some"	4	"Plasma cells: 449.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	62	"memory B-cell: 124.9;naive B-cell: 108.5;plasmacytoid DC: 103.3"	"Group enriched"	"Detected in many"	63	"B-cells: 124.9;dendritic cells: 103.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 179.6;RPMI-8226: 296.0;U-266/70: 829.4;U-266/84: 453.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA		2000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (1.35e-5)"	"unprognostic (3.41e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.41e-2)"	"unprognostic (6.47e-2)"	"prognostic favorable (1.58e-6)"	"unprognostic (9.75e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.85e-6)"	"unprognostic (2.06e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.10e-1)"	0.4	1.1	0.0	14.9	0.3	1.9	14.1	0.4	0.4	1.4	0.0	28.9	29.0	0.5	0.2	1.9	0.6	3.1	0.4	0.2	0.3	0.3	1.0	2.0	31.9	0.3	0.0	0.8	0.5	0.1	0.1	0.1	0.3	0.4	22.1	0.1	15.4	0.9	0.0	0.3	15.2	0.6	0.0	20.3	24.4	2.2	0.3	14.8	0.7	0.1	47.9	9.9	0.3	0.6	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.8	0.3	0.1	0.0	0.0	49.2	0.1	0.3	0.1	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	179.6	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.6	0.0	296.0	0.0	0.1	0.0	0.2	0.0	0.2	0.3	0.1	0.0	0.6	0.0	0.5	0.5	0.0	0.5	829.4	453.4	68.1	0.7	0.2	0.0	1.2	0.4	0.2	0.3	0.1	0.4	124.9	0.2	0.2	0.2	108.5	0.1	0.2	1.8	0.7	0.1	103.3	0.1	12.6	0.0	0.3	0.4	0.4	0.2	0.3	0.3	0.0	0.3	0.0	0.3	0.6	0.0	0.0	0.0	0.0	91.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	10.9	0.0	0.0	0.7	0.0	5.3	0.1	0.0	0.0	0.4	2.0	0.0	0.0	0.4	1.8	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	5.0	0.0	0.3	106.7	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	449.5	0.2	0.0	0.1	0.0	0.0	6.6	0.0	0.1	0.7	0.6	0.0	0.6	0.0	6.0	0.0	1.0	0.0
TNNC2	"CFAP85, FAP85"	ENSG00000101470	"Troponin C2, fast skeletal type"	P02585	20	45823214-45833745	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	109	"skeletal muscle: 30416.4;tongue: 8088.6"	"Group enriched"	"Detected in many"	4	"Proximal enterocytes: 338.7;Skeletal myocytes: 1165.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 20.2;head and neck cancer: 22.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Hep G2: 10.0;HSkMC: 14.8;SCLC-21H: 11.3"	"Region enriched"	"Detected in some"	5	"olfactory bulb: 6.1"	"Low region specificity"	"Detected in some"			"HPA043174, HPA058481"	Enhanced		Approved	Nucleoplasm,Vesicles		No	NA		560000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	Vesicles	"HPA043174: AB_10806380, HPA058481: AB_2683729"	"unprognostic (1.13e-1)"	"unprognostic (7.25e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.21e-5)"	"unprognostic (1.80e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.12e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.03e-3)"	"unprognostic (7.15e-3)"	"unprognostic (4.79e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.13e-1)"	6.6	5.5	4.8	0.4	5.7	1.1	8.3	5.2	6.9	2.2	4.4	5.3	2.5	4.2	1.0	128.5	3.0	2.2	4.0	4.8	4.5	1.7	2.5	3.2	0.5	4.4	4.5	6.5	2.2	1.2	3.1	0.2	4.5	44.3	2.2	1.3	176.3	1.3	30416.4	10.1	7.8	1.0	4.1	1.8	2.4	4.6	4.8	6.7	5.1	8088.6	0.7	2.5	3.0	5.5	0.1	0.0	0.2	0.4	1.6	1.0	1.7	0.1	0.4	0.0	0.1	0.2	1.1	0.4	1.1	1.0	0.4	0.4	0.0	0.4	0.0	0.0	0.3	0.0	1.0	10.0	0.4	0.3	0.2	14.8	0.2	0.1	0.7	0.3	0.0	1.2	0.1	0.5	0.2	1.2	0.7	0.1	0.0	0.4	0.6	0.3	0.6	0.2	0.4	0.1	11.3	0.5	1.6	0.1	0.4	0.5	1.3	0.4	0.5	0.2	0.3	0.9	0.2	1.5	0.4	0.2	1.4	0.1	0.2	0.0	0.6	1.3	0.1	1.1	0.6	5.3	1.3	0.2	0.3	4.6	0.0	0.3	2.0	0.3	0.8	0.8	3.9	8.7	4.8	5.7	5.2	6.9	4.8	4.5	4.4	4.5	4.5	4.1	4.8	5.5	0.9	3.2	0.6	0.3	3.1	0.8	0.5	2.0	0.0	4.2	3.1	1.7	0.5	2.8	3.6	3.7	0.0	2.4	0.5	171.7	3.9	1.5	6.9	37.1	1.0	3.8	22.9	0.0	1.9	5.1	0.4	7.2	0.5	2.3	0.0	13.9	0.0	1.1	0.3	0.0	0.7	108.2	14.2	0.3	1.1	47.0	1.2	22.4	0.0	0.0	2.1	1.4	1.0	0.0	0.6	3.3	92.9	3.0	0.5	0.7	338.7	1.0	4.3	2.4	0.0	1165.3	9.5	2.5	5.5	0.1	8.4	0.1	4.7	7.2	37.0	0.7
TOR3A	"ADIR, ADIR2, FLJ22345"	ENSG00000186283	"Torsin family 3 member A"	Q9H497	1	179082070-179098023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 112.6;Plasma cells: 153.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 281.7;U-266/84: 322.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028766	Approved				"Intracellular and membrane"	NA	Yes		24000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA028766: AB_10602251"	"unprognostic (5.55e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.90e-1)"	"unprognostic (8.82e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.99e-1)"	"prognostic unfavorable (4.78e-8)"	"unprognostic (4.26e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.35e-1)"	17.0	15.5	16.9	30.8	17.9	39.7	19.5	16.4	18.6	16.7	19.3	26.1	23.3	16.1	12.8	15.8	17.8	18.1	12.8	17.2	19.4	17.0	27.8	20.4	46.4	18.3	17.2	14.8	23.4	22.5	16.9	15.3	17.2	17.9	26.0	9.5	23.9	17.0	24.4	17.8	23.1	18.8	17.6	37.4	26.5	4.3	19.9	26.7	18.6	13.9	44.8	23.3	13.5	19.3	56.8	65.5	18.6	52.6	38.2	29.9	57.1	41.4	50.0	48.0	34.8	29.8	86.4	90.0	70.2	41.1	28.9	68.5	53.7	34.6	25.3	70.8	49.4	98.3	38.5	45.9	62.9	109.6	80.6	33.1	31.0	35.3	31.9	19.2	35.5	34.8	123.9	164.3	33.8	121.4	66.3	60.5	38.6	68.0	36.4	49.4	33.9	88.4	30.5	76.8	37.8	49.3	61.9	96.9	25.5	32.5	71.5	80.1	22.0	36.2	25.6	59.9	54.3	281.7	322.8	77.4	25.1	77.3	26.5	5.2	71.3	19.3	33.6	56.5	41.4	97.8	29.9	37.7	85.7	73.1	22.7	27.6	14.1	31.5	59.4	93.1	43.3	53.3	16.9	17.9	16.4	18.6	17.2	19.4	18.3	17.2	17.2	17.6	19.9	19.3	24.8	3.2	11.7	4.9	65.2	17.0	14.0	19.2	10.8	3.7	14.8	11.3	11.5	25.8	11.1	11.0	10.4	30.1	32.5	18.6	3.9	34.0	1.1	10.6	16.8	19.3	14.4	18.3	4.4	44.5	57.5	19.8	20.9	11.1	10.8	14.3	13.9	10.7	57.4	0.0	4.6	18.9	32.6	22.0	112.6	1.1	17.1	36.4	16.0	5.6	50.6	17.1	16.5	3.0	4.0	18.9	17.9	18.8	153.7	19.5	15.1	10.3	13.4	9.6	6.6	18.9	17.3	0.8	5.3	12.7	15.8	10.9	24.8	21.2	27.0	12.3
UGT8	CGT	ENSG00000174607	"UDP glycosyltransferase 8"	Q16880	4	114598770-114678225	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 266.4"	"Cell type enriched"	"Detected in many"	8	"Oligodendrocytes: 821.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory B-cell: 6.9;naive B-cell: 10.7"	"Lineage enriched"	"Detected in single"	12	"B-cells: 10.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 58.4;OE19: 123.7;RPTEC TERT1: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014405, HPA065785"	Enhanced		Approved	Mitochondria		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA014405: AB_1858606, HPA065785: AB_2685559"	"unprognostic (7.38e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (8.55e-5)"	"unprognostic (2.80e-1)"	"unprognostic (1.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.49e-1)"	0.6	0.6	58.6	4.6	153.7	1.1	4.6	166.2	94.5	7.0	9.7	26.8	30.3	3.8	0.3	1.5	4.4	11.0	0.3	66.2	94.7	31.0	0.2	1.1	4.9	220.9	132.8	0.4	8.5	0.2	0.2	0.2	200.6	0.5	27.7	2.2	7.3	0.7	0.5	2.2	27.7	1.6	139.2	1.7	16.8	5.0	132.4	0.6	13.5	0.4	5.0	0.6	0.6	266.4	0.6	0.2	4.4	0.6	0.3	0.0	0.7	0.2	0.0	0.1	3.4	17.7	58.4	17.6	1.2	0.2	13.8	25.8	0.0	0.1	0.1	0.3	14.3	0.3	24.6	0.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	5.4	0.1	0.2	16.1	3.0	0.1	0.3	0.3	1.7	6.4	123.7	8.8	1.6	28.9	0.3	55.2	0.6	31.4	4.6	0.2	5.4	0.8	1.1	0.9	5.4	1.0	1.1	19.2	0.7	19.6	6.3	0.8	0.6	29.2	0.9	17.9	0.2	0.0	0.8	0.0	0.0	0.6	6.9	0.0	0.0	0.0	10.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.3	58.6	153.7	166.2	94.5	66.2	94.7	220.9	132.8	200.6	139.2	132.4	266.4	0.1	6.4	1.5	1.0	22.0	0.0	1.8	0.3	6.8	0.0	5.7	6.1	0.8	8.6	3.9	25.8	0.0	0.0	0.1	19.0	9.8	1.4	9.2	9.6	1.7	0.5	48.4	0.0	1.0	13.1	0.0	0.6	19.4	21.4	0.0	0.2	0.0	0.0	0.0	0.0	3.7	27.9	0.0	0.0	0.0	3.5	1.2	0.5	1.8	2.8	0.0	0.0	0.0	98.5	821.1	10.8	14.6	0.0	4.0	0.7	24.2	1.4	1.5	0.0	0.0	0.0	0.4	20.9	34.0	5.9	0.1	0.0	0.4	0.1	26.9	0.9
USP45	MGC14793	ENSG00000123552	"Ubiquitin specific peptidase 45"	Q70EL2	6	99432325-99521728	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"brain: 53.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 47.1;Inhibitory neurons: 44.4;Oligodendrocytes: 39.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 53.5"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029602, HPA029604"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA029602: AB_10600418, HPA029604: AB_10602283"	"unprognostic (7.81e-3)"	"unprognostic (3.10e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.77e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.91e-2)"	6.1	4.4	5.2	4.9	5.8	4.4	4.6	53.5	9.4	4.3	3.8	5.3	7.3	5.1	4.8	5.3	4.0	6.2	6.2	5.8	6.3	6.3	4.2	3.7	7.4	6.0	7.7	4.5	4.0	4.5	3.6	5.2	8.2	5.1	6.7	6.7	4.0	4.2	6.0	6.3	5.8	4.5	5.3	4.6	4.4	3.3	6.2	3.1	5.3	5.5	5.2	4.3	3.8	9.0	5.9	4.0	8.1	11.2	14.3	13.5	8.7	10.3	11.1	10.1	14.7	8.2	6.4	15.2	7.3	10.3	11.9	7.7	12.1	9.8	13.9	12.2	12.0	15.2	8.4	6.7	11.4	14.2	8.3	15.3	7.6	9.2	15.5	10.7	15.4	13.8	37.2	14.8	9.6	5.5	4.5	13.3	12.8	9.1	8.9	6.8	5.9	8.9	13.8	6.8	11.3	9.2	7.0	9.1	7.8	10.0	4.9	6.8	15.5	5.5	7.1	8.1	15.5	6.3	6.2	29.1	9.8	13.1	10.1	2.9	1.4	0.4	3.2	0.8	4.2	5.3	2.7	4.0	2.4	6.7	1.9	1.9	0.3	1.9	2.0	3.6	2.6	1.0	5.2	5.8	53.5	9.4	5.8	6.3	6.0	7.7	8.2	5.3	6.2	9.0	13.3	3.2	5.8	22.5	13.3	2.3	9.6	6.8	4.6	10.3	4.4	4.6	9.4	4.3	4.7	3.7	18.8	6.4	7.3	5.9	5.9	4.3	15.7	10.1	10.3	7.6	2.4	4.2	47.1	2.5	6.6	7.1	9.7	4.3	2.5	5.8	6.8	4.5	4.0	10.1	44.4	2.9	10.2	4.8	2.6	10.2	13.1	4.6	3.6	22.5	10.0	5.4	2.1	32.6	39.4	5.0	3.1	8.6	6.5	8.6	8.3	15.8	10.4	7.4	0.0	6.3	6.7	1.9	7.5	5.2	2.8	7.4	7.1	5.8	7.3	6.9
UTS2B	"U2B, URP, UTS2D"	ENSG00000188958	"Urotensin 2B"	Q765I0	3	191267168-191330536	"Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"retina: 14.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;B-cells: 2.6;Early spermatids: 8.3;Late spermatids: 2.3;Oligodendrocyte precursor cells: 3.0;Spermatocytes: 2.6;Spermatogonia: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"memory B-cell: 2.8;naive B-cell: 1.8"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"PC-3: 3.3"	"Region enriched"	"Detected in some"	9	"pons and medulla: 11.3"	"Region enriched"	"Detected in single"	46	"spinal cord: 6.0"	HPA026992	Uncertain				"Secreted - unknown location"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA026992: AB_1858703"	"unprognostic (1.73e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.58e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.10e-2)"	1.0	1.2	0.8	0.8	0.5	0.5	1.2	4.1	1.4	0.2	0.0	0.5	5.3	0.7	0.5	0.7	1.0	1.2	0.7	0.7	0.5	0.6	3.2	0.5	1.0	0.7	0.4	1.0	0.5	0.2	0.0	0.4	1.1	0.6	0.4	14.9	0.6	0.2	0.5	1.1	3.2	0.5	0.1	0.6	1.6	2.3	0.6	0.1	0.5	0.0	0.3	0.4	0.1	0.9	0.4	1.0	1.3	0.6	0.3	1.6	0.4	1.0	0.5	0.3	0.2	0.7	0.5	0.7	0.5	0.4	2.6	0.5	0.4	0.0	1.6	0.6	0.5	0.6	1.4	2.9	0.3	0.8	0.4	0.6	0.2	0.2	0.3	0.9	0.3	0.6	0.4	0.6	0.5	0.6	0.2	0.5	0.7	1.3	3.3	0.9	1.5	0.2	0.2	1.6	0.7	0.5	0.6	0.7	0.4	0.5	0.5	0.5	1.4	0.7	0.4	1.3	0.4	1.1	0.6	0.6	0.9	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.5	4.1	1.4	0.7	0.5	0.7	0.4	1.1	0.1	0.6	0.9	0.2	3.2	1.1	0.7	2.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	8.3	1.4	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.0	0.2	0.1	0.0	0.7	1.6	0.0	0.2	0.1	1.5	0.0	0.0	0.1	0.2	2.6	2.1	0.0	0.3	0.3	0.0	0.1	0.0	0.1
VRK2		ENSG00000028116	"VRK serine/threonine kinase 2"	Q86Y07	2	57907629-58159920	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"Oligodendrocytes: 540.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046459, HPA047503"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Endoplasmic reticulum"		"CAB046459: AB_1858773, HPA047503: AB_2680071"	"unprognostic (1.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (6.32e-6)"	"unprognostic (3.90e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.56e-1)"	14.8	13.2	14.9	20.2	26.4	18.8	17.2	15.1	16.2	10.8	9.3	14.0	10.9	15.3	16.7	19.5	13.4	11.9	15.6	12.8	16.0	10.7	16.8	15.9	22.5	23.9	21.1	10.7	19.7	14.7	7.6	14.6	23.0	14.2	16.4	4.8	13.8	11.4	14.3	13.3	11.0	19.4	14.8	18.0	13.7	13.3	18.9	12.7	18.6	15.1	26.0	14.7	12.6	40.6	37.1	24.3	2.7	16.3	16.7	30.6	48.4	32.8	33.3	22.7	22.9	49.8	38.5	44.3	43.0	29.8	37.1	27.4	34.9	36.7	33.7	80.9	23.1	50.9	19.0	35.8	27.8	44.1	29.0	17.7	42.6	36.3	52.8	26.1	64.9	6.2	50.2	28.5	38.2	21.2	0.3	32.9	29.9	56.9	11.6	49.4	12.0	30.6	36.8	30.2	9.4	0.3	52.5	31.2	27.5	26.2	22.0	26.1	37.0	0.5	74.4	20.6	0.6	40.5	33.9	24.0	18.2	52.7	38.4	31.0	24.5	35.3	15.1	32.2	18.4	30.6	14.2	17.7	25.5	31.7	10.6	13.6	9.0	18.7	34.3	26.4	18.5	15.4	14.9	26.4	15.1	16.2	12.8	16.0	23.9	21.1	23.0	14.8	18.9	40.6	17.9	22.4	11.2	1.3	26.4	9.8	12.6	21.8	14.8	1.0	14.0	10.2	21.8	7.2	22.4	18.4	0.0	21.2	13.7	6.5	15.6	27.1	23.0	12.7	10.9	15.8	6.6	39.1	2.7	26.2	21.1	14.0	16.3	12.7	17.7	9.6	8.9	8.4	18.4	0.0	4.7	5.1	30.5	19.1	19.1	8.4	5.9	26.2	10.6	54.4	41.7	5.3	16.5	32.2	540.8	24.8	8.7	6.0	25.7	18.4	2.5	9.5	30.7	4.0	6.6	7.4	14.3	22.0	10.9	19.2	8.4	19.4	16.5	6.8	7.9	16.4
WDR19	"DYF-2, FAP66, FLJ23127, IFT144, KIAA1638, NPHP13, ORF26, Oseg6, Pwdmp"	ENSG00000157796	"WD repeat domain 19"	Q8NEZ3	4	39182504-39285810	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Ectodermal dysplasia, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 61.8;Inhibitory neurons: 82.5;Respiratory ciliated cells: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 45.3;ASC TERT1: 47.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039616, HPA058847"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Centrosome, Cytosol"	"HPA039616: AB_10796331, HPA058847: AB_2683834"	"unprognostic (1.80e-1)"	"unprognostic (9.32e-2)"	"unprognostic (6.40e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.26e-3)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.63e-2)"	"prognostic favorable (2.70e-4)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.56e-2)"	7.5	8.0	3.1	5.3	2.5	3.7	9.2	5.3	3.8	10.5	10.8	6.8	1.9	16.0	13.3	3.9	20.3	8.4	4.2	2.3	2.5	8.8	6.3	8.8	4.7	5.3	3.6	17.9	5.4	8.1	9.1	6.2	2.9	7.7	4.2	13.0	5.7	8.4	2.3	5.5	4.7	9.1	3.5	4.6	6.2	14.0	2.7	6.9	16.7	2.4	4.9	6.2	6.8	3.6	6.1	5.2	10.3	12.1	45.3	47.0	4.7	7.5	17.2	8.1	10.6	2.8	6.5	10.4	4.1	7.8	17.2	4.0	10.9	5.4	8.6	0.5	8.5	2.2	10.3	6.1	16.1	9.6	2.6	30.5	11.1	11.9	7.2	24.6	10.7	11.0	8.7	9.1	9.9	2.1	7.7	8.1	3.5	3.7	5.6	8.2	10.4	4.2	7.0	2.9	11.5	10.4	10.2	2.4	6.1	13.1	5.5	3.6	7.9	7.9	5.3	17.5	7.8	7.2	7.6	7.6	11.9	3.3	3.7	0.1	0.3	0.2	0.3	0.5	0.3	0.8	0.5	0.6	0.3	1.2	0.5	0.6	0.3	0.8	0.5	0.1	0.3	0.2	3.1	2.5	5.3	3.8	2.3	2.5	5.3	3.6	2.9	3.5	2.7	3.6	5.5	12.8	9.3	26.1	5.4	4.8	4.9	4.6	2.2	10.1	7.3	7.4	4.5	2.8	9.4	18.4	10.4	1.2	1.8	0.7	0.0	5.5	5.1	32.3	14.6	6.7	2.4	4.0	61.8	3.6	3.2	10.8	2.0	12.0	2.5	13.4	4.2	10.0	3.2	25.2	82.5	2.0	12.2	3.2	3.6	3.4	16.4	3.0	1.8	19.7	1.8	6.7	1.0	18.1	19.7	2.9	0.2	18.8	3.9	3.0	0.3	4.0	46.6	21.7	0.0	10.9	7.9	33.8	10.2	3.9	4.7	1.4	2.9	13.1	1.1	1.9
WNT16		ENSG00000002745	"Wnt family member 16"	Q9UBV4	7	121325367-121341104	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix: 6.0;skin 1: 20.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 4.6;Basal keratinocytes: 10.1;Endometrial stromal cells: 3.6;Inhibitory neurons: 6.0;Microglial cells: 3.7;Plasma cells: 2.6;Suprabasal keratinocytes: 11.5"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	145	"memory B-cell: 15.6;naive B-cell: 15.4"	"Lineage enriched"	"Detected in single"	146	"B-cells: 15.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.3;HEK 293: 5.4;hTEC/SVTERT24-B: 1.6;U-2197: 2.6;U-266/70: 1.6"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"spinal cord: 4.4"						"Secreted to extracellular matrix"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 61: Skin - Cornification"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (6.53e-2)"	"unprognostic (3.63e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.94e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.57e-10)"	"unprognostic (5.89e-3)"	"unprognostic (2.73e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.66e-1)"	0.2	0.3	0.3	0.3	0.6	0.0	1.4	0.2	0.4	6.0	0.5	0.5	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.4	0.2	0.1	0.2	0.3	1.1	0.2	0.2	0.0	0.1	0.0	0.3	0.4	0.1	0.6	0.1	0.1	0.1	1.8	0.1	20.5	0.5	0.2	0.3	0.8	0.2	0.1	0.0	0.1	0.1	0.0	0.4	0.1	3.2	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.2	0.0	0.5	0.1	0.5	0.0	0.0	0.0	0.0	5.4	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.3	1.6	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	15.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.6	0.2	0.4	0.4	0.2	0.2	0.2	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	4.6	10.1	0.1	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	3.6	0.1	0.0	0.4	0.1	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	3.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	11.5	0.0	0.1	0.0	0.1	0.0
YBEY	C21orf57	ENSG00000182362	"YbeY metalloendoribonuclease"	P58557	21	46286342-46297751	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 78.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 376.6;Late spermatids: 276.0;Spermatocytes: 273.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 85.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016593, HPA018162"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA016593: AB_1845698, HPA018162: AB_1845699"	"prognostic favorable (5.54e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.24e-3)"	"unprognostic (4.81e-1)"	"unprognostic (2.78e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.51e-2)"	"unprognostic (7.50e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.64e-3)"	12.0	13.0	13.8	5.4	15.1	5.9	13.4	15.5	17.8	12.1	12.9	14.5	11.5	10.0	14.4	9.7	10.1	8.7	15.9	13.3	14.6	14.0	18.3	7.8	11.4	15.0	14.5	12.6	17.1	11.8	11.8	6.0	15.2	12.8	12.1	7.5	13.7	8.1	16.5	16.1	16.1	4.2	14.6	11.0	11.1	78.8	14.4	10.9	9.4	12.8	14.3	8.9	9.2	16.7	24.4	21.1	17.7	21.5	13.2	50.0	17.2	16.4	24.3	15.8	19.2	11.2	4.0	30.7	13.9	17.0	8.4	7.9	7.7	7.5	14.3	29.3	29.9	8.9	13.9	4.4	37.7	10.1	1.0	34.8	31.9	12.5	25.9	20.7	10.5	15.2	21.6	36.0	18.6	20.7	19.9	13.2	51.5	9.3	21.7	41.4	8.4	59.6	32.5	11.2	13.0	22.6	22.3	10.0	46.6	5.8	5.1	8.8	12.8	15.1	5.6	12.2	10.8	44.4	85.2	53.8	27.5	11.1	9.3	27.7	9.1	7.3	13.2	10.4	13.2	32.7	16.3	16.9	10.5	24.9	15.8	18.2	3.2	21.3	12.5	24.1	26.6	10.3	13.8	15.1	15.5	17.8	13.3	14.6	15.0	14.5	15.2	14.6	14.4	16.7	16.9	3.2	7.4	12.1	35.2	46.3	38.4	49.6	45.5	14.4	44.7	46.1	21.6	21.5	23.1	18.4	8.4	17.5	33.3	45.1	64.6	36.4	376.6	31.4	31.2	22.3	32.0	13.7	7.9	77.2	27.9	27.6	28.5	17.9	11.4	20.5	26.4	50.5	25.2	16.8	13.5	55.5	30.5	37.8	45.8	276.0	40.7	24.6	39.2	7.5	27.7	21.3	40.2	11.6	18.4	47.9	58.4	24.5	36.9	28.1	103.4	65.6	20.6	20.8	6.6	21.1	19.5	273.7	31.8	31.2	60.5	9.6	30.2	32.5	55.6	36.8
ZBTB32	"FAXF, FAZF, Rog, TZFP, ZNF538"	ENSG00000011590	"Zinc finger and BTB domain containing 32"	Q9Y2Y4	19	35704558-35717038	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 49.0"	"Cell type enhanced"	"Detected in some"		"B-cells: 24.0;Early spermatids: 39.6;granulocytes: 17.7;Late spermatids: 73.0;Plasma cells: 25.6;Spermatocytes: 115.5"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.4"	"Immune cell enhanced"	"Detected in some"		"memory B-cell: 10.5"	"Lineage enriched"	"Detected in many"	5	"B-cells: 10.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.3;hTEC/SVTERT24-B: 2.0;U-266/70: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076730	Enhanced					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA076730: AB_2732320"	"unprognostic (2.11e-3)"	"unprognostic (1.08e-4)"	"unprognostic (3.87e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-5)"	"unprognostic (2.59e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.02e-8)"	"unprognostic (2.44e-3)"	"unprognostic (2.25e-1)"	"unprognostic (6.26e-5)"	"unprognostic (1.94e-3)"	0.1	0.1	0.2	2.0	0.1	0.6	0.0	1.4	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.3	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.3	3.4	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.4	0.0	0.0	0.1	1.7	0.1	0.0	2.6	0.5	49.0	0.1	0.3	0.1	0.0	1.3	0.5	0.0	0.1	0.7	0.6	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.3	0.1	0.0	1.0	0.0	0.0	0.0	0.7	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.7	0.0	0.1	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.4	0.0	0.1	0.3	0.0	0.0	0.4	0.1	0.3	0.0	1.2	1.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	10.5	0.5	0.6	0.0	3.8	0.1	0.3	0.0	0.0	0.0	0.0	2.3	0.6	0.2	0.1	1.4	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.0	1.3	0.0	24.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	39.6	0.0	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.5	0.0	17.7	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	73.0	1.2	0.3	1.8	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	1.2	25.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	115.5	0.8	0.0	0.0	0.0	4.1	0.0	0.1	0.0
ZNF285	ZNF285A	ENSG00000267508	"Zinc finger protein 285"	Q96NJ3	19	44382298-44401608	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 5.8;Oligodendrocyte precursor cells: 4.5;Oligodendrocytes: 5.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 6.0"									"HPA046100, HPA049212"	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"			"HPA046100: AB_2679538, HPA049212: AB_2680677"	"unprognostic (3.23e-2)"	"unprognostic (1.90e-3)"	"unprognostic (6.42e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.91e-3)"	"unprognostic (3.60e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.42e-6)"	"unprognostic (1.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.55e-3)"	1.1	2.0	4.6	0.9	4.6	0.2	2.5	5.5	5.5	1.6	3.3	2.1	0.8	1.9	1.6	1.0	2.8	1.1	2.4	4.4	4.7	2.1	0.6	0.7	1.3	4.3	4.3	6.3	1.1	2.5	2.0	1.1	4.4	2.0	1.1	5.6	0.9	1.9	1.8	0.8	0.9	1.9	4.2	1.6	1.4	2.9	4.8	1.7	2.8	2.3	1.4	2.0	1.2	5.4	0.1	3.1	3.0	0.0	2.3	2.4	0.1	1.1	1.1	1.5	2.0	0.5	1.9	0.0	1.6	0.7	2.0	1.0	0.0	2.1	2.6	0.0	2.0	4.4	1.2	0.9	3.3	0.6	0.0	1.9	0.0	0.6	6.0	4.4	2.7	0.0	0.1	0.1	2.0	0.0	0.0	0.1	0.8	0.8	1.5	0.0	0.0	1.9	1.6	2.5	1.3	2.2	0.1	0.5	0.0	2.9	3.7	1.5	2.6	1.6	1.3	0.8	0.1	1.9	4.2	0.0	1.5	0.0	1.9	1.8	0.1	0.0	0.1	0.2	0.1	1.6	0.3	0.2	0.5	4.0	2.2	2.3	0.0	1.2	0.4	0.4	0.6	0.6	4.6	4.6	5.5	5.5	4.4	4.7	4.3	4.3	4.4	4.2	4.8	5.4	0.7	0.0	0.0	2.9	0.9	0.3	0.5	0.5	0.0	2.4	0.8	0.8	3.7	0.0	0.9	1.8	4.2	0.5	0.2	0.3	0.0	0.9	1.5	1.0	0.6	0.8	1.2	1.7	5.8	0.6	0.5	0.4	0.0	0.7	0.0	3.9	1.8	0.2	0.4	1.7	3.6	0.6	2.0	0.0	0.6	0.2	0.3	0.4	0.0	0.0	0.1	1.1	3.1	4.5	5.9	0.2	0.2	1.2	0.0	0.9	0.8	0.6	0.6	0.9	0.0	1.1	0.5	3.9	3.0	0.0	0.1	0.0	0.4	1.4	1.1	0.4
ZNF35	"HF.10, HF10, Zfp105"	ENSG00000169981	"Zinc finger protein 35"	P13682	3	44648732-44660791	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051859, HPA054738"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA051859: AB_2681642, HPA054738: AB_2682588"	"unprognostic (1.54e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.91e-3)"	"unprognostic (9.91e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.30e-1)"	3.9	2.7	2.2	1.6	2.4	1.9	3.1	2.9	2.5	3.1	1.4	4.1	1.3	4.3	2.8	3.9	2.8	1.7	4.0	2.3	2.4	3.5	2.0	2.8	1.4	2.3	2.5	2.3	2.8	2.0	3.5	1.4	2.4	3.4	1.6	2.5	3.1	2.1	3.8	3.3	2.9	3.2	2.1	3.1	3.2	7.1	2.3	1.3	3.1	2.3	2.4	3.6	3.3	2.9	3.2	2.4	6.2	8.0	4.0	3.2	1.1	3.9	5.4	6.7	6.4	4.3	1.4	2.8	1.7	5.4	2.9	2.2	0.3	5.6	6.9	0.1	2.2	9.3	4.3	0.2	3.6	9.3	6.8	3.3	4.1	6.0	5.3	3.3	5.4	0.0	6.3	2.6	7.4	1.9	0.2	3.0	13.9	2.3	6.7	0.1	6.6	4.9	3.6	9.0	3.4	8.8	4.9	3.0	0.8	5.1	8.0	5.7	5.7	7.1	5.2	3.9	7.8	7.1	11.8	1.6	6.1	4.5	5.6	0.0	1.7	0.7	0.9	1.9	0.6	1.5	0.2	1.0	1.8	1.9	0.4	0.5	0.1	2.3	1.8	0.7	0.1	1.0	2.2	2.4	2.9	2.5	2.3	2.4	2.3	2.5	2.4	2.1	2.3	2.9	6.6	6.4	8.7	6.8	5.3	2.8	3.9	3.0	1.8	4.9	4.8	3.4	3.2	2.8	3.3	1.8	0.0	0.3	3.7	2.8	1.9	8.1	10.2	2.2	4.2	9.3	2.4	3.8	7.5	8.7	0.1	5.8	2.6	3.5	0.0	5.7	5.0	1.5	3.8	6.7	8.5	2.4	10.2	2.8	1.4	6.5	1.2	3.2	1.8	4.7	3.6	4.4	7.2	8.0	11.2	10.3	3.3	4.5	4.0	4.3	2.0	3.8	3.4	6.4	0.0	4.8	5.5	30.7	11.7	3.0	2.8	0.4	2.6	5.7	3.0	3.3
ZNF418	"FLJ31551, KIAA1956"	ENSG00000196724	"Zinc finger protein 418"	Q8TF45	19	57921882-57935402	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 9.1;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 11.1;SuSa: 7.6;T-47d: 6.9"									"HPA043800, HPA053762, HPA072145"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: "	"unprognostic (4.41e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.27e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.92e-3)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (1.63e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.36e-3)"	2.2	2.8	4.9	2.4	5.7	2.0	5.9	10.3	5.0	3.2	0.2	4.5	1.0	4.1	5.3	2.0	4.7	2.4	8.7	4.5	5.6	4.1	2.3	2.6	5.2	2.6	3.3	6.2	4.5	6.2	5.3	5.7	2.5	4.7	1.5	12.4	3.5	5.6	3.3	9.0	2.5	4.0	1.4	5.1	3.5	4.4	4.9	4.6	6.7	4.9	4.5	3.6	2.9	9.2	0.3	1.3	11.1	3.6	1.7	3.6	1.2	3.4	1.1	2.5	0.2	0.2	1.2	0.4	2.3	1.7	3.3	1.0	0.0	2.8	3.0	0.3	1.0	0.2	0.7	0.1	1.0	0.3	2.3	3.0	0.8	3.1	0.0	0.0	0.5	1.0	0.9	0.8	2.1	0.4	0.6	0.4	5.7	0.1	0.4	0.5	0.8	4.0	2.1	1.4	0.2	0.5	0.1	2.0	0.1	7.6	6.9	1.2	0.0	0.7	0.5	0.4	0.6	1.8	4.7	2.9	0.3	1.3	2.2	1.3	0.5	0.5	0.1	1.3	0.4	3.2	1.1	0.7	1.0	5.5	1.8	0.5	0.6	4.3	0.5	1.8	0.0	0.8	4.9	5.7	10.3	5.0	4.5	5.6	2.6	3.3	2.5	1.4	4.9	9.2	1.7	0.0	0.6	4.2	2.9	0.4	0.8	0.4	0.6	4.3	1.8	1.4	9.1	1.5	1.0	0.0	4.2	1.0	0.8	0.0	1.9	1.2	0.1	1.8	0.9	1.9	0.0	2.5	4.1	0.6	0.6	1.9	1.1	1.1	5.7	2.5	2.5	0.8	0.8	3.3	3.5	0.0	0.0	0.3	0.7	0.9	0.3	0.6	0.0	1.9	0.2	4.3	1.0	4.0	6.3	0.2	1.2	1.5	0.1	1.1	0.0	1.1	5.6	5.9	13.1	0.7	1.3	2.6	5.6	0.7	0.4	0.8	0.7	0.3	0.2	0.8
ZNF460	"HZF8, ZNF272"	ENSG00000197714	"Zinc finger protein 460"	Q14592	19	57280051-57294069	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.7"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 22.2;Squamous epithelial cells: 21.5"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 3.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 13.5"									"HPA053004, HPA066506"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA053004: AB_2682012, HPA066506: AB_2685681"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.20e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.10e-2)"	1.9	4.9	5.1	0.7	7.9	6.0	1.6	7.9	6.2	1.4	3.6	0.9	0.3	1.0	0.8	1.3	1.0	1.0	1.4	3.4	4.6	1.1	1.5	1.3	0.9	7.8	6.8	2.3	1.0	1.3	1.7	1.4	9.2	1.1	0.6	2.6	1.3	1.1	1.5	1.9	0.7	1.1	4.8	1.4	0.9	1.8	5.2	1.0	1.4	1.3	1.0	1.1	1.3	19.7	1.2	1.9	1.5	2.1	1.5	1.3	3.8	0.8	1.2	0.9	2.8	2.4	0.7	1.9	0.9	1.0	0.8	0.8	2.0	1.0	1.6	1.4	3.9	1.8	1.6	1.2	1.7	3.2	2.0	0.7	1.8	2.5	2.8	0.7	0.6	2.0	1.8	13.5	1.1	0.9	1.9	0.5	2.1	1.0	1.8	1.4	2.1	0.9	0.6	2.4	1.9	1.0	2.1	1.1	1.2	1.0	0.9	2.2	0.9	2.8	3.3	0.4	1.7	5.7	2.7	3.1	1.0	1.2	0.9	0.0	0.5	1.0	0.7	1.1	0.8	0.8	0.5	0.4	0.1	2.2	1.2	0.5	1.2	0.8	0.7	0.0	1.1	0.7	5.1	7.9	7.9	6.2	3.4	4.6	7.8	6.8	9.2	4.8	5.2	19.7	7.9	3.2	1.5	3.9	11.6	3.1	3.6	0.7	22.2	4.3	4.1	2.8	5.9	1.5	2.0	0.0	0.0	1.4	6.6	1.3	0.0	1.5	3.4	7.0	9.5	4.9	0.0	11.2	6.2	0.4	2.0	7.3	10.2	13.1	0.0	4.7	7.1	2.0	1.1	8.4	5.9	1.2	4.1	1.9	2.2	0.7	1.8	3.3	1.8	1.9	4.0	2.4	4.1	2.5	13.3	1.7	0.2	1.5	16.3	3.0	0.7	0.8	2.4	3.2	0.0	8.1	8.4	3.6	1.4	21.5	2.4	2.6	7.8	3.6	1.3	4.4
ZNF595	FLJ31740	ENSG00000272602	"Zinc finger protein 595"	Q8IYB9	4	53286-88208	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"placenta: 60.5"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 106.0;K-562: 249.2;SH-SY5Y: 159.9"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 57: B-cells - Immune response"				"unprognostic (1.03e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.63e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.56e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.46e-2)"	8.0	8.4	4.3	7.1	4.3	8.9	9.9	12.1	6.9	8.7	1.6	6.5	4.3	10.7	6.0	5.2	7.7	5.1	4.8	4.2	5.4	4.9	6.3	7.2	10.2	6.5	5.0	14.7	10.1	5.4	4.2	60.5	7.1	7.4	6.1	10.1	5.6	4.3	5.3	7.4	6.1	10.9	3.7	9.5	6.3	8.7	4.5	10.6	10.3	6.6	10.1	5.9	7.3	6.2	4.0	13.8	8.9	8.3	50.4	61.9	68.3	4.8	4.4	5.3	6.9	6.6	5.7	106.0	7.9	4.0	9.0	3.0	50.3	4.7	7.8	8.5	7.2	0.4	0.1	0.0	3.2	0.1	26.8	6.8	6.1	5.2	5.5	5.7	4.4	47.9	249.2	1.1	4.3	30.5	0.3	29.6	15.6	0.0	6.2	0.1	2.0	0.1	7.7	4.5	7.3	159.9	6.1	7.0	2.8	35.3	50.3	17.1	29.3	5.4	39.3	3.2	6.1	0.4	53.4	12.6	0.2	0.1	18.0	5.9	2.7	16.0	8.5	3.5	3.9	16.3	4.7	5.8	4.3	17.3	6.4	6.3	4.5	23.3	3.2	15.7	4.0	4.9	4.3	4.3	12.1	6.9	4.2	5.4	6.5	5.0	7.1	3.7	4.5	6.2	9.1	6.4	11.7	10.7	11.3	4.6	10.1	4.3	6.8	8.7	5.0	6.5	5.6	8.6	12.5	3.7	2.1	10.5	10.8	2.9	15.6	8.1	5.4	2.0	7.6	9.9	0.0	1.7	21.9	4.4	9.8	8.2	3.1	2.6	7.6	18.8	10.8	3.8	4.0	3.3	24.0	3.4	2.0	1.8	4.2	6.1	11.1	2.7	5.4	22.5	1.6	11.8	33.0	24.1	34.9	3.1	2.9	9.1	13.2	6.4	3.0	4.6	2.3	6.8	0.0	9.7	5.7	16.0	16.8	2.6	4.5	8.5	5.0	9.3	3.4	6.6
ZNF621	FLJ45246	ENSG00000172888	"Zinc finger protein 621"	Q6ZSS3	3	40524878-40574685	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA065518, HPA071440"			Enhanced	"Nuclear speckles"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA065518: AB_2685501, HPA071440: AB_2686395"	"unprognostic (1.09e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.52e-3)"	"unprognostic (9.50e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.04e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.19e-1)"	"unprognostic (5.33e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.01e-3)"	13.0	10.0	15.7	5.9	18.9	7.1	12.9	15.0	16.5	12.7	13.4	11.2	5.3	11.2	8.1	9.5	11.5	5.7	9.4	13.2	17.1	15.2	12.4	13.2	6.2	19.4	16.3	12.0	12.2	7.7	14.6	5.5	19.4	14.4	5.7	7.4	12.1	6.9	7.2	10.0	11.7	6.1	17.0	12.7	10.7	7.6	17.5	5.5	13.2	5.6	6.1	11.0	11.5	21.0	8.9	5.0	12.2	12.0	7.8	13.4	6.9	9.5	11.1	11.7	11.6	11.1	4.8	3.7	6.9	12.4	8.8	3.1	12.2	7.2	13.7	14.9	15.1	12.4	20.8	10.1	13.6	11.6	11.8	10.4	14.9	12.2	19.0	12.7	9.9	4.4	13.3	10.8	10.1	5.6	2.9	13.8	7.7	3.5	10.2	1.1	8.2	4.4	6.1	11.0	4.3	10.9	10.2	6.9	12.0	11.7	11.4	9.4	13.1	20.2	9.8	10.2	13.4	16.1	17.4	8.3	9.9	8.6	12.5	2.5	1.0	0.9	1.3	1.3	0.8	2.3	1.3	1.8	0.9	3.3	1.6	1.2	1.2	1.8	0.7	1.3	1.3	0.7	15.7	18.9	15.0	16.5	13.2	17.1	19.4	16.3	19.4	17.0	17.5	21.0	13.2	9.6	12.3	22.5	9.6	1.5	5.2	2.3	9.1	13.8	6.3	5.0	12.1	10.0	7.7	11.0	12.5	5.5	9.5	4.9	5.9	7.7	10.8	11.1	16.4	12.0	10.2	12.4	4.1	5.6	3.5	9.0	7.7	12.2	3.8	15.0	5.0	5.6	3.7	15.2	4.2	7.1	4.1	8.1	3.0	7.9	7.5	6.9	3.6	11.2	9.4	7.1	10.3	19.1	26.1	7.5	4.9	12.0	8.8	6.6	6.7	3.2	4.6	16.7	0.0	13.6	9.1	10.6	6.3	7.5	1.8	5.5	8.1	12.9	5.8	4.4
ZNF671	FLJ23506	ENSG00000083814	"Zinc finger protein 671"	Q8TAW3	19	57719751-57727624	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 10.1"					"Low region specificity"	"Detected in all"			"HPA046099, HPA056043"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA046099: AB_10962484, HPA056043: "	"prognostic favorable (2.20e-4)"	"unprognostic (4.16e-3)"	"unprognostic (6.02e-2)"	"unprognostic (5.91e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.97e-3)"	"unprognostic (6.12e-2)"	"unprognostic (5.56e-3)"	"unprognostic (8.26e-3)"	"unprognostic (2.04e-1)"	"prognostic favorable (3.57e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.22e-1)"	2.9	6.8	6.8	3.7	7.1	4.4	4.3	11.0	7.7	3.4	7.1	6.5	1.8	2.5	5.3	2.0	4.5	2.8	6.8	6.6	7.7	6.0	2.8	4.0	7.9	6.7	7.1	3.3	3.4	9.4	9.7	4.0	6.8	5.8	2.3	8.3	3.8	5.8	7.7	2.2	6.4	2.7	7.3	13.5	2.7	6.4	7.8	13.7	8.3	6.9	8.5	4.8	2.0	7.4	0.1	0.2	2.2	0.0	0.4	0.1	0.0	2.5	1.4	4.8	1.7	0.3	0.4	5.2	0.8	3.6	1.5	0.1	1.9	2.1	5.6	5.7	3.6	0.1	0.8	0.0	4.2	0.0	7.3	6.2	1.5	3.0	1.7	5.6	0.7	5.4	0.8	2.5	4.4	0.1	10.1	0.1	3.2	0.0	5.1	3.9	6.8	3.2	1.8	0.2	0.2	0.0	0.0	0.1	3.5	5.4	1.4	7.3	0.0	0.5	2.6	0.0	1.9	4.5	0.1	2.8	0.5	1.2	1.6	19.4	10.5	19.3	8.0	9.5	21.4	22.7	17.0	14.1	14.9	30.4	24.2	19.7	7.3	20.9	15.1	13.7	18.9	15.0	6.8	7.1	11.0	7.7	6.6	7.7	6.7	7.1	6.8	7.3	7.8	7.4	1.1	0.0	0.6	5.9	5.2	0.6	0.7	0.9	0.0	5.8	1.3	1.0	5.4	4.3	1.2	3.7	0.0	2.3	2.0	0.0	1.9	3.7	0.2	0.8	0.4	1.7	0.0	3.4	3.4	0.0	1.1	0.7	0.0	0.7	2.5	2.9	1.1	1.2	3.8	6.7	4.1	0.2	6.1	2.7	0.8	0.7	0.0	2.3	1.8	2.8	1.9	8.4	6.2	4.0	2.8	0.3	0.1	0.4	3.8	0.5	0.9	1.6	0.9	7.8	0.0	0.2	1.6	7.0	5.0	0.4	0.4	0.8	4.1	0.6	0.5	0.1
ZNF711	"CMPX1, dJ75N13.1, MRX65, MRX97, Zfp711, ZNF4, ZNF5, ZNF6"	ENSG00000147180	"Zinc finger protein 711"	Q9Y462	X	85243991-85273362	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 37.3"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 38.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"AF22: 34.4;HAP1: 50.3;HEK 293: 46.0;Karpas-707: 30.7;MOLT-4: 28.4;RH-30: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030654	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA030654: AB_10670561"	"unprognostic (2.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.75e-2)"	"unprognostic (9.11e-3)"	"unprognostic (7.40e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.50e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.62e-3)"	1.4	15.1	6.3	1.6	8.0	7.2	5.7	6.7	7.9	5.8	1.7	3.6	3.1	9.2	2.8	2.6	4.6	4.1	3.8	7.7	7.6	5.1	0.5	1.8	2.4	5.7	6.3	9.4	4.9	1.4	10.9	7.7	5.2	4.0	1.7	5.7	4.1	2.6	1.6	12.2	4.6	3.3	6.5	5.0	2.7	37.3	7.5	16.3	4.9	1.5	2.5	3.0	3.2	5.5	0.0	3.3	34.4	27.0	0.0	0.0	2.6	0.5	0.0	0.0	0.0	7.5	3.0	0.1	1.2	0.5	5.5	0.7	50.3	0.0	0.0	0.0	46.0	16.5	0.9	1.9	1.3	0.0	0.4	3.2	0.3	0.0	6.3	0.0	0.3	15.6	5.1	30.7	6.1	1.7	28.4	0.0	16.7	3.1	0.7	0.0	41.9	0.0	0.0	2.5	10.0	25.8	0.1	0.9	0.0	20.0	4.6	4.5	0.1	0.0	11.1	0.1	0.0	11.4	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	1.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.3	8.0	6.7	7.9	7.7	7.6	5.7	6.3	5.2	6.5	7.5	5.5	1.8	3.2	1.1	14.0	3.6	12.0	7.6	2.7	18.2	9.0	18.1	17.4	6.6	1.5	1.8	1.8	0.0	0.3	1.0	0.3	5.9	2.1	2.7	2.9	18.8	4.2	18.5	5.9	19.0	0.5	0.1	8.1	1.1	4.2	0.0	15.2	3.6	0.1	0.3	3.3	21.3	2.3	2.0	0.6	3.2	5.7	3.1	0.9	5.4	11.2	0.1	7.8	0.0	38.2	12.0	0.6	1.9	3.8	2.2	3.0	0.9	2.7	1.2	1.4	0.0	8.7	8.1	13.0	23.6	10.9	9.1	0.3	0.9	12.6	2.6	2.9